Sentence,class,file
"21  (2005)  661–665,  doi: http://dx.doi.org/10.1016/j.bios.2004.12.008 .",OADS,/arxiv_data1/oa_pdf/49/df/main.PMC5466103.pdf
"21  (2005)  645–654,  doi:http://dx.doi.org/10.1016/j.bios.2004.12.020 .",OADS,/arxiv_data1/oa_pdf/49/df/main.PMC5466103.pdf
"23 (2007)  613–662,  doi:http://dx.doi.org/10.1016/j.bios.2007.07.010 .",OADS,/arxiv_data1/oa_pdf/49/df/main.PMC5466103.pdf
"22  (2006)  233–240,  doi:http://dx.doi.org/ 10.1016/j.bios.2005.12.025 .",OADS,/arxiv_data1/oa_pdf/49/df/main.PMC5466103.pdf
"389 (2007)  517–525,  doi:http://dx.doi.org/10.1007/s00216-007-1443-4.",Non-OADS,/arxiv_data1/oa_pdf/49/df/main.PMC5466103.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ee/78/main.PMC5466104.pdf
http://dx.doi.org/10.1016/j.btre.2014.06.0082215-017X/ ã 2014  The  Authors.,OADS,/arxiv_data1/oa_pdf/ee/78/main.PMC5466104.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology  Reports  3  (2014)  99–107 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/ee/78/main.PMC5466104.pdf
"[32]  G.  Roth,  C.  Gustafson,  Corncobs  for  biofuel  production  Unpublished  results http://www.extension.org/pages/26619/corn-cobs-for-biofuel-production#- cite_note-1  (retrieved  30.1.14.)",Non-OADS,/arxiv_data1/oa_pdf/ee/78/main.PMC5466104.pdf
"(2014), doi:http://dx.doi.org/10.1039/c3gc42401d .",Non-OADS,/arxiv_data1/oa_pdf/ee/78/main.PMC5466104.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/a7/d2/main.PMC5466106.pdf
http://dx.doi.org/10.1016/j.btre.2014.06.005 2215-017X/ ã  2014  The  Authors.,OADS,/arxiv_data1/oa_pdf/a7/d2/main.PMC5466106.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology  Reports  3  (2014)  60–64 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/a7/d2/main.PMC5466106.pdf
These results open a new perspective to test these proteins as pos- sible candidates to develop new drugs that would be active against microbes but not against mammalian cells and considerer these http://dx.doi.org/10.1016/j.btre.2014.05.007 2215-017X © 2014 Published by Elsevier B.V.Open access under CC BY-NC-ND license.,Non-OADS,/arxiv_data1/oa_pdf/22/c4/main.PMC5466107.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/24/sfw145.PMC5466108.pdf
Supplementary data Supplementary data are available online at http://ckj.oxford journals.org.,Non-OADS,/arxiv_data1/oa_pdf/7d/24/sfw145.PMC5466108.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/52/sfx024.PMC5466109.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/4f/sfw146.PMC5466110.pdf
Supplementary data Supplementary data are available online at http://ckj.oxford journals.org.,Non-OADS,/arxiv_data1/oa_pdf/59/4f/sfw146.PMC5466110.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/f3/sfw115.PMC5466111.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/fc/be/main.PMC5466112.pdf
"In the case ofrecombinant human SCOMT (hSCOMT), it has been produced viadifferent expression systems, such as transfected mammalian cells[9], insect cells (via mammalian and baculovirus vectors) [10], plant cells (via a potyvirus) [11] and prokaryotic cells, such as http://dx.doi.org/10.1016/j.btre.2014.05.005 2215-017X/© 2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/fc/be/main.PMC5466112.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/fc/be/main.PMC5466112.pdf
"https://doi.org/10.1177/1179548417710928 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Clinical Medicine Insights: Circulatory,  Respiratory and Pulmonary Medicine Volume 11: 1–11 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1179548417710928 Introduction Chronic obstructive pulmonary disease (COPD) is one of the  major causes of chronic morbidity and mortality worldwide.1  Although the forced expiratory volume (FEV1) is the diagnos- tic tool for COPD, the disease is heterogeneous, and various methods are necessary to confirm initial diagnosis, define the phenotype, and identify the regions of the airway in which it manifests.",Non-OADS,/arxiv_data1/oa_pdf/2c/d6/10.1177_1179548417710928.PMC5466113.pdf
"26 The summarization step additionally made use of  the custom Chip Definition Files (CDF) environment HGU133Plus2_Hs_ENTREZG v16.0, 27 which directly  converted the final expression matrix into the HGNC names-pace used in the downstream network analysis (http://www.genenames.org/).",OADS,/arxiv_data1/oa_pdf/2c/d6/10.1177_1179548417710928.PMC5466113.pdf
"37–40  The network models are available for view in http://www.causalbionet.com/, and Supplementary Table 1 lists all 29 net-work models and their overarching biological grouping that were applied in the current analysis.",OADS,/arxiv_data1/oa_pdf/2c/d6/10.1177_1179548417710928.PMC5466113.pdf
"Paper presented at: International Conference on Harmonisation of  Technical Requirements for Registration of Pharmaceuticals for Human Use;  June 10, 1996. https://www.ich.org/fileadmin/Public_Web_Site/ICH_ Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pdf  24.",Non-OADS,/arxiv_data1/oa_pdf/2c/d6/10.1177_1179548417710928.PMC5466113.pdf
2013;S:12.  http://dx.doi.org/10.4172/2161-0495.S12-002  33.,Non-OADS,/arxiv_data1/oa_pdf/2c/d6/10.1177_1179548417710928.PMC5466113.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/b1/sfx017.PMC5466114.pdf
"http://www.who.int/medicines/ publications/essentialmedicines/18th_EML.pdf (18 December2015, date last accessed) 9.",Non-OADS,/arxiv_data1/oa_pdf/a6/b1/sfx017.PMC5466114.pdf
"Canberra: Diabetes Australia and the NHMRC, 2009. http://www.nhmrc.gov.au/_ﬁles_nhmrc/publications/attachments/di19- diabetes-blood-glucose-control.pdf (18 December 2015, date last accessed) 28.",Non-OADS,/arxiv_data1/oa_pdf/a6/b1/sfx017.PMC5466114.pdf
"Clinical Practice Guideline .2 0 1 3 http://guidelines.diabetes.ca/App_Themes/CDACPG/resources/cpg_2013_full_en.pdf (18 December 2015, date last accessed) 29.",Non-OADS,/arxiv_data1/oa_pdf/a6/b1/sfx017.PMC5466114.pdf
http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/a6/b1/sfx017.PMC5466114.pdf
"2016 http://www.fda.gov/downloads/Drugs/ DrugSafety/UCM494140.pdf (5 December 2016, date last accessed)304 | T.H.",Non-OADS,/arxiv_data1/oa_pdf/a6/b1/sfx017.PMC5466114.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/b0/sfx003.PMC5466115.pdf
"London: Royal College ofPhysicians, 2013. http://www.ncbi.nlm.nih.gov/books/NBK247665/ (13 June 2016, date last accessed) 16.",Non-OADS,/arxiv_data1/oa_pdf/34/b0/sfx003.PMC5466115.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/9a/sfw151.PMC5466116.pdf
"A Race Equalities Foundation Brieﬁng Paper 6, 2007. http://www.better-health.org.uk/brieﬁngs/tackling-health-inequalities-minority-ethTime, timing, talking and training |423",Non-OADS,/arxiv_data1/oa_pdf/59/9a/sfw151.PMC5466116.pdf
"End of Life Care Strategy , 2006. http://www.ncpc.org.uk/sites/default/ﬁles/NCPC_EoLC_ Submission.pdf 11.",Non-OADS,/arxiv_data1/oa_pdf/59/9a/sfw151.PMC5466116.pdf
http://www.nepho.org.uk/topics/ Renal%20disease 13.,Non-OADS,/arxiv_data1/oa_pdf/59/9a/sfw151.PMC5466116.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/fb/sfw144.PMC5466117.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/e3/sfw133.PMC5466118.pdf
"http://ansm.sante.fr/con tent/download/61981/795269/version/2/ﬁle/ANSM-rapport_NACOs-avril þ2014.pdf (22 April 2014, date last accessed) 2.",Non-OADS,/arxiv_data1/oa_pdf/f9/e3/sfw133.PMC5466118.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/6e/main.PMC5466119.pdf
http://dx.doi.org/10.1016/j.btre.2014.06.010 2215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/d8/6e/main.PMC5466119.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 4 (2014) 1 –4 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/d8/6e/main.PMC5466119.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/45/8d/main.PMC5466121.pdf
http://dx.doi.org/10.1016/j.btre.2014.07.0032215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/45/8d/main.PMC5466121.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 4 (2014) 5 –13 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/45/8d/main.PMC5466121.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/6d/main.PMC5466122.pdf
http://dx.doi.org/10.1016/j.btre.2014.07.004 2215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/e8/6d/main.PMC5466122.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 4 (2014) 14 –20 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/e8/6d/main.PMC5466122.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/f6/5e/main.PMC5466123.pdf
http://dx.doi.org/10.1016/j.btre.2014.08.005 2215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/f6/5e/main.PMC5466123.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 4 (2014) 73 –79 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/f6/5e/main.PMC5466123.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/7b/7b/main.PMC5466124.pdf
http://dx.doi.org/10.1016/j.btre.2014.09.002 2215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/7b/7b/main.PMC5466124.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 4 (2014) 86 –93 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/7b/7b/main.PMC5466124.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/03/main.PMC5466125.pdf
http://dx.doi.org/10.1016/j.btre.2014.07.0052215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/c2/03/main.PMC5466125.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 4 (2014) 34 –41 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/c2/03/main.PMC5466125.pdf
"Health (2013) , doi:http://dx.doi.org/10.1177/0748233713483199 .D.",Non-OADS,/arxiv_data1/oa_pdf/c2/03/main.PMC5466125.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/f4/95/main.PMC5466126.pdf
http://dx.doi.org/10.1016/j.btre.2014.07.001 2215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/f4/95/main.PMC5466126.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 4 (2014) 21 –29 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/f4/95/main.PMC5466126.pdf
"Barrona, Carboxylate-Alumoxanes: Precursors for Heterogeneous Catalysts, MRS Proceedings 581, 659 (1999), doi: http://dx.doi.org/10.1557/PROC-581-659 .",Non-OADS,/arxiv_data1/oa_pdf/f4/95/main.PMC5466126.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/64/78/main.PMC5466127.pdf
http://dx.doi.org/10.1016/j.btre.2014.08.002 2215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/64/78/main.PMC5466127.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 4 (2014) 42 –49 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/64/78/main.PMC5466127.pdf
"Retrieved [11th July, 2014], from http://www.nanotechproject.org/cpi [35] M.A.",OADS,/arxiv_data1/oa_pdf/64/78/main.PMC5466127.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/75/a3/main.PMC5466128.pdf
http://dx.doi.org/10.1016/j.btre.2014.08.004 2215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/75/a3/main.PMC5466128.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 4 (2014) 66 –72 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/75/a3/main.PMC5466128.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b7/6d/main.PMC5466130.pdf
http://dx.doi.org/10.1016/j.btre.2014.09.004 2215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/b7/6d/main.PMC5466130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 4 (2014) 99 –106 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/b7/6d/main.PMC5466130.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/45/9e/main.PMC5466131.pdf
http://dx.doi.org/10.1016/j.btre.2014.09.005 2215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/45/9e/main.PMC5466131.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 4 (2014) 80– 85 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/45/9e/main.PMC5466131.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/02/d8/main.PMC5466132.pdf
http://dx.doi.org/10.1016/j.btre.2014.09.0072215-017X/ ã2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/02/d8/main.PMC5466132.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 4 (2014) 128 –133 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/02/d8/main.PMC5466132.pdf
The partial sequence of the 16S rRNA gene was compared with known DNA sequences using Basic Local Alignment Search Tool (BLAST) analysis ( http://blast.ncbi.nlm.nih.gov ).,OADS,/arxiv_data1/oa_pdf/02/d8/main.PMC5466132.pdf
The sequence was deposited into the GenBank (http://www.ncbi.nlm.nih.nov ) database under the accession number AB935326.,Non-OADS,/arxiv_data1/oa_pdf/02/d8/main.PMC5466132.pdf
"M6 and NM1 have been deposited in the Korean Collection for Type Cultures (http://kctc.kribb.re.kr ) (World Data Center for Microorganisms, WDCM597) under the collectionnumbers KCTC 11519 and KCTC 32429, respectively.2.2.",OADS,/arxiv_data1/oa_pdf/02/d8/main.PMC5466132.pdf
Length and diameters were measured using ImageJ version 1.47 (http://imagej.nih.gov/ij/ )(n= 20).,OADS,/arxiv_data1/oa_pdf/02/d8/main.PMC5466132.pdf
"Multiple forward and reverse primer sets were designed for each gene, based on the rRNA (accession number: GQ255542 ), pMMO (AB936294), MDH (AB936295), and FADH (AB936293) genesequences using Primer-BLAST (http://www.ncbi.nlm.nih.gov/ tools/primer-blast/ ).",OADS,/arxiv_data1/oa_pdf/02/d8/main.PMC5466132.pdf
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC5466133.pdf
: +49 331 5699112. http://dx.doi.org/10.1016/j.btre.2014.08.0012215-017X/ã 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC5466133.pdf
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).Biotechnology Reports 4 (2014) 60– 65 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC5466133.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/31/f3/main.PMC5466134.pdf
http://dx.doi.org/10.1016/j.btre.2014.09.008 2215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/31/f3/main.PMC5466134.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 4 (2014) 134– 138 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/31/f3/main.PMC5466134.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c3/28/main.PMC5466135.pdf
http://dx.doi.org/10.1016/j.btre.2014.07.006 2215-017X/ã 2014 The Author.,Non-OADS,/arxiv_data1/oa_pdf/c3/28/main.PMC5466135.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 4 (2014) 30 –33 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/c3/28/main.PMC5466135.pdf
"Key physicochemical characteristics The concentrations of the inhibitory byproducts, such as acetic acid, hydroxymethylfurfural, and furfural, and the theoretical maximum enzymatic hydrolysis of the WEBI-pretreated RS were analyzed by following the standard methods of the National Renewable Energy Laboratory (NREL) ( http://www.nrel.gov/bio- mass/analytical_procedures.html ).",OADS,/arxiv_data1/oa_pdf/c3/28/main.PMC5466135.pdf
"Lastly, the generation of reactive oxygen species(hydrogen peroxide) was measured using the OxiSelect ﬂuoro- metric assay STA-344 (Cell Biolabs, San Diego, CA, USA), which uses 10-acetyl-3,7-dihydroxyphenoxazine/horseradish peroxidase- based hydrogen peroxide detection according to the manufac- turer’ s directions (http://www.cellbiolabs.com/ ).",OADS,/arxiv_data1/oa_pdf/c3/28/main.PMC5466135.pdf
"(2014), doi:http://dx.doi.org/10.1111/1751-7915.12134 .",Non-OADS,/arxiv_data1/oa_pdf/c3/28/main.PMC5466135.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e6/90/main.PMC5466136.pdf
http://dx.doi.org/10.1016/j.btre.2014.10.002 2215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/e6/90/main.PMC5466136.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 4 (2014) 147 –150 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/e6/90/main.PMC5466136.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/1d/4b/main.PMC5466137.pdf
http://dx.doi.org/10.1016/j.btre.2014.10.0062215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/1d/4b/main.PMC5466137.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 4 (2014) 156 –160 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/1d/4b/main.PMC5466137.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/77/f8/main.PMC5466138.pdf
http://dx.doi.org/10.1016/j.btre.2014.10.004 2215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/77/f8/main.PMC5466138.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 4 (2014) 161 –170 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/77/f8/main.PMC5466138.pdf
http://dx.doi.org/10.1016/j.btre.2014.10.001 2215-017X/ ã2014 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/09/d0/main.PMC5466139.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 4 (2014) 139 –146 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/09/d0/main.PMC5466139.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/58/main.PMC5466140.pdf
: +86 18875039043. http://dx.doi.org/10.1016/j.btre.2014.09.003 2215-017X/ ã2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/58/main.PMC5466140.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 4 (2014) 107 –119 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/3b/58/main.PMC5466140.pdf
"5,6 When physicians propose a new high-risk medi- cation, like etanercept for RA, it is common practice/C211The Author(s) 2017 Reprints and permission: http://www.sagepub.com/journalsPermissions.navDOI: 10.1177/0272989X17696995 ORIGINAL ARTICLE MEDICAL DECISION MAKING/JULY 2017 577",Non-OADS,/arxiv_data1/oa_pdf/94/8d/10.1177_0272989X17696995.PMC5466141.pdf
Supplementary Material for this article is available on the Medical Decision Making Web site at http://journals.sagepub.com/home/mdm.,Non-OADS,/arxiv_data1/oa_pdf/94/8d/10.1177_0272989X17696995.PMC5466141.pdf
Available from: URL: http://decisionaid.ohri.ca/odsf.html.,OADS,/arxiv_data1/oa_pdf/94/8d/10.1177_0272989X17696995.PMC5466141.pdf
"PI: v48, MG: v7: Available from: URL: http://pi.amgen.com/united_states/enbrel/derm/enbrel_pi.pdf.",Non-OADS,/arxiv_data1/oa_pdf/94/8d/10.1177_0272989X17696995.PMC5466141.pdf
"https://doi.org/10.1177/0956797617693004Psychological Science 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/fc/40/10.1177_0956797617693004.PMC5466142.pdf
Supplemental Material  Additional supporting information can be found at http:// journals.sagepub.com/doi/suppl/10.1177/0956797617693004 Open Practices     All data and materials have been made publicly available via the Open Science Framework and can be accessed at https://osf.io/3xgtk/.,Non-OADS,/arxiv_data1/oa_pdf/fc/40/10.1177_0956797617693004.PMC5466142.pdf
"The design and analysis plans for Studies 2, 3,  and 4 were preregistered at the Open Science Framework and  can be accessed at https://osf.io/f9dh7/, https://osf.io/tcb3a/, and https://osf.io/nfj5k/, respectively.",Non-OADS,/arxiv_data1/oa_pdf/fc/40/10.1177_0956797617693004.PMC5466142.pdf
More information about the Open Practices badges can be found at http://www.psychologicalscience.org/publications/badges.,Non-OADS,/arxiv_data1/oa_pdf/fc/40/10.1177_0956797617693004.PMC5466142.pdf
Retrieved from  http://www.electionstudies.org/studypages/anes_time   series_2012/anes_timeseries_2012.htm American National Election Studies.,OADS,/arxiv_data1/oa_pdf/fc/40/10.1177_0956797617693004.PMC5466142.pdf
"Retrieved from http://www.election  studies.org/studypages/anes_pilot_2016/anes_pilot_2016   .htm Bates, D., Maechler, M., Bolker, B., & Walker, S. (2015).",OADS,/arxiv_data1/oa_pdf/fc/40/10.1177_0956797617693004.PMC5466142.pdf
Retrieved from https://web .archive.org/web/20150419150524/http://www.newrepublic   .com/article/120330/bill-clinton-speech-new-republics- 100-year-anniversary-gala,Non-OADS,/arxiv_data1/oa_pdf/fc/40/10.1177_0956797617693004.PMC5466142.pdf
"Reprints and permissions: http://www.sagepub.co.uk/ journalsPermissions.nav Correspondence to: Bert A ’t Hart Department of Immunobiology, BiomedicalPrimate Research Centre, Lange Kleiweg 161, 2288GJ Rijswijk, The Netherlands hart@bprc.nl Bert A ’t Hart, Department of Immunobiology, Biomedical Primate Research Centre,Rijswijk, The Netherlands Department of Neuroscience, University of Groningen Medical Center, The Netherlands Yolanda S Kap, Department of Immunobiology, BiomedicalPrimate Research Centre, Rijswijk, The Netherlands Creative Commons CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www .creativecommons.org/ licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the origin al work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/d7/01/10.1177_2055217317690184.PMC5466146.pdf
"Reprints and permissions: http://www.sagepub.co.uk/ journalsPermissions.nav Correspondence to: Gabriel Leonard Cognitive Neuroscience Unit, Montreal NeurologicalInstitute, 3801 University St, Room #270, Montreal, Quebec H3A 2B4, Canada.",Non-OADS,/arxiv_data1/oa_pdf/50/34/10.1177_2055217317690561.PMC5466147.pdf
Supplementary Material Supplementary material for this paper can be found at http://journals.sagepub.com/doi/suppl/10.1177/20 55217317690561 References 1.,Non-OADS,/arxiv_data1/oa_pdf/50/34/10.1177_2055217317690561.PMC5466147.pdf
http://dx.doi.org/10.1016/j.btre.2014.10.009 2215-017X/ ã2014 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/51/69/main.PMC5466187.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 5 (2015) 22 –26 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/51/69/main.PMC5466187.pdf
http://dx.doi.org/10.1016/j.btre.2014.10.007 2215-017X/ ã2014 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/a1/1c/main.PMC5466188.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 5 (2015) 1 –6 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/a1/1c/main.PMC5466188.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.btre.2014.10.007 .",OADS,/arxiv_data1/oa_pdf/a1/1c/main.PMC5466188.pdf
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/3f/82/main.PMC5466189.pdf
http://dx.doi.org/10.1016/j.btre.2014.11.0022215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/3f/82/main.PMC5466189.pdf
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).Biotechnology Reports 5 (2015) 27 –30 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/3f/82/main.PMC5466189.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
http://dx.doi.org/10.1016/j.btre.2014.10.0102215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 5 (2015) 46 –54 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"Identi ﬁcation was performed by comparing the obtained 16S rRNA contigs with 16S rRNA sequence data forreference strains, type strains, and environmental clones available in public databases —GenBank ( www.ncbi.nlm.nih.gov ) and RDP (Ribosomal Database Project –Release 9; http://rdp.cme.msu.edu/ )—using the BLASTn and Classi ﬁer routines, respectively.",OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"Energy 32 (2007) 3141 –3146, doi:http://dx.doi.org/10.1016/j.ijhydene.2006.02.034 .",OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"Energy 33 (2008) 1813 –1819, doi:http://dx.doi.org/10.1016/j.ijhydene.2008.01.038 .",OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"Energy 33 (2008) 3289 –3294, doi:http://dx.doi.org/10.1016/j.ijhydene.2008.04.022.",OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"Energy 34 (2009) 3305 –3312, doi:http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"57 (2008) 809 –814, doi:http://dx.doi.org/10.2166/wst.2008.089 .",Non-OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"23 (2013) 443 –462, doi:http://dx.doi.org/10.1016/j.rser.2013.02.019 .",OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"98 (2007) 2229 –2239, doi:http://dx.doi.org/10.1016/j.biortech.2006.09.039 .",OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"1125 (2008) 100 –128, doi:http://dx.doi.org/10.1196/annals.1419.016 .",Non-OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"28 (1956)350–356, doi:http://dx.doi.org/10.1021/ac60111a017 .",Non-OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"Energy 39 (2014) 16852– 16862, doi:http://dx.doi.org/10.1016/j.ijhydene.2014.08.017 .",OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"Energy 35 (2010) 81 –92, doi:http://dx.doi.org/10.1016/j.ijhydene.2009.10.051 .",OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"27 (2009) 287 –297, doi:http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"56 (2006) 695 –702, doi:http://dx.doi.org/10.1099/ijs.0.63699-0 .",Non-OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"41 (2006) 199 –207, doi:http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"97 (2007) 742 –758, doi:http://dx.doi.org/10.1002/bit.21299 .",Non-OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"33 (1999) 2579 –2586, doi:http://dx.doi.org/10.1016/S0043-1354(98) .",Non-OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"Energy 33 (2008) 579 –586, doi:http://dx.doi.org/10.1016/ j.ijhydene.2007.10.009.",OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"Energy 37 (2012) 9630 –9635, doi:http://dx.doi.org/10.1016/j.ijhydene.2012.03.097 .",OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"Energy 29 (2004) 41 –45, doi: http://dx.doi.org/10.1016/S0360-3199(03)83-1 .",OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"55 (2005) 2085 –2091, doi:http://dx.doi.org/10.1099/ijs.0.63482-0 .",Non-OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"33 (2008) 4083 –4090, doi:http://dx.doi.org/ 10.1016/j.ijhydene.2008.05.052 .",OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"Energy 36 (2011) 8953 –8966, doi:http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"22 (2011) 365– 370, doi:http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"9 (2007) 1112 –1125, doi:http://dx.doi.org/10.1111/j.1462- 2920.2006.01234.x .",Non-OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"Energy 34 (2009) 3689 –3696, doi:http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"Energy 34 (2009) 799– 811, doi:http://dx.doi.org/ 10.1016/j.ijhydene.2008.11.015 .",OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"(2011) , doi:http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"(2006) 755 –760, doi:http://dx.doi.org/10.1099/ijs.0.63926-0 .",Non-OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
"(2009) , doi:http://dx.doi.org/10.1016/j.biortech.2009.02.066 .54 M.P.",OADS,/arxiv_data1/oa_pdf/c2/7d/main.PMC5466190.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/6a/36/main.PMC5466191.pdf
http://dx.doi.org/10.1016/j.btre.2014.11.0012215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/6a/36/main.PMC5466191.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 5 (2015) 31 –39 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/6a/36/main.PMC5466191.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.btre.2014.11.001 .",OADS,/arxiv_data1/oa_pdf/6a/36/main.PMC5466191.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/02/72/main.PMC5466192.pdf
http://dx.doi.org/10.1016/j.btre.2014.11.0032215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/02/72/main.PMC5466192.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 5 (2015) 40– 45 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/02/72/main.PMC5466192.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.btre.2014.11.003.",OADS,/arxiv_data1/oa_pdf/02/72/main.PMC5466192.pdf
"Specht, DNA barcoding in thecycadales: Testing the potential of proposed barcoding markers for species identi ﬁcation of cycads, PLoS One 2 (2007) e1154, doi:http://dx.doi.org/ 10.1111/j.",OADS,/arxiv_data1/oa_pdf/02/72/main.PMC5466192.pdf
"10 (2010) 594 –605, doi:http://dx.doi.org/10.1111/j.1755-0998.2009.02815.x.",Non-OADS,/arxiv_data1/oa_pdf/02/72/main.PMC5466192.pdf
"Chen, Use of ITS 2region as the universal DNA barcode for plants and animals, PLoS One 5 (2010) e13102, doi:http://dx.doi.org/10.1371/journal.pone.0013102 .",OADS,/arxiv_data1/oa_pdf/02/72/main.PMC5466192.pdf
"51 (6)(2013) 704 –714, doi:http://dx.doi.org/10.1111/jse.12050 .",Non-OADS,/arxiv_data1/oa_pdf/02/72/main.PMC5466192.pdf
"Chaudhary, S. Roy, Theinternal transcribed spacer (ITS) region and trnH–psbA are suitable candidate loci for DNA barcoding of tropical tree species of India, PLoS One 8 (2) (2013)e57934, doi:http://dx.doi.org/10.1371/journal.pone.0057934 .",OADS,/arxiv_data1/oa_pdf/02/72/main.PMC5466192.pdf
"Plant Mol Biol Rep. 31 (2013) 1116 –1130, doi:http://dx.doi.org/10.1007/s11105- 013-0575-2 .",Non-OADS,/arxiv_data1/oa_pdf/02/72/main.PMC5466192.pdf
"46 (2013) 29 –40, doi:http://dx.doi.org/ 10.1016/j.jmgm.2013.09.006 .",OADS,/arxiv_data1/oa_pdf/02/72/main.PMC5466192.pdf
"[14] I. Marin, Evolution of plant hect ubiquitin ligases, PLoS One 8 (7) (2013)e68536, doi:http://dx.doi.org/10.1371/journal.pone.0068536 .",Non-OADS,/arxiv_data1/oa_pdf/02/72/main.PMC5466192.pdf
"Higgins, Clustal X version 2.0, Bioinformatics 23 (2007) 2947 –2948, doi:http://dx.doi.org/10.1093/bioinformatics/btm404 .",Non-OADS,/arxiv_data1/oa_pdf/02/72/main.PMC5466192.pdf
"[16] Librado, J. Rozas, DnaSP v5: a software for comprehensive analysis of DNA polymorphism data, Bioinformatics 25 (2009) 1451 –1452, doi:http://dx.doi.",OADS,/arxiv_data1/oa_pdf/02/72/main.PMC5466192.pdf
"30 (2013)2725 –2729, doi:http://dx.doi.org/10.1093/molbev/mst197 .",Non-OADS,/arxiv_data1/oa_pdf/02/72/main.PMC5466192.pdf
"Cimon, Molecular phylogeny of Juglans (Juglandaceae): abiogeographic perspective, Tree Genet Genomes 3 (2007) 363 –378, doi:http://dx.doi.org/10.1007/s11295-006-0078-5 .",OADS,/arxiv_data1/oa_pdf/02/72/main.PMC5466192.pdf
"Hou, J.J. Li, Revealinggenetic diversity of tree peonies at micro-evolution level with hyper-variable chloroplast markers and ﬂoral traits, Plant Cell Rep. 31 (2012) 2199 –2213, doi: http://dx.doi.org/10.1007/s00299-012-1330-0 .Z.",OADS,/arxiv_data1/oa_pdf/02/72/main.PMC5466192.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/30/6a/main.PMC5466193.pdf
http://dx.doi.org/10.1016/j.btre.2014.12.0032215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/30/6a/main.PMC5466193.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 5 (2015) 63 –69 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/30/6a/main.PMC5466193.pdf
A list of bitter peptides can be found in BIOPEP database under “sensory peptides and amino acids ”athttp://www.uwm.,Non-OADS,/arxiv_data1/oa_pdf/30/6a/main.PMC5466193.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b2/7c/main.PMC5466194.pdf
http://dx.doi.org/10.1016/j.btre.2014.12.004 2215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/b2/7c/main.PMC5466194.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 5 (2015) 77 –88 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/b2/7c/main.PMC5466194.pdf
"[107] Biofuel.org, UK, 2014 History of Biofuels http://biofuel.org.uk/history-of- biofuels.html (Retrieved on 03.02.14).",Non-OADS,/arxiv_data1/oa_pdf/b2/7c/main.PMC5466194.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/1c/main.PMC5466195.pdf
http://dx.doi.org/10.1016/j.btre.2014.12.001 2215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/92/1c/main.PMC5466195.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 5 (2015) 112 –119 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/92/1c/main.PMC5466195.pdf
"[20] A. Ivask, I. Kurvet, K. Kasemets, I. Blinova, V. Aruoja, et al., Size-dependenttoxicity of silver nanoparticles to bacteria, yeast, algae, crustaceans and mammalian cells in vitro, PLoS ONE 9 (7) (2014) e102108, doi:http://dx.doi.org/10.1371/journal.pone.0102108.",OADS,/arxiv_data1/oa_pdf/92/1c/main.PMC5466195.pdf
: +55 19 32 427 022. http://dx.doi.org/10.1016/j.btre.2014.12.006 2215-017X/Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/a2/ae/main.PMC5466196.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 5 (2015) 70 –76 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/a2/ae/main.PMC5466196.pdf
Available in http://www.unica.com.br .,Non-OADS,/arxiv_data1/oa_pdf/a2/ae/main.PMC5466196.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/cc/17/main.PMC5466197.pdf
http://dx.doi.org/10.1016/j.btre.2014.12.007 2215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/cc/17/main.PMC5466197.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 5 (2015) 98 –104 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/cc/17/main.PMC5466197.pdf
Band sequences were compared using the BLAST software at the National Centre of Biotechnology Information website (http://www.ncbi.nlm.nih.gov/ ) for identi ﬁ- cation and phylogenetic classi ﬁcation.,OADS,/arxiv_data1/oa_pdf/cc/17/main.PMC5466197.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/f4/72/main.PMC5466199.pdf
: +1 306 966 1267; fax: +1 306 966 5427. http://dx.doi.org/10.1016/j.btre.2014.12.0022215-017X/ ã2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/72/main.PMC5466199.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 5 (2015) 55 –62 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/f4/72/main.PMC5466199.pdf
"(2014) , doi:http://dx.doi.org/10.1007/s10237-014-0606-4.",Non-OADS,/arxiv_data1/oa_pdf/f4/72/main.PMC5466199.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
http://dx.doi.org/10.1016/j.btre.2014.12.005 2215-017X/ ã2014 The Authors.,OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Biotechnology Reports 5 (2015) 89 –97 Contents lists available at ScienceDirect Biotechnology Reports journal homepage: www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
Osmotic pressure online calculator hosted by Georgia State University was used for calculation of osmotic shock (http://hyperphysics.phy-astr.gsu.,OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.btre.2014.12.005.",OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"138 (1992) 1629– 1638, doi:http://dx.doi.org/ 10.1099/00221287-138-8-1629.",Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"176 (2001) 294 –300, doi:http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"43 (2010) 732 –744, doi: http://dx.doi.org/10.1016/j.clinbiochem.2010.03.009 .",OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"7 (1998) 139 –148, doi: http://dx.doi.org/10.1016/S0926-6690(97)42-3 .",Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"47 (2006) 706 –714, doi:http://dx.doi.org/ 10.1093/pcp/pcj041 .",Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"18 (2005) 31, doi: http://dx.doi.org/10.1079/NRR200493 .",Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
http://www.google.co.in/patents/US4359430 .,Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"5 (1993) 231 –234, doi:http://dx.doi.org/10.1007/BF00004023 .",Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"[12] http://www.in-cosmetics.com/__novadocuments/7930 , (accessed 07.08.14).",Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"143 (1986) 365 –369, doi:http://dx.doi.org/10.1007/BF00412804 .",Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"21 (1975) 1500 –1511, doi: http://dx.doi.org/10.1139/m75 –222.",Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"12 (2002) 541 –553, doi:http://dx.doi.org/10.1016/S0958– 6946(02)38-9 .",Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"Interface 5 (2008) S131 –S138, doi:http://dx.doi.org/10.1098/rsif.2008.0009.focus .",OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"8 (1986) 194 –204, doi:http://dx.doi.org/ 10.1016/0141 –0229(86)90087-6 .",Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"13 (1995) 491 –551, doi:http://dx.doi.org/10.1016/0734 –9750(95)2007-P .",Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"18 (2013) 132–137, doi:http://dx.doi.org/10.1016/j.ifset.2013.02.006 .",OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"448 (2014) 1 –8, doi:http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"47 (1997) 52 –57, doi:http://dx.doi.org/10.1007/ s002530050887 .",Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"Tuma, A simpli ﬁed procedure for the determination of betaine in liver, Lipids 14 (1979) 860 –863, doi:http://dx.doi.org/10.1007/ BF02534129 .",Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"77 (2002) 263 –265, doi:http://dx.doi.org/10.1016/ S0308 –8146(01)324-7 .",OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"29 (2011) 442 –452, doi:http://dx.doi.org/10.1016/j.biotechadv.2011.04.002 .",OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"26 (1988) 359 –395, doi:http://dx.doi.org/10.1080/10408398809527473 .",Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"143 (1986) 370 –378, doi:http://dx.doi.org/10.1007/BF00412805 .",Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"63 (2008) 706 –709, doi:http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"Methods 58 (2004) 31 –38, doi: http://dx.doi.org/10.1016/j.mimet.2004.02.015 .",OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
"194 (2012) 4802 –4809, doi:http://dx.doi.org/10.1128/JB.00576-12 .",Non-OADS,/arxiv_data1/oa_pdf/36/bb/main.PMC5466200.pdf
Medicine (2017) 96:23(e6904)Received: 9 March 2017 / Received in ﬁnal form: 14 April 2017 / Accepted: 20 April 2017 http://dx.doi.org/10.1097/MD.0000000000006904Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/cc/ae/medi-96-e6904.PMC5466204.pdf
Medicine (2017) 96:23(e6908)Received: 3 November 2016 / Received in ﬁnal form: 12 April 2017 / Accepted: 20 April 2017 http://dx.doi.org/10.1097/MD.0000000000006908Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b8/58/medi-96-e6908.PMC5466205.pdf
Medicine (2017) 96:23(e6961)Received: 24 January 2017 / Received in ﬁnal form: 25 April 2017 / Accepted: 3 May 2017 http://dx.doi.org/10.1097/MD.0000000000006961Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/37/af/medi-96-e6961.PMC5466208.pdf
"Only a handful of patients of PCS have been reported in the literaturewhich are summarized in Additional ﬁle 1 (refer to Additional ﬁle 1, which summarizes the literatures; http://links.lww.com/MD/ B729).",Non-OADS,/arxiv_data1/oa_pdf/37/af/medi-96-e6961.PMC5466208.pdf
Medicine (2017) 96:23(e6973)Received: 1 September 2016 / Received in ﬁnal form: 31 March 2017 / Accepted: 28 April 2017 http://dx.doi.org/10.1097/MD.0000000000006973Quality Improvement Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/79/d1/medi-96-e6973.PMC5466209.pdf
Medicine (2017) 96:23(e7023)Received: 14 March 2017 / Received in ﬁnal form: 1 May 2017 / Accepted: 2 May 2017 http://dx.doi.org/10.1097/MD.0000000000007023Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/dc/05/medi-96-e7023.PMC5466210.pdf
Medicine (2017) 96:23(e7024)Received: 1 March 2017 / Received in ﬁnal form: 16 April 2017 / Accepted: 20 April 2017 http://dx.doi.org/10.1097/MD.0000000000007024Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/2b/5e/medi-96-e7024.PMC5466211.pdf
"Information sources and search strategy Manuscripts containing the following MeSH keywords and terms were identi ﬁed by surveying MEDLINE, EMBASE, LILACS, COCHRANE, and CINAHL databases: rheumatic diseases, Behçet Syndrome, spondylitis, vasculitis, juvenile arthritis, rheumatoid arthritis, Sjogren ’s Syndrome, polymyalgia rheumatica, systemic lupus erythematosus, systemic sclerosis, dermatomyositis, vitamin D, cholecalciferol, hydroxycholecalci- ferols, ergocalciferols, 25-hydroxyvitamin D. Depending on thesearch mechanisms of each database, our strategy was adapted (supplementary File, http://links.lww.com/MD/B725).",OADS,/arxiv_data1/oa_pdf/2b/5e/medi-96-e7024.PMC5466211.pdf
Medicine (2017) 96:23(e7026)Received: 25 January 2017 / Received in ﬁnal form: 3 May 2017 / Accepted: 8 May 2017 http://dx.doi.org/10.1097/MD.0000000000007026Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f4/80/medi-96-e7026.PMC5466212.pdf
"Probands were shown a LLETZ training video (available as Supplemental Video 1, http://links.lww.com/MD/B717).",Non-OADS,/arxiv_data1/oa_pdf/f4/80/medi-96-e7026.PMC5466212.pdf
Medicine (2017) 96:23(e7031)Received: 1 November 2016 / Received in ﬁnal form: 1 May 2017 / Accepted: 5 May 2017 http://dx.doi.org/10.1097/MD.0000000000007031Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7e/b8/medi-96-e7031.PMC5466213.pdf
Medicine (2017) 96:23(e7034)Received: 2 September 2016 / Received in ﬁnal form: 7 May 2017 / Accepted: 8 May 2017 http://dx.doi.org/10.1097/MD.0000000000007034Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/9e/c8/medi-96-e7034.PMC5466214.pdf
Medicine (2017) 96:23(e7043)Received: 12 February 2017 / Received in ﬁnal form: 5 May 2017 / Accepted: 8 May 2017 http://dx.doi.org/10.1097/MD.0000000000007043Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b3/f9/medi-96-e7043.PMC5466216.pdf
Medicine (2017) 96:23(e7057)Received: 18 November 2016 / Received in ﬁnal form: 9 March 2017 / Accepted: 10 May 2017 http://dx.doi.org/10.1097/MD.0000000000007057Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/36/76/medi-96-e7057.PMC5466217.pdf
Medicine (2017) 96:23(e7059)Received: 28 December 2016 / Received in ﬁnal form: 1 May 2017 / Accepted: 2 May 2017 http://dx.doi.org/10.1097/MD.0000000000007059Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/40/ad/medi-96-e7059.PMC5466218.pdf
Medicine (2017) 96:23(e7064)Received: 4 November 2016 / Received in ﬁnal form: 10 May 2017 / Accepted: 11 May 2017 http://dx.doi.org/10.1097/MD.0000000000007064Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f0/0b/medi-96-e7064.PMC5466219.pdf
Medicine (2017) 96:23(e7067)Received: 20 December 2016 / Received in ﬁnal form: 6 April 2017 / Accepted: 25 April 2017 http://dx.doi.org/10.1097/MD.0000000000007067Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ba/e5/medi-96-e7067.PMC5466221.pdf
"1, http://links.lww.com/MD/B726).",Non-OADS,/arxiv_data1/oa_pdf/ba/e5/medi-96-e7067.PMC5466221.pdf
"The performance of other risk scores including US screening score, [27]Thai score,[28]and Rotterdam model,[29]revealed AUCs ranged from 0.579 to 0.643 (Supplementary table 1, http://links.lww.com/MD/B726).To investigate whether KDS score re ﬂects components of insulin resistance or beta-cell function, we analyzed AUCs of riskmodels of HOMA-IR or IGI for predicting KDS ≥5 (Supplemen- tary table 2, http://links.lww.com/MD/B726).",Non-OADS,/arxiv_data1/oa_pdf/ba/e5/medi-96-e7067.PMC5466221.pdf
Medicine (2017) 96:23(e7083)Received: 7 January 2017 / Received in ﬁnal form: 1 April 2017 / Accepted: 20 April 2017 http://dx.doi.org/10.1097/MD.0000000000007083Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f8/e8/medi-96-e7083.PMC5466227.pdf
"According to study quality assessment criteria (Supplemental Table 1, http://links.lww.com/MD/B723), the study participation was adequate and the baseline study sample was completelydelineated in all included articles.",OADS,/arxiv_data1/oa_pdf/f8/e8/medi-96-e7083.PMC5466227.pdf
"Moreover, 5-year survival rates based on these cutoff points were listed in Supplemental Table 2, http://links.lww.com/MD/B723.",Non-OADS,/arxiv_data1/oa_pdf/f8/e8/medi-96-e7083.PMC5466227.pdf
"Serum SP-A levels in patients with ILD and pulmonary infections were signi ﬁcantly higher than controls (SMD: 2.200 [1.627, 2.773]; 1.097 [0.420,1.774], Supplemental Fig 1, http://links.lww.com/MD/B724).These comparisons suggest a high level of heterogeneity ( I 2= 95.8%, 87.0%, respectively, with P<.001, Supplemental Fig 1, http://links.lww.com/MD/B724).",Non-OADS,/arxiv_data1/oa_pdf/f8/e8/medi-96-e7083.PMC5466227.pdf
"Surfactant protein-D levels are signiﬁcantly elevated in patients with ILD (SMD: 1.935 [1.504, 2.367], Supplemental Fig 2, http://links.lww.com/MD/B724), aswell as pulmonary infections (SMD: 2.466 [0.558, 4.374], Supplemental Fig.",Non-OADS,/arxiv_data1/oa_pdf/f8/e8/medi-96-e7083.PMC5466227.pdf
"2, http://links.lww.com/MD/B724).",Non-OADS,/arxiv_data1/oa_pdf/f8/e8/medi-96-e7083.PMC5466227.pdf
Medicine (2017) 96:23(e7091)Received: 3 October 2016 / Received in ﬁnal form: 22 February 2017 / Accepted: 14 May 2017 http://dx.doi.org/10.1097/MD.0000000000007091Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/95/68/medi-96-e7091.PMC5466229.pdf
Medicine (2017) 96:23(e7092)Received: 21 November 2016 / Received in ﬁnal form: 13 May 2017 / Accepted: 15 May 2017 http://dx.doi.org/10.1097/MD.0000000000007092Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b5/d4/medi-96-e7092.PMC5466230.pdf
"Available at: https://www.hpa.gov.tw/EngPages/EngTopicList.aspx?nodeid=1072,pp.",OADS,/arxiv_data1/oa_pdf/b5/d4/medi-96-e7092.PMC5466230.pdf
Available at: http://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=1057&pid=6024.,OADS,/arxiv_data1/oa_pdf/b5/d4/medi-96-e7092.PMC5466230.pdf
Available at: http://www.nhi.gov.tw/English/Content_List.aspx?n=3CAE4AD5B87ADF05&topn=616B97F8DF2C3614.,Non-OADS,/arxiv_data1/oa_pdf/b5/d4/medi-96-e7092.PMC5466230.pdf
Medicine (2017) 96:23(e7098)Received: 29 March 2017 / Received in ﬁnal form: 3 May 2017 / Accepted: 4 May 2017 http://dx.doi.org/10.1097/MD.0000000000007098Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/37/12/medi-96-e7098.PMC5466231.pdf
Medicine (2017) 96:23(e7106)Received: 3 September 2016 / Received in ﬁnal form: 29 April 2017 / Accepted: 14 May 2017 http://dx.doi.org/10.1097/MD.0000000000007106Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ad/9e/medi-96-e7106.PMC5466233.pdf
Medicine (2017) 96:23(e7107)Received: 8 December 2016 / Received in ﬁnal form: 7 April 2017 / Accepted: 13 May 2017 http://dx.doi.org/10.1097/MD.0000000000007107Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/02/76/medi-96-e7107.PMC5466234.pdf
Medicine (2017) 96:23(e7108)Received: 11 December 2016 / Received in ﬁnal form: 12 May 2017 / Accepted: 16 May 2017 http://dx.doi.org/10.1097/MD.0000000000007108Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/41/96/medi-96-e7108.PMC5466235.pdf
"2016. http://nhird.nhri.org.tw/en/Data_Subsets.html# [Accessed on October 10, 2016].",OADS,/arxiv_data1/oa_pdf/41/96/medi-96-e7108.PMC5466235.pdf
Medicine (2017) 96:23(e7110)Received: 13 December 2016 / Received in ﬁnal form: 8 May 2017 / Accepted: 15 May 2017 http://dx.doi.org/10.1097/MD.0000000000007110Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/15/51/medi-96-e7110.PMC5466236.pdf
"After multidisciplinary consultation, the patient diagnosed as having hepatocellular carcinoma initially underwent an laparot-omy by surgical team (see supplement ﬁrgue 1, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/15/51/medi-96-e7110.PMC5466236.pdf
"Till the November 2016 (seesupplement Figure 2, http://links.lww.com/MD/B732), the pa-tient was still alive over 22 months, even the recent abdominal enhanced CT showed no evidence of recurrence or metastasis (Fig.",Non-OADS,/arxiv_data1/oa_pdf/15/51/medi-96-e7110.PMC5466236.pdf
Medicine (2017) 96:23(e7112)Received: 16 February 2017 / Received in ﬁnal form: 3 April 2017 / Accepted: 15 May 2017 http://dx.doi.org/10.1097/MD.0000000000007112Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/9e/1a/medi-96-e7112.PMC5466237.pdf
Medicine (2017) 96:23(e7113)Received: 1 December 2016 / Received in ﬁnal form: 16 May 2017 / Accepted: 17 May 2017 http://dx.doi.org/10.1097/MD.0000000000007113Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ad/9c/medi-96-e7113.PMC5466238.pdf
Medicine (2017) 96:23(e7123)Received: 1 August 2016 / Received in ﬁnal form: 8 April 2017 / Accepted: 8 May 2017 http://dx.doi.org/10.1097/MD.0000000000007123Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/20/cb/medi-96-e7123.PMC5466240.pdf
Medicine (2017) 96:23(e7125)Received: 10 April 2017 / Received in ﬁnal form: 11 May 2017 / Accepted: 15 May 2017 http://dx.doi.org/10.1097/MD.0000000000007125Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/81/c3/medi-96-e7125.PMC5466241.pdf
"Natick, MA), which generates an attenuation image for every OCT frame (see supplement video 1, http://links.lww.com/MD/B733).",Non-OADS,/arxiv_data1/oa_pdf/81/c3/medi-96-e7125.PMC5466241.pdf
"1, B2 and C2; see supplement video 1, http://links.lww.com/MD/ B733).",Non-OADS,/arxiv_data1/oa_pdf/81/c3/medi-96-e7125.PMC5466241.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/af/d1/main.PMC5466250.pdf
http://dx.doi.org/10.1016/j.btre.2014.12.0112215-017X/ ã 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/af/d1/main.PMC5466250.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  6  (2015)  1–7 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/af/d1/main.PMC5466250.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/bc/main.PMC5466251.pdf
http://dx.doi.org/10.1016/j.btre.2014.11.0042215-017X/ ã 2015  The  Authors.,OADS,/arxiv_data1/oa_pdf/52/bc/main.PMC5466251.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  6  (2015)  85–90 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/52/bc/main.PMC5466251.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.btre.2014.11.004 .",OADS,/arxiv_data1/oa_pdf/52/bc/main.PMC5466251.pdf
http://dx.doi.org/10.1016/j.btre.2015.01.0012215-017X/Published by  Elsevier  B.V.,Non-OADS,/arxiv_data1/oa_pdf/d6/51/main.PMC5466252.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  6  (2015)  27–35 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/d6/51/main.PMC5466252.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.btre.2015.01.001 .",OADS,/arxiv_data1/oa_pdf/d6/51/main.PMC5466252.pdf
"Goldman,  Development and  evaluation  of  single  domain  antibodies  for  vaccinia  and  the  L1  antigen, PLoS  One  9  (9)  (2014)  e106263,  doi:http://dx.doi.org/10.1371/journal.",Non-OADS,/arxiv_data1/oa_pdf/d6/51/main.PMC5466252.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/df/main.PMC5466253.pdf
http://dx.doi.org/10.1016/j.btre.2014.12.0092215-017X/ ã 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/df/main.PMC5466253.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  6  (2015)  8–12 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/b1/df/main.PMC5466253.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f8/ec/main.PMC5466254.pdf
http://dx.doi.org/10.1016/j.btre.2015.01.003 2215-017X/ ã  2015  The  Authors.,OADS,/arxiv_data1/oa_pdf/f8/ec/main.PMC5466254.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  6  (2015)  20–26 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/f8/ec/main.PMC5466254.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.btre.2015.01.003.",OADS,/arxiv_data1/oa_pdf/f8/ec/main.PMC5466254.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/cf/5b/main.PMC5466255.pdf
http://dx.doi.org/10.1016/j.btre.2015.01.0042215-017X/ ã 2015  The  Authors.,OADS,/arxiv_data1/oa_pdf/cf/5b/main.PMC5466255.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  6  (2015)  36–40 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/cf/5b/main.PMC5466255.pdf
http://dx.doi.org/10.1016/j.btre.2015.02.0012215-017X/ ã 2015  Published  by  Elsevier  B.V.,Non-OADS,/arxiv_data1/oa_pdf/d7/b6/main.PMC5466256.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  6  (2015)  51–55 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/d7/b6/main.PMC5466256.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/31/1a/main.PMC5466257.pdf
http://dx.doi.org/10.1016/j.btre.2015.02.0052215-017X/ ã 2015  The  Author.,Non-OADS,/arxiv_data1/oa_pdf/31/1a/main.PMC5466257.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  6  (2015)  137 –143 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/31/1a/main.PMC5466257.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/67/79/main.PMC5466258.pdf
http://dx.doi.org/10.1016/j.btre.2015.02.0032215-017X/ ã 2015  The  Authors.,OADS,/arxiv_data1/oa_pdf/67/79/main.PMC5466258.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  6  (2015)  45–50 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/67/79/main.PMC5466258.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/fb/9c/main.PMC5466259.pdf
http://dx.doi.org/10.1016/j.btre.2014.12.0122215-017X/ ã 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/fb/9c/main.PMC5466259.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  6  (2015)  13–19 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/fb/9c/main.PMC5466259.pdf
"Catalase  immobilized  in  capsules  in microorganisms  removed  from  drinking  water,  milk  and  beverages,  Deswater (2015)  ,  doi:http://dx.doi.org/10.1080/19443994.2014.939857 .",Non-OADS,/arxiv_data1/oa_pdf/fb/9c/main.PMC5466259.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/4a/24/main.PMC5466260.pdf
http://dx.doi.org/10.1016/j.btre.2014.12.0102215-017X/ã 2015  The  Author.,Non-OADS,/arxiv_data1/oa_pdf/4a/24/main.PMC5466260.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  6  (2015)  100–107 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/4a/24/main.PMC5466260.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d2/f4/main.PMC5466261.pdf
:  +91  7512230019. http://dx.doi.org/10.1016/j.btre.2015.02.0042215-017X/ ã 2015  The  Author.,Non-OADS,/arxiv_data1/oa_pdf/d2/f4/main.PMC5466261.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  6  (2015)  129–136 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/d2/f4/main.PMC5466261.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.btre.2015.02.004 .",OADS,/arxiv_data1/oa_pdf/d2/f4/main.PMC5466261.pdf
"Kamboj,  R.  Jain,  Electrochemical  immunosensor  for Staphylococcal  enterotoxin  B  (SEB)  based  on  platinum  nanoparticles-modiﬁed electrode  using  hydrogen  evolution  inhibition  approach,  Electroanalysis  26 (2014)  2320 –2327,  doi:http://dx.doi.org/10.1002/elan.201400100 .",OADS,/arxiv_data1/oa_pdf/d2/f4/main.PMC5466261.pdf
http://dx.doi.org/10.1016/j.btre.2015.03.0052215-017X/ ã 2015  Published  by  Elsevier  B.V.,Non-OADS,/arxiv_data1/oa_pdf/47/ca/main.PMC5466264.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  6  (2015)  112 –118 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/47/ca/main.PMC5466264.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.btre.2015.03.005.",OADS,/arxiv_data1/oa_pdf/47/ca/main.PMC5466264.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/f4/66/main.PMC5466265.pdf
http://dx.doi.org/10.1016/j.btre.2015.03.0042215-017X/ã 2015  The  Author.,Non-OADS,/arxiv_data1/oa_pdf/f4/66/main.PMC5466265.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  6  (2015)  108 –111 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.elsevier.com/locate/btre,Non-OADS,/arxiv_data1/oa_pdf/f4/66/main.PMC5466265.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/f9/main.PMC5466267.pdf
http://dx.doi.org/10.1016/j.btre.2015.03.0022215-017X/ ã 2015  The  Author.,Non-OADS,/arxiv_data1/oa_pdf/8a/f9/main.PMC5466267.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).Biotechnology  Reports  6  (2015)  91–99 Contents  lists  available  at  ScienceDirect Biotechnology  Reports journal  homepage:  www.else  vie  r.com/locat  e/btre,Non-OADS,/arxiv_data1/oa_pdf/8a/f9/main.PMC5466267.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.btre.2015.03.002.",OADS,/arxiv_data1/oa_pdf/8a/f9/main.PMC5466267.pdf
"https://doi.org/10.1177/2333721417713096Gerontology & Geriatric Medicine Volume 3: 1 –7 © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav DOI: 10.1177/2333721417713096 journals.sagepub.com/home/ggm Creative Commons CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use,  reproduction and distribution of the work  without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Case Report Introduction and Rationale The goal of this project is to describe and evaluate a  cooperative effort between a provider of senior services and a health care organization in the United States.",Non-OADS,/arxiv_data1/oa_pdf/da/cb/10.1177_2333721417713096.PMC5466277.pdf
Retrieved from http://www.healthypeople.,Non-OADS,/arxiv_data1/oa_pdf/da/cb/10.1177_2333721417713096.PMC5466277.pdf
"https://doi.org/10.1177/2333721417713095Gerontology & Geriatric Medicine Volume 3: 1 –4 © The Author(s) 2017Reprints and permissions: sagepub.com/journalsPermissions.nav DOI: 10.1177/2333721417713095 journals.sagepub.com/home/ggm Creative Commons CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use,  reproduction and distribution of the work  without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Article Introduction Older adults (age 65 years and older) continue to be the  fastest growing population in the United States and developing countries (United Nations Population Division, Department of Economic and Social Affairs, 2015).",Non-OADS,/arxiv_data1/oa_pdf/8d/4b/10.1177_2333721417713095.PMC5466280.pdf
Retrieved from http://www.un.org/en/development/desa/population/publications/pdf/ageing/WPA2015_Report.pdf,Non-OADS,/arxiv_data1/oa_pdf/8d/4b/10.1177_2333721417713095.PMC5466280.pdf
"The Declaration of Helsinki as a statement of ethical  principles for medical research involving human subjects,  including research on identifiable human material and data, 2013, https://www.wma.net/policies-post/wma-declaration- of-helsinki-ethical-principles-for-medical-research-involving- human-subjects/  22.",Non-OADS,/arxiv_data1/oa_pdf/82/bc/10.1177_2050312117713647.PMC5466281.pdf
"Copyright © 2017  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/52/jos-2016-01669.PMC5466282.pdf
pISSN: 2287-6391 • eISSN: 2287-6405236 http://j-stroke.org Letter to the Editor Journal of Stroke 2017;19(2):236-238 https://doi.org/10.5853/ jos.2016.01669  Acute Ischemic Stroke in Nonconvulsive Status  Epilepticus–Underestimated?,Non-OADS,/arxiv_data1/oa_pdf/b9/52/jos-2016-01669.PMC5466282.pdf
"2 / May 2017http://j-stroke.org  237  https://doi.org/10.5853/ jos.2016.01669 8–22% of patients to be the underlying etiology of SE.5-7 Al- though in line with these previous studies, the rather small num - ber of AIS in our SE cohort might result from our strict criteria of  close temporal association of AIS and SE (i.e.",Non-OADS,/arxiv_data1/oa_pdf/b9/52/jos-2016-01669.PMC5466282.pdf
Acute Ischemic Stroke in Nonconvulsive Status Epilepticus238 http://j-stroke.org  https://doi.org/10.5853/ jos.2016.01669 9.,Non-OADS,/arxiv_data1/oa_pdf/b9/52/jos-2016-01669.PMC5466282.pdf
"Copyright © 2017  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405166 http://j-stroke.org Journal of Stroke 2017;19(2):166-187 https://doi.org/10.5853/jos.2016.01368 Review Introduction Stroke   Stroke is the major cause of adult physical disability and the  second leading cause of death in the world.1,2 Stroke is one of  the most important and devastating of all neurological disor - ders, accounting for 5.5 million deaths annually, with 44 mil - lion physical disabilities worldwide.3 The consequences of  stroke injuries are profound and persistent, causing a high bur - den to both the individual patient and society because of their  increasing incidence, the physical disability and mortality they  cause, and their economic impact, mainly in low- and mid - dle-income countries.4Ischemic stroke is responsible for 80% of all strokes, while  hemorrhagic stroke accounts for 15% and the other 5% are  due to unknown etiology.5 In the present review we will discuss  the pathogenic mechanisms related to ischemic stroke such as  excitotoxicity, oxidative stress, inflammation and apoptosis,  and how microRNAs may play a role in these pathogenic pro - cess.",Non-OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
"2 / May 2017 https://doi.org/10.5853/jos.2016.01368http://j-stroke.org  167emic stroke, neurons are deprived of oxygen and energy, so  that their normal metabolic substrates stop functioning in sec - onds and display signs of structural injury after only 2 min - utes.7 Immediately after ischemia, cellular energy-dependent  processes fail and neurons are unable to sustain their normal  transmembrane ionic gradient, resulting in an imbalance be - tween ions and water thus leading to apoptosis and necrotic  cell death.8,9 During ischemia the brain tissues are not affected equally  owing to differential lessening of blood supply to the different  zones.",Non-OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
"MicroRNAs and Ischemic Stroke https://doi.org/10.5853/jos.2016.01368168 http://j-stroke.orgto the inhibition of translation or degradation of the respective  mRNA.16 miRNAs have been implicated in the regulation of a  variety of cellular processes and diseases such as neuronal de - velopment, differentiation, synaptic plasticity, proliferation,  metabolism, apoptosis, neurodegenerative diseases and tumor - igenesis.17-22 miRNAs are initially transcribed from genomic  DNA, and RNA polymerase II is responsible for transcription of  primary miRNA (pri-miRNA).23 Pri-miRNAs can be thousands of  base pairs in length and consist of at least one hairpin loop,  which is recognized and cleaved by the endonuclease Drosha,  and which generates a precursor miRNA (pre-miRNA), with the  help of DGCR8, a double stranded RNA-binding protein.24,25 The  pre-miRNA is transported from the nucleus into the cytoplasm  through the function of exportin-5.",Non-OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
"2 / May 2017 https://doi.org/10.5853/jos.2016.01368http://j-stroke.org  169miR-155miR-181c TLR4 miR-181c  NF-κB  COX2   miR-let-7c-5pmiR-210  miR-let-7c-5p miR-491-5p miR-106a  miR-29a  miR-107  miR-223miR-125bIL-10 NR2A  GLT-1 miR-181c miR-let-7c-5p miR-181a miR-146aSOCS1, MyD88 PUMAmiR-424 miR-let-7c-5p miR-124 TNF-α IL-1α/β IL-6 iNOS MMP-9 GluR2  NR2B miR-223 Microglia  activation  miR-101 miR-146a miR- 106b-5p  miR-145 MEDA miR-424   MDA   miR-424   H2O2  miR-424   ROS  miR-23a-3p  RNS  SOD miR- 93  miR-124Nrf2 Inﬂammation ApoptosisExcitotoxicityOxidative stress Pathogenic mechanisms miR-200c  miR-125b Fas/FasL  Caspase 3iASPP miR-let-7c-5p miR-99aFAP-1miR-25  miR-21  p53miR-134 HSPA12B miR-106b-5p  Mcl-1 miR-497  Bcl-w miR-9 Bcl2L11 miR-181a miR-106b-5p miR-384-5p   miR- 494 miR- 497 miR-134Bcl-2DamageIschemic Stroke Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
"MicroRNAs and Ischemic Stroke https://doi.org/10.5853/jos.2016.01368170 http://j-stroke.orgreduces activation of NDC and prevent the excitotoxic neuro - nal injury induced by ischemic stroke.45,46 So, the NR2B subunit  is a major hub for NDC formation.45,47,48 Also, binding of glutamate to mGluR caused release of the  intracellular calcium store.37,39 These events result in accumula - tion of intracellular calcium which changes the osmolarity of  the cell and activation some of endogenous enzymes such as  proteases, lipases and endonucleases.",OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
2 / May 2017 https://doi.org/10.5853/jos.2016.01368http://j-stroke.org  171Table 2.,Non-OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
"MicroRNAs and Ischemic Stroke https://doi.org/10.5853/jos.2016.01368172 http://j-stroke.orging cerebral ischemia through decreasing methane dicarboxylic  aldehyde levels and increasing SOD and GSH levels.83 In addi - tion, ischemic stroke caused to the down-regulation of SOD  and GSH activity and the up-regulation of methane dicarbox - ylic aldehyde.83 It has been determined that acute ischemic  stroke caused a significant increase of miR-106b-5p.",Non-OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
"2 / May 2017 https://doi.org/10.5853/jos.2016.01368http://j-stroke.org  173emic stroke and are responsible for the migration of the leuko - cytes through the brain endothelial cells.111 During ischemia, neutrophils that are recruited to the isch - emic tissue produced the MMPs to infiltrate the blood brain  barrier (BBB).",Non-OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
"MicroRNAs and Ischemic Stroke https://doi.org/10.5853/jos.2016.01368174 http://j-stroke.orgenzymes, which leads to nDNA damage and apoptotic cell  death.",Non-OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
"2 / May 2017 https://doi.org/10.5853/jos.2016.01368http://j-stroke.org  175ing intracranial hemorrhage,177 and neurotoxicity.178 In addition,  studies showed that inhibition of tPA with plasminogen activa - tor inhibitor-1 or neuroserpin have neuroprotective effects  against ischemic brain damage.179,180 Other alternative treat - ments include the use of other anti-thrombotic agents, me - chanical thrombectomy and anti-platelet agents such as aspi - rin.181 As noted, there are many limitations of thrombolytic  treatment for stroke.",Non-OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
"MicroRNAs and Ischemic Stroke https://doi.org/10.5853/jos.2016.01368176 http://j-stroke.orgemic stroke associated with microglial activation.126 Studies  showed that miR-424 overexpression has a neuroprotective  effect on cerebral ischemia injury through mechanisms relating  to the preventing of microglia activation.116 In the microglia  and macrophages miR-106a and miR-124 leading to increas - ing in IL-10 and TGF- β respectively.118,134,135 In turn, IL-10 and  TGF-β inhibit expression of adhesion molecules in endothelial  cells and production of pro-inflammatory cytokines.191,192  Therefore, TGF- β and IL-10 are neuroprotective factors against  neuro-inflammation.193-195 As mentioned in the other sections, during ischemic stroke,  there is increased production of reactive oxygen free radicals  due to glutamate excitotoxicity.196 Accordingly, the free radical  scavengers potentially have neuroprotective roles.",Non-OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
"2 / May 2017 https://doi.org/10.5853/jos.2016.01368http://j-stroke.org  177survival rate of stroke patients.216 miRNAs that regulate the  process of angiogenesis have been offered as a potential treat - ment strategy for ischemic stroke.217 Overexpression of miR- 210 promotes focal angiogenesis in the adult mouse brain,  which was associated with local increased VEGF levels.204 Also,  miR-210 can trigger vascular endothelial cell migration and  tube formation under hypoxia in vitro .204 Overexpression of  miR-210 in patients with acute ischemic stroke show better  clinical outcomes.218 Hence, miR-210 is specifically sensitive to  hypoxic stimuli in almost all of cells,219 and its expression is  enhanced by hypoxia-related transcription factors, such as  HIF-1 α.220,221 miR-92a regulates angiogenesis targeting several  proangiogenic proteins, including the integrin subunit alpha5.",Non-OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
MicroRNAs and Ischemic Stroke https://doi.org/10.5853/jos.2016.01368178 http://j-stroke.orgprobable that an increasing number of these molecules will prog - ress and will eventually be developed to become approved treat - ment for ischemic stroke in the coming years.,Non-OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
2 / May 2017 https://doi.org/10.5853/jos.2016.01368http://j-stroke.org  1792008;451:1125-1129.,Non-OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
MicroRNAs and Ischemic Stroke https://doi.org/10.5853/jos.2016.01368180 http://j-stroke.orgstroke therapy.,Non-OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
2 / May 2017 https://doi.org/10.5853/jos.2016.01368http://j-stroke.org  1812015;46:513-519.,Non-OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
http://dx.doi.org/10.1007/s12035-016-9842-1.,Non-OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
MicroRNAs and Ischemic Stroke https://doi.org/10.5853/jos.2016.01368182 http://j-stroke.org106.,Non-OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
2 / May 2017 https://doi.org/10.5853/jos.2016.01368http://j-stroke.org  183phages.,Non-OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
MicroRNAs and Ischemic Stroke https://doi.org/10.5853/jos.2016.01368184 http://j-stroke.orgbetween autophagy and apoptosis.,Non-OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
2 / May 2017 https://doi.org/10.5853/jos.2016.01368http://j-stroke.org  185186.,Non-OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
MicroRNAs and Ischemic Stroke https://doi.org/10.5853/jos.2016.01368186 http://j-stroke.org211.,Non-OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
2 / May 2017 https://doi.org/10.5853/jos.2016.01368http://j-stroke.org  187240.,Non-OADS,/arxiv_data1/oa_pdf/18/7f/jos-2016-01368.PMC5466283.pdf
"Copyright © 2017  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/jos-2017-00283.PMC5466284.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405Journal of Stroke 2017;19(2):131-142 https://doi.org/10.5853/jos.2017.00283 Special Review http://j-stroke.org  131In a meta-analysis of individual patient data from 5 randomized controlled trials, endovascular  treatment (EVT) mainly using a stent retriever achieved successful recanalization in 71.1% of  patients suffering from acute stroke due to anterior circulation large artery occlusion (LAO).",Non-OADS,/arxiv_data1/oa_pdf/31/5a/jos-2017-00283.PMC5466284.pdf
"Kim Causes and Solutions of Stent Retriever Failure https://doi.org/10.5853/jos.2017.00283132 http://j-stroke.orgBasic Technique of Stent Retrieval Guiding catheter placement  In an SR thrombectomy for a typical case of acute LAO, a large  bore (8 F or 9 F) balloon guide catheter (BGC) is preferred over a  conventional guide catheter, as a BGC improves the recanaliza - tion rate and clinical outcome.14-16 Inflation of the BGC arrests  the downstream blood flow and thus prevents distal emboliza - tion of captured clots during the retrieval of the clots engaged  by the SR.16,17 A coaxial technique is invariably easier than an  exchange technique for BGC placement.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/jos-2017-00283.PMC5466284.pdf
"2 / May 2017 https://doi.org/10.5853/jos.2017.00283http://j-stroke.org  133usually the case, it is unclear whether to first treat the intracra - nial artery occlusion or the cervical artery occlusion.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/jos-2017-00283.PMC5466284.pdf
Kim Causes and Solutions of Stent Retriever Failure https://doi.org/10.5853/jos.2017.00283134 http://j-stroke.orgvanced to the distal end of the carotid stent to avoid the  SR getting stuck on the struts of the placed carotid stent.,Non-OADS,/arxiv_data1/oa_pdf/31/5a/jos-2017-00283.PMC5466284.pdf
2 / May 2017 https://doi.org/10.5853/jos.2017.00283http://j-stroke.org  135bolization.,Non-OADS,/arxiv_data1/oa_pdf/31/5a/jos-2017-00283.PMC5466284.pdf
"Kim Causes and Solutions of Stent Retriever Failure https://doi.org/10.5853/jos.2017.00283136 http://j-stroke.org(Figure 6).29-36 To prevent repeated re-occlusion in the case of an  LAO due to ICAS, inhibition of the platelet function can play a  key role.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/jos-2017-00283.PMC5466284.pdf
2 / May 2017 https://doi.org/10.5853/jos.2017.00283http://j-stroke.org  137Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/31/5a/jos-2017-00283.PMC5466284.pdf
Kim Causes and Solutions of Stent Retriever Failure https://doi.org/10.5853/jos.2017.00283138 http://j-stroke.orgble.,Non-OADS,/arxiv_data1/oa_pdf/31/5a/jos-2017-00283.PMC5466284.pdf
"2 / May 2017 https://doi.org/10.5853/jos.2017.00283http://j-stroke.org  139of an ICAS occlusion, the problem is mainly due to repeated oc - clusion.29,31–36,48 As mentioned above, a glycoprotein IIb/IIIa in - hibitor can help prevent such reocclusion.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/jos-2017-00283.PMC5466284.pdf
"Kim Causes and Solutions of Stent Retriever Failure https://doi.org/10.5853/jos.2017.00283140 http://j-stroke.orgment of the affected brain indicates not only complete infarction,  but also the breakdown of the blood-brain barrier and potentially  increased hemorrhagic risk.",Non-OADS,/arxiv_data1/oa_pdf/31/5a/jos-2017-00283.PMC5466284.pdf
2 / May 2017 https://doi.org/10.5853/jos.2017.00283http://j-stroke.org  141trieval in acute stroke: the push and fluff technique for  closed-cell stent retrievers.,Non-OADS,/arxiv_data1/oa_pdf/31/5a/jos-2017-00283.PMC5466284.pdf
https://doi.org/10.5853/jos.2017.00283142 http://j-stroke.orgKim Causes and Solutions of Stent Retriever Failure al.,Non-OADS,/arxiv_data1/oa_pdf/31/5a/jos-2017-00283.PMC5466284.pdf
"Copyright © 2017  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/41/jos-2016-01109.PMC5466285.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405http://j-stroke.org  229Letter to the Editor Journal of Stroke 2017;19(2):229-231 https://doi.org/10.5853/ jos.2016.01109  Simple Estimates of Symptomatic Intracranial  Hemorrhage Risk and Outcome after Intravenous  Thrombolysis Using Age and Stroke Severity Hye Jung Lee,a Ji Sung Lee,b Jay Chol Choi,c Yong-Jin Cho,a Beom Joon Kim,d Hee-Joon Bae,d  Dong-Eog Kim,e Wi-Sun Ryu,e Jae-Kwan Cha,f Dae Hyun Kim,f Hyun-Wook Nah,f Kang-Ho Choi,g  Joon-Tae Kim,g Man-Seok Park,g Jeong-Ho Hong,h Sung Il Sohn,h Kyusik Kang,i Jong-Moo Park,i  Wook-Joo Kim,j Jun Lee,k Dong-Ick Shin,l Min-Ju Yeo,l Kyung Bok Lee,m Jae Guk Kim,n Soo Joo Lee,n  Byung-Chul Lee,o Mi Sun Oh,o Kyung-Ho Yu,o Tai Hwan Park,p Juneyoung Lee,q Keun-Sik Honga aDepartment of Neurology, Ilsan Paik Hospital, Inje University, Goyang, Korea bClinical Research Center, Asan Medical Center, Seoul, Korea cDepartment of Neurology, Jeju National University, Jeju, Korea dDepartment of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea eDepartment of Neurology, Dongguk University Ilsan Hospital, Goyang, Korea fDepartment of Neurology, Dong-A University College of Medicine, Busan, Korea gDepartment of Neurology, Chonnam National University Medical School and Hospital, Gwangju, Korea hDepartment of Neurology, Keimyung University Dongsan Medical Center, Daegu, Korea iDepartment of Neurology, Eulji General Hospital, Eulji University, Seoul, Korea jDepartment of Neurology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea kDepartment of Neurology, Yeungnam University Hospital, Daegu, Korea lDepartment of Neurology, Chungbuk National University Hospital, Cheongju, Korea mDepartment of Neurology, Soonchunhyang University College of Medicine, Seoul, Korea nDepartment of Neurology, Eulji University Hospital, Daejeon, Korea oDepartment of Neurology, Hallym University Sacred Heart Hospital, Anyang, Korea pDepartment of Neurology, Seoul Medical Center, Seoul, Korea qDepartment of Biostatistics, Korea University College of Medicine, Seoul, Korea Dear Sir: Several models have been developed to predict the risk of symp - tomatic intracranial hemorrhage (SICH) and functional outcome  in patients treated with intravenous tissue plasminogen activa - tor (IV-TPA).",Non-OADS,/arxiv_data1/oa_pdf/fa/41/jos-2016-01109.PMC5466285.pdf
Risk and Outcome Estimates after Thrombolysishttps://doi.org/10.5853/ jos.2016.01109 230 http://j-stroke.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/fa/41/jos-2016-01109.PMC5466285.pdf
"2 / May 2017https://doi.org/10.5853/ jos.2016.01109 http://j-stroke.org  231NIHSS categories, the relatively small sample in each cell resulted  in a less uniform trend.",OADS,/arxiv_data1/oa_pdf/fa/41/jos-2016-01109.PMC5466285.pdf
"Copyright © 2017  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/10/jos-2016-01655.PMC5466286.pdf
pISSN: 2287-6391 • eISSN: 2287-6405http://j-stroke.org  205 Journal of Stroke 2017;19(2):205-212 https://doi.org/10.5853/jos.2016.01655 Original Article Background  and Purpose  Recombinant tissue plasminogen activator (rtPA) is one of the proven  therapies that improve the outcome of patients with acute ischemic stroke (AIS).,Non-OADS,/arxiv_data1/oa_pdf/6c/10/jos-2016-01655.PMC5466286.pdf
"National project for ischemic stroke in Taiwan https://doi.org/10.5853/jos.2016.01655206 http://j-stroke.orgIntroduction Stroke has been one of the top three causes of death and the  most common cause of disability among adults in Taiwan over  the past 30 years.1,2 The impact of the stroke-related medical  and economic burdens on families and society is considerable.",Non-OADS,/arxiv_data1/oa_pdf/6c/10/jos-2016-01655.PMC5466286.pdf
"2 / May 2017 https://doi.org/10.5853/jos.2016.01655http://j-stroke.org  207item 3 divided by the number of item 1 and then multi - plied by 100%) B.   Protocol adherence rate, indicating the proportion of pa - tients with AIS who qualified for rtPA therapy and re - ceived the treatment (calculated as the number of item 4  divided by the number of item 2 and then multiplied by  100%) C.   In-time treatment rate, indicating the proportion of pa - tients with AIS who received IV rtPA treatment within 60  minutes (calculated as the number of item 5 divided by  the number of item 3 and then multiplied by 100%) D.   SICH rate, indicating the proportion of patients with SICH  after IV rtPA therapy (calculated as the number of item 6  divided by the number of item 3 and then multiplied by  100%)  To achieve HECAL-Stroke accreditation, all hospitals must  reach the minimal target goals within a four-year period, in - cluding a 1% treatment rate, 50% protocol adherence rate,  and 30% in-time treatment rate every year.8 The study protocols were approved by the Institutional Re - view Board of Chi Mei Medical Center (approval No.",Non-OADS,/arxiv_data1/oa_pdf/6c/10/jos-2016-01655.PMC5466286.pdf
"National project for ischemic stroke in Taiwan https://doi.org/10.5853/jos.2016.01655208 http://j-stroke.orgthan 80 years old or 3–4.5 hours of AIS onset, in the MeD  group (Table 2, Figure 3B, Supplementary Table 1, Supplemen - tary Figure 1B).",Non-OADS,/arxiv_data1/oa_pdf/6c/10/jos-2016-01655.PMC5466286.pdf
"2 / May 2017 https://doi.org/10.5853/jos.2016.01655http://j-stroke.org  209Table 1, Supplementary Figure 1C).",Non-OADS,/arxiv_data1/oa_pdf/6c/10/jos-2016-01655.PMC5466286.pdf
"National project for ischemic stroke in Taiwan https://doi.org/10.5853/jos.2016.01655210 http://j-stroke.orgcomplication rates were significant, with the highest rate of  15.6% observed in the MeD group, followed by 5.8% in the HD  group and 5.1% in the MoD group (Table 2, Figure 3D).",Non-OADS,/arxiv_data1/oa_pdf/6c/10/jos-2016-01655.PMC5466286.pdf
2 / May 2017 https://doi.org/10.5853/jos.2016.01655http://j-stroke.org  211time treatment rate increased from 26% to 60.1% from 2009  to 2014.,Non-OADS,/arxiv_data1/oa_pdf/6c/10/jos-2016-01655.PMC5466286.pdf
Supplementary Materials Supplementary materials related to this article can be found  online at https://doi.org/10.5853/jos.2016.01655.,Non-OADS,/arxiv_data1/oa_pdf/6c/10/jos-2016-01655.PMC5466286.pdf
http://www.mohw.gov.tw/CHT/ DOS/Statistic.aspx?f_list_no=474 &fod_list_no=3443.,OADS,/arxiv_data1/oa_pdf/6c/10/jos-2016-01655.PMC5466286.pdf
National project for ischemic stroke in Taiwan https://doi.org/10.5853/jos.2016.01655212 http://j-stroke.org6.,Non-OADS,/arxiv_data1/oa_pdf/6c/10/jos-2016-01655.PMC5466286.pdf
http://www.mohw.gov.tw/CHT/ DOMA/DM1.aspx?f_list_no=935 &fod_list_no=5771.,OADS,/arxiv_data1/oa_pdf/6c/10/jos-2016-01655.PMC5466286.pdf
2 / May 2017 http://j-stroke.org https://doi.org/10.5853/jos.2016.01655Supplementary Methods 1.,Non-OADS,/arxiv_data1/oa_pdf/6c/10/jos-2016-01655.PMC5466286.pdf
National project for ischemic stroke in Taiwan http://j-stroke.org https://doi.org/10.5853/jos.2016.01655 Supplementary Table 1.,Non-OADS,/arxiv_data1/oa_pdf/6c/10/jos-2016-01655.PMC5466286.pdf
2 / May 2017 http://j-stroke.org https://doi.org/10.5853/jos.2016.01655 Treatment rate (%)8 6 4 2 0In-time treatment rate  (%) Protocol adherence rate (%) SICH rate (%)80 60 40 20 030 25 20 15 10 5 0100 80 604020 0 HD MoD MeD Hospital level HD MoD MeD Hospital levelHD MoD MeD Hospital level HD MoD MeD Hospital level2009 2010 2011 2012 2013 2014 (year) 2009 2010 2011 2012 2013 2014 (year) 2009 2010 2011 2012 2013 2014 (year) 2009 2010 2011 2012 2013 2014 (year) Supplementary Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/6c/10/jos-2016-01655.PMC5466286.pdf
"Copyright © 2017  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/4b/jos-2016-01347.PMC5466287.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405http://j-stroke.org  213 Journal of Stroke 2017;19(2):213-221 https://doi.org/10.5853/jos.2016.01347 Original Article Background  and Purpose One explanation  for the ‘obesity paradox’, where obese patients seem to  have better cardiovascular outcomes than lean patients, is that obese patients display an  identifiable high cardiovascular risk phenotype that may lead to receiving or seeking earlier/more  aggressive treatment.",Non-OADS,/arxiv_data1/oa_pdf/d5/4b/jos-2016-01347.PMC5466287.pdf
"Secondary Stroke Prevention by Obesity Status https://doi.org/10.5853/jos.2016.01347214 http://j-stroke.orgbeen proposed for this paradox including that obese patients  display a readily identifiable high cardiovascular risk phenotype  that may lead to their receiving or seeking earlier/more aggres - sive treatment, thereby changing the course of the disease  when compared with lean patients.4 Mounting evidence suggests that the systematic combining  of individually proven secondary prevention drugs may improve  cardiovascular outcomes.5-7 Indeed, a recently published study  found that the optimal combination drug treatment (OCT) for  secondary prevention after a recent stroke was broadly associ - ated with a significantly lower risk of vascular events.8,9 If lean  stroke survivors are actually receiving or seeking later/less ag - gressive treatment than obese stroke patients, OCT may have a  differentially beneficial effect for lean stroke survivors.",Non-OADS,/arxiv_data1/oa_pdf/d5/4b/jos-2016-01347.PMC5466287.pdf
"2 / May 2017 https://doi.org/10.5853/jos.2016.01347http://j-stroke.org  215medication and statin therapy, and antihypertensive medica - tion in the case of established or newly diagnosed hyperten - sion.12 We also reviewed secondary prevention classes (levels 0  to III) using an appropriateness algorithm for various secondary  prevention strategies based on a previous study.13 Composite  OCT level was determined for each patient as follows: level 0,  none of the indicated medications were prescribed; level I, 1  medication was prescribed even though 3 medications were  indicated; level II, 2 medications were prescribed even though  3 medications were indicated or 1 medication was prescribed  even though 2 medications were indicated; and level III, all in - dicated medications were prescribed (AH+AT+LM) as the OCT.",Non-OADS,/arxiv_data1/oa_pdf/d5/4b/jos-2016-01347.PMC5466287.pdf
Secondary Stroke Prevention by Obesity Status https://doi.org/10.5853/jos.2016.01347216 http://j-stroke.orgAdjusted effect of secondary prevention  medication classes on outcome events by obesity  status Table 3 shows the multivariable risk adjusted effect of second - ary prevention OCT on the 2-year risk of outcome events by  appropriateness strata.,Non-OADS,/arxiv_data1/oa_pdf/d5/4b/jos-2016-01347.PMC5466287.pdf
"2 / May 2017 https://doi.org/10.5853/jos.2016.01347http://j-stroke.org  217and level III groups (HR 0.23, 95% CI, 0.10–0.54; P=0.001).",OADS,/arxiv_data1/oa_pdf/d5/4b/jos-2016-01347.PMC5466287.pdf
Secondary Stroke Prevention by Obesity Status https://doi.org/10.5853/jos.2016.01347218 http://j-stroke.orgslopes for the HRs across BMI categories were parallel.,Non-OADS,/arxiv_data1/oa_pdf/d5/4b/jos-2016-01347.PMC5466287.pdf
"2 / May 2017 https://doi.org/10.5853/jos.2016.01347http://j-stroke.org  219obesity paradox was observed in terms of the outcome of  death, its significance disappeared after multivariable adjust - ment.",Non-OADS,/arxiv_data1/oa_pdf/d5/4b/jos-2016-01347.PMC5466287.pdf
"Secondary Stroke Prevention by Obesity Status https://doi.org/10.5853/jos.2016.01347220 http://j-stroke.orgvation of renal function.16 During the VISP trial, the use of RAS  modulator+CCB combination therapy was not high.",Non-OADS,/arxiv_data1/oa_pdf/d5/4b/jos-2016-01347.PMC5466287.pdf
Supplementary Materials Supplementary materials related to this article can be found  online at https://doi.org/10.5853/jos.2016.01347.,Non-OADS,/arxiv_data1/oa_pdf/d5/4b/jos-2016-01347.PMC5466287.pdf
2 / May 2017 https://doi.org/10.5853/jos.2016.01347http://j-stroke.org  221vascular disease.,Non-OADS,/arxiv_data1/oa_pdf/d5/4b/jos-2016-01347.PMC5466287.pdf
Secondary Stroke Prevention by Obesity Status https://doi.org/10.5853/jos.2016.01347 http://j-stroke.orgSupplementary Table 1.,Non-OADS,/arxiv_data1/oa_pdf/d5/4b/jos-2016-01347.PMC5466287.pdf
2 / May 2017 https://doi.org/10.5853/jos.2016.01347 http://j-stroke.orgSupplementary Table 2.,Non-OADS,/arxiv_data1/oa_pdf/d5/4b/jos-2016-01347.PMC5466287.pdf
Secondary Stroke Prevention by Obesity Status https://doi.org/10.5853/jos.2016.01347 http://j-stroke.orgSupplementary Table 3.,Non-OADS,/arxiv_data1/oa_pdf/d5/4b/jos-2016-01347.PMC5466287.pdf
2 / May 2017 https://doi.org/10.5853/jos.2016.01347 http://j-stroke.orgSupplementary Table 4.,Non-OADS,/arxiv_data1/oa_pdf/d5/4b/jos-2016-01347.PMC5466287.pdf
Secondary Stroke Prevention by Obesity Status https://doi.org/10.5853/jos.2016.01347 http://j-stroke.orgSupplementary Table 5.,Non-OADS,/arxiv_data1/oa_pdf/d5/4b/jos-2016-01347.PMC5466287.pdf
2 / May 2017 https://doi.org/10.5853/jos.2016.01347 http://j-stroke.orgSupplementary Table 6.,Non-OADS,/arxiv_data1/oa_pdf/d5/4b/jos-2016-01347.PMC5466287.pdf
Secondary Stroke Prevention by Obesity Status https://doi.org/10.5853/jos.2016.01347 http://j-stroke.orgSupplementary Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/d5/4b/jos-2016-01347.PMC5466287.pdf
"Copyright © 2017  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/86/jos-2016-01739.PMC5466288.pdf
pISSN: 2287-6391 • eISSN: 2287-6405222 http://j-stroke.org  Journal of Stroke 2017;19(2):222-228 https://doi.org/10.5853/jos.2016.01739 Original Article Background  and Purpose  Leptomeningeal collaterals maintain arterial perfusion in acute arterial  occlusion but may fluctuate subject to arterial blood pressure (ABP).,Non-OADS,/arxiv_data1/oa_pdf/c4/86/jos-2016-01739.PMC5466288.pdf
"2 / May 2017http://j-stroke.org  223 https://doi.org/10.5853/jos.2016.01739zation treatment.9 In addition, autoregulation of collaterals  varies, leading to dependence of at-risk tissue on systolic mean  arterial pressure.10 The corollary is that increase in arterial  blood pressure may improve arterial perfusion in acute isch - emic stroke, leading to minimization of final infarct volume in  animal model.11 Furthermore, raised arterial blood pressure may  reduce hypoperfusion in acute ischemic stroke.12,13 Of note, a  U-shaped relationship between blood pressure on hospital ad - mission during the acute phase of ischemic stroke and mortali - ty has been described,14-16 suggesting that undue hypotension  leads to worse outcome, likely explained by underperfusion.",Non-OADS,/arxiv_data1/oa_pdf/c4/86/jos-2016-01739.PMC5466288.pdf
Blood Pressure Relates to Collaterals in Acute Stroke224 http://j-stroke.org https://doi.org/10.5853/jos.2016.01739 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/c4/86/jos-2016-01739.PMC5466288.pdf
"2 / May 2017http://j-stroke.org  225 https://doi.org/10.5853/jos.2016.01739 20 15 10 50 SBP (mm Hg)100 150 200 250rFTD (seconds) 2015 10 50 DBP (mm Hg)40 60 80 100 120rFTD (seconds) 2015 10 50 MBP (mm Hg)60 80 100 120 140rFTD (seconds) 0-5 s) with a large proportion of 0 second (68/270, 25.2%).",Non-OADS,/arxiv_data1/oa_pdf/c4/86/jos-2016-01739.PMC5466288.pdf
Blood Pressure Relates to Collaterals in Acute Stroke226 http://j-stroke.org https://doi.org/10.5853/jos.2016.01739P<0.001) (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/c4/86/jos-2016-01739.PMC5466288.pdf
"2 / May 2017http://j-stroke.org  227 https://doi.org/10.5853/jos.2016.01739patients with pretreatment images and blood pressure records,  therefore we have excluded a group of patients due to lack of  completed data and cannot perform further comparative study  in dynamic blood pressure and reliable collateral circulation  changing.",Non-OADS,/arxiv_data1/oa_pdf/c4/86/jos-2016-01739.PMC5466288.pdf
Blood Pressure Relates to Collaterals in Acute Stroke228 http://j-stroke.org https://doi.org/10.5853/jos.2016.01739sion mismatch analysis in acute stroke.,Non-OADS,/arxiv_data1/oa_pdf/c4/86/jos-2016-01739.PMC5466288.pdf
"Copyright © 2017  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/08/jos-2017-00164.PMC5466289.pdf
pISSN: 2287-6391 • eISSN: 2287-6405152 http://j-stroke.orgJournal of Stroke 2017;19(2):152-165 https://doi.org/10.5853/jos.2017.00164 Review Elevated blood pressure (BP) is the leading modifiable risk factor for stroke and the benefit of BP  lowering therapy on the stroke risk reduction is well established.,Non-OADS,/arxiv_data1/oa_pdf/36/08/jos-2017-00164.PMC5466289.pdf
2 / May 2017 https://doi.org/10.5853/jos.2017.00164http://j-stroke.org  153sociated with an increased risk of stroke mortality.,Non-OADS,/arxiv_data1/oa_pdf/36/08/jos-2017-00164.PMC5466289.pdf
Hong Blood Pressure Management and Stroke https://doi.org/10.5853/jos.2017.00164154 http://j-stroke.orgfrom epidemiological studies.,Non-OADS,/arxiv_data1/oa_pdf/36/08/jos-2017-00164.PMC5466289.pdf
"2 / May 2017 https://doi.org/10.5853/jos.2017.00164http://j-stroke.org  155and other factors.14 Pleiotropic effect, BP variability, and central BP have been  proposed to explain the different effect on stroke outcome be - tween antihypertensive classes.",Non-OADS,/arxiv_data1/oa_pdf/36/08/jos-2017-00164.PMC5466289.pdf
"Hong Blood Pressure Management and Stroke https://doi.org/10.5853/jos.2017.00164156 http://j-stroke.org0.68–0.90).34 In another meta-analysis of 11 placebo-controlled  RCTs published until July 2016, antihypertensive therapy re - duced recurrent stroke (RR 0.73, 95% CI 0.62–0.87), disabling  or fatal stroke (0.71, 0.59–0.85) and vascular death (0.85, 0.75– 0.96).38 Post hoc analyses of R CTs testing intervention  other than BP lowering In a post hoc analysis of the Vitamin Intervention for Stroke  Prevention (VISP) trial which enrolled patients with recent  stroke, patients with mean follow-up BP<140/90 mm Hg versus  those with BP ≥140/90  mm Hg had lower risks of recurrent  stroke (HR 0.76, 95% CI 0.59–0.98) and major cardiovascular  events (0.76, 0.62–0.92).",Non-OADS,/arxiv_data1/oa_pdf/36/08/jos-2017-00164.PMC5466289.pdf
"2 / May 2017 https://doi.org/10.5853/jos.2017.00164http://j-stroke.org  157tensive SPB control was associated with a lower risk of stroke  (OR 0.83, 95% CI 0.73 –0.95) as well as all-cause death (0.90,  0.83–0.98), but with an increased risk of serious adverse events  (1.20, 1.08 –1.32).",Non-OADS,/arxiv_data1/oa_pdf/36/08/jos-2017-00164.PMC5466289.pdf
"Hong Blood Pressure Management and Stroke https://doi.org/10.5853/jos.2017.00164158 http://j-stroke.orgneutral in the intermediate tertile, and worse in the lowest  tertile; P for trend=0.02), suggesting a J-curve phenomenon.",Non-OADS,/arxiv_data1/oa_pdf/36/08/jos-2017-00164.PMC5466289.pdf
2 / May 2017 https://doi.org/10.5853/jos.2017.00164http://j-stroke.org  159to benefit most from intensive BP control.,Non-OADS,/arxiv_data1/oa_pdf/36/08/jos-2017-00164.PMC5466289.pdf
"Hong Blood Pressure Management and Stroke https://doi.org/10.5853/jos.2017.00164160 http://j-stroke.orgdid not reduce functional disability and major cardiovascular  events at 90 days, but had more early neurological deterioration  within 7 days (OR 2.43, 95% CI 1.25–4.73).",Non-OADS,/arxiv_data1/oa_pdf/36/08/jos-2017-00164.PMC5466289.pdf
2 / May 2017 https://doi.org/10.5853/jos.2017.00164http://j-stroke.org  161sive BP lowering (target SBP 140 mm Hg) vs .,Non-OADS,/arxiv_data1/oa_pdf/36/08/jos-2017-00164.PMC5466289.pdf
Hong Blood Pressure Management and Stroke https://doi.org/10.5853/jos.2017.00164162 http://j-stroke.org10.,Non-OADS,/arxiv_data1/oa_pdf/36/08/jos-2017-00164.PMC5466289.pdf
2 / May 2017 https://doi.org/10.5853/jos.2017.00164http://j-stroke.org  16329.,Non-OADS,/arxiv_data1/oa_pdf/36/08/jos-2017-00164.PMC5466289.pdf
Hong Blood Pressure Management and Stroke https://doi.org/10.5853/jos.2017.00164164 http://j-stroke.orgSPRINT starts the marathon.,Non-OADS,/arxiv_data1/oa_pdf/36/08/jos-2017-00164.PMC5466289.pdf
2 / May 2017 https://doi.org/10.5853/jos.2017.00164http://j-stroke.org  165early intensive vs. guideline-recommended blood pressure  lowering in patients with acute ischaemic stroke eligible for  thrombolysis treatment.,Non-OADS,/arxiv_data1/oa_pdf/36/08/jos-2017-00164.PMC5466289.pdf
"Copyright © 2017  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/12/81/jos-2017-00752.PMC5466290.pdf
pISSN: 2287-6391 • eISSN: 2287-6405Journal of Stroke 2017;19(2):121-130 https://doi.org/10.5853/jos.2017.00752 Special Review http://j-stroke.org  121The overwhelming clinical benefit of intra-arterial stroke therapy owes to the major advance in  revascularization brought on by the current generation of thrombectomy devices.,Non-OADS,/arxiv_data1/oa_pdf/12/81/jos-2017-00752.PMC5466290.pdf
"Yoo and Andersson  Addressing Challenges to Stroke Thrombectomy https://doi.org/10.5853/jos.2017.00752122 http://j-stroke.orgapproaching 50%  (Table 1) .12-15 Devices and techniques that are  less prone to clot fragmentation should improve these results,  but there is a likely upper limit to this rate determined by the  prevalence of distal emboli at baseline.",Non-OADS,/arxiv_data1/oa_pdf/12/81/jos-2017-00752.PMC5466290.pdf
"2 / May 2017 https://doi.org/10.5853/jos.2017.00752http://j-stroke.org  123Challenges to procedural success Despite the groundbreaking results of the recent trials, the  variability in angiographic and clinical outcomes highlight  the need to further improve neurointerventional tools and  techniques (Fig ure 3).",Non-OADS,/arxiv_data1/oa_pdf/12/81/jos-2017-00752.PMC5466290.pdf
"Yoo and Andersson  Addressing Challenges to Stroke Thrombectomy https://doi.org/10.5853/jos.2017.00752124 http://j-stroke.orgadded technical difficulty of treating tandem lesions, there is  no justification to withhold treatment from these patients as  the presence of a tandem cervical lesion did not modify treat - ment effect in the recent trials.23 Thrombus removal The primary challenge for neurointerventionists is the 20–30%  of thrombi that are resistant to current retrieval approaches.",Non-OADS,/arxiv_data1/oa_pdf/12/81/jos-2017-00752.PMC5466290.pdf
2 / May 2017 https://doi.org/10.5853/jos.2017.00752http://j-stroke.org  125an intermediate catheter (IMC) in close proximity to the  thrombus ensures that the greatest effective retrieval force is  generated when removing the device (Figure 5).,Non-OADS,/arxiv_data1/oa_pdf/12/81/jos-2017-00752.PMC5466290.pdf
"Yoo and Andersson  Addressing Challenges to Stroke Thrombectomy https://doi.org/10.5853/jos.2017.00752126 http://j-stroke.org(32.8% vs. 23.8%, P=0.053).",Non-OADS,/arxiv_data1/oa_pdf/12/81/jos-2017-00752.PMC5466290.pdf
"2 / May 2017 https://doi.org/10.5853/jos.2017.00752http://j-stroke.org  127friction, once the retrieval is begun, the pull should be steady  until the thrombus is removed from the body.",Non-OADS,/arxiv_data1/oa_pdf/12/81/jos-2017-00752.PMC5466290.pdf
"Yoo and Andersson  Addressing Challenges to Stroke Thrombectomy https://doi.org/10.5853/jos.2017.00752128 http://j-stroke.orgalize distal fragments, originally present or dislodged during  the procedure.",Non-OADS,/arxiv_data1/oa_pdf/12/81/jos-2017-00752.PMC5466290.pdf
Stent retriever thrombectomy versus thrombus com - position (https://doi.org/10.5853/jos.2017.00752.v002).,Non-OADS,/arxiv_data1/oa_pdf/12/81/jos-2017-00752.PMC5466290.pdf
2 / May 2017 https://doi.org/10.5853/jos.2017.00752http://j-stroke.org  1297.,Non-OADS,/arxiv_data1/oa_pdf/12/81/jos-2017-00752.PMC5466290.pdf
Yoo and Andersson  Addressing Challenges to Stroke Thrombectomy https://doi.org/10.5853/jos.2017.00752130 http://j-stroke.org30.,Non-OADS,/arxiv_data1/oa_pdf/12/81/jos-2017-00752.PMC5466290.pdf
"Copyright © 2017  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/1e/jos-2017-00626.PMC5466291.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405http://j-stroke.org  143Journal of Stroke 2017;19(2):143-151 https://doi.org/10.5853/jos.2017.00626 Special Review Intracranial  atherosclerosis-related occlusion (ICAS-O) is frequently encountered at the time of  endovascular revascularization treatment (ERT), especially in Asian countries.",Non-OADS,/arxiv_data1/oa_pdf/4f/1e/jos-2017-00626.PMC5466291.pdf
"https://doi.org/10.5853/jos.2017.00626144 http://j-stroke.org Lee, et al.",OADS,/arxiv_data1/oa_pdf/4f/1e/jos-2017-00626.PMC5466291.pdf
https://doi.org/10.5853/jos.2017.00626http://j-stroke.org  145 Vol.,Non-OADS,/arxiv_data1/oa_pdf/4f/1e/jos-2017-00626.PMC5466291.pdf
"https://doi.org/10.5853/jos.2017.00626146 http://j-stroke.org Lee, et al.",OADS,/arxiv_data1/oa_pdf/4f/1e/jos-2017-00626.PMC5466291.pdf
https://doi.org/10.5853/jos.2017.00626http://j-stroke.org  147 Vol.,Non-OADS,/arxiv_data1/oa_pdf/4f/1e/jos-2017-00626.PMC5466291.pdf
"https://doi.org/10.5853/jos.2017.00626148 http://j-stroke.org Lee, et al.",OADS,/arxiv_data1/oa_pdf/4f/1e/jos-2017-00626.PMC5466291.pdf
https://doi.org/10.5853/jos.2017.00626http://j-stroke.org  149 Vol.,Non-OADS,/arxiv_data1/oa_pdf/4f/1e/jos-2017-00626.PMC5466291.pdf
"https://doi.org/10.5853/jos.2017.00626150 http://j-stroke.org Lee, et al.",OADS,/arxiv_data1/oa_pdf/4f/1e/jos-2017-00626.PMC5466291.pdf
https://doi.org/10.5853/jos.2017.00626http://j-stroke.org  151 Vol.,Non-OADS,/arxiv_data1/oa_pdf/4f/1e/jos-2017-00626.PMC5466291.pdf
"Copyright © 2017  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/02/jos-2017-00192.PMC5466292.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405242 http://j-stroke.org  Journal of Stroke 2017;19(2):242-243 https://doi.org/10.5853/jos.2017.00192 Letter to the Editor Audiovestibular Loss of a Vascular Cause: A Distinction  Should Be Made between Cochlear and Vestibular  Symptoms Antonio Pirodda, Maria Chiara Raimondi, Cristina Brandolini Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy Dear Sir: An interesting paper recently published in Journal of Stroke1  thoroughly reviews the vascular causes of audiovestibular loss  in order to appropriately deal with them.",Non-OADS,/arxiv_data1/oa_pdf/2f/02/jos-2017-00192.PMC5466292.pdf
2 / May 2017 https://doi.org/10.5853/jos.2017.00192http://j-stroke.org  2434.,Non-OADS,/arxiv_data1/oa_pdf/2f/02/jos-2017-00192.PMC5466292.pdf
"Copyright © 2017  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/9d/jos-2016-01102.PMC5466293.pdf
pISSN: 2287-6391 • eISSN: 2287-6405232 http://j-stroke.org Letter to the Editor Journal of Stroke 2017;19(2):232-235 https://doi.org/10.5853/jos.2016.01102 Dear Sir: The factors influencing oral anticoagulant (OAC) prescription  for atrial fibrillation (AF) are not well understood.1-3 Novel oral  anticoagulants (NOACs) have increased treatment options and  complicated the decision making process for patients with AF.,Non-OADS,/arxiv_data1/oa_pdf/9c/9d/jos-2016-01102.PMC5466293.pdf
2 / May 2017http://j-stroke.org  233 https://doi.org/10.5853/jos.2016.01102Table 1.,Non-OADS,/arxiv_data1/oa_pdf/9c/9d/jos-2016-01102.PMC5466293.pdf
"Oral Anticoagulants for Atrial Fibrillation234 http://j-stroke.org https://doi.org/10.5853/jos.2016.01102(19%), and neurologists (33%) thought this statement was false  (P=0.13).",Non-OADS,/arxiv_data1/oa_pdf/9c/9d/jos-2016-01102.PMC5466293.pdf
2 / May 2017http://j-stroke.org  235 https://doi.org/10.5853/jos.2016.01102titudes and approaches but does not directly measure prescrip - tions; this may reflect opinions but not actual clinical practices.,Non-OADS,/arxiv_data1/oa_pdf/9c/9d/jos-2016-01102.PMC5466293.pdf
"Copyright © 2017  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/29/jos-2016-01620.PMC5466294.pdf
pISSN: 2287-6391 • eISSN: 2287-6405http://j-stroke.org  239  Journal of Stroke 2017;19(2):239-241 https://doi.org/10.5853/jos.2016.01620 Letter to the Editor Dear Sir: We have read with interest the article by Bridge and Thijs1 fo- cused on how selecting cryptogenic stroke patients to screen for  atrial fibrillation (AF).,Non-OADS,/arxiv_data1/oa_pdf/11/29/jos-2016-01620.PMC5466294.pdf
"P Wave Dispersion in Cryptogenic Stroke240 http://j-stroke.org https://doi.org/10.5853/jos.2016.01739dy11demonstrated increased PWD values in cryptogenic stroke  patients, also suggesting an association with impaired left atrial  mechanical functions and atrial enlargement, involved in the  pathophysiology of AF.",Non-OADS,/arxiv_data1/oa_pdf/11/29/jos-2016-01620.PMC5466294.pdf
2 / May 2017http://j-stroke.org  241 https://doi.org/10.5853/jos.2016.01739tion after stroke: insights from insertable cardiac monitoring  devices.,Non-OADS,/arxiv_data1/oa_pdf/11/29/jos-2016-01620.PMC5466294.pdf
"Copyright © 2017  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/03/jos-2017-00773.PMC5466295.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405244 http://j-stroke.org Journal of Stroke 2017;19(2):244-245 https://doi.org/10.5853/jos.2017.00773 Response to Letter  Response to Letter by Dr. Cristina Brandolini Hyun-Ah Kim,a,b Hyung Lee,a,b aDepartment of Neurology, Keimyung University School of Medicine, Daegu, Korea bBrain Research Institute, Keimyung University School of Medicine, Daegu, Korea Dear Sir: We appreciate the interest of Dr. Cristina Brandolini and co- workers in our paper1 on the audiovestibular loss of a vascular  cause.",Non-OADS,/arxiv_data1/oa_pdf/fd/03/jos-2017-00773.PMC5466295.pdf
2 / May 2017 https://doi.org/10.5853/jos.2017.00773http://j-stroke.org  245emia.,Non-OADS,/arxiv_data1/oa_pdf/fd/03/jos-2017-00773.PMC5466295.pdf
"Copyright © 2017  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/22/jos-2016-01802.PMC5466296.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405196 http://j-stroke.orgJournal of Stroke 2017;19(2):196-204 https://doi.org/10.5853/jos.2016.01802 Original Article Background  and Purpose  Decreasing the time delay for thrombolysis, including intravenous  thrombolysis (IVT) with tissue plasminogen activator and intra-arterial thrombectomy (IAT), is  critical for decreasing the morbidity and mortality of patients experiencing acute stroke.",Non-OADS,/arxiv_data1/oa_pdf/60/22/jos-2016-01802.PMC5466296.pdf
2 / May 2017 https://doi.org/10.5853/jos.2016.01802http://j-stroke.org  197highly time dependent.,Non-OADS,/arxiv_data1/oa_pdf/60/22/jos-2016-01802.PMC5466296.pdf
"Reduction of Delay for Thrombolysis https://doi.org/10.5853/jos.2016.01802198 http://j-stroke.org(POCT), preparing tPA kits, injecting tPA on the CT table, and the  follow-up group messages.",Non-OADS,/arxiv_data1/oa_pdf/60/22/jos-2016-01802.PMC5466296.pdf
2 / May 2017 https://doi.org/10.5853/jos.2016.01802http://j-stroke.org  199coefﬁcient for each investigator.,Non-OADS,/arxiv_data1/oa_pdf/60/22/jos-2016-01802.PMC5466296.pdf
Reduction of Delay for Thrombolysis https://doi.org/10.5853/jos.2016.01802200 http://j-stroke.organd 47 patients who received thrombolysis (IVT only: n=28; IAT  only: n=13; IVT plus IAT: n=6) after SAT implementation.,Non-OADS,/arxiv_data1/oa_pdf/60/22/jos-2016-01802.PMC5466296.pdf
"2 / May 2017 https://doi.org/10.5853/jos.2016.01802http://j-stroke.org  201Discussion We implemented the SAT that was feasible for 24 h/day as a  prospective performance improvement initiative to minimize  the in-hospital delay for thrombolysis (i.e., IVT and IAT).",Non-OADS,/arxiv_data1/oa_pdf/60/22/jos-2016-01802.PMC5466296.pdf
Reduction of Delay for Thrombolysis https://doi.org/10.5853/jos.2016.01802202 http://j-stroke.orgSAT members for each step.,Non-OADS,/arxiv_data1/oa_pdf/60/22/jos-2016-01802.PMC5466296.pdf
"2 / May 2017 https://doi.org/10.5853/jos.2016.01802http://j-stroke.org  203Conclusions Using a multidisciplinary approach, we showed that SAT signifi - cantly reduced in-hospital delay for thrombolysis treatment.",Non-OADS,/arxiv_data1/oa_pdf/60/22/jos-2016-01802.PMC5466296.pdf
Supplementary Materials Supplementary materials related to this article can be found online at https://doi.org/10.5853/jos.2016.01802 .,Non-OADS,/arxiv_data1/oa_pdf/60/22/jos-2016-01802.PMC5466296.pdf
Reduction of Delay for Thrombolysis https://doi.org/10.5853/jos.2016.01802204 http://j-stroke.org19.,Non-OADS,/arxiv_data1/oa_pdf/60/22/jos-2016-01802.PMC5466296.pdf
2 / May 2017 https://doi.org/10.5853/jos.2016.01802 http://j-stroke.orgSupplementary Methods 1.,Non-OADS,/arxiv_data1/oa_pdf/60/22/jos-2016-01802.PMC5466296.pdf
Reduction of Delay for Thrombolysis https://doi.org/10.5853/jos.2016.01802 http://j-stroke.org(3) it was <12 h after symptom onset.,Non-OADS,/arxiv_data1/oa_pdf/60/22/jos-2016-01802.PMC5466296.pdf
2 / May 2017 https://doi.org/10.5853/jos.2016.01802 http://j-stroke.orgSupplementary Table 1.,Non-OADS,/arxiv_data1/oa_pdf/60/22/jos-2016-01802.PMC5466296.pdf
Reduction of Delay for Thrombolysis https://doi.org/10.5853/jos.2016.01802 http://j-stroke.org Supplementary Table 2.,Non-OADS,/arxiv_data1/oa_pdf/60/22/jos-2016-01802.PMC5466296.pdf
2 / May 2017 https://doi.org/10.5853/jos.2016.01802 http://j-stroke.orgSupplementary Table 3.,Non-OADS,/arxiv_data1/oa_pdf/60/22/jos-2016-01802.PMC5466296.pdf
Reduction of Delay for Thrombolysis https://doi.org/10.5853/jos.2016.01802 http://j-stroke.orgSupplementary Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/60/22/jos-2016-01802.PMC5466296.pdf
2 / May 2017 https://doi.org/10.5853/jos.2016.01802 http://j-stroke.orgSupplementary Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/60/22/jos-2016-01802.PMC5466296.pdf
Reduction of Delay for Thrombolysis https://doi.org/10.5853/jos.2016.01802 http://j-stroke.org0306090120150180210 No Yes EMSP=0.035Door-to-IAT time (min) 0306090120150180210 No YesP=0.044Door-to-IAT time (min) Prenoti/f_ication102030405060 No YesDoor-to-IVT* time (min) EMSP=0.006 0102030405060 No YesDoor-to-IVT* time (min) Prenoti/f_icationP=0.008Prenoti/f_ication No YesEMS No Yes Supplementary Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/60/22/jos-2016-01802.PMC5466296.pdf
"Copyright © 2017  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/a8/jos-2017-01039.PMC5466297.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405http://j-stroke.org  119Journal of Stroke 2017;19(2):119-120 https://doi.org/10.5853/jos.2017.01039 Editorial Endovascular Therapy: The Second Round Begins Jin Soo Lee,a Keun-Sik Hongb aDepartment of Neurology, Ajou University School of Medicine, Suwon, Korea bDepartment of Neurology, Ilsan Paik Hospital, Inje University, Goyang, Korea Recently, randomized controlled trials have consistently con - firmed the benefit of endovascular therapy in patients with  acute large intracranial artery occlusion up to 6 hours.",Non-OADS,/arxiv_data1/oa_pdf/56/a8/jos-2017-01039.PMC5466297.pdf
https://doi.org/10.5853/jos.2017.01039120 http://j-stroke.org Lee and Hong  Endovascular Therapy: The Second Round Beginset al.,Non-OADS,/arxiv_data1/oa_pdf/56/a8/jos-2017-01039.PMC5466297.pdf
"Copyright © 2017  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/f6/jos-2016-01270.PMC5466298.pdf
pISSN: 2287-6391 • eISSN: 2287-6405188 http://j-stroke.org Journal of Stroke 2017;19(2):188-195 https://doi.org/10.5853/jos.2016.01270 Background  and Purpose  Large  cohort studies on relationship between family history of stroke  (FHS) and stroke risk are lacking in Asians.,Non-OADS,/arxiv_data1/oa_pdf/8e/f6/jos-2016-01270.PMC5466298.pdf
"2 / May 2017 https://doi.org/10.5853/jos.2016.01270http://j-stroke.org  189Introduction Stroke is the second most frequent cause of death worldwide.1  In China, there is 2.5 million new stroke cases annually and 7.5  million stroke survivors.2 Therefore, it is important to explore  more efficient and targeted prevention measures to reduce the  stroke incidence.",Non-OADS,/arxiv_data1/oa_pdf/8e/f6/jos-2016-01270.PMC5466298.pdf
Family History and Incident Stroke in Chinese https://doi.org/10.5853/jos.2016.01270190 http://j-stroke.orgdefined as reporting a positive history for either or both par - ents.,Non-OADS,/arxiv_data1/oa_pdf/8e/f6/jos-2016-01270.PMC5466298.pdf
"The  statistical analyses were performed with R software (version  3.1.1, 2014-07-10; R Foundation for Statistical Computing,  http://www.cran.r-project.org/).",OADS,/arxiv_data1/oa_pdf/8e/f6/jos-2016-01270.PMC5466298.pdf
2 / May 2017 https://doi.org/10.5853/jos.2016.01270http://j-stroke.org  191Table 1.,Non-OADS,/arxiv_data1/oa_pdf/8e/f6/jos-2016-01270.PMC5466298.pdf
"Family History and Incident Stroke in Chinese https://doi.org/10.5853/jos.2016.01270192 http://j-stroke.orgmembers with stroke, the age- and gender- adjusted HRs (95%  CIs) of stroke were 1.41 (1.37-1.46), 1.98 (1.86-2.11), and 2.47  (2.15-2.84) for subjects whose FHS involving 1, 2, and ≥3  members ( Ptrend <0.001), respectively, in comparison with those  without FHS.",Non-OADS,/arxiv_data1/oa_pdf/8e/f6/jos-2016-01270.PMC5466298.pdf
2 / May 2017 https://doi.org/10.5853/jos.2016.01270http://j-stroke.org  193(1.48 [1.43-1.54]) and maternal history (1.49 [1.43-1.55]) ( Phet- erogeneity =0.866).,Non-OADS,/arxiv_data1/oa_pdf/8e/f6/jos-2016-01270.PMC5466298.pdf
"Family History and Incident Stroke in Chinese https://doi.org/10.5853/jos.2016.01270194 http://j-stroke.orgChinese population, especially for the individuals with FHS.",Non-OADS,/arxiv_data1/oa_pdf/8e/f6/jos-2016-01270.PMC5466298.pdf
Supplementary Materials Supplementary materials related to this article can be found  online at https://doi.org/10.5853/jos.2016.01270.References  1.,Non-OADS,/arxiv_data1/oa_pdf/8e/f6/jos-2016-01270.PMC5466298.pdf
2 / May 2017 https://doi.org/10.5853/jos.2016.01270http://j-stroke.org  195farction or stroke and risk of cardiovascular disease in the  elderly: the Cardiovascular Health Study.,Non-OADS,/arxiv_data1/oa_pdf/8e/f6/jos-2016-01270.PMC5466298.pdf
Family History and Incident Stroke in Chinese https://doi.org/10.5853/jos.2016.01270 http://j-stroke.orgSupplementary Table 1.,Non-OADS,/arxiv_data1/oa_pdf/8e/f6/jos-2016-01270.PMC5466298.pdf
2 / May 2017 https://doi.org/10.5853/jos.2016.01270 http://j-stroke.orgSupplementary Table 2.,Non-OADS,/arxiv_data1/oa_pdf/8e/f6/jos-2016-01270.PMC5466298.pdf
Family History and Incident Stroke in Chinese https://doi.org/10.5853/jos.2016.01270 http://j-stroke.orgSupplementary Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/8e/f6/jos-2016-01270.PMC5466298.pdf
"2 / May 2017 https://doi.org/10.5853/jos.2016.01270 http://j-stroke.orgAppendix Details for members of the China Kadoorie Biobank collabora - tive group: International Steering Committee: Junshi Chen,  Zhengming Chen (PI), Rory Collins, Liming Li (PI), Richard Peto.",Non-OADS,/arxiv_data1/oa_pdf/8e/f6/jos-2016-01270.PMC5466298.pdf
"Keywords Hyperalgesia, allodynia, reactive oxygen species, central sensitization, capsaicin Date received: 14 March 2017; revised: 9 May 2017; accepted: 11 May 2017 Introduction Central sensitization is deﬁned as an increased respon-siveness of nociceptive neurons in the central nervoussystem to their normal or subthreshold aﬀerent input (see IASP taxonomy webpage: http://www.iasp-pain.",Non-OADS,/arxiv_data1/oa_pdf/82/28/10.1177_1744806917713907.PMC5466348.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4b/3c/ott-10-2805.PMC5466362.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2805–2813OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2805Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12879 7 Panel of seven long noncoding rna as a candidate  prognostic biomarker for ovarian cancer Xiaohui Zhan1,2 chuanpeng Dong3 gang liu3 Yixue li1,2,4 lei liu3 1Key lab of computational Biology,   cas-MPg Partner institute for  computational Biology, shanghai  institutes for Biological sciences,   chinese academy of sciences,   shanghai, 2University of chinese  academy of sciences, Beijing,   3institute of Biomedical sciences,   shanghai Medical college, Fudan  University, shanghai, 4shanghai center  for Bioinformation T echnology,   shanghai industrial Technology  institute, shanghai, People’s  republic of chinaAbstract:  Ovarian cancer is one of the most common and lethal gynecological malignancies.",Non-OADS,/arxiv_data1/oa_pdf/4b/3c/ott-10-2805.PMC5466362.pdf
"Using the publicly released ovarian cancer dataset (GSE9891)15 correspondence: lei liu institute of Biomedical sciences, shanghai  Medical college, Fudan University, 131  Dong-an road, Xuhui, shanghai 200032,  People’s republic of china email liulei_sibs@163.co m  Yixue li Key laboratory of computational  Biology, cas-MPg Partner institute  for computational Biology, shanghai  institutes for Biological sciences, chinese  academy of sciences, Yueyang rd,  shanghai 200031, People’s republic  of china email yxli@sibs.ac.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Zhan et al Running head recto: Panel of seven long noncoding RNA DOI: http://dx.doi.org/10.2147/OTT.S128797",Non-OADS,/arxiv_data1/oa_pdf/4b/3c/ott-10-2805.PMC5466362.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/4b/3c/ott-10-2805.PMC5466362.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/3c/ott-10-2805.PMC5466362.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9d/df/ott-10-2791.PMC5466363.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2791–2804OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2791Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13401 6 silencing of aQP3 induces apoptosis of gastric  cancer cells via downregulation of glycerol intake  and downstream inhibition of lipogenesis and  autophagy liang chen* Zheng li* Qiang Zhang* song Wei Bowen li Xuan Zhang lei Zhang Qing li hao Xu Zekuan Xu Department of general surgery, The  First affiliated hospital of nanjing  Medical University, nanjing, People’s  republic of china *These authors contributed equally  to this workAbstract:  Gastric cancer (GC) has a poor prognosis and is a leading cause of cancer-related  death.",Non-OADS,/arxiv_data1/oa_pdf/9d/df/ott-10-2791.PMC5466363.pdf
"AQP3, a member of the aquaporin family of integral transmembrane proteins, is  mainly expressed in the epithelial cells of the upper digestive tract.2–6 AQP3 is primarily  responsible for transporting water and other small molecules such as glycerol and urea  across the plasma membrane.7–10 AQP3 is also involved in several signal transduc - tion pathways in cancer cells, such as epidermal growth factor receptor signaling and  the stress response via H2O2 transport.11,12 Several studies have implicated abnormal  expression of AQP3 in dysregulation of intestinal barrier integrity and function13 and  in cell proliferation, invasion, migration and apoptosis of various cancer types, includ - ing GC.14–17 In addition, functional inhibition of AQP3 has been reported to block cell  proliferation.18 We have previously demonstrated that AQP3 promotes proliferation  of GC cells by upregulating intracellular lipid metabolism, and the dysregulation of correspondence: hao Xu; Zekuan Xu Department of general surgery, The  First Affiliated Hospital of Nanjing  Medical University, no 300, guangzhou  road, nanjing 210029, Jiangsu, People’s  republic of china Fax +86 025 8378 1992 email hxu@njmu.edu.c n;   xuzekuan@njmu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Chen et al Running head recto: Reduced glycerol uptake induces apoptosis of AQP3-deficient GC cells DOI: http://dx.doi.org/10.2147/OTT.S134016",Non-OADS,/arxiv_data1/oa_pdf/9d/df/ott-10-2791.PMC5466363.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9d/df/ott-10-2791.PMC5466363.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/df/ott-10-2791.PMC5466363.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/6/e1700121/DC1Supplementary Textfig.,Non-OADS,/arxiv_data1/oa_pdf/c7/35/1700121.PMC5466366.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/6/e1602297/DC1section S1.,Non-OADS,/arxiv_data1/oa_pdf/a5/24/1602297.PMC5466367.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/6/e1602562/DC1Cooling rate dependence of the volume fraction of the quenched SkL stateAzimuthal angle profiles measured in the H⊥k iconfiguration Magnetic field and temperature dependence of the quenched SkL statesfig.,Non-OADS,/arxiv_data1/oa_pdf/ad/cb/1602562.PMC5466368.pdf
S15C).SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/6/e1603213/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/bf/dc/1603213.PMC5466369.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/6/e1700176/DC1Sample morphologyC 60Multilayers Stem contrast of the sandwich Fourier filtering Unfiltered stem images of the C 60sandwich Additional filtered views of the C 60sandwich Stem simulations of a C 60-C60with two bonds and singly bonded C 60-C59 fig.,Non-OADS,/arxiv_data1/oa_pdf/df/76/1700176.PMC5466370.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/6/e1602007/DC1The magnetic laboratoryAnalysis and data collection in RActivity level of the animalsProtocol of the tests with the DISC in situ in the fjordCollection and maintenance of the glass eels Statistics Details of the testsAnalysis of the orientation at the individual levelMagnetic laboratory protocol detailsfig.,Non-OADS,/arxiv_data1/oa_pdf/11/7d/1602007.PMC5466372.pdf
"3. International Council for the Exploration of the Sea (ICES), “Report of the Working G r o u po nE e l s( W G E E L ) ”(ICES CM 2016/ACOM:19, ICES, 2016); http://ices.dk/sites/ pub/Publication%20Reports/Expert% 20Group%20Report/acom/2016/WGEEL/ wgeel_2016.pdf.SCIENCE ADVANCES |RESEARCH ARTICLE Cresci et al.,Sci.",Non-OADS,/arxiv_data1/oa_pdf/11/7d/1602007.PMC5466372.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/6/e1602071/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/71/cb/1602071.PMC5466373.pdf
"M. Henry, J. Wendland, P. M. Harrison, D. Hand, “Rapid laser patterning versus wet-etch lithography for flat panel display manufacture: A technical & commercialcomparison (Technical Report M505, Laser Institute of America, 2007);http://www.powerlase-photonics.com/wp-content/uploads/2011/data-sheets/ICALEO07%20Oct07%20Rapid%20Laser%20Patterning.pdf.",Non-OADS,/arxiv_data1/oa_pdf/71/cb/1602071.PMC5466373.pdf
"Futurrex Inc., “Resist Developers ”(Futurrex Inc., 2007); http://futurrex.com/en/products/ resist-developers.html (accessed on May 8, 2017).",OADS,/arxiv_data1/oa_pdf/71/cb/1602071.PMC5466373.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/3/6/e1603180/DC1Supplementary Textfig.,Non-OADS,/arxiv_data1/oa_pdf/f0/ca/1603180.PMC5466374.pdf
"MeSH Keywords:  Estrogen Receptor alpha • Radiation • Transfection • Triple Negative Breast Neoplasms  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/904810Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Radiation Oncology, Fudan University Shanghai Cancer Center,  Shanghai, P.R.",Non-OADS,/arxiv_data1/oa_pdf/70/05/medscimonit-23-2674.PMC5466376.pdf
The variants of the 19 genes in each  sample were annotated using online software Ion Reporter  (https://ionreporter.lifetechnologies.com/ir/secure/home.html).,OADS,/arxiv_data1/oa_pdf/a4/27/ijmm-40-01-0121.PMC5466385.pdf
"The missense variant was considered to be possibly related  with HCM on the basis of the following criteria (19,20):  i) the variant has been reported as an HCM-related muta - tion according to the documents or Human Gene Mutation  Database (HGMD, http://www.hgmd.cf.ac.uk/ac/index.",Non-OADS,/arxiv_data1/oa_pdf/a4/27/ijmm-40-01-0121.PMC5466385.pdf
"php), and/or ii) the predicted amino acid showed a change  in a highly conserved evolution site across many species;  iii) the missense variant was absent in the 100 healthy  controls and its minor allele frequency (MAF) was <5% in the 1000  Genomes Project (http://www.1000genomes.org/),  HapMap (http://hapmap.ncbi.nlm.nih.gov/) and/or Exome  Aggregation Consortium (ExAC) databases (http://exac.",Non-OADS,/arxiv_data1/oa_pdf/a4/27/ijmm-40-01-0121.PMC5466385.pdf
"Evolutionary conservation analysis of the rare and novel  mutations, which were performed in many species (including  Macaca mulatta , Mus musculus , Danio rerio , Drosophila  melanogaster , Xenopus tropicalis , Bos taurus and Loxodonta ),  was conducted using Clustal W (http://www.genome.jp/tools/ clustalw/) and the Weblogo (http://weblogo.berkeley.edu/ logo.cgi) (15).",OADS,/arxiv_data1/oa_pdf/a4/27/ijmm-40-01-0121.PMC5466385.pdf
"Based on the lowest energy theory, the struc - ture of the proteins with a rare mutation found in this study  was predicted by using Robetta (http://robetta.bakerlab.org/)  and SWISS -MODEL (http://www.swissmodel.expasy.org/)  online program, and the result was visualized using the Visual  Molecular Dynamics (VMD) software package (version 1.9.2,  http://www.ks.uiuc.edu/Research/vmd/index.html).",OADS,/arxiv_data1/oa_pdf/a4/27/ijmm-40-01-0121.PMC5466385.pdf
One novel single mutation in TAZ  (p.Ile208Val) was found neither in the 1000 Genomes Project  databases (http://www.1000genomes.org/) nor in the 100 healthy  control chromosomes.,Non-OADS,/arxiv_data1/oa_pdf/a4/27/ijmm-40-01-0121.PMC5466385.pdf
"This mutation had a very low minor allele frequency (1/60,659) in ExAC browser  Beta database (http://exac.broadinstitute.org/).",Non-OADS,/arxiv_data1/oa_pdf/a4/27/ijmm-40-01-0121.PMC5466385.pdf
"The microarray data of  GSE54015 were downloaded, which was deposited in the  National Center of Biotechnology Information (NCBI) Gene  Expression Omnibus  (GEO)  (http://www.ncbi.nlm.nih.gov /geo/)  database by Chiu et al (2).",OADS,/arxiv_data1/oa_pdf/84/06/ijmm-40-01-0137.PMC5466388.pdf
The CEL raw  data were downloaded and preprocessed using oligo (13) in  R of Bioconductor  (http://www.bioconductor.org/packages/ release/bioc/html/) with the method of robust multiarray  average (RMA) (14).,OADS,/arxiv_data1/oa_pdf/84/06/ijmm-40-01-0137.PMC5466388.pdf
"The  GO (http://www.geneontology.org) project is used to provide  consistent descriptors for gene products in different databases,  and to standardize classifications for sequences (17).",OADS,/arxiv_data1/oa_pdf/84/06/ijmm-40-01-0137.PMC5466388.pdf
"The  analysis tool was the Database for Annotation, Visualization  and Integrated Discovery  (DA VID)  (http://david.niaid.nih.",OADS,/arxiv_data1/oa_pdf/84/06/ijmm-40-01-0137.PMC5466388.pdf
The Search Tool for the Retrieval  of Interacting Genes (STRING) (http://string-db.org/) data - base (20) is a precomputed global resource used for evaluating  PPI information.,OADS,/arxiv_data1/oa_pdf/84/06/ijmm-40-01-0137.PMC5466388.pdf
"Additionally, 3 methods including degree  centrality, betweenness centrality and subgraph centrality  were used to analyze the hub gene in the PPI network using  the CytoNCA cytoscape plugin (http://apps.cytoscape.",OADS,/arxiv_data1/oa_pdf/84/06/ijmm-40-01-0137.PMC5466388.pdf
"In order to predict the role of TFs in hypertension,  we selected the TFs from the DEG corresponding proteins,  and predicted the target associations between the TFs  and the DEGs based on the TRANSFAC database in the  iRegulon cytoscape plugin (http://iregulon.aertslab.org) (23),  as previously described.",OADS,/arxiv_data1/oa_pdf/84/06/ijmm-40-01-0137.PMC5466388.pdf
"293T cells (http://www.cellbank.com.cn/) were grown in  Dulbecco's modified Eagle's medium (DMEM; 12491‑015;  Invitrogen, Carlsbad, CA, USA) containing 10% FBS.",Non-OADS,/arxiv_data1/oa_pdf/c2/44/ijmm-40-01-0090.PMC5466391.pdf
"From previous bioinformatic  analyses, particularly research from http://www.targetscan.org/vert_61/ and http://zmf.umm.uni ‑heidelberg.de/apps/zmf/ mirwalk2/ , miR‑24, miR‑34b, miR‑34c, miR‑27a, miR‑122,  miR-128, miR -150, miR -204, miR -214 and miR -216a were  identified as candidate miRNAs for binding to the 3'‑UTR of  CRHR1 mRNA (Fig.",OADS,/arxiv_data1/oa_pdf/c2/44/ijmm-40-01-0090.PMC5466391.pdf
Database searching was performed  using the Mascot (http://www.matrixscience.com) program.RT-qPCR.,OADS,/arxiv_data1/oa_pdf/8a/0d/ijmm-40-01-0047.PMC5466393.pdf
"The analysis of potential microRNA  target sites was performed using the commonly used prediction  algorithm,  miRanda (http://www.microrna.org/).",OADS,/arxiv_data1/oa_pdf/93/69/ijmm-40-01-0083.PMC5466395.pdf
"To further confirm whether PAK1 is regulated  by microRNAs, we used the commonly used prediction algo - rithm,  miRanda (http://www.microrna.org/microrna/home.do),  to analyze the 3' untranslated region (3'UTR) of PAK1.",OADS,/arxiv_data1/oa_pdf/93/69/ijmm-40-01-0083.PMC5466395.pdf
Primer3  was used to design the primers (http://primer3.sourceforge.,OADS,/arxiv_data1/oa_pdf/e6/1e/ijmm-40-01-0146.PMC5466398.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/a1/nihms863136.PMC5466415.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, seven figures, and seven tables and can be found with this  article online at http://dx.doi.org/10.1016/j.celrep.2015.10.004 .",OADS,/arxiv_data1/oa_pdf/27/a1/nihms863136.PMC5466415.pdf
"2017;59:e40Page 1 of 13 REVIEW http://dx.doi.org/10.1590/S1678-9946201759040UNESP - Universidade Estadual Paulista  Julio de Mesquita Filho, Faculdade  de Medicina Veterinária e Zootecnia,  Departamento de Higiene Veterinária e  Saúde Pública, Botucatu, São Paulo, Brazil Correspondence to: Márcio Garcia Ribeiro   Universidade Estadual Paulista Julio de  Mesquita Filho, Faculdade de Medicina  Veterinária e Zootecnia, Departamento  de Higiene Veterinária e Saúde Pública,  CEP 18618-681, Botucatu, SP , Brazil   Tel: +55 14 3880-2102 E-mail: mgribeiro@fmvz.unesp.br Received:  16 September 2016 Accepted:  22 February 2017Diagnosis of mycobacteria in bovine milk: an overview Carmen Alicia Daza Bolaños, Carolina Lechinski de Paula, Simony Trevizan  Guerra, Marília Masello Junqueira Franco, Márcio Garcia Ribeiro   ABSTRACT Tuberculosis remains as the world’s biggest threat.",Non-OADS,/arxiv_data1/oa_pdf/29/5a/1678-9946-rimtspt-S1678-9946201759040.PMC5466425.pdf
[cited  2017 Jan 16] Available from: http://portalsaude.saude.gov.br/ index.php?option=com_content&view=article&id=11045& Itemid=674  17.,Non-OADS,/arxiv_data1/oa_pdf/29/5a/1678-9946-rimtspt-S1678-9946201759040.PMC5466425.pdf
Available from:  http://www.cdc.gov/tb/ publications/factsheets/general/mbovis.htm  24.,Non-OADS,/arxiv_data1/oa_pdf/29/5a/1678-9946-rimtspt-S1678-9946201759040.PMC5466425.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any  medium, provided the original work is not altered or transformed in any way, and that the  work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/3f/ofx052.PMC5466428.pdf
"Available at: https://www.census.gov/quickfacts/table/PST045216/3916000,00.",OADS,/arxiv_data1/oa_pdf/25/3f/ofx052.PMC5466428.pdf
Keywords BOLD fMRI; Denoising methods; Motion artifacts; Physiological noise; Multi-echo; Phase-based  methods This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/BY-NC-ND/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c2/fb/nihms839603.PMC5466511.pdf
"Nomenclature of targets and ligands Key protein targets and ligands in this article arehyperlinked to corresponding entries in http://www.guidetopharmacology.org, the common portal for data fromthe IUPHAR/BPS Guide to PHARMACOLOGY (Southan et al., 2016), and are permanently archived in the Concise Guideto PHARMACOLOGY 2015/16 (Alexander et al., 2015).",OADS,/arxiv_data1/oa_pdf/83/a7/BPH-174-2085.PMC5466536.pdf
https://doi.org/10.1111/bph.13820 Figure S1 Speci ﬁcity of anti-S1P 1antibody used and negative control experiment of immunohistochemistry in BJPRY a m a m o t oe ta l .,Non-OADS,/arxiv_data1/oa_pdf/83/a7/BPH-174-2085.PMC5466536.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/aa/main.PMC5466546.pdf
"The  esophagoscopy revealed  the  narrowing  of  the  esophagus  at  12  cm  of  dental  arch, and  anterior  bourgeoning  yellow  mass  bleeding  easily  on  contact http://dx.doi.org/10.1016/j.ijscr.2017.05.028 2210-2612/© 2017  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/2a/aa/main.PMC5466546.pdf
The study inclusion criteria were: 1–The samples were performed by autopsy within 2 h (the time in- terval between death and sampling) after death of the subjects; http://dx.doi.org/10.1016/j.bbacli.2017.05.002 Received 28 February 2017; Received in revised form 3 May 2017; Accepted 10 May 2017⁎Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/8c/02/main.PMC5466547.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/02/main.PMC5466547.pdf
"Transparency document The http://dx.doi.org/10.1016/j.bbacli.2017.05.002 associated with this article can be found, in online version.Acknowledgements Authors thank the grant from “Fund of the First President of the Republic of Kazakhstan “.",Non-OADS,/arxiv_data1/oa_pdf/8c/02/main.PMC5466547.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/22/main.PMC5466548.pdf
The  classic  presentation  of  bilateral non-tender cervical  adenopathy  occurs  in  approximately  90%  of http://dx.doi.org/10.1016/j.ijscr.2017.05.011 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/85/22/main.PMC5466548.pdf
"5  (2)  (2010)  19–30  (Accessed  April  6,  2015)  http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/85/22/main.PMC5466548.pdf
"12  (4)  (2010) 194–196  (accessed  April  6,  2015)  http://www.jkscience.org/archive/ volume124/Rosai-DorfmanDisease.pdf .",Non-OADS,/arxiv_data1/oa_pdf/85/22/main.PMC5466548.pdf
"185  (4)  (2005)  971–972  (Accessed  April  6, 2015) http://www.ajronline.org/doi/pdf/10.2214/AJR.05.0224 .",Non-OADS,/arxiv_data1/oa_pdf/85/22/main.PMC5466548.pdf
"[4]  D. Samir, E.  Sagatys,  S. Lubomir, K.  Timothy,  Rosai-Dorfman  disease:  tumor biology,  clinical  features,  pathology,  and  treatment,  Cancer  Control  21  (4) (2014) 322–326  (Accessed  April  6,  2015)  https://www.mercy.net/sites/default/ ﬁles/vendor-resources/dalia  et  al  ccj  rosai  dorfman  oct  2014.pdf .",Non-OADS,/arxiv_data1/oa_pdf/85/22/main.PMC5466548.pdf
"21  (6)  (1997)  664–668 (Accessed  April  6,  2015)  http://ovidsp.tx.ovid.com.arktos.nyit.edu/sp-3.21.0a/ ovidweb.cgi?&S=NKABFPDCFNDDHEFANCIKJHJCLKPKAA00&Link+Set=S.sh.48%7c1%7csl 10.",Non-OADS,/arxiv_data1/oa_pdf/85/22/main.PMC5466548.pdf
"95  (2015)  758–759  (Accessed  April  12,  2015)  http://www.google.com/ url?sa=t&rct=j&q=&esrc=s&source=web&cd=4&cad=rja&uact=8&ved=0CDQQFjAD&url=http://www.medicaljournals.se/acta/content/download.php?doi=10.2340/00015555-2057&ei=aGo VaTeOMLXsAWkzYH4DA&usg =AFQjCNEuXZnCaDJR6RAiQE7p8cqDTkCxMg&sig2=hUE5YyEu SDFE1FpVYtjQA .",Non-OADS,/arxiv_data1/oa_pdf/85/22/main.PMC5466548.pdf
"[7] A. Perera, A. Keleher, M. Nath, Rosai-Dorfman  disease  presenting  as  a  male breast mass,  The  American  Surgeon  73  (3)  (2007)  294–295  (Accessed  April  6, 2015)  http://www.ncbi.nlm.nih.gov/pubmed/17375792 .",Non-OADS,/arxiv_data1/oa_pdf/85/22/main.PMC5466548.pdf
"54  (3)  (2010)  349–352  (accessed April 6, 2015)  http://www.ncbi.nlm.nih.gov/pubmed/20518426 .",Non-OADS,/arxiv_data1/oa_pdf/85/22/main.PMC5466548.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/57/f7/main.PMC5466549.pdf
"During  surgery,  the  colon  was  noted  to  be  discolored,  dark red  and  spotty,  with  the  presence  of  pneumatosis  intestinalis, http://dx.doi.org/10.1016/j.ijscr.2017.05.038 2210-2612/© 2017  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/57/f7/main.PMC5466549.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/c3/main.PMC5466550.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.05.036 2049-0801/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/c3/main.PMC5466550.pdf
This  is  an  open  access  article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/1c/main.PMC5466552.pdf
"Two  weeks  post  internal  ﬁxation,  the  external  ﬁxator  was http://dx.doi.org/10.1016/j.ijscr.2017.05.029 2210-2612/© 2017  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.",Non-OADS,/arxiv_data1/oa_pdf/d9/1c/main.PMC5466552.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/1f/main.PMC5466553.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com/locate/ijppaw http://dx.doi.org/10.1016/j.ijppaw.2017.05.003 2213-2244/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0d/1f/main.PMC5466553.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/95/main.PMC5466554.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/95/main.PMC5466554.pdf
http://dx.doi.org/10.1016/j.eucr.2017.04.015Urology Case Reports 14 (2017) 15 e17,Non-OADS,/arxiv_data1/oa_pdf/ac/95/main.PMC5466554.pdf
http://dx.doi.org/10.1371/journal.pone.0096705 .,Non-OADS,/arxiv_data1/oa_pdf/ac/95/main.PMC5466554.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/af/main.PMC5466556.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com/locate/ijppaw http://dx.doi.org/10.1016/j.ijppaw.2017.05.004 2213-2244/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/af/main.PMC5466556.pdf
Blackwell Pub- lishing Ltd. 1 e8.http://dx.doi.org/10.1111/1755-0998.12082 (Accessed 3 March 2017).,Non-OADS,/arxiv_data1/oa_pdf/c6/af/main.PMC5466556.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9c/90/main.PMC5466558.pdf
"However,  since  she  had  varicosities  in the  left  labia  majora,  she  ﬁrst  underwent  color  Doppler  ultrasonog- http://dx.doi.org/10.1016/j.ijscr.2017.05.006 2210-2612/© 2017  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/9c/90/main.PMC5466558.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/2f/main.PMC5466559.pdf
Laboratory  data http://dx.doi.org/10.1016/j.ijscr.2017.05.031 2210-2612/© 2017  The  Author(s).,OADS,/arxiv_data1/oa_pdf/5f/2f/main.PMC5466559.pdf
"66  (2009)  168–173,  http://dx.doi.org/10.1016/ j.jsurg.2008.12.001.4 .",OADS,/arxiv_data1/oa_pdf/5f/2f/main.PMC5466559.pdf
"7  (2014)  265–270,  http://dx.doi.org/10.1007/s12328-014- 0480-8  (Epub  2014  Apr  3).",Non-OADS,/arxiv_data1/oa_pdf/5f/2f/main.PMC5466559.pdf
"31  (2014)  79–86,  http://dx.doi.org/ 10.1159/000357149 .",Non-OADS,/arxiv_data1/oa_pdf/5f/2f/main.PMC5466559.pdf
"38  (2009)  261–266,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5f/2f/main.PMC5466559.pdf
"18 (2012)  1538–1544,  http://dx.doi.org/10.3748/wjg.v18.",Non-OADS,/arxiv_data1/oa_pdf/5f/2f/main.PMC5466559.pdf
"37  (2009)  132–135,  http://dx.doi.org/10.1002/dc.20985 .",Non-OADS,/arxiv_data1/oa_pdf/5f/2f/main.PMC5466559.pdf
"5  (2016) 396–398,  http://dx.doi.org/10.4103/2303-9027.195873 .",Non-OADS,/arxiv_data1/oa_pdf/5f/2f/main.PMC5466559.pdf
"At day 0, routine hematological parameters were normal; blood and urine cultures were sterile; c-reactive protein, erythrocyte sedimenta- tion rate, serum levels of liver enzymes, bilirubin and lactate dehy- drogenase were within reference ranges; serologic tests for human im- munode ﬁciency virus (HIV), hepatitis B virus, hepatitis C virus, herpes simplex virus, Borrelia burgdorferi ,Brucella ,Bartonella ,Histoplasma and interferon-gamma release assays were negative; previous contact/in- fection and immunity –immunoglobulin (Ig) M negative and IgG po- sitive –were documented to Chlamydia trachomatis , epstein-barr virus, Chlamydophila pneumoniae , Cytomegalovirus, Toxoplasma and Varicella zoster ; routine serologic antibodies for autoimmune diseases were also http://dx.doi.org/10.1016/j.mmcr.2017.04.003 Received 4 January 2017; Received in revised form 9 April 2017; Accepted 24 April 2017⁎Corresponding author.Medical Mycology Case Reports 17 (2017) 14–16 Available online 29 April 2017 2211-7539/ © 2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3a/a3/main.PMC5466580.pdf
This is an open access article under the CC  BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/3a/a3/main.PMC5466580.pdf
Received 22 March 2017; accepted 24 March 2017; http://dx.doi.org/10.1016/j.omtm.2017.03.008 .,Non-OADS,/arxiv_data1/oa_pdf/75/09/main.PMC5466581.pdf
1 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/75/09/main.PMC5466581.pdf
This is a n open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: StatinsSedentary lifestyleCardiovascular prevention 1.,Non-OADS,/arxiv_data1/oa_pdf/bd/f5/main.PMC5466582.pdf
http://dx.doi.org/10.1016/j.pmedr.2017.05.019 2211-3355/© 2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bd/f5/main.PMC5466582.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/f5/main.PMC5466582.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/bd/f5/main.PMC5466582.pdf
A full list of PONS investigators and participant institutions can be found at http://www.projectpons.pl .,Non-OADS,/arxiv_data1/oa_pdf/bd/f5/main.PMC5466582.pdf
Health Metrics 11:7. http://dx.doi.org/10.1186/1478-7954-11-7 .,Non-OADS,/arxiv_data1/oa_pdf/bd/f5/main.PMC5466582.pdf
Lan- cethttp://dx.doi.org/10.1016/S0140-6736(16)30370-1 .,OADS,/arxiv_data1/oa_pdf/bd/f5/main.PMC5466582.pdf
http://dx.doi.org/10.1016/j.amepre.2015.05.023 .108 G.D. Vaidean et al.,OADS,/arxiv_data1/oa_pdf/bd/f5/main.PMC5466582.pdf
12:156. http://dx.doi.org/10.1186/s12966-015- 0315-0 .,Non-OADS,/arxiv_data1/oa_pdf/bd/f5/main.PMC5466582.pdf
http://dx.doi.org/10.1016/S0140- 6736(12)61426-3 .,OADS,/arxiv_data1/oa_pdf/bd/f5/main.PMC5466582.pdf
http://dx.doi.org/10.1001/jamainternmed.2014.2266 .,OADS,/arxiv_data1/oa_pdf/bd/f5/main.PMC5466582.pdf
http://dx.doi.org/10.1136/bjsports-2015-f5577rep .,Non-OADS,/arxiv_data1/oa_pdf/bd/f5/main.PMC5466582.pdf
"http://stakeholders.ofcom.org.uk/market- data-research/market-data/communications- market-reports/cmr15/international/ (Accessed September 15, 2016).",OADS,/arxiv_data1/oa_pdf/bd/f5/main.PMC5466582.pdf
http://dx.doi.org/10.1093/eurheartj/ehw106 .,Non-OADS,/arxiv_data1/oa_pdf/bd/f5/main.PMC5466582.pdf
http://dx.doi.org/10.1249/MSS.0000000000000520 .,Non-OADS,/arxiv_data1/oa_pdf/bd/f5/main.PMC5466582.pdf
BMJ 333 (7557):15. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bd/f5/main.PMC5466582.pdf
http://dx.doi.org/10.1016/j.jacc.2013.11.002 .,OADS,/arxiv_data1/oa_pdf/bd/f5/main.PMC5466582.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bd/f5/main.PMC5466582.pdf
http://dx.doi.org/10.1097/EDE.,Non-OADS,/arxiv_data1/oa_pdf/bd/f5/main.PMC5466582.pdf
http://dx.doi.org/10.1016/j.amepre.2011.,OADS,/arxiv_data1/oa_pdf/bd/f5/main.PMC5466582.pdf
"http://www.bls.gov/news.release/atus.nr0.htm .A c c e s s e dS e p t e m - ber 15, 2016).",Non-OADS,/arxiv_data1/oa_pdf/bd/f5/main.PMC5466582.pdf
http://dx.doi.org/10.1161/CIR.0000000000000440 .109 G.D. Vaidean et al.,OADS,/arxiv_data1/oa_pdf/bd/f5/main.PMC5466582.pdf
"18Although PEG-ADA replacement was withdrawn in our trial, the patients never received preconditioning chemotherapy before the Received 4 April 2016; accepted 18 May 2017; http://dx.doi.org/10.1016/j.omtm.2017.05.005 .",Non-OADS,/arxiv_data1/oa_pdf/c2/89/main.PMC5466583.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c2/89/main.PMC5466583.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes three ﬁgures and four tables and can be found with this article online at http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/c2/89/main.PMC5466583.pdf
"In addition, the immune capacity in the human body plays a critical role in the induction and deterioration of athero-sclerosis, with monocytes/macrophages playing critical roles in this http://dx.doi.org/10.1016/j.redox.2017.05.027 Received 21 May 2017; Accepted 31 May 2017⁎Correspondence to: Department of Physical Therapy, College of Medicine, National Cheng Kung University, 701 No.",Non-OADS,/arxiv_data1/oa_pdf/26/9e/main.PMC5466584.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/26/9e/main.PMC5466584.pdf
This sensitivity is due to the reactivity and position of the selenocysteine (Sec) residue in the open C-terminal of TrxR's active site http://dx.doi.org/10.1016/j.redox.2017.05.024 Received 2 May 2017; Received in revised form 29 May 2017; Accepted 30 May 2017⁎Corresponding authors.,Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"S1) (Central Institute for Experi- mental Animals, Japan; http://www.ciea.or.jp ).",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2017.05.024 .,OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"36 (2006) 609 –662, http://dx.doi.org/10.1080/ 10408440600845619 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"256 (2011) 405 –417, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"283 (2008) 11913– 11923, http://dx.doi.org/10.1074/jbc.M710133200 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"Rooney, The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury, Toxicology 234 (2007) 145 –156, http://dx.doi.org/ 10.1016/j.tox.2007.02.016 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"66 (2014) 75 –87,http://dx.doi.org/10.1016/j.freeradbiomed.2013.07.036 .",OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"396 (2010) 120–124, http://dx.doi.org/10.1016/j.bbrc.2010.03.083 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"288 (2013) 32241 –32247, http://dx.doi.org/ 10.1074/jbc.M113.495150 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"48 (2010) 1370 –1381, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"286 (2015) 216 –223, http://dx.doi.org/10.1016/j.taap.2015.05.002 .",OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"251 (2011) 95 –103, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"52 (2012) 781 –793, http://dx.doi.org/10.1016/j.freeradbiomed.",OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"62 (2000) 33 –57,http://dx.doi.org/10.1016/j.pneurobio.2014.01.002 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"5 (1985) 816 –831, http://dx.doi.org/10.1093/ toxsci/5.5.816 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"26 (2014) 40 –51,http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"[17] P. Kaur, M. Aschner, T. Syversen, Glutathione modulation in ﬂuences methyl mer- cury induced neurotoxicity in primary cell cultures of neurons and astrocytes,Neurotoxicology 27 (2006) 492 –500, http://dx.doi.org/10.1016/j.neuro.2006.01.",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"James, W. Slikker, S. Melnyk, E. New, M. Pogribna, S. Jernigan, Thimerosal neurotoxicity is associated with glutathione depletion: protection with glutathioneprecursors, Neurotoxicology 26 (2005) 1 –8,http://dx.doi.org/10.1016/j.neuro.",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"2016 (2016) 1 –11,http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"284 (2009) 8233 –8240, http://dx.doi.org/10.1074/jbc.M809338200 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"287 (2012) 38210 –38219, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"21 (2014) 669 –681, http://dx.doi.org/10.1089/ars.2013.5499 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"9 (2012) 119 –125, http://dx.doi.org/10.1038/nchembio.1142 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"73 (2014) 95 –105, http://dx.doi.org/10.1016/j.freeradbiomed.",OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"72 (1976) 248 –254, http://dx.doi.org/10.1016/0003-2697(76)90527-3 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"(2001), http://dx.doi.org/10.1002/0471140856.tx0704s05 Chapter 7, Unit 7.4.",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"252 (1995) 283–292, http://dx.doi.org/10.1016/0076-6879(95)52031-7 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"1 (2006) 3159 –3165, http://dx.doi.org/10.1038/nprot.2006.378 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"393 (2009) 129 –131, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"347 (2002) 317 –326, http://dx.doi.org/10.1016/S0076-6879(02) 47031-0 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"45 (2008) 494 –502, http://dx.doi.org/10.1016/j.freeradbiomed.2008.04.",OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"473 (2010) 179 –197, http://dx.doi.org/10.1016/S0076- 6879(10)73009-3 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"(2009) e990, http://dx.doi.org/10.3791/990 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"Health Part B 20 (2017) 119 –154, http://dx.doi.org/10.1080/10937404.2017.1289834 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"38 (2005) 1543 –1552, http://dx.doi.org/10.1016/j.freeradbiomed.",OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"288 (2013) 26497 –26504, http://dx.doi.org/10.1074/jbc.R113.461368 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"276 (2001) 26269 –26275, http://dx.doi.org/ 10.1074/jbc.M011605200 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"191 (2002) 95 –104, http://dx.doi.org/10.1002/jcp.10080 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"85 (2003) 50 –61,http://dx.doi.org/10.1046/j.1471-4159.",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"275 (2000)26576 –26581, http://dx.doi.org/10.1074/jbc.M003412200 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"100 (2007) 109 –117, http://dx.doi.org/10.1093/toxsci/kfm205 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"101 (2008) 341 –349, http://dx.doi.org/ 10.1093/toxsci/kfm273 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"20(2000) 2198 –2208, http://dx.doi.org/10.1128/MCB.20.6.2198-2208.2000 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"90 (2002) 1259 –1266, http://dx.doi.org/10.1161/01.RES.0000022160.64355.62 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"1780 (2008) 1325 –1336, http://dx.doi.org/10.1016/j.bbagen.2007.12.",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"32 (2015) 200 –208, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"Public Health 3 (2006) 38 –42,http://dx.doi.org/10.3390/ijerph2006030005 .",Non-OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"[53] Z. Yin, E. Lee, M. Ni, H. Jiang, D. Milatovic, L. Rongzhu, et al., Methylmercury- induced alterations in astrocyte functions are attenuated by ebselen, Neurotoxicology 32 (2011) 291 –299, http://dx.doi.org/10.1016/j.neuro.2011.01.",OADS,/arxiv_data1/oa_pdf/33/27/main.PMC5466585.pdf
"The number of individuals su ﬀering from macular degeneration http://dx.doi.org/10.1016/j.redox.2017.05.015 Received 17 April 2017; Accepted 23 May 2017⁎Corresponding author at: 380 Lions Research Bldg., 2001 6th St.",Non-OADS,/arxiv_data1/oa_pdf/96/6c/main.PMC5466586.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/96/6c/main.PMC5466586.pdf
Supporting information Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2017.05.015 .,OADS,/arxiv_data1/oa_pdf/96/6c/main.PMC5466586.pdf
"〈http://www.eyeresearch.org/pdf/ValueBrochure/Value_of_Vision_Research_ Brochure_Page_1.pdf 〉, 2013.",Non-OADS,/arxiv_data1/oa_pdf/96/6c/main.PMC5466586.pdf
"The ligation of GPIIb/IIIa and ﬁbrinogen leads to platelet aggregation and further trigger a second wave of intracellular stimulatory signals (so called “outside-in ”sig- naling) that results in stabilization of platelet aggregates, platelet http://dx.doi.org/10.1016/j.redox.2017.05.019 Received 3 April 2017; Received in revised form 22 May 2017; Accepted 25 May 2017⁎Corresponding author at: Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung, Taiwan.",Non-OADS,/arxiv_data1/oa_pdf/b3/7a/main.PMC5466588.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b3/7a/main.PMC5466588.pdf
The crystal structure was downloaded from the Protein DataBank ( http://www.rcsb.org/pdb/index.html ; PDB code: 4EKZ).,OADS,/arxiv_data1/oa_pdf/b3/7a/main.PMC5466588.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/7f/main.PMC5466592.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.06.001 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/7f/main.PMC5466592.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 22 (2017) 15 e18,Non-OADS,/arxiv_data1/oa_pdf/ef/7f/main.PMC5466592.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0a/be/main.PMC5466594.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.05.005 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0a/be/main.PMC5466594.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 22 (2017) 19 e23,Non-OADS,/arxiv_data1/oa_pdf/0a/be/main.PMC5466594.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e7/d7/main.PMC5466595.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals .elsevier.com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2017.05.004 2352-2895/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/d7/main.PMC5466595.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 7 (2017) 74 e79,Non-OADS,/arxiv_data1/oa_pdf/e7/d7/main.PMC5466595.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/55/main.PMC5466596.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.05.009 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a8/55/main.PMC5466596.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 22 (2017) 24 e27,Non-OADS,/arxiv_data1/oa_pdf/a8/55/main.PMC5466596.pdf
"We previously http://dx.doi.org/10.1016/j.redox.2017.06.001 Received 23 March 2017; Received in revised form 17 May 2017; Accepted 1 June 2017⁎Correspondence to: Department of Kinesiology and Nutrition and Department of Physical Therapy, University of Illinois at Chicago, 1919 W. Taylor St. (AHSB), Room 506J, Chicago, IL 60612, USA.",Non-OADS,/arxiv_data1/oa_pdf/d1/5c/main.PMC5466665.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d1/5c/main.PMC5466665.pdf
- Korean J Orthod 2017;47:77-86 https://doi.org/10.4041/kjod.2017.47.4.213213www.e-kjo.orgpISSN 2234-7518 eISSN 2005-372X,Non-OADS,/arxiv_data1/oa_pdf/a1/18/kjod-47-213.PMC5466902.pdf
"Replied by  Yoon Jeong Choi Department of Orthodontics, College of Dentistry, Yonsei University,  Seoul, Korea www.e-kjo.org https://doi.org/10.4041/kjod.2017.47.4.213This is an Open Access article distributed under the terms of the  Creative Commons Attribution n on-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.References 1.",Non-OADS,/arxiv_data1/oa_pdf/a1/18/kjod-47-213.PMC5466902.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttps://doi.org/10.4041/kjod.2017.47.4.215",Non-OADS,/arxiv_data1/oa_pdf/40/86/kjod-47-215.PMC5466903.pdf
Kim • Perception of orthodontic treatment according to age www.e-kjo.org 216 https://doi.org/10.4041/kjod.2017.47.4.215 INTRODUCTION The increase in average life expectancy and national  income has led to an increase in the number of middle- aged or old adult patients receiving orthodontic tre-atment.,Non-OADS,/arxiv_data1/oa_pdf/40/86/kjod-47-215.PMC5466903.pdf
Kim • Perception of orthodontic treatment according to age www.e-kjo.org 217 https://doi.org/10.4041/kjod.2017.47.4.215 Percentage of interest in orthodontic treatment com­ pared by age The rate of positive perception towards orthodontic  treatment was 48.5% within the total sampled po-pulation (Figure 1).,OADS,/arxiv_data1/oa_pdf/40/86/kjod-47-215.PMC5466903.pdf
Kim • Perception of orthodontic treatment according to age www.e-kjo.org 218 https://doi.org/10.4041/kjod.2017.47.4.215 Order of priority of chief complaints according to age The order of priority of chief complaints showed  definite differences according to age.,Non-OADS,/arxiv_data1/oa_pdf/40/86/kjod-47-215.PMC5466903.pdf
"Kim • Perception of orthodontic treatment according to age www.e-kjo.org 219 https://doi.org/10.4041/kjod.2017.47.4.215 that even respondents in their 40s and 50s showed  considerably high interest towards orthodontic treatment (46.2% and 45.1%, respectively).",Non-OADS,/arxiv_data1/oa_pdf/40/86/kjod-47-215.PMC5466903.pdf
Kim • Perception of orthodontic treatment according to age www.e-kjo.org 220 https://doi.org/10.4041/kjod.2017.47.4.215 more scientific information to the middle-aged about  the limitations and possibilities of orthodontic treatment in order to increase its acceptance.,Non-OADS,/arxiv_data1/oa_pdf/40/86/kjod-47-215.PMC5466903.pdf
Kim • Perception of orthodontic treatment according to age www.e-kjo.org 221 https://doi.org/10.4041/kjod.2017.47.4.215 Supplement 1.,Non-OADS,/arxiv_data1/oa_pdf/40/86/kjod-47-215.PMC5466903.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttps://doi.org/10.4041/kjod.2017.47.4.222",Non-OADS,/arxiv_data1/oa_pdf/1b/56/kjod-47-222.PMC5466904.pdf
Lee et al • Botox induces bony change www.e-kjo.org 223 https://doi.org/10.4041/kjod.2017.47.4.222 INTRODUCTION Both genetic and environmental factors play im - portant roles in determining craniofacial morphology.,OADS,/arxiv_data1/oa_pdf/1b/56/kjod-47-222.PMC5466904.pdf
Lee et al • Botox induces bony change www.e-kjo.org 224 https://doi.org/10.4041/kjod.2017.47.4.222 an upright position with maximum intercuspation.,OADS,/arxiv_data1/oa_pdf/1b/56/kjod-47-222.PMC5466904.pdf
Lee et al • Botox induces bony change www.e-kjo.org 225 https://doi.org/10.4041/kjod.2017.47.4.222 Table 1.,OADS,/arxiv_data1/oa_pdf/1b/56/kjod-47-222.PMC5466904.pdf
"Lee et al • Botox induces bony change www.e-kjo.org 226 https://doi.org/10.4041/kjod.2017.47.4.222 Hard-tissue changes: Width and volume of the mandibular  angle area  No statistically significant differences in the width of  the mandibular angle area were observed within either group, or between the two groups.",OADS,/arxiv_data1/oa_pdf/1b/56/kjod-47-222.PMC5466904.pdf
Lee et al • Botox induces bony change www.e-kjo.org 227 https://doi.org/10.4041/kjod.2017.47.4.222 mandibular angle volume in the single injection group.,OADS,/arxiv_data1/oa_pdf/1b/56/kjod-47-222.PMC5466904.pdf
Lee et al • Botox induces bony change www.e-kjo.org 228 https://doi.org/10.4041/kjod.2017.47.4.222 disuse induced by the Clostridium botulinum toxin.,OADS,/arxiv_data1/oa_pdf/1b/56/kjod-47-222.PMC5466904.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttps://doi.org/10.4041/kjod.2017.47.4.229",Non-OADS,/arxiv_data1/oa_pdf/0a/be/kjod-47-229.PMC5466905.pdf
Choi et al • Mechanical properties of zirconia micro-implants www.e-kjo.org 230 https://doi.org/10.4041/kjod.2017.47.4.229 INTRODUCTION The use of orthodontic micro-implants or temporary  anchorage devices for orthodontic treatment for  reinforcement of anchorage without reliance on patient compliance has increased in popularity.,Non-OADS,/arxiv_data1/oa_pdf/0a/be/kjod-47-229.PMC5466905.pdf
Choi et al • Mechanical properties of zirconia micro-implants www.e-kjo.org 231 https://doi.org/10.4041/kjod.2017.47.4.229 composition and mechanical properties of zirconia and  titanium alloy are shown in Table 1.,OADS,/arxiv_data1/oa_pdf/0a/be/kjod-47-229.PMC5466905.pdf
"Choi et al • Mechanical properties of zirconia micro-implants www.e-kjo.org 232 https://doi.org/10.4041/kjod.2017.47.4.229 version 16.0; SPSS, Chicago, IL, USA).",OADS,/arxiv_data1/oa_pdf/0a/be/kjod-47-229.PMC5466905.pdf
Choi et al • Mechanical properties of zirconia micro-implants www.e-kjo.org 233 https://doi.org/10.4041/kjod.2017.47.4.229 Table 4.,OADS,/arxiv_data1/oa_pdf/0a/be/kjod-47-229.PMC5466905.pdf
"Choi et al • Mechanical properties of zirconia micro-implants www.e-kjo.org 234 https://doi.org/10.4041/kjod.2017.47.4.229 from that required to displace titanium alloy micro- implants at any distances or angulations ( p > 0.05,  independent t-test) (Table 4).",OADS,/arxiv_data1/oa_pdf/0a/be/kjod-47-229.PMC5466905.pdf
Choi et al • Mechanical properties of zirconia micro-implants www.e-kjo.org 235 https://doi.org/10.4041/kjod.2017.47.4.229 zirconia micro-implants and further biomechanical and  histomorphometric investigations are needed.,Non-OADS,/arxiv_data1/oa_pdf/0a/be/kjod-47-229.PMC5466905.pdf
Choi et al • Mechanical properties of zirconia micro-implants www.e-kjo.org 236 https://doi.org/10.4041/kjod.2017.47.4.229 CONCLUSION The zirconia micro-implants used in this study demo- nstrated acceptable initial stability without fracture  during the tests.,OADS,/arxiv_data1/oa_pdf/0a/be/kjod-47-229.PMC5466905.pdf
Choi et al • Mechanical properties of zirconia micro-implants www.e-kjo.org 237 https://doi.org/10.4041/kjod.2017.47.4.229 Recommended placement torque when tightening  an orthodontic mini-implant.,Non-OADS,/arxiv_data1/oa_pdf/0a/be/kjod-47-229.PMC5466905.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttps://doi.org/10.4041/kjod.2017.47.4.238",Non-OADS,/arxiv_data1/oa_pdf/6d/ca/kjod-47-238.PMC5466906.pdf
"Yun et al • Recycling of retrieved orthodontic miniscrews www.e-kjo.org 239 https://doi.org/10.4041/kjod.2017.47.4.238 INTRODUCTION   Orthodontic miniscrews are commonly used to  reinforce anchorage, as they can be placed at various sites, do not depend on patient compliance, and can be loaded immediately.",Non-OADS,/arxiv_data1/oa_pdf/6d/ca/kjod-47-238.PMC5466906.pdf
Yun et al • Recycling of retrieved orthodontic miniscrews www.e-kjo.org 240 https://doi.org/10.4041/kjod.2017.47.4.238 were performed under general anesthesia.,OADS,/arxiv_data1/oa_pdf/6d/ca/kjod-47-238.PMC5466906.pdf
Yun et al • Recycling of retrieved orthodontic miniscrews www.e-kjo.org 241 https://doi.org/10.4041/kjod.2017.47.4.238 engine driver.,OADS,/arxiv_data1/oa_pdf/6d/ca/kjod-47-238.PMC5466906.pdf
Yun et al • Recycling of retrieved orthodontic miniscrews www.e-kjo.org 242 https://doi.org/10.4041/kjod.2017.47.4.238 on a graph (Figure 5).,OADS,/arxiv_data1/oa_pdf/6d/ca/kjod-47-238.PMC5466906.pdf
"Yun et al • Recycling of retrieved orthodontic miniscrews www.e-kjo.org 243 https://doi.org/10.4041/kjod.2017.47.4.238 Mechanical characteristics   All 10 (5 MS, 5 ES) unused screws were successfully  inserted in artificial bone, whereas 2 recycled MS and 2 recycled ES failed to penetrate the cortical bone (40% failure rate).",Non-OADS,/arxiv_data1/oa_pdf/6d/ca/kjod-47-238.PMC5466906.pdf
"Yun et al • Recycling of retrieved orthodontic miniscrews www.e-kjo.org 244 https://doi.org/10.4041/kjod.2017.47.4.238 Biological responses   According to the healing period, PTV showed an  increasing tendency, with the increase at 8 weeks show-ing statistical significance (Table 4).",OADS,/arxiv_data1/oa_pdf/6d/ca/kjod-47-238.PMC5466906.pdf
"Yun et al • Recycling of retrieved orthodontic miniscrews www.e-kjo.org 245 https://doi.org/10.4041/kjod.2017.47.4.238 with treated surfaces is gradually increasing, with im- proved success rates.9,10 Therefore, we assessed both MS  and ES in the present study.",Non-OADS,/arxiv_data1/oa_pdf/6d/ca/kjod-47-238.PMC5466906.pdf
Yun et al • Recycling of retrieved orthodontic miniscrews www.e-kjo.org 246 https://doi.org/10.4041/kjod.2017.47.4.238 Orthodontic miniscrews are primarily fabricated from  Ti6Al4V alloy.,OADS,/arxiv_data1/oa_pdf/6d/ca/kjod-47-238.PMC5466906.pdf
Yun et al • Recycling of retrieved orthodontic miniscrews www.e-kjo.org 247 https://doi.org/10.4041/kjod.2017.47.4.238 3.,Non-OADS,/arxiv_data1/oa_pdf/6d/ca/kjod-47-238.PMC5466906.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttps://doi.org/10.4041/kjod.2017.47.4.248",Non-OADS,/arxiv_data1/oa_pdf/48/12/kjod-47-248.PMC5466907.pdf
"Anderson et al • Craniofacial pattern in snoring children www.e-kjo.org 249 https://doi.org/10.4041/kjod.2017.47.4.248 INTRODUCTION Snoring is the primary symptom of pediatric sleep- disordered breathing (SDB).1 Persistent snoring in  children is considered a warning sign because it may  progress into more severe obstructive sleep apnea (OSA),2  leading to irreparable problems such as somatic growth retardation, behavioral and cognitive disturbance, low performance in school, and craniofacial deformation.",Non-OADS,/arxiv_data1/oa_pdf/48/12/kjod-47-248.PMC5466907.pdf
"Anderson et al • Craniofacial pattern in snoring children www.e-kjo.org 250 https://doi.org/10.4041/kjod.2017.47.4.248 previous ENT surgery, previous orthodontic treatment,  other medical and genetic disorders, congenital craniofacial anomaly, severe psychological or behavioral problems, and severe obesity.",Non-OADS,/arxiv_data1/oa_pdf/48/12/kjod-47-248.PMC5466907.pdf
Anderson et al • Craniofacial pattern in snoring children www.e-kjo.org 251 https://doi.org/10.4041/kjod.2017.47.4.248 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/48/12/kjod-47-248.PMC5466907.pdf
"Anderson et al • Craniofacial pattern in snoring children www.e-kjo.org 252 https://doi.org/10.4041/kjod.2017.47.4.248 RESULTS The intra-examiner reliability of the cephalometric  values was examined by using the intraclass correlation  coefficient (r = 0.815), which indicated high rep-roducibility of measurements.",OADS,/arxiv_data1/oa_pdf/48/12/kjod-47-248.PMC5466907.pdf
Anderson et al • Craniofacial pattern in snoring children www.e-kjo.org 253 https://doi.org/10.4041/kjod.2017.47.4.248 providing clinical evidence on the latest age when AT  surgery ought to be recommended to the patient.,Non-OADS,/arxiv_data1/oa_pdf/48/12/kjod-47-248.PMC5466907.pdf
"Anderson et al • Craniofacial pattern in snoring children www.e-kjo.org 254 https://doi.org/10.4041/kjod.2017.47.4.248 Nevertheless, he acknowledged that orthodontic or  orthopedic treatment was inevitable in many of these patients because the growth acceleration was not always sufficient to resolve the already-formed discrepancy.",Non-OADS,/arxiv_data1/oa_pdf/48/12/kjod-47-248.PMC5466907.pdf
Anderson et al • Craniofacial pattern in snoring children www.e-kjo.org 255 https://doi.org/10.4041/kjod.2017.47.4.248 Otorhinolaryngol 2010;74:137-43.,Non-OADS,/arxiv_data1/oa_pdf/48/12/kjod-47-248.PMC5466907.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttps://doi.org/10.4041/kjod.2017.47.4.256",Non-OADS,/arxiv_data1/oa_pdf/cb/17/kjod-47-256.PMC5466908.pdf
"Song et al • Stability of preorthodontic orthognathic surgery www.e-kjo.org 257 https://doi.org/10.4041/kjod.2017.47.4.256 INTRODUCTION Conventional orthognathic surgery (CS) for patients  with skeletal Class III malocclusion and facial asymmetry  comprises three steps: presurgical orthodontic treatment, orthognathic surgery, and postsurgical orthodontic treatment.",Non-OADS,/arxiv_data1/oa_pdf/cb/17/kjod-47-256.PMC5466908.pdf
Song et al • Stability of preorthodontic orthognathic surgery www.e-kjo.org 258 https://doi.org/10.4041/kjod.2017.47.4.256 piece Le Fort I and mandibular bilateral intraoral vertical  ramus osteotomy.,OADS,/arxiv_data1/oa_pdf/cb/17/kjod-47-256.PMC5466908.pdf
Song et al • Stability of preorthodontic orthognathic surgery www.e-kjo.org 259 https://doi.org/10.4041/kjod.2017.47.4.256 Reliability  All variables for 20 randomly selected patients were  measured by one author and repeated after a 2-week  interval.,OADS,/arxiv_data1/oa_pdf/cb/17/kjod-47-256.PMC5466908.pdf
Song et al • Stability of preorthodontic orthognathic surgery www.e-kjo.org 260 https://doi.org/10.4041/kjod.2017.47.4.256 the difference in measurements between the deviated  and nondeviated sides at each time point.,OADS,/arxiv_data1/oa_pdf/cb/17/kjod-47-256.PMC5466908.pdf
"Song et al • Stability of preorthodontic orthognathic surgery www.e-kjo.org 261 https://doi.org/10.4041/kjod.2017.47.4.256 and point B [SNB]; angle of the lines connecting point  A, the nasion, and point B [ANB]; angle of the plane formed by the sella and the nasion to the mandibular plane formed by the gonion and the mention [SN-MP]; and menton deviation) between men and women.",Non-OADS,/arxiv_data1/oa_pdf/cb/17/kjod-47-256.PMC5466908.pdf
"Song et al • Stability of preorthodontic orthognathic surgery www.e-kjo.org 262 https://doi.org/10.4041/kjod.2017.47.4.256 Surgical changes between the two groups at T1–T2 Immediately after surgery, the ramal length on the  nondeviated side in both the CS group and the POGS  group decreased significantly at −8.6 ± 3.6 mm and −8.5 ± 2.8 mm, respectively ( p < 0.001; Table 3).",Non-OADS,/arxiv_data1/oa_pdf/cb/17/kjod-47-256.PMC5466908.pdf
Song et al • Stability of preorthodontic orthognathic surgery www.e-kjo.org 263 https://doi.org/10.4041/kjod.2017.47.4.256 mandibular body length decreased by 1.3 ± 1.9 mm on  the nondeviated side ( p = 0.021) in the CS group (Table  4).,OADS,/arxiv_data1/oa_pdf/cb/17/kjod-47-256.PMC5466908.pdf
Song et al • Stability of preorthodontic orthognathic surgery www.e-kjo.org 264 https://doi.org/10.4041/kjod.2017.47.4.256 The hypothesis was that there would be no significant  difference in the transverse dental axis of either arch with and without presurgical orthodontic treatment 1 year after surgery in patients with mandibular prognathism and facial asymmetry.,Non-OADS,/arxiv_data1/oa_pdf/cb/17/kjod-47-256.PMC5466908.pdf
Song et al • Stability of preorthodontic orthognathic surgery www.e-kjo.org 265 https://doi.org/10.4041/kjod.2017.47.4.256 correction of the skeletal discrepancy (Table 3).,Non-OADS,/arxiv_data1/oa_pdf/cb/17/kjod-47-256.PMC5466908.pdf
"Song et al • Stability of preorthodontic orthognathic surgery www.e-kjo.org 266 https://doi.org/10.4041/kjod.2017.47.4.256 and dental measurements, including the buccolingual  dental axis of either arch, between the CS and POGS groups.",OADS,/arxiv_data1/oa_pdf/cb/17/kjod-47-256.PMC5466908.pdf
Song et al • Stability of preorthodontic orthognathic surgery www.e-kjo.org 267 https://doi.org/10.4041/kjod.2017.47.4.256 using 3-dimensional computed tomography.,OADS,/arxiv_data1/oa_pdf/cb/17/kjod-47-256.PMC5466908.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSCase Report pISSN 2234-7518 • eISSN 2005-372Xhttps://doi.org/10.4041/kjod.2017.47.4.268 268",Non-OADS,/arxiv_data1/oa_pdf/0b/78/kjod-47-268.PMC5466909.pdf
"Jung et al • Maxillary molar derotation and distalization www.e-kjo.org 269 https://doi.org/10.4041/kjod.2017.47.4.268 INTRODUCTION   Although conventional brackets have proven effective  in the migration of teeth to desired positions, the use of these brackets causes oral discomfort and makes hygiene control difficult.",Non-OADS,/arxiv_data1/oa_pdf/0b/78/kjod-47-268.PMC5466909.pdf
Jung et al • Maxillary molar derotation and distalization www.e-kjo.org 270 https://doi.org/10.4041/kjod.2017.47.4.268 TREATMENT OBJECTIVES   Derotation of the maxillary left first premolar and  maxillary left first molar was needed to gain sufficient space for the eruption of the maxillary left second premolar.,Non-OADS,/arxiv_data1/oa_pdf/0b/78/kjod-47-268.PMC5466909.pdf
Jung et al • Maxillary molar derotation and distalization www.e-kjo.org 271 https://doi.org/10.4041/kjod.2017.47.4.268 was successively regained after 2.5 months without  spring reactivation during the monthly check-ups.,OADS,/arxiv_data1/oa_pdf/0b/78/kjod-47-268.PMC5466909.pdf
"Jung et al • Maxillary molar derotation and distalization www.e-kjo.org 272 https://doi.org/10.4041/kjod.2017.47.4.268 unintentionally leaving patients in poor oral health.8,9  The aim of this treatment was to achieve a similar  treatment outcome rather than better results with a simpler appliance than the ones used in conventional treatment methods.",Non-OADS,/arxiv_data1/oa_pdf/0b/78/kjod-47-268.PMC5466909.pdf
"Jung et al • Maxillary molar derotation and distalization www.e-kjo.org 273 https://doi.org/10.4041/kjod.2017.47.4.268 anchorage preparation, simple wire-bonding was used  without miniscrew anchorage in this case.",Non-OADS,/arxiv_data1/oa_pdf/0b/78/kjod-47-268.PMC5466909.pdf
Jung et al • Maxillary molar derotation and distalization www.e-kjo.org 274 https://doi.org/10.4041/kjod.2017.47.4.268 applicable if the anchorage is reinforced by using  miniscrews or by splinting with adjacent teeth.,Non-OADS,/arxiv_data1/oa_pdf/0b/78/kjod-47-268.PMC5466909.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Ahn SH, Koo ST , Do JW , et al.",Non-OADS,/arxiv_data1/oa_pdf/24/bc/acupmed-2016-011105.PMC5466910.pdf
"See: http://creativecommons.org/licenses/by- nc/4.0/ REFERENCES 1 Lim B, Manheimer E, Lao L, et al.",Non-OADS,/arxiv_data1/oa_pdf/b7/29/acupmed-2015-010854.PMC5466911.pdf
http://www.missingdata.org.uk 13 Lee Y-H. A note on Rao ’s reduction of Potthof and Roy ’s generalized linear model.,Non-OADS,/arxiv_data1/oa_pdf/b7/29/acupmed-2015-010854.PMC5466911.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Li X, Tian P .",Non-OADS,/arxiv_data1/oa_pdf/65/d3/acupmed-2016-011216.PMC5466912.pdf
"See: http://creativecommons.org/licenses/by- nc/4.0/ REFERENCES 1 Landgren K, Hallström I.",OADS,/arxiv_data1/oa_pdf/87/79/acupmed-2016-011208.PMC5466913.pdf
See: http://creativecommons.org/licenses/by- nc/4.0/REFERENCES 1 English B. Neural and psychosocial mechanisms of pain sensitivity in fibromyalgia.,Non-OADS,/arxiv_data1/oa_pdf/96/b0/acupmed-2015-010986.PMC5466914.pdf
"See: http://creativecommons.org/licenses/by- nc/4.0/ REFERENCES 1 T albott JF , Loy DN, Liu Y , Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes.Exp Neurol 2005;192:11 –24.",Non-OADS,/arxiv_data1/oa_pdf/79/b7/acupmed-2016-011134.PMC5466916.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Vixner L, Schytt E, Stener-Victorin E, et al.",Non-OADS,/arxiv_data1/oa_pdf/f1/ed/acupmed-2016-011164.PMC5466917.pdf
To view  please visit the journal online (http://dx.doi.org/10.1136/archdischild-2015-309813).,Non-OADS,/arxiv_data1/oa_pdf/c5/c2/archdischild-2015-309813.PMC5466918.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Janicke DM, Steele RG, Gayes LA, et al.",Non-OADS,/arxiv_data1/oa_pdf/c5/c2/archdischild-2015-309813.PMC5466918.pdf
http://www.who.int/growthref/tools/en (accessed 17 Aug 2014).,OADS,/arxiv_data1/oa_pdf/c5/c2/archdischild-2015-309813.PMC5466918.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Bravo JA, Dinan TG, Cryan JF .",Non-OADS,/arxiv_data1/oa_pdf/4b/39/acupmed-2016-011080.PMC5466919.pdf
http://www.csp.org.uk/ your-health/healthy-living/public-information-lea ﬂets/ back-pain-myth-busters 4 Daily Mail back pain article.,Non-OADS,/arxiv_data1/oa_pdf/03/cc/bjsports-2016-097253.PMC5466921.pdf
http://www.dailymail.co.,Non-OADS,/arxiv_data1/oa_pdf/03/cc/bjsports-2016-097253.PMC5466921.pdf
"https://twitter.com/ search?q=%23backmyths&src=typd PostScript To cite McCarthy CJ, Yeowell G. Br J Sports Med  2017;51:758.",Non-OADS,/arxiv_data1/oa_pdf/03/cc/bjsports-2016-097253.PMC5466921.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/archdischild-2016-311530).,Non-OADS,/arxiv_data1/oa_pdf/47/ce/archdischild-2016-311530.PMC5466923.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Diabetes Control and Complication Trial Research Group.,Non-OADS,/arxiv_data1/oa_pdf/47/ce/archdischild-2016-311530.PMC5466923.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Mathews B.,Non-OADS,/arxiv_data1/oa_pdf/5d/75/archdischild-2016-311540.PMC5466924.pdf
General Assembly Resolution 217 A. December 1948. http://www.un.org/en/universal-declaration-human-rights/ (Accessed December 2016).,Non-OADS,/arxiv_data1/oa_pdf/5d/75/archdischild-2016-311540.PMC5466924.pdf
"Convention on the elimination of all forms of discrimination against women, 1979. http://www.un.org/womenwatch/daw/cedaw/ (Accessed December 2016).",Non-OADS,/arxiv_data1/oa_pdf/5d/75/archdischild-2016-311540.PMC5466924.pdf
https://www.unicef.org/crc/ ﬁles/Rights_overview.pdf (Accessed December 2016).,Non-OADS,/arxiv_data1/oa_pdf/5d/75/archdischild-2016-311540.PMC5466924.pdf
"ISBN:978-92-806-4703-7. https://www.unicef.org/publications/index_69875.html (Accessed December 2016).Table 4 Useful educational resources about FGM/C for health professionals Resource Available from Female genital mutilation: Australian law, policy and practical challenges for doctorshttps://www.ag.gov.au/publications/documents/reviewofaustraliasfemalegenitalmutilationlegalframework/review%20of%20australias%20female%20genital%20mutilation%20legal%20framework.pdf Female Genital Mutilation FGM/C —Issues for Clinical Practice DVDhttp://www.rch.org.au/erc/media_production/Female_Genital_Mutilation_FGM_-_Issues_for_Clinical_ Practice/ Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) —FGM e learning training packagehttp://www.ranzcog.edu.au New Zealand FGM/C Education ProgrammeFemale Genital MutilationInformation for Health & Child Protection Professionalshttp://fgm.co.nz/resources/ The Royal Women ’s Hospital Female circumcision (traditional cutting) and the law in Victoriahttps://thewomens.r.worldssl.net/images/uploads/fact-sheets/Female-circumcision-and-the-Law.pdf Family Planning VictoriaImproving the health care of women and girls affected byfemale genital mutilation/cutting: A service coordination guidehttp://www.fpv.org.au/assets/GUIDEBOOK-FARREP-Service-Coordination-GuideFINALJuly292013.pdf The National Education Toolkit for FGM/C Awareness (NETFA):National Standards Framework for FGM/C-related Educational Resourceshttp://www.netfa.com.au/downloads/NETFA%202015%20National%20Standards%20Framework.pdf New South Wales Educational program on Female Genital Mutilationhttp://www.dhi.health.nsw.gov.au/NSW-Education-Program-on-Female-Genital-Mutilation/Resources/default.aspx Government of Western Australia Department of Health.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/archdischild-2016-311540.PMC5466924.pdf
"E-learning package for health professionalshttp://www.wnhs.health.wa.gov.au/services/womens_health_policy_and_projects/elearning/fgm/story.html No FGM Australia http://www.nofgmoz.com/for-professionals/ FGM/C, female genital mutilation/cutting.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/archdischild-2016-311540.PMC5466924.pdf
2014. http://www.kidsnewtocanada.ca/screening/fgm 14 Denholm N. Female genital mutilation in New Zealand: understanding and responding.,Non-OADS,/arxiv_data1/oa_pdf/5d/75/archdischild-2016-311540.PMC5466924.pdf
"Female Genital Mutilation/Cutting: A Global Concern, February 2016. https://www.unicef.org/media/ ﬁles/FGMC_2016_brochure_ ﬁnal_UNICEF_SPREAD.",Non-OADS,/arxiv_data1/oa_pdf/5d/75/archdischild-2016-311540.PMC5466924.pdf
https://www.gov.uk/government/uploads/system/uploads/attachment_data/ ﬁle/461524/FGM_Statement_September_2015.pdf (Accessed December 2016).,Non-OADS,/arxiv_data1/oa_pdf/5d/75/archdischild-2016-311540.PMC5466924.pdf
"Female Genital Mutilation (FGM) Enhanced Dataset April 2015 to March 2016, Experimental Statistics, July 2016. http://content.digital.nhs.uk/catalogue/PUB21206 (Accessed December 2016).",Non-OADS,/arxiv_data1/oa_pdf/5d/75/archdischild-2016-311540.PMC5466924.pdf
2013. https://www.ranzcog.edu.au/RANZCOG_SITE/media/DOCMAN-ARCHIVE/Female%20Genital%20Mutilation%20(C-Gyn%201)%20Review%20Nov13.pdf (Accessed December 2016).,Non-OADS,/arxiv_data1/oa_pdf/5d/75/archdischild-2016-311540.PMC5466924.pdf
2014. http://www.dhi.health.nsw.gov.au/NSW-Education- Program-on-Female-Genital-Mutilation/NSW-Education-Program-on-Female-Genital-Mutilation/default.aspx (Accessed December 2016).,Non-OADS,/arxiv_data1/oa_pdf/5d/75/archdischild-2016-311540.PMC5466924.pdf
2014. http://whwest.org.,Non-OADS,/arxiv_data1/oa_pdf/5d/75/archdischild-2016-311540.PMC5466924.pdf
2012. http://www.sahealth.sa.gov.au/wps/wcm/connect/04961e804ee46be5bc81bdd150ce4f37/Female-genital-mutilation-WCHN-PPG-20032012.pdf?MOD=AJPERES (Accessed December 2016).,Non-OADS,/arxiv_data1/oa_pdf/5d/75/archdischild-2016-311540.PMC5466924.pdf
2016. http://www.wnhs.health.wa.gov.au/health_professionals/WHCSP/docs/FGC_M_A_guide_for_health_professionals_booklet.pdf (Accessed December 2016).,Non-OADS,/arxiv_data1/oa_pdf/5d/75/archdischild-2016-311540.PMC5466924.pdf
2015. http://www.rcpch.ac.uk/ bpsu-female-genital-mutilation-children-and-young-people-under-age-16-uk-and-roi (Accessed December 2016).,Non-OADS,/arxiv_data1/oa_pdf/5d/75/archdischild-2016-311540.PMC5466924.pdf
"http://www.cdc.gov/nchs/fastats/  leading-causes-of-death.htm (accessed November 29, 2016).",Non-OADS,/arxiv_data1/oa_pdf/c3/31/jgc-14-05-342.PMC5466941.pdf
"https://health.gov/  dietaryguidelines/2015/guidelin es/chapter-1/ (accessed Feb- ruary 26, 2017).",Non-OADS,/arxiv_data1/oa_pdf/c3/31/jgc-14-05-342.PMC5466941.pdf
"https://health.gov/dietaryguidelines/2015-scienti-fic-report/PDFs/Scientific-Report-of-the-2015-Dietary-Guidelines-Advisory-Committee.pdf (Accessed November 29, 2016).",Non-OADS,/arxiv_data1/oa_pdf/c3/31/jgc-14-05-342.PMC5466941.pdf
"Vitamin B12, 2016. http://www.merckmanuals.",Non-OADS,/arxiv_data1/oa_pdf/b6/f0/jgc-14-05-355.PMC5466942.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)CP is inef ﬁcient at inducing PC AK Swidnicka-Siergiejko et al 3158 Oncogene (2017) 3149 –3158",Non-OADS,/arxiv_data1/oa_pdf/d0/80/onc2016461a.PMC5467016.pdf
"Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu) OPEN Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual diseasemonitoring in a phase II trial for multiple myeloma Leukemia (2017) 31,1446 –1449; doi:10.1038/leu.2017.58 Theﬁrst step for the cure of multiple myeloma (MM) is to achieve a complete response (CR);1,2however, regardless of CR improvement, most patients experience disease progression orrelapse in part due to the persistence of low levels of clonalplasma cells after treatment (minimal residual disease (MRD)).",Non-OADS,/arxiv_data1/oa_pdf/9f/02/leu201758a.PMC5467041.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017Letters to the Editor 1449 © 2017 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/9f/02/leu201758a.PMC5467041.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)Kd vs Vd in relapsed/refractory MM based on cytogenetic risk W-J Chng et al 1374 Leukemia (2017) 1368 –1374",Non-OADS,/arxiv_data1/oa_pdf/1c/e9/leu2016390a.PMC5467042.pdf
"This article is published under the terms of the Creative Commons Attribution-NonCommercial-No Derivatives License (CC BY NC ND) https://creativecommons.org/licenses/by-nc-nd/4.0/.Letters to the Editor 1461 © 2017 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/41/5f/leu201776a.PMC5467043.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu) Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma Leukemia (2017) 31,1463 –1466; doi:10.1038/leu.2017.83 Frontline induction chemotherapy followed by high-dose therapy (HDT) and autologous stem cell transplantation (ASCT) remains thestandard treatment for newly diagnosed multiple myeloma(NDMM) in transplant-eligible patients.",Non-OADS,/arxiv_data1/oa_pdf/41/5f/leu201776a.PMC5467043.pdf
"World J  Gastroenterol  2017; 23(21): 3761-3764  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i21/3761.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i21.3761 INTRODUCTION Endoscopic resection of large lesions leads to extensive  mucosal defects and submucosal exposure, with a  substantial risk of complications.",Non-OADS,/arxiv_data1/oa_pdf/1f/b6/WJG-23-3761.PMC5467061.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Vicente Lorenzo-Zúñiga, MD, PhD,  Professor,  Endoscopy Unit, Department of Gastroenterology,  Hospital Universitari Germans Trias i Pujol, Carretera de Canyet,  s/n, 08916 Badalona, Spain.",Non-OADS,/arxiv_data1/oa_pdf/1f/b6/WJG-23-3761.PMC5467061.pdf
"vlorenzo.germanstrias@gencat.ca t Telephone:  +34-93-4978443      Received:  January 27, 2017 Peer-review started:  February 6, 2017 First decision:  March 3, 2017 Revised:  March 21, 2017 Accepted:  May 4, 2017    Article in press:  May 4, 2017 Published online: June 7, 2017EDITORIALSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i21.3761 3761 June 7, 2017 |Volume 23 |Issue 21 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 June 7; 23(21): 3761-3764  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/1f/b6/WJG-23-3761.PMC5467061.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452   1",Non-OADS,/arxiv_data1/oa_pdf/1f/b6/WJG-23-3761.PMC5467061.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Trond A Buanes, MD, PhD, Professor,  Department of Hepato-Pancreatico-Biliary Surgery, Oslo  University Hospital, Institute of Clinical Medicine, Faculty of  Medicine, University of Oslo, Nydalen, Pb 4956 N-0424 Oslo,  Norway.",Non-OADS,/arxiv_data1/oa_pdf/6e/96/WJG-23-3765.PMC5467062.pdf
"Also chemotherapy is essential, and serious  postoperative complications or rapid disease progression EDITORIALSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i21.3765 3765 June 7, 2017 |Volume 23 |Issue 21 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 June 7; 23(21): 3765-3770  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/6e/96/WJG-23-3765.PMC5467062.pdf
"World J  Gastroenterol  2017; 23(21): 3765-3770  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i21/3765.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i21.3765 INTRODUCTION What should be the first treatment intervention in a  patient with resectable pancreatic cancer (PC), surgery  or chemotherapy?",Non-OADS,/arxiv_data1/oa_pdf/6e/96/WJG-23-3765.PMC5467062.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452   1",Non-OADS,/arxiv_data1/oa_pdf/6e/96/WJG-23-3765.PMC5467062.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dan Lucian Dumitraşcu, MD, Professor,   2nd Medical Department, “Iuliu Haţieganu” University of  Medicine and Pharmacy, 4 Clinicilor Street, 400006 Cluj-Napoca,  Romania.",Non-OADS,/arxiv_data1/oa_pdf/d2/73/WJG-23-3771.PMC5467063.pdf
"Published by Baishideng Publishing  Group Inc. All rights reserved.REVIEW 3771 June 7, 2017 |Volume 23 |Issue 21 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i21.3771World J Gastroenterol   2017 June 7; 23(21): 3771-3783  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/d2/73/WJG-23-3771.PMC5467063.pdf
World J Gastroenterol  2017; 23(21): 3771-3783   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i21/3771.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.,Non-OADS,/arxiv_data1/oa_pdf/d2/73/WJG-23-3771.PMC5467063.pdf
Available from: URL: https://www.bda.uk.com/ foodfacts/IBSfoodfacts.pdf 22 U.S. Department of Health and Human Services and U.S.  Department of Agriculture .,Non-OADS,/arxiv_data1/oa_pdf/d2/73/WJG-23-3771.PMC5467063.pdf
"Available from: URL: http://health.gov/dietaryguidelines/2015/ guidelines/ 23 Rao SS , Welcher K, Zimmerman B, Stumbo P. Is coffee a colonic  stimulant?",Non-OADS,/arxiv_data1/oa_pdf/d2/73/WJG-23-3771.PMC5467063.pdf
"Available from: URL:  http://www.fao.org/3/a-i1953e.pdf 45 Ford AC , Moayyedi P, Lacy BE, Lembo AJ, Saito YA, Schiller  LR, Soffer EE, Spiegel BM, Quigley EM.",Non-OADS,/arxiv_data1/oa_pdf/d2/73/WJG-23-3771.PMC5467063.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452   1",Non-OADS,/arxiv_data1/oa_pdf/d2/73/WJG-23-3771.PMC5467063.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript   Correspondence to: Dr. Konstantinos Triantafyllou,  Associate Professor,  Hepatogastroenterology Unit, Second  Department of Internal Medicine, Propaedeutic, Research  Institute and Diabetes Center, Medical School, National and  Kapodistrian University of Athens, Attikon University General  Hospital, 1 Rimini Street, 12462 Athens,  Greece.",Non-OADS,/arxiv_data1/oa_pdf/eb/9a/WJG-23-3784.PMC5467064.pdf
"ktriant@med.uoa.g r Telephone:  +30­210­5832087 Fax:  +30­210­5326454  Received:  January 27, 2017 Peer-review started:  February 6, 2017 First decision:  March 16, 2017 Revised:  March 24, 2017 Accepted:  May 9, 2017    Article in press:  May 9, 2017 Published online: June 7, 2017 MINIREVIEWSSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i21.3784 3784 June 7, 2017 |Volume 23 |Issue 21 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 June 7; 23(21): 3784-3796  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/eb/9a/WJG-23-3784.PMC5467064.pdf
World J Gastroenterol  2017; 23(21): 3784 ­3796   Available from: URL: http://www.wjgnet.com/1007 ­9327/full/ v23/i21/3784.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.,Non-OADS,/arxiv_data1/oa_pdf/eb/9a/WJG-23-3784.PMC5467064.pdf
"Available from: URL: https://seer.cancer.gov/ statfacts/html/colorect.html 2 Rex DK , Johnson DA, Anderson JC, Schoenfeld PS, Burke CA,  Inadomi JM.",Non-OADS,/arxiv_data1/oa_pdf/eb/9a/WJG-23-3784.PMC5467064.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452   1",Non-OADS,/arxiv_data1/oa_pdf/eb/9a/WJG-23-3784.PMC5467064.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Kenya Kamimura, MD, PhD,  Division of  Gastroenterology and Hepatology, Graduate School of Medical  and Dental Sciences, Niigata University, 1-757 Asahimachido-ri,  Chuo-ku, Niigata 951-8510, Japan.",Non-OADS,/arxiv_data1/oa_pdf/7d/7e/WJG-23-3797.PMC5467065.pdf
"kenya-k@med.niigata-u.ac.jp Telephone:  +81-25-2272207 Fax:  +81-25-2270776 Received:  February 17, 2017 Peer­review started:  February 20, 2017 First decision:  March 16, 2017 Revised:  March 22, 2017 Accepted:  May 4, 2017 Article in press:  May 4, 2017 Published online: June 7, 2017MINIREVIEWS 3797 June 7, 2017 |Volume 23 |Issue 21 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i21.3797World J Gastroenterol   2017 June 7; 23(21): 3797-3804  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/7d/7e/WJG-23-3797.PMC5467065.pdf
wjgnet.com/1007-9327/full/v23/i21/3797.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7d/7e/WJG-23-3797.PMC5467065.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452   1",Non-OADS,/arxiv_data1/oa_pdf/7d/7e/WJG-23-3797.PMC5467065.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Xian-Qin Qu, PhD, MD,  School of  Medical and Molecular Biosciences, University of Technology  Sydney, 15 Broadway, NSW 2007,  Australia.",Non-OADS,/arxiv_data1/oa_pdf/bc/b0/WJG-23-3805.PMC5467066.pdf
"At the end  of experiment, serum and liver tissue were collected  for measurement of metabolic parameters, alanine  aminotransferase (ALT) and aspartate amin otransferase  3805 June 7, 2017 |Volume 23 |Issue 21 | WJG|www.wjgnet.comORIGINAL ARTICLE Green tea polyphenols ameliorate non-alcoholic fatty liver  disease through upregulating AMPK activation in high fat  fed Zucker fatty ratsBasic Study Yi Tan, Jane Kim, Jing Cheng, Madeleine Ong, Wei-Guo Lao, Xing-Liang Jin, Yi-Guang Lin, Linda Xiao,  Xue-Qiong Zhu, Xian-Qin QuSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i21.3805World J Gastroenterol   2017 June 7; 23(21): 3805-3814  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/bc/b0/WJG-23-3805.PMC5467066.pdf
wjgnet.com/1007-9327/full/v23/i21/3805.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bc/b0/WJG-23-3805.PMC5467066.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452   1",Non-OADS,/arxiv_data1/oa_pdf/bc/b0/WJG-23-3805.PMC5467066.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Danuta Januszkiewicz-Lewandowska,  MD, PhD, Professor,  Department of Pediatric Oncology,  Hematology and Bone Marrow Transplantation, Poznan  University of Medical Sciences, Szpitalna 27/33, 60-572 Poznan,  Poland.",Non-OADS,/arxiv_data1/oa_pdf/76/41/WJG-23-3815.PMC5467067.pdf
"danuta.januszkiewicz@ump.edu.pl Telephone:  +48-60-1781821 Fax:  +48-61-8233235 Received:  January 27, 2017 Peer-review started:  February 12, 2017 First decision:  March 3, 2017 Revised:  March 17, 2017 Accepted:  May 4, 2017   Article in press:  May 4, 2017 Published online: June 7, 2017 3815 June 7, 2017 |Volume 23 |Issue 21 | WJG|www.wjgnet.comORIGINAL ARTICLE Prevalence of IFNL3  rs4803217 single nucleotide  polymorphism and clinical course of chronic hepatitis CBasic Study Bogna Świątek-Kościelna, Ewelina Kałużna, Ewa Strauss, Jerzy Nowak, Iwona Bereszyńska, Ewelina Gowin,  Jacek Wysocki, Jolanta Rembowska, Dominika Barcińska, Iwona Mozer-Lisewska, Danuta Januszkiewicz- Lewandowska Submit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i21.3815World J Gastroenterol   2017 June 7; 23(21): 3815-3824  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/76/41/WJG-23-3815.PMC5467067.pdf
"Świątek-Kościelna B, Kałużna E, Strauss E, Nowak J,  Bereszyńska I, Gowin E, Wysocki J, Rembowska J, Barcińska D,  Mozer-Lisewska I, Januszkiewicz-Lewandowska D. Prevalence  of IFNL3  rs4803217 single nucleotide polymorphism and clinical  course of chronic hepatitis C. World J Gastroenterol  2017;  23(21): 3815-3824  Available from: URL: http://www.wjgnet.",Non-OADS,/arxiv_data1/oa_pdf/76/41/WJG-23-3815.PMC5467067.pdf
com/1007-9327/full/v23/i21/3815.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/76/41/WJG-23-3815.PMC5467067.pdf
Statistical analysis  Genotype frequencies were tested for Hardy-Weinberg  equilibrium by the χ2 test (https://ihg.gsf.de/cgi-bin/ hw/hwa1.pl).,OADS,/arxiv_data1/oa_pdf/76/41/WJG-23-3815.PMC5467067.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452   1",Non-OADS,/arxiv_data1/oa_pdf/76/41/WJG-23-3815.PMC5467067.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Sei Jin Youn, MD,  Department of Internal  Medicine, Chungbuk National University College of Medicine,  410 Seong bong-ro, Heungduk-gu, Cheongju, Chungcheongbuk- do 28644, South Korea.",Non-OADS,/arxiv_data1/oa_pdf/8a/b7/WJG-23-3825.PMC5467068.pdf
"3825 June 7, 2017 |Volume 23 |Issue 21 | WJG|www.wjgnet.comORIGINAL ARTICLE Corticotropin-releasing factor stimulates colonic motility  via muscarinic receptors in the ratBasic Study Kyung-Jo Kim, Ki Bae Kim, Soon Man Yoon, Joung-Ho Han, Hee Bok Chae, Seon Mee Park, Sei Jin YounSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i21.3825World J Gastroenterol   2017 June 7; 23(21): 3825-3831  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/8a/b7/WJG-23-3825.PMC5467068.pdf
World J Gastroenterol  2017;  23(21): 3825-3831  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/8a/b7/WJG-23-3825.PMC5467068.pdf
com/1007-9327/full/v23/i21/3825.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8a/b7/WJG-23-3825.PMC5467068.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452   1",Non-OADS,/arxiv_data1/oa_pdf/8a/b7/WJG-23-3825.PMC5467068.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Dr. Ai-Lan Qin,  Department of Infectious  Diseases, The First Affiliated Hospital of Soochow University,  899 Pinghai Road Gusu District, Suzhou 215000, Jiangsu  Province, China.",Non-OADS,/arxiv_data1/oa_pdf/7a/46/WJG-23-3832.PMC5467069.pdf
"3832 June 7, 2017 |Volume 23 |Issue 21 | WJG|www.wjgnet.comORIGINAL ARTICLE Clinical significance of changes in the Th17/Treg ratio in  autoimmune liver diseaseBasic Study Ting-Ting Feng, Ting Zou, Xin Wang, Wei-Feng Zhao, Ai-Lan QinSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i21.3832World J Gastroenterol   2017 June 7; 23(21): 3832-3838  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/7a/46/WJG-23-3832.PMC5467069.pdf
World J Gastroenterol  2017; 23(21): 3832-3838  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i21/3832.htm    DOI: http://dx.doi.org/10.3748/wjg.v23.i21.3832 INTRODUCTION Autoimmune liver disease (AILD) is a class of chronic  diseases characterized by immunopathological damage  to the liver.,Non-OADS,/arxiv_data1/oa_pdf/7a/46/WJG-23-3832.PMC5467069.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452   1",Non-OADS,/arxiv_data1/oa_pdf/7a/46/WJG-23-3832.PMC5467069.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Dr. Dao-Rong Jiang,  Department of  Infectious Diseases, Affiliated Hospital of Nantong University,  No.",Non-OADS,/arxiv_data1/oa_pdf/1f/fc/WJG-23-3839.PMC5467070.pdf
"The mortality rate in the model  3839 June 7, 2017 |Volume 23 |Issue 21 | WJG|www.wjgnet.comORIGINAL ARTICLE Inhibitory effect of oxymatrine on hepatocyte apoptosis via  TLR4/PI3K/Akt/GSK-3 β signaling pathwayBasic Study Xian Zhang, Wei Jiang, Ai-Ling Zhou, Min Zhao, Dao-Rong JiangSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i21.3839World J Gastroenterol   2017 June 7; 23(21): 3839-3849  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/1f/fc/WJG-23-3839.PMC5467070.pdf
World J Gastroenterol  2017;  23(21): 3839-3849  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/1f/fc/WJG-23-3839.PMC5467070.pdf
com/1007-9327/full/v23/i21/3839.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/fc/WJG-23-3839.PMC5467070.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452   1",Non-OADS,/arxiv_data1/oa_pdf/1f/fc/WJG-23-3839.PMC5467070.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Dr. Chang-Long Lu, Professor, Department  of Immunology, China Medical University, No.",Non-OADS,/arxiv_data1/oa_pdf/72/97/WJG-23-3850.PMC5467071.pdf
"The  3850 June 7, 2017 |Volume 23 |Issue 21 | WJG|www.wjgnet.comORIGINAL ARTICLE Sodium selenite ameliorates dextran sulfate sodium- induced chronic colitis in mice by decreasing Th1, Th17,  and γδT and increasing CD4(+)CD25(+) regulatory T-cell  responsesBasic Study Li-Xuan Sang, Bing Chang, Jun-Feng Zhu, Fang-Li Yang, Yan Li, Xue-Feng Jiang, Da-Nan Wang,  Chang-Long Lu, Xun SunSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i21.3850World J Gastroenterol   2017 June 7; 23(21): 3850-3863  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/72/97/WJG-23-3850.PMC5467071.pdf
World J Gastroenterol  2017; 23(21): 3850-3863   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i21/3850.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.,Non-OADS,/arxiv_data1/oa_pdf/72/97/WJG-23-3850.PMC5467071.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452   1",Non-OADS,/arxiv_data1/oa_pdf/72/97/WJG-23-3850.PMC5467071.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Moustafa Nouh Elemeery, MSc,  Laboratory of Medical Biotechnology, Genetic Engineering and  Biotechnology Research Division, National Research Centre,  Dokki, Cairo 12622, Egypt.",Non-OADS,/arxiv_data1/oa_pdf/05/bd/WJG-23-3864.PMC5467072.pdf
"RESULTS Expression of the selected miRNAs in serum was Submit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i21.3864 3864 June 7, 2017 |Volume 23 |Issue 21 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 June 7; 23(21): 3864-3875  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Validation of a serum microRNA panel as biomarkers for  early diagnosis of hepatocellular carcinoma post-hepatitis C  infection in Egyptian patientsCase Control Study Moustafa Nouh Elemeery, Ahmed Noah Badr, Marwa Anwar Mohamed, Doaa Ahmed Ghareeb",Non-OADS,/arxiv_data1/oa_pdf/05/bd/WJG-23-3864.PMC5467072.pdf
World J Gastroenterol  2017; 23(21): 3864-3875   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i21/3864.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.,Non-OADS,/arxiv_data1/oa_pdf/05/bd/WJG-23-3864.PMC5467072.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452   1",Non-OADS,/arxiv_data1/oa_pdf/05/bd/WJG-23-3864.PMC5467072.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Cumali Efe, MD,  Department of  Gastroenterology, Hacettepe University School of Medicine,  06100 Ankara, Turkey.",Non-OADS,/arxiv_data1/oa_pdf/13/c7/WJG-23-3876.PMC5467073.pdf
"Receiver operating characteristic  analysis suggested that 24.5 U/L was the optimum  cut-off point of ADA level for severe interface hepatitis  (sensitivity 88%, speciﬁcity 85.2%, area under the  3876 June 7, 2017 |Volume 23 |Issue 21 | WJG|www.wjgnet.comORIGINAL ARTICLE Relationship between serum adenosine deaminase levels  and liver histology in autoimmune hepatitisRetrospective Study Murat Torgutalp, Cumali Efe, Hakan Babaoglu, Taylan KavSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i21.3876World J Gastroenterol   2017 June 7; 23(21): 3876-3882  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/13/c7/WJG-23-3876.PMC5467073.pdf
World J Gastroenterol  2017; 23(21):  3876-3882  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/13/c7/WJG-23-3876.PMC5467073.pdf
com/1007-9327/full/v23/i21/3876.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/13/c7/WJG-23-3876.PMC5467073.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452   1",Non-OADS,/arxiv_data1/oa_pdf/13/c7/WJG-23-3876.PMC5467073.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Ji Young Park, MD,  Division of  Gastroenterology, Department of Internal Medicine, Inje  University College of Medicine, Sanggye Paik Hospital, Dongil- ro 1342, Nowon-gu, Seoul 01757,  South Korea.",Non-OADS,/arxiv_data1/oa_pdf/d3/f9/WJG-23-3883.PMC5467074.pdf
"The optimal cut-off value for  baseline NLR was 4.76 in predicting severity and 4.88  3883 June 7, 2017 |Volume 23 |Issue 21 | WJG|www.wjgnet.comORIGINAL ARTICLE Clinical significance of the neutrophil-lymphocyte ratio as  an early predictive marker for adverse outcomes in patients  with acute pancreatitisRetrospective Study Tae Joo Jeon, Ji Young ParkSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i21.3883World J Gastroenterol   2017 June 7; 23(21): 3883-3889  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/d3/f9/WJG-23-3883.PMC5467074.pdf
World J  Gastroenterol  2017; 23(21): 3883-3889  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i21/3883.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i21.3883 INTRODUCTION Acute pancreatitis is an acute inflammatory process  of the pancreas that starts with local acinar cell injury  with variable involvement of other regional tissues  or remote organ systems[1].,Non-OADS,/arxiv_data1/oa_pdf/d3/f9/WJG-23-3883.PMC5467074.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452   1",Non-OADS,/arxiv_data1/oa_pdf/d3/f9/WJG-23-3883.PMC5467074.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Levinus A Dieleman, MD, PhD,   Department of Medicine, Division of Gastroenterology and  CEGIIR, University of Alberta, 130 University Campus, 2-24  Zeidler Ledcor Bldg, Edmonton, AB T6G 2X8,  Canada.",Non-OADS,/arxiv_data1/oa_pdf/40/3c/WJG-23-3890.PMC5467075.pdf
"METHODS In this prospective pilot study, UC patients in clinical  3890 June 7, 2017 |Volume 23 |Issue 21 | WJG|www.wjgnet.comORIGINAL ARTICLE Dietary and metabolomic determinants of relapse in  ulcerative colitis patients: A pilot prospective cohort studyProspective Study Ammar Hassanzadeh Keshteli, Floris F van den Brand, Karen L Madsen, Rupasri Mandal, Rosica Valcheva,  Karen I Kroeker, Beomsoo Han, Rhonda C Bell, Janis Cole, Thomas Hoevers, David S Wishart, Richard N  Fedorak, Levinus A DielemanSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i21.3890World J Gastroenterol   2017 June 7; 23(21): 3890-3899  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/40/3c/WJG-23-3890.PMC5467075.pdf
World J Gastroenterol  2017;  23(21): 3890-3899  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/40/3c/WJG-23-3890.PMC5467075.pdf
com/1007-9327/full/v23/i21/3890.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/40/3c/WJG-23-3890.PMC5467075.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452   1",Non-OADS,/arxiv_data1/oa_pdf/40/3c/WJG-23-3890.PMC5467075.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source:  Unsolicited manuscript Correspondence to: Li- qun Pan, MD, PhD,  nanjing  University of Traditional chinese medicine, no.138 Xianlin  avenue, nanjing 210046, Jiangsu Province,  china.",Non-OADS,/arxiv_data1/oa_pdf/88/6b/WJG-23-3900.PMC5467076.pdf
"RESULTS Patients with CP had significantly shorter IAS length  3900 June 7, 2017 |Volume 23 |Issue 21 | WJG|www.wjgnet.comORIGINAL ARTICLE Role of three-dimensional endoanal ultrasound in assessing  the anal sphincter morphology of female patients with  chronic proctalgiaProspective Study Ya-hong Xue, Shu-qing Ding, Yi-jiang Ding, Li-qun PanSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i21.3900World J Gastroenterol   2017 June 7; 23(21): 3900-3906  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/88/6b/WJG-23-3900.PMC5467076.pdf
wjgnet.com/1007-9327/full/v23/i21/3900.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/88/6b/WJG-23-3900.PMC5467076.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452   1",Non-OADS,/arxiv_data1/oa_pdf/88/6b/WJG-23-3900.PMC5467076.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source:  Unsolicited manuscript Correspondence to: Dr. She-Gan Gao,  Henan Key Laboratory  of Cancer Epigenetics, Cancer Institute, the First Affiliated  Hospital and College of Clinical Medicine of Henan University  of Science and Technology, 24 Jinghua Road, Jianxi District,  Luoyang 471003, Henan Province, China.",Non-OADS,/arxiv_data1/oa_pdf/73/6b/WJG-23-3907.PMC5467077.pdf
"RESULTS The expression rates of PTN and N-syndecan proteins Submit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i21.3907 3907 June 7, 2017 |Volume 23 |Issue 21 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 June 7; 23(21): 3907-3914  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Pleiotrophin and N-syndecan promote perineural invasion  and tumor progression in an orthotopic mouse model of  pancreatic cancerRandomized Controlled Trial Jun Yao, Lu-Lin Zhang, Xu-Mei Huang, Wen-Yao Li, She-Gan Gao",Non-OADS,/arxiv_data1/oa_pdf/73/6b/WJG-23-3907.PMC5467077.pdf
World J  Gastroenterol  2017; 23(21): 3907-3914  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i21/3907.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i21.3907 INTRODUCTION Pancreatic cancer is a deadly cancer.,Non-OADS,/arxiv_data1/oa_pdf/73/6b/WJG-23-3907.PMC5467077.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452   1",Non-OADS,/arxiv_data1/oa_pdf/73/6b/WJG-23-3907.PMC5467077.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Yuan-Pang Wang, MD, PhD,  Institute  & Department of Psychiatry (LIM-23), University of São Paulo  Medical School, R. Dr. Ovídio Pires de Campos, 785, São Paulo,  SP 01060-970, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/c5/ea/WJG-23-3915.PMC5467078.pdf
"Fourteen (53.9%) studies recruited their target samples from schools, 11 (42.3%) from health - care settings and the remaining one (3.8%) from online SYSTEMATIC REVIEWS 3915 June 7, 2017 |Volume 23 |Issue 21 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i21.3915World J Gastroenterol   2017 June 7; 23(21): 3915-3927  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/c5/ea/WJG-23-3915.PMC5467078.pdf
wjgnet.com/1007-9327/full/v23/i21/3915.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/ea/WJG-23-3915.PMC5467078.pdf
"For inclusion, each study had to: (1) contain children  and adolescents between 4 and 18 years old; (2)  report functional gastrointestinal symptoms and/or  disorders according to Rome  Ⅱ, Ⅲ or Ⅳ criteria[13,14]  (http://www.romecriteria.org /); (3) design sample  from a birth-cohort, population-based, school-based  or clinical setting; and (4) report epidemiological  outcomes (prevalence, incidence or frequency) for  general FGIDs and subtypes.",Non-OADS,/arxiv_data1/oa_pdf/c5/ea/WJG-23-3915.PMC5467078.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452   1",Non-OADS,/arxiv_data1/oa_pdf/c5/ea/WJG-23-3915.PMC5467078.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Hiromi Tamura, MD, Clinical fellow,   Department of Pathology, City Hospital of Toyonaka, Shibahara- cho 4-14-1, Toyonaka, Osaka 560-8565,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/1a/da/WJG-23-3928.PMC5467079.pdf
"Key words:  Esophageal adenocarcinoma; Bilayered  structure; Esophageal gland ductCASE REPORT 3928 June 7, 2017 |Volume 23 |Issue 21 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i21.3928World J Gastroenterol   2017 June 7; 23(21): 3928-3933  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/1a/da/WJG-23-3928.PMC5467079.pdf
"World J Gastroenterol  2017; 23(21): 3928-3933  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i21/3928.htm    DOI: http://dx.doi.org/10.3748/wjg.v23.i21.3928 INTRODUCTION Although the frequency of esophageal adenocarcinoma  has dramatically increased in recent years in the  United States, squamous cell carcinoma remains  predominant and adenocarcinomas are relatively rare  in Asian countries.",Non-OADS,/arxiv_data1/oa_pdf/1a/da/WJG-23-3928.PMC5467079.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452   1",Non-OADS,/arxiv_data1/oa_pdf/1a/da/WJG-23-3928.PMC5467079.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Zong-Ming Zhang, MD, PhD, Professor  and Chair,  Department of General Surgery, Beijing Electric  Power Hospital, State Grid Corporation of China, Capital  Medical University, No.",Non-OADS,/arxiv_data1/oa_pdf/b2/8f/WJG-23-3934.PMC5467080.pdf
"zhangzongming@mail.tsinghua.edu.c n Telephone:  +86-10-63503046 Fax:  +86-10-63465865CASE REPORT 3934 June 7, 2017 |Volume 23 |Issue 21 | WJG|www.wjgnet.comSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i21.3934World J Gastroenterol   2017 June 7; 23(21): 3934-3944  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/b2/8f/WJG-23-3934.PMC5467080.pdf
World  J Gastroenterol  2017; 23(21): 3934-3944  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i21/3934.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i21.3934 INTRODUCTION Drug-induced stenosis of the sigmoid colon is very  rare[1].,Non-OADS,/arxiv_data1/oa_pdf/b2/8f/WJG-23-3934.PMC5467080.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452   1",Non-OADS,/arxiv_data1/oa_pdf/b2/8f/WJG-23-3934.PMC5467080.pdf
This article is available under the Creative Commons License CC-BY- NC (http://creativecommons.org/licenses/by-nc/4.0).,Non-OADS,/arxiv_data1/oa_pdf/65/ea/nat.2016.0650.PMC5467133.pdf
This article is available under the Creative Commons License CC-BY-NC (http://creativecommons.org/licenses/by-nc/4.0).,Non-OADS,/arxiv_data1/oa_pdf/a8/ba/nat.2016.0641.PMC5467152.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Loss of anti-contractile effect of perivascular adipose tissue in offspring of obese rats KE Zaborska, M Wareing, G Edwards and C Austin International Journal of Obesity (2017) 41,997; doi:10.1038/ijo.2017.17; published online 30 March 2017 Correction to: International Journal of Obesity (2016) 40, 1205 –1214; doi:10.1038/ijo.2016.62The licence type of this article has been changed from CC-BY-ND to CC-BY since publication.OPENInternational Journal of Obesity (2017) 41,997 © 2017 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/63/5d/41366_2017_Article_BFijo201746.PMC5467239.pdf
"Population numbers were obtained from Eurostats for 2015 for the European countries, (http://appsso.eurostat.ec.europa.",OADS,/arxiv_data1/oa_pdf/68/93/bmt201734a.PMC5467246.pdf
"For the purpose of this analysis, we have grouped countries according to World Bank income group gross national income per capita in USD in 2015, (http://data.worldbank.org/data-catalog/world-development-indicators).",OADS,/arxiv_data1/oa_pdf/68/93/bmt201734a.PMC5467246.pdf
"WHO: Geneva, Swtizerland, 2015. http://www.who.int/topics/transplantation/en/.",Non-OADS,/arxiv_data1/oa_pdf/68/93/bmt201734a.PMC5467246.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on Bone Marrow Transplantation website (http://www.nature.com/bmt)EBMT activity survey 2015 JR Passweg et al 817 Bone Marrow Transplantation (2017) 811 –817",Non-OADS,/arxiv_data1/oa_pdf/68/93/bmt201734a.PMC5467246.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/d6/hnx011.PMC5467400.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/e7/hnw045.PMC5467404.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/c8/hnx003.PMC5467405.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/8f/hnx012.PMC5467407.pdf
Strength maintenance exercises Exercise Video links Side plank raises https://youtu.be/x_F_xﬁCZtA Front planks https://youtu.be/3_YvcCUitzQ Band walks https://youtu.be/baeAQXHvwhY Supine bridge https://youtu.be/WQrmXZDyLrUSingle leg squat reach https://youtu.be/_R5ZbG-eYRM Fig.,Non-OADS,/arxiv_data1/oa_pdf/a9/8f/hnx012.PMC5467407.pdf
Dynamic warm-up Exercise Repetitions Video links Knee hug to calf raise 2 /C220 steps https://youtu.be/RiYVoDjdbys In/out heel taps 2 /C220 steps https://youtu.be/6lZT2tPZsmw Swing kicks 2 /C220 steps https://youtu.be/0G6czNCrTXg Soldier walks 2 /C220 steps https://youtu.be/hB3OsqYJuW8 Glute kicks 2 /C220 steps https://youtu.be/H2OQ9v4k8g8 Walking lunges with reach and rotation 2 /C210 steps https://youtu.be/0GO1ZsckaDk Lunge twist 2 /C210 steps https://youtu.be/DVFwBCQQnHo Quick steps 2 /C2: 20 in place then forward 20 ft 20 in place then backward 20 fthttps://youtu.be/BMLrzElmuNM Single-leg mini-squat to calf raise /C212 each leg https://youtu.be/BqDe0lrGoasReturn to running after arthroscopic hip surgery /C15125,Non-OADS,/arxiv_data1/oa_pdf/a9/8f/hnx012.PMC5467407.pdf
"Level I plyometric program Exercise Repetitions Video links Ladders (40 ft) Forward—2 feet each box Lateral—2 feet each box Forward—1 foot each box In-in/out-out In-in/out (zig–zag shufﬂe) Rest 2 min, then repeat /C23https://youtu.be/fK-4giDn9Wc 2 foot line jumps Front/back with bounce 3 /C212 https://youtu.be/7cqjvO8yhUk 2 foot dot hops 3 /C23 rounds each way https://youtu.be/zB6s32K_654 Alternating hop/hold 3 /C210 total jumps https://youtu.be/f33-b-spZeo Alternating 1 leg hops with bounce 3 /C210 total jumps https://youtu.be/hjxtS7t0_SU Table V. Walk/jog progression Run interval (min) Walk interval (min) Repetitions Total run time (min) Total time spent (min) 11 /C277 1 4 2–3 1 /C25 10–15 15–20 3–5 1 20 24 þ Run until fatigue or form failure, then walk 1–2 min, then repeat for a total run time of 25–30 minInitiate running outdoorsJog every other day with a goal of reaching 30 consecutive min Patients should end each run with a 3–5 min walk and mobility/stretching exercises.",Non-OADS,/arxiv_data1/oa_pdf/a9/8f/hnx012.PMC5467407.pdf
Level II plyometric program Exercise Video links Lateral shufﬂes http://youtu.be/IcTPmEF1apU High knees https://youtu.be/sUVnMWﬂ210 Forward/backward skips https://youtu.be/nPkXN_AhO6kBackpedal https://youtu.be/xkiPM47agQo Grapevine https://youtu.be/rQL7PJYu6nY Boxer shufﬂes https://youtu.be/ug1A8gfDzjoLateral skips https://youtu.be/As1THjXMufs Tap skips https://youtu.be/JUOpDv4uPUMReturn to running after arthroscopic hip surgery /C15127,Non-OADS,/arxiv_data1/oa_pdf/a9/8f/hnx012.PMC5467407.pdf
Level III plyometric program Exercise Repetitions Video links Matrix jacks 3 /C230 s https://youtu.be/2LT9CbeAVfQ 1 foot forward line hops a.,Non-OADS,/arxiv_data1/oa_pdf/a9/8f/hnx012.PMC5467407.pdf
3/C212https://youtu.be/niv_fS0usGc 1 foot line hops with bounce a. Front/back b. Side/sidea.,Non-OADS,/arxiv_data1/oa_pdf/a9/8f/hnx012.PMC5467407.pdf
3/C210https://www.youtube.com/watch?v ¼DALpKQE6zfs 1 foot dot hops* 2–3 /C23 each way https://youtu.be/kQfms_RmTpo Skater hops 3 /C245–60 s https://youtu.be/0I4ziA73p7w Box hoppers 3 /C212 https://youtu.be/JdSVfzDfT0A Jump rope 2–3 sets of: 2 feet/C250 R/L alternate /C250 R only /C215 L only /C215 R/L¼right/left.,Non-OADS,/arxiv_data1/oa_pdf/a9/8f/hnx012.PMC5467407.pdf
"This is an Open Access article distributed under t he terms of the Creative Commons Attribution Non-C ommercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-comme rcial re-use, distribution, and reproduction in a ny medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/f9/hnx001.PMC5467408.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/9e/hnw043.PMC5467409.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/d8/hnw044.PMC5467411.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/e0/hnw048.PMC5467412.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/83/hnw036.PMC5467413.pdf
"METHODS A 21-question, IRB-exempt, HIPAA-compliant survey was conducted using SurveyMonkey (http://www.surveymon key.com).",OADS,/arxiv_data1/oa_pdf/31/83/hnw036.PMC5467413.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/b3/hnx013.PMC5467415.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/51/hnx009.PMC5467416.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/fb/hnx010.PMC5467417.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/f2/hnx008.PMC5467418.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f6/44/hnw040.PMC5467419.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/1a/hnx002.PMC5467420.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/3d/hnw047.PMC5467421.pdf
Arthrosc Tech 2013. http://dx.doi.org/10.1016/j.eats.2013.02.,OADS,/arxiv_data1/oa_pdf/9b/3d/hnw047.PMC5467421.pdf
Arthrosc Tech 2013. http://dx.doi.org/10.1016/j.eats.2013.02.,OADS,/arxiv_data1/oa_pdf/9b/3d/hnw047.PMC5467421.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/ff/hnw037.PMC5467422.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/e5/hnx015.PMC5467423.pdf
Available at: http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1a/e5/hnx015.PMC5467423.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/20473128.,Non-OADS,/arxiv_data1/oa_pdf/1a/e5/hnx015.PMC5467423.pdf
Available at: http://linkinghub.elsevier.com/retrieve/pii/ S0749806315003217.,Non-OADS,/arxiv_data1/oa_pdf/1a/e5/hnx015.PMC5467423.pdf
Available at: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/1a/e5/hnx015.PMC5467423.pdf
Available from: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1a/e5/hnx015.PMC5467423.pdf
Available at: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/1a/e5/hnx015.PMC5467423.pdf
Available at: http://www.pubmedcentral.nih.gov/articleren der.fcgi?artid ¼3206516&tool ¼pmcentrez&rendertype ¼abstract.,OADS,/arxiv_data1/oa_pdf/1a/e5/hnx015.PMC5467423.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/17761612.,Non-OADS,/arxiv_data1/oa_pdf/1a/e5/hnx015.PMC5467423.pdf
Available at: http://dx.doi.org/10.1007/s11999-015-4255-4.,Non-OADS,/arxiv_data1/oa_pdf/1a/e5/hnx015.PMC5467423.pdf
Available at: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/1a/e5/hnx015.PMC5467423.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/15043095.,Non-OADS,/arxiv_data1/oa_pdf/1a/e5/hnx015.PMC5467423.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/ 16651565.,Non-OADS,/arxiv_data1/oa_pdf/1a/e5/hnx015.PMC5467423.pdf
Available at: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/1a/e5/hnx015.PMC5467423.pdf
Available at: http://dx.doi.org/10.1016/j.arthro.2009.,OADS,/arxiv_data1/oa_pdf/1a/e5/hnx015.PMC5467423.pdf
Available at: http://ajs.sage pub.com/lookup/doi/10.1177/0363546511434578.,Non-OADS,/arxiv_data1/oa_pdf/1a/e5/hnx015.PMC5467423.pdf
Available at: http://dx.doi.org/10.1016/j.arthro.2008.12.014.,OADS,/arxiv_data1/oa_pdf/1a/e5/hnx015.PMC5467423.pdf
Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid ¼2884887&tool ¼pmcentrez&rendertype ¼abstract.,OADS,/arxiv_data1/oa_pdf/1a/e5/hnx015.PMC5467423.pdf
Available at: http://ajs.sagepub.com/lookup/doi/ 10.1177/0363546513500766.,Non-OADS,/arxiv_data1/oa_pdf/1a/e5/hnx015.PMC5467423.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/11/hnx005.PMC5467424.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/86/hnw050.PMC5467425.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0e/78/hnw038.PMC5467426.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/07/hnw051.PMC5467427.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/82/hnw049.PMC5467428.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/1e/hnw046.PMC5467429.pdf
Available at: http://www.ish ameetings.net/meetings/2012/asm/proceedings/contents/ﬁles/Paper_31.pdf.,Non-OADS,/arxiv_data1/oa_pdf/71/1e/hnw046.PMC5467429.pdf
available (http://www.millisecond.com).,OADS,/arxiv_data1/oa_pdf/27/0b/LIO2-1-154.PMC5467524.pdf
":(+81)48-467-9373, Fax:(+81)48-462-4666 e-mail :gohirai@riken.jp sodeoka@riken.jp [b]M.Morita, G.Hirai, M.Sodeoka AMED-CREST ,2-1Hirosawa, Wako,Saitama 351-0198 (Japan) [c]H.Koshino, G.Hirai, M.Sodeoka RIKEN Center forSustainable Resource Science, 2-1Hirosawa, Wako,Saitama 351-0198 (Japan) [d]D.Hashizume RIKEN Center forEmergent Matter Science, 2-1Hirosawa, Wako,Saitama 351-0198 (Japan) [e]K.Maruoka Department ofChemistry ,Graduate School ofScience, KyotoUniversity ,Sakyo, Kyoto606-8502 (Japan) Supporting information forthisarticle isavailable ontheWWW under http://dx.doi.org/10.1002/ijch.201600110.",Non-OADS,/arxiv_data1/oa_pdf/0d/33/IJCH-57-309.PMC5467525.pdf
"Tissue for EM was then depara ﬃnized in xylene, rehydrated in http://dx.doi.org/10.1016/j.pvr.2016.09.002 Received 9 June 2016; Received in revised form 20 August 2016; Accepted 25 September 2016⁎Corresponding author at: New York University Langone Medical Center, 550 First Avenue, New York, NY 10016, USA.",Non-OADS,/arxiv_data1/oa_pdf/30/59/main.PMC5467539.pdf
This is an open access article under the  CC BY-NC-ND license (http://creativecommons.org/licenses/by/4.0/).Available online 28 September 2016 crossmark,Non-OADS,/arxiv_data1/oa_pdf/30/59/main.PMC5467539.pdf
Database URL: http://silkpathdb.swu.edu.cn VCThe Author(s) 2017.,OADS,/arxiv_data1/oa_pdf/b7/d1/bax001.PMC5467577.pdf
"Page 1 of 6 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/d1/bax001.PMC5467577.pdf
Today over 178 000 metric tons of silk are produced annually world-wide (http://inserco.org/en/?,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/bax001.PMC5467577.pdf
"q¼statistics), the biggest producers being China and India (http://sericulturecouncil.com/world-raw-silk-production/).Silkworm diseases, including pe ´brine (caused by microspori- dian Nosema bombycis ) which was first described in France in 1856 ( 1,2), were one of the factors contributing to the decline of the silk industry in Europe.",Non-OADS,/arxiv_data1/oa_pdf/b7/d1/bax001.PMC5467577.pdf
"The implementation of SilkPathDB integrates and harnesses three complemen- tary, mature and well supported technologies; Chado ( 11), GBrowse ( 12) and Drupal (http://www.drupal.org).",OADS,/arxiv_data1/oa_pdf/b7/d1/bax001.PMC5467577.pdf
"The SilkPathDB data are stored in a Chado- compliant PostgreSQL database using the Generic ModelOrganism Database (GMOD, http://gmod.org).",OADS,/arxiv_data1/oa_pdf/b7/d1/bax001.PMC5467577.pdf
"The Bootstrap framework (http://getbootstrap.com) is employed to make a responsive, clean and in- tuitive user interface that supports both desktop and mo- bile devices.",Non-OADS,/arxiv_data1/oa_pdf/b7/d1/bax001.PMC5467577.pdf
"JQWidgets(http://www.jqwidgets.com) is applied to manage and dis- play the feature index, search result, BLAST output and host-responsive data.Page 2 of 6 Database , Vol.",OADS,/arxiv_data1/oa_pdf/b7/d1/bax001.PMC5467577.pdf
Data and processing The majority of the data in our database were downloaded from the GenBank (http://www.ncbi.nlm.nih.gov/genbank/) or the Silkworm Database (SilkDB) (http://www.silkdb.org) (15).,OADS,/arxiv_data1/oa_pdf/b7/d1/bax001.PMC5467577.pdf
Gene pre- dictions obtained by different methods are combined using GLENA (http://sourceforge.net/projects/glean-gene) to makeconsensus data sets.,OADS,/arxiv_data1/oa_pdf/b7/d1/bax001.PMC5467577.pdf
"Transposable elements (TEs) are identified using RepeatModeler version open-1.0.8 (http://www.repeatmasker.org/RepeatModeler.html), which implements RepeatScout(28) and RECON ( 29).",OADS,/arxiv_data1/oa_pdf/b7/d1/bax001.PMC5467577.pdf
The consensus sequences from RepeatModeler are then mapped across each genome with RepeatMasker version open-4.0.6 (http://www.repeatmas ker.org) against Repbase Update 20.11 ( 30).,OADS,/arxiv_data1/oa_pdf/b7/d1/bax001.PMC5467577.pdf
"Protein subcellular localizations are predicted via EuSecPred (http://silkpathdb.swu.edu.cn/eusecpred) andProSecPred (http://silkpathdb.swu.edu.cn/prosecpred), which have been developed for identifying subcellular localizations of eukaryotic and prokaryotic proteins, respectively.",Non-OADS,/arxiv_data1/oa_pdf/b7/d1/bax001.PMC5467577.pdf
(1996–2009) http://blast.advbiocomp.com/.33.,Non-OADS,/arxiv_data1/oa_pdf/b7/d1/bax001.PMC5467577.pdf
"MeSH Keywords:  Gastritis • Ischemia • Lymphoma, Follicular  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/903506Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Internal Medicine, PinnacleHealth, Harrisburg, PA, U.S.A. 2 Department of Hematology and Oncology, PinnacleHealth, Harrisburg, PA, U.S.A.ISSN 1941-5923 © Am J Case Rep, 2017; 18: 617-621 DOI: 10.12659/AJCR.903506 617 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/ad/83/amjcaserep-18-617.PMC5467582.pdf
"liCenCe © 2016 The author(s)This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/)   which permits non-commercial use, reproduction and distribution of the work with-out further permission provided the original work is attributed.",Non-OADS,/arxiv_data1/oa_pdf/70/34/eor-1-279.PMC5467635.pdf
https://www.nice.org.uk/guidance/ta304 (date last accessed 24 June 2016).2.,Non-OADS,/arxiv_data1/oa_pdf/70/34/eor-1-279.PMC5467635.pdf
http://www.gettingitrightfirsttime.com/ downloads/briggsreporta4_fin.pdf (date last accessed 24 June 2016).,Non-OADS,/arxiv_data1/oa_pdf/70/34/eor-1-279.PMC5467635.pdf
"This is an Open Access article, distributed under the terms of the Creative Commons Att ribution- NonCommercial-ShareAlike licence (http://creativecommons.org/licenses/by-nc-sa/4.0/), which permits non-commercial re-use, distributio n, and reproduction in any medium, provided the same Creative Commons licence is included and the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/2e/S2059866116000169a.PMC5467637.pdf
( http://www.nbme.org/pdf/crp/crp_boi.pdf ) 2.,Non-OADS,/arxiv_data1/oa_pdf/93/2e/S2059866116000169a.PMC5467637.pdf
( https://www.aamc.org/download/271072/data/ scienti ﬁcfoundationsforfuturephysicians.pdf ) 3.,Non-OADS,/arxiv_data1/oa_pdf/93/2e/S2059866116000169a.PMC5467637.pdf
( https://ctsacentral.org/wp-content/documents/ CTSA%20Core%20Competencies_%20 ﬁnal%202011.pdf ) 4.,Non-OADS,/arxiv_data1/oa_pdf/93/2e/S2059866116000169a.PMC5467637.pdf
"Global patterns in coronavirus diversity Simon J. Anthony,1,2,3,* Christine K. Johnson,4Denise J. Greig,4 Sarah Kramer,1,5Xiaoyu Che,1Heather Wells,1Allison L. Hicks1, Damien O. Joly,6,7Nathan D. Wolfe,6Peter Daszak,3William Karesh3, W. I. Lipkin,1,2Stephen S. Morse,2PREDICT Consortium,8Jonna A. K. Mazet,4,† and Tracey Goldstein4,*,† 1Center for Infection and Immunity, Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY 10032, USA,2Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 West 168thStreet, New York, NY 10032, USA,3EcoHealth Alliance, 460 West 34thStreet, New York, NY 10001, USA,4One Health Institute & Karen C Drayer Wildlife Health Center, School of Veterinary Medicine, University of California Davis, Davis, CA 95616, USA,5Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, 722 West 168thStreet, New York, NY 10032, USA,6Metabiota, Inc. One Sutter, Suite 600, San Francisco, CA 94104, USA,7Wildlife Conservation Society, New York, NY 10460, USA and8http://www.vetmed.ucdavis.edu/ohi/predict/publications/Authorship.cfm *Corresponding author: E-mail: sja2127@cumc.columbia.edu; tgoldstein@ucdavis.edu †Joint senior author.",Non-OADS,/arxiv_data1/oa_pdf/81/04/vex012.PMC5467638.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/81/04/vex012.PMC5467638.pdf
"2.3 Phylogenetics Coronavirus sequences from the Quan and Watanabe datasets were aligned with reference sequences collected from GenBank using MUSCLE ( Edgar 2004 ), followed by manual alignment in Se-Al v2.0a11 (http://tree.bio.ed.ac.uk).",OADS,/arxiv_data1/oa_pdf/81/04/vex012.PMC5467638.pdf
"© 2017 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdID: 17-0030; June 2017 DOI: 10.1530/EDM-17-0030Hypothyroidism in TPN patient S Pearson and others Endemic goitre and hypothyroidism in an  adult female patient dependent on total parenteral nutrition S Pearson1, C Donnellan2, L Turner2, E Noble2, K Seejore1 and R D Murray1 Departments of 1Endocrinology and 2Gastroenterology, Leeds Centre for Diabetes & Endocrinology,  Leeds Teaching Hospitals NHS Trust, Leeds, UK Summary We present the case of a thirty-year-old female patient who was referred to the endocrinology team with an enlarging  goitre and biochemical hypothyroidism.",Non-OADS,/arxiv_data1/oa_pdf/c5/d2/edmcr-2017-170030.PMC5467649.pdf
p S Pearson and others Hypothyroidism in TPN patientID: 17-0030; June 2017 DOI: 10.1530/EDM-17-0030 http://www.edmcasereports.com  2enrichment of foodstuffs with iodine salts.,Non-OADS,/arxiv_data1/oa_pdf/c5/d2/edmcr-2017-170030.PMC5467649.pdf
p S Pearson and othersID: 17-0030; June 2017 DOI: 10.1530/EDM-17-0030 Hypothyroidism in TPN patient http://www.edmcasereports.com  3iodine supplementation ( 2 ).,Non-OADS,/arxiv_data1/oa_pdf/c5/d2/edmcr-2017-170030.PMC5467649.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License .© 2017 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdID: 17-0049; June 2017 DOI: 10.1530/EDM-17-0049Lipodystrophy and proteinuric  renal diseaseA Fountas and others Familial partial lipodystrophy and proteinuric  renal disease due to a missense c.1045C > T  LMNA  mutation Athanasios Fountas1, Zoe Giotaki1, Evangelia Dounousi2, George Liapis3,  Alexandra Bargiota4, Agathocles Tsatsoulis1 and Stelios Tigas1 Departments of 1Endocrinology and 2Nephrology, University Hospital of Ioannina, Ioannina, Greece,  3First Department of Pathology, Medical School, National and Kapodistrian University of Athens,  Athens, Greece, and 4Department of Endocrinology and Metabolic Diseases, University Hospital of  Larissa, Larissa, Greece Summary Proteinuric renal disease is prevalent in congenital or acquired forms of generalized lipodystrophy.",Non-OADS,/arxiv_data1/oa_pdf/6e/4a/edmcr-2017-170049.PMC5467650.pdf
"A Fountas and others Lipodystrophy and proteinuric  renal diseaseID: 17-0049; June 2017 DOI: 10.1530/EDM-17-0049 http://www.edmcasereports.com  2The severity of these metabolic derangements is dependent  on the extent of fat loss ( 3, 4).",Non-OADS,/arxiv_data1/oa_pdf/6e/4a/edmcr-2017-170049.PMC5467650.pdf
A Fountas and othersID: 17-0049; June 2017 DOI: 10.1530/EDM-17-0049 Lipodystrophy and proteinuric  renal disease http://www.edmcasereports.com  3<150 mg/24 h).,Non-OADS,/arxiv_data1/oa_pdf/6e/4a/edmcr-2017-170049.PMC5467650.pdf
"A Fountas and others Lipodystrophy and proteinuric  renal diseaseID: 17-0049; June 2017 DOI: 10.1530/EDM-17-0049 http://www.edmcasereports.com  4Outcome and follow-up In view of the progressive proteinuria, low-dose  angiotensin-converting-enzyme inhibitor treatment was  initiated.",Non-OADS,/arxiv_data1/oa_pdf/6e/4a/edmcr-2017-170049.PMC5467650.pdf
"A Fountas and othersID: 17-0049; June 2017 DOI: 10.1530/EDM-17-0049 Lipodystrophy and proteinuric  renal disease http://www.edmcasereports.com  5in transgenic mice leads to glomerulosclerosis and a  lipodystrophy-like syndrome ( 24, 25).",Non-OADS,/arxiv_data1/oa_pdf/6e/4a/edmcr-2017-170049.PMC5467650.pdf
A Fountas and others Lipodystrophy and proteinuric  renal diseaseID: 17-0049; June 2017 DOI: 10.1530/EDM-17-0049 http://www.edmcasereports.com  6Journal of the American College of Cardiology  52 1250–1260.,Non-OADS,/arxiv_data1/oa_pdf/6e/4a/edmcr-2017-170049.PMC5467650.pdf
"lICEnCE © 2017 The author(s)This article is distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International (CC BY-NC 4.0) licence (https://creativecommons.org/ licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribu- tion of the work without further permission provided the original work is attributed.",Non-OADS,/arxiv_data1/oa_pdf/65/7b/eor-2-179.PMC5467651.pdf
"p This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License .© 2017 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdID: 17-0061; June 2017 DOI: 10.1530/EDM-17-0061GH and IGF1 influences  Graves’ diseaseA Di Cerbo and others Growth hormone and insulin-like growth  factor 1 affect the severity of Graves’ disease Alfredo Di Cerbo1, Federica Pezzuto2 and Alessandro Di Cerbo2 1Endocrinology, ‘Casa Sollievo della Sofferenza’, IRCCS, San Giovanni Rotondo, Foggia, Italy and 2Department of   Medical, Oral and Biotechnological Sciences, Dental School, University ‘G.",Non-OADS,/arxiv_data1/oa_pdf/e2/58/edmcr-2017-170061.PMC5467652.pdf
"p A Di Cerbo and others GH and IGF1 influences  Graves’ diseaseID: 17-0061; June 2017 DOI: 10.1530/EDM-17-0061 http://www.edmcasereports.com  2endocrine factors, in particular GH, intervene in regulating  the production and synergizing the stimulatory activity of  IgGs responsible for the development and maintenance of  Graves’ disease.",Non-OADS,/arxiv_data1/oa_pdf/e2/58/edmcr-2017-170061.PMC5467652.pdf
p A Di Cerbo and othersID: 17-0061; June 2017 DOI: 10.1530/EDM-17-0061 GH and IGF1 influences  Graves’ disease http://www.edmcasereports.com  3the patient also showed a significant improvement of  all indexes of Graves’ disease activity.,Non-OADS,/arxiv_data1/oa_pdf/e2/58/edmcr-2017-170061.PMC5467652.pdf
p A Di Cerbo and others GH and IGF1 influences  Graves’ diseaseID: 17-0061; June 2017 DOI: 10.1530/EDM-17-0061 http://www.edmcasereports.com  4GH is involved in immunoregulation acting upon  a cell by binding its receptor at the cell membrane.,Non-OADS,/arxiv_data1/oa_pdf/e2/58/edmcr-2017-170061.PMC5467652.pdf
"p A Di Cerbo and othersID: 17-0061; June 2017 DOI: 10.1530/EDM-17-0061 GH and IGF1 influences  Graves’ disease http://www.edmcasereports.com  5signaling, are also involved in TSH/cAMP-induced thyroid  cell proliferation ( 49, 50, 51).",Non-OADS,/arxiv_data1/oa_pdf/e2/58/edmcr-2017-170061.PMC5467652.pdf
"p A Di Cerbo and others GH and IGF1 influences  Graves’ diseaseID: 17-0061; June 2017 DOI: 10.1530/EDM-17-0061 http://www.edmcasereports.com  6 3 Munck A, Guyre PM & Holbrook NJ 1984 Physiological functions  of glucocorticoids in stress and their relation to pharmacological  actions.",Non-OADS,/arxiv_data1/oa_pdf/e2/58/edmcr-2017-170061.PMC5467652.pdf
"p A Di Cerbo and othersID: 17-0061; June 2017 DOI: 10.1530/EDM-17-0061 GH and IGF1 influences  Graves’ disease http://www.edmcasereports.com  7 37 Dogan S, Atmaca A, Dagdelen S, Erbas B & Erbas T 2014 Evaluation  of thyroid diseases and differentiated thyroid cancer in acromegalic  patients.",Non-OADS,/arxiv_data1/oa_pdf/e2/58/edmcr-2017-170061.PMC5467652.pdf
"© 2017 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdID: 17-0045; June 2017 DOI: 10.1530/EDM-17-0045SOX9 duplication in 46,XX  ovotesticular DSDN Shankara Narayana and others Painful ovulation in a 46,XX SRY − ve adult  male with SOX9  duplication Nandini Shankara Narayana1,2, Anne-Maree Kean1, Lisa Ewans1,3, Thomas Ohnesorg4,  Katie L Ayers4,5, Geoff Watson1, Arthur Vasilaras1, Andrew H Sinclair4,5,  Stephen M Twigg1 and David J Handelsman2 1Royal Prince Alfred Hospital, Sydney, New South Wales, Australia, 2ANZAC Research Institute, University of Sydney,  Sydney, New South Wales, Australia, 3Central Clinical School, Sydney Medical School, University of Sydney,   New South Wales, Australia, 4Murdoch Childrens Research Institute, Melbourne, Victoria, Australia, and   5Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia Summary 46,XX disorders of sexual development (DSDs) occur rarely and result from disruptions of the genetic pathways underlying  gonadal development and differentiation.",Non-OADS,/arxiv_data1/oa_pdf/41/6f/edmcr-2017-170045.PMC5467653.pdf
"N Shankara Narayana  and othersSOX9 duplication in 46,XX ovotesticular DSDID: 17-0045; June 2017 DOI: 10.1530/EDM-17-0045 http://www.edmcasereports.com 2systematic approach to establish diagnosis through a  multidisciplinary approach.",Non-OADS,/arxiv_data1/oa_pdf/41/6f/edmcr-2017-170045.PMC5467653.pdf
"N Shankara Narayana  and othersID: 17-0045; June 2017 DOI: 10.1530/EDM-17-0045 SOX9 duplication in 46,XX  ovotesticular DSD http://www.edmcasereports.com 3chronological age.",Non-OADS,/arxiv_data1/oa_pdf/41/6f/edmcr-2017-170045.PMC5467653.pdf
"N Shankara Narayana  and othersSOX9 duplication in 46,XX ovotesticular DSDID: 17-0045; June 2017 DOI: 10.1530/EDM-17-0045 http://www.edmcasereports.com 4Table 2 Clinical characteristics, histopathology of the gonad removed and hormonal profile, semen analysis and karyotype of phenotypic men with evidence  of ovulation.",Non-OADS,/arxiv_data1/oa_pdf/41/6f/edmcr-2017-170045.PMC5467653.pdf
"N Shankara Narayana  and othersID: 17-0045; June 2017 DOI: 10.1530/EDM-17-0045 SOX9 duplication in 46,XX  ovotesticular DSD http://www.edmcasereports.com 5Table 3 Summary of case reports with SOX9/upstream duplication.",Non-OADS,/arxiv_data1/oa_pdf/41/6f/edmcr-2017-170045.PMC5467653.pdf
"N Shankara Narayana  and othersSOX9 duplication in 46,XX ovotesticular DSDID: 17-0045; June 2017 DOI: 10.1530/EDM-17-0045 http://www.edmcasereports.com 6hemorrhagic corpus luteum as well as a corpus albicans,  indicating prior ovulation.",Non-OADS,/arxiv_data1/oa_pdf/41/6f/edmcr-2017-170045.PMC5467653.pdf
"N Shankara Narayana  and othersID: 17-0045; June 2017 DOI: 10.1530/EDM-17-0045 SOX9 duplication in 46,XX  ovotesticular DSD http://www.edmcasereports.com 7including reproductive recurrence risks), psychological  aspects (sensitive individualized counseling including  patient gender identity and preference), endocrinological  (hormone replacement), surgical (cosmetic, prophylactic  gonadectomy) fertility preservation, reproductive  opportunities and metabolic health (cardiovascular  and bones).",Non-OADS,/arxiv_data1/oa_pdf/41/6f/edmcr-2017-170045.PMC5467653.pdf
"P This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License.© 2017 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdID: 17-0024; May 2017 DOI: 10.1530/EDM-17-0024Diabetes insipidus in HIV C Tavares Bello and others Diabetes insipidus and hypopituitarism in HIV:  an unexpected cause Carlos Tavares Bello, Francisco Sousa Santos, João Sequeira Duarte and  Carlos Vasconcelos Endocrinology Department, Hospital de Egas Moniz, Lisboa, Portugal Summary Central diabetes insipidus (DI) is a rare clinical entity characterized by low circulating levels of antidiuretic hormone (ADH) presenting with polyuria and volume depletion.",Non-OADS,/arxiv_data1/oa_pdf/7a/5d/edmcr-2017-170024.PMC5467654.pdf
P C Tavares Bello and others Diabetes insipidus in HIVID: 17-0024; May 2017 DOI: 10.1530/EDM-17-0024 http://www.edmcasereports.com  2is needed due to the high disease complexity and poor  prognosis.,Non-OADS,/arxiv_data1/oa_pdf/7a/5d/edmcr-2017-170024.PMC5467654.pdf
"P C Tavares Bello and othersID: 17-0024; May 2017 DOI: 10.1530/EDM-17-0024 Diabetes insipidus in HIV http://www.edmcasereports.com  3and cross-sectional imaging of chest, abdomen and pelvis  were unremarkable.",Non-OADS,/arxiv_data1/oa_pdf/7a/5d/edmcr-2017-170024.PMC5467654.pdf
"P C Tavares Bello and others Diabetes insipidus in HIVID: 17-0024; May 2017 DOI: 10.1530/EDM-17-0024 http://www.edmcasereports.com  4water clearance, therefore preventing dehydration.",Non-OADS,/arxiv_data1/oa_pdf/7a/5d/edmcr-2017-170024.PMC5467654.pdf
P C Tavares Bello and othersID: 17-0024; May 2017 DOI: 10.1530/EDM-17-0024 Diabetes insipidus in HIV http://www.edmcasereports.com  5with an average overall survival of 18–26  months ( 12 ).,Non-OADS,/arxiv_data1/oa_pdf/7a/5d/edmcr-2017-170024.PMC5467654.pdf
"p This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License .© 2017 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdID: 17-0040; June 2017 DOI: 10.1530/EDM-17-0040Fetal goitre and TG mutations P Vasudevan and others Intrauterine death following intraamniotic  triiodothyronine and thyroxine therapy for  fetal goitrous hypothyroidism associated with  polyhydramnios and caused by a  thyroglobulin mutation Pradeep Vasudevan1, Corrina Powell1, Adeline K Nicholas2, Ian Scudamore3,  James Greening4, Soo-Mi Park5 and Nadia Schoenmakers2 1Leicester Clinical Genetics, Women’s and Children’s Services, Leicester Royal Infirmary, Leicester, UK,  2University of Cambridge Metabolic Research Laboratories, Wellcome Trust-Medical Research Council  Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge, UK, 3Department of Obstetrics and  Gynaecology, Women’s and Prenatal Services, Leicester General Hospital, Leicester, UK, 4Department of  Paediatric Endocrinology, Leicester Royal Infirmary, Leicester, UK, and 5Department of Clinical Genetics,  Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK Summary In the absence of maternal thyroid disease or iodine deficiency, fetal goitre is rare and usually attributable to  dyshormonogenesis, for which genetic ascertainment is not always undertaken in the UK.",Non-OADS,/arxiv_data1/oa_pdf/82/47/edmcr-2017-170040.PMC5467655.pdf
"p P Vasudevan and others Fetal goitre and TG mutationsID: 17-0040; June 2017 DOI: 10.1530/EDM-17-0040 http://www.edmcasereports.com  2Background Congenital hypothyroidism (CH) is the commonest  neonatal endocrine disorder, (incidence 1:1500 in Europe)  and a national UK screening programme enables prompt  diagnosis and initiation of levothyroxine treatment ( 1).",Non-OADS,/arxiv_data1/oa_pdf/82/47/edmcr-2017-170040.PMC5467655.pdf
p P Vasudevan and othersID: 17-0040; June 2017 DOI: 10.1530/EDM-17-0040 Fetal goitre and TG mutations http://www.edmcasereports.com  3which were conservatively managed.,Non-OADS,/arxiv_data1/oa_pdf/82/47/edmcr-2017-170040.PMC5467655.pdf
p P Vasudevan and others Fetal goitre and TG mutationsID: 17-0040; June 2017 DOI: 10.1530/EDM-17-0040 http://www.edmcasereports.com  4previously reported in association with CH without  fetal goitre ( 6) Fig.,Non-OADS,/arxiv_data1/oa_pdf/82/47/edmcr-2017-170040.PMC5467655.pdf
"p P Vasudevan and othersID: 17-0040; June 2017 DOI: 10.1530/EDM-17-0040 Fetal goitre and TG mutations http://www.edmcasereports.com  5(3, 2, 4, 14).",Non-OADS,/arxiv_data1/oa_pdf/82/47/edmcr-2017-170040.PMC5467655.pdf
p P Vasudevan and others Fetal goitre and TG mutationsID: 17-0040; June 2017 DOI: 10.1530/EDM-17-0040 http://www.edmcasereports.com  6in Obstetrics and Gynecology  19 501–505.,Non-OADS,/arxiv_data1/oa_pdf/82/47/edmcr-2017-170040.PMC5467655.pdf
"AUTHOR COPY ONLY This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License .© 2017 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdID: 17-0034; May 2017 DOI: 10.1530/EDM-17-0034Lugol’s solution-induced  painless thyroiditisJ W Yang and J How Lugol’s solution-induced painless thyroiditis Ji Wei Yang  and Jacques How Division of Endocrinology and Metabolism, Department of Medicine, McGill University Health Centre,  Montreal, Quebec, Canada Summary Lugol’s solution is usually employed for a limited period for thyroidectomy preparation in patients with Graves’ disease  and for the control of severe thyrotoxicosis and thyroid storm.",Non-OADS,/arxiv_data1/oa_pdf/5c/57/edmcr-2017-170034.PMC5467656.pdf
AUTHOR COPY ONLY J W Yang and J How Lugol’s solution-induced  painless thyroiditisID: 17-0034; May 2017 DOI: 10.1530/EDM-17-0034 http://www.edmcasereports.com  2per day for the relief of menopausal symptoms.,Non-OADS,/arxiv_data1/oa_pdf/5c/57/edmcr-2017-170034.PMC5467656.pdf
"AUTHOR COPY ONLY J W Yang and J HowID: 17-0034; May 2017 DOI: 10.1530/EDM-17-0034 Lugol’s solution-induced  painless thyroiditis http://www.edmcasereports.com  3Our interpretation for our patient’s clinical picture is  that of a painless thyroiditis, induced by the uncommon  prolonged use of Lugol’s solution.",Non-OADS,/arxiv_data1/oa_pdf/5c/57/edmcr-2017-170034.PMC5467656.pdf
"http://doi.org/10.1183/20734735.002217  Breathe | June 2017 | Volume 13 | No 2 81 Cite as: Schönhofer B, Hart N,  Scala R, et al.",Non-OADS,/arxiv_data1/oa_pdf/4d/a0/EDU-0022-2017.PMC5467657.pdf
@ ERSpublications Faculty and delegates of the @ERStalk course on basic concepts in NIV describe their experiences http://ow.ly/zUPn30b7jLbB.,Non-OADS,/arxiv_data1/oa_pdf/4d/a0/EDU-0022-2017.PMC5467657.pdf
http://doi.org/10.1183/20734735.004717  Breathe | June 2017 | Volume 13 | No 2 101 This review article is an update of what should be known for practicing basic lung ultrasound in the  critically ill (LUCI) and is also of interest for less critical disciplines (e.g.,Non-OADS,/arxiv_data1/oa_pdf/cb/9f/EDU-0047-2017.PMC5467658.pdf
"@ ERSpublications What you need to know to practice basic lung ultrasound in the critically ill: the BLUE, FALLS and SESAME protocols http://ow.ly/uDx630aNUN1Cite as: Lichtenstein D. Novel approaches to ultrasonography of the lung and pleural space: where are we now?",Non-OADS,/arxiv_data1/oa_pdf/cb/9f/EDU-0047-2017.PMC5467658.pdf
"Breathe | June 2017 | Volume 13 | No 2 111 Ultrasonography of the lung and pleural spaceAcknowledgements and notes  on videos I thank François Jardin (Medical ICU, Boulogne,  France), who made this project possible by allowing us to formally join his ICU.Videos of the A-profile (normal anterior lung  surface), B-profile (usually seen in haemodynamic pulmonary oedema), B′ -profile (pneumonia/ acute respiratory distress syndrome) and A′ -profile  (usually pneumothorax) mentioned in this article  can be seen at will at http://www.ceurf.net/en/ blueprotocol.htm Conflict of interest None declared.",Non-OADS,/arxiv_data1/oa_pdf/cb/9f/EDU-0047-2017.PMC5467658.pdf
"http://doi.org/10.1183/20734735.006616  Breathe | June 2017 | Volume 13 | No 2 129 Top tips to deal with challenging  situations: doctor–patient interactions Doing science Raise your words, not your voice.",Non-OADS,/arxiv_data1/oa_pdf/e4/c1/EDU-0066-2016.PMC5467659.pdf
http://ow.ly/J1GI30bD5wp,Non-OADS,/arxiv_data1/oa_pdf/e4/c1/EDU-0066-2016.PMC5467659.pdf
"http://doi.org/10.1183/20734735.007717  Breathe | June 2017 | Volume 13 | No 2 137 To sleep, or not to sleep – that is  the question, for polysomnography As the English dramatist Thomas Dekker wrote, “Sleep is that golden chain that ties health and our bodies together”.",Non-OADS,/arxiv_data1/oa_pdf/8b/67/EDU-0077-2017.PMC5467660.pdf
http://ow.ly/UxCU30bNopqLandmark papers in respiratory medicine,Non-OADS,/arxiv_data1/oa_pdf/8b/67/EDU-0077-2017.PMC5467660.pdf
http://doi.org/10.1183/20734735.008617  Breathe | June 2017 | Volume 13 | No 2 75 This issue is dedicated to technological advances and  their contribution to the advancement of respiratory medicine.,Non-OADS,/arxiv_data1/oa_pdf/73/20/EDU-0086-2017.PMC5467661.pdf
@ ERSpublications The June issue of Breathe looks at biomedical engineering in respiratory disorders   http://ow.ly/rn7N30c2qvg,Non-OADS,/arxiv_data1/oa_pdf/73/20/EDU-0086-2017.PMC5467661.pdf
"http://doi.org/10.1183/20734735.019516  Breathe | June 2017 | Volume 13 | No 2 113 Cite as: Aljanabi M, Khatib S,  Gharaibeh NS.",Non-OADS,/arxiv_data1/oa_pdf/e1/c7/EDU-0195-2016.PMC5467662.pdf
http://ow.ly/13Y830bgExG,Non-OADS,/arxiv_data1/oa_pdf/e1/c7/EDU-0195-2016.PMC5467662.pdf
http://doi.org/10.1183/20734735.132117  Breathe | June 2017 | Volume 13 | No 2 143 Case 2 A 29-year-old male presents with fever and night sweats.,Non-OADS,/arxiv_data1/oa_pdf/ed/e3/EDU-1321-2017.PMC5467663.pdf
"http://doi.org/10.1183/20734735.132217  Breathe | June 2017 | Volume 13 | No 2 141 Association of borderline pulmonary hyper - tension with mortality and hospitalization  in a large patient cohort: insights from the  Veterans Affairs Clinical Assessment,  Reporting, and Tracking programAuthors: Maron BA, Hess E, Maddox TM, et al.Circulation 2016; 133: 1240–1248.",Non-OADS,/arxiv_data1/oa_pdf/40/72/EDU-1322-2017.PMC5467664.pdf
"With regard to  adenocarcinomas, the study adds important details  regarding how certain mutations may differentially shape the local immune response.Reviewed by: Sebastian Marwitz (Germany,  Assembly 3) The PEARL score predicts 90-day readmis - sion or death after hospitalisation for acute  exacerbation of COPD Authors: Echevarria C, Steer J, Heslop-Marshall K, et al.Thorax 2017 [in press https://doi.org/10.1136/ thoraxjnl-2016-209298] Summary: Echevarria et al.",Non-OADS,/arxiv_data1/oa_pdf/40/72/EDU-1322-2017.PMC5467664.pdf
"Find out about the candidates and vote now https://www.ersnet.org/the-society/who-we-are/ leadership/ers-elections We are excited to announce that registration for this year’s ERS International Congress is now open and if you register  before July 5, 2017 , you will beneﬁ  t from an early-bird discount.",Non-OADS,/arxiv_data1/oa_pdf/c5/0d/EDU-news132.PMC5467666.pdf
"MeSH Keywords:  Mesothelioma, Cystic • Sirolimus • TOR Serine-Threonine Kinases • Treatment Outcome  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/903548Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Medical and Surgical Sciences, Nephrology, Dialysis and  Transplantation Unit, University of Foggia, Foggia, Italy 2 Department of Medical and Surgical Sciences, Urology and Renal Transplantation  Unit, University of Foggia, Foggia, Italy 3 Department of Medical and Surgical Sciences, Radiology Unit, University of  Foggia, Foggia, ItalyISSN 1941-5923 © Am J Case Rep, 2017; 18: 627-631 DOI: 10.12659/AJCR.903548 627 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/6c/92/amjcaserep-18-627.PMC5467667.pdf
"MeSH Keywords:  Acidosis, Renal Tubular • Diabetes Insipidus • Sjögren’s Syndrome  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/903476Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Medicine, University of California, Los Angeles, CA, U.S.A. 2 Department of Pathology, Shahid Beheshti University of Medical Sciences,  Tehran, IranISSN 1941-5923 © Am J Case Rep, 2017; 18: 622-626 DOI: 10.12659/AJCR.903476 622 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/d5/85/amjcaserep-18-622.PMC5467668.pdf
"MeSH Keywords:  Adenocarcinoma • Carcinoid Tumor • Colonic Neoplasms • Neoplasms, Multiple Primary •  Neuroendocrine Tumors  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/903580Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Division of Gastroenterology and Hepatology, University of Missouri, Columbia,  MO, U.S.A.. 2 Department of Pathology, University of Missouri, Columbia, MO, U.S.A.ISSN 1941-5923 © Am J Case Rep, 2017; 18: 632-636 DOI: 10.12659/AJCR.903580 632 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/af/95/amjcaserep-18-632.PMC5467669.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License .© 2017 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdID: 16-0136; May 2017 DOI: 10.1530/EDM-16-0136Lenvatinib efficacy in  anaplastic thyroid cancerK Oishi and others Efficacy of lenvatinib in a patient with  anaplastic thyroid cancer Kazuyuki Oishi, Daisuke Takabatake  and Yuichi Shibuya Kochi Health Sciences Center – Divisions of Breast & Thyroid Surgery, Kochi, Japan Summary We experienced a case of an 82-year-old woman who presented to our hospital with a 1-month history of dysphagia  and dyspnea.",Non-OADS,/arxiv_data1/oa_pdf/41/8e/edmcr-2017-160136.PMC5467670.pdf
K Oishi and others Lenvatinib efficacy in  anaplastic thyroid cancerID: 16-0136; May 2017 DOI: 10.1530/EDM-16-0136 http://www.edmcasereports.com  2survival was 10.6  months.,OADS,/arxiv_data1/oa_pdf/41/8e/edmcr-2017-160136.PMC5467670.pdf
K Oishi and othersID: 16-0136; May 2017 DOI: 10.1530/EDM-16-0136 Lenvatinib efficacy in  anaplastic thyroid cancer http://www.edmcasereports.com  3healing could be delayed due to radiation exposure just  after the tracheostomy.,Non-OADS,/arxiv_data1/oa_pdf/41/8e/edmcr-2017-160136.PMC5467670.pdf
"K Oishi and others Lenvatinib efficacy in  anaplastic thyroid cancerID: 16-0136; May 2017 DOI: 10.1530/EDM-16-0136 http://www.edmcasereports.com  4It was very likely that the infection caused by saliva that  was aspirated and flowed into the tracheostomy area had  promoted delayed wound healing, tissue necrosis and  blood vessel permeation around the common carotid  artery.",Non-OADS,/arxiv_data1/oa_pdf/41/8e/edmcr-2017-160136.PMC5467670.pdf
"K Oishi and othersID: 16-0136; May 2017 DOI: 10.1530/EDM-16-0136 Lenvatinib efficacy in  anaplastic thyroid cancer http://www.edmcasereports.com  5 4 Schlumberger M, Tahara M, Wirth LJ, Robinson B, Brose MS, Elisei  R, Habra MA, Newbold K, Shah MH, Hoff AO,  et al.",Non-OADS,/arxiv_data1/oa_pdf/41/8e/edmcr-2017-160136.PMC5467670.pdf
"lICEnCE © 2017 The author(s)This article is distributed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International (CC BY-NC 4.0) licence (https://creativecommons.org/ licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribu- tion of the work without further permission provided the original work is attributed.",Non-OADS,/arxiv_data1/oa_pdf/2d/db/eor-2-141.PMC5467673.pdf
https://apps.webofknowledge.com/WOS_GeneralSearch_ input.do?product=WOS&search_mode=GeneralSearch&SID=S22PEzgzz3r63GOVGZR&preferencesSaved= 6. scopus: Elsevier.,Non-OADS,/arxiv_data1/oa_pdf/4e/4a/eor-2-126.PMC5467674.pdf
https://www.elsevier.com/solutions/scopus7.,Non-OADS,/arxiv_data1/oa_pdf/4e/4a/eor-2-126.PMC5467674.pdf
https://www.elsevier.com/solutions/ embase-biomedical-research8.,Non-OADS,/arxiv_data1/oa_pdf/4e/4a/eor-2-126.PMC5467674.pdf
http://www.bl.uk/ (date last accessed 01  March 2017).,Non-OADS,/arxiv_data1/oa_pdf/4e/4a/eor-2-126.PMC5467674.pdf
http://apo.org.au/  (date last accessed 01 March 2017).,Non-OADS,/arxiv_data1/oa_pdf/4e/4a/eor-2-126.PMC5467674.pdf
https://arxiv.org/ (date last accessed 01 March 2017).,Non-OADS,/arxiv_data1/oa_pdf/4e/4a/eor-2-126.PMC5467674.pdf
http://repec.org/ (date last accessed 01 March 2017).,Non-OADS,/arxiv_data1/oa_pdf/4e/4a/eor-2-126.PMC5467674.pdf
http://www.greynet.org/ (date last  accessed 01 March 2017).,Non-OADS,/arxiv_data1/oa_pdf/4e/4a/eor-2-126.PMC5467674.pdf
https://www.ebsco.com/ (date  last accessed 01 March 2017).,Non-OADS,/arxiv_data1/oa_pdf/4e/4a/eor-2-126.PMC5467674.pdf
"fundIng No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.lICEnCE © 2017 The author(s)This article is distributed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International (CC BY-NC 4.0) licence (https://creativecommons.org/ licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribu- tion of the work without further permission provided the original work is attributed.",Non-OADS,/arxiv_data1/oa_pdf/7d/91/eor-2-241.PMC5467677.pdf
"lICEnCE © 2017 The author(s)This article is distributed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International (CC BY-NC 4.0) licence (https://creativecommons.org/ licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribu- tion of the work without further permission provided the original work is attributed.",Non-OADS,/arxiv_data1/oa_pdf/cc/50/eor-2-171.PMC5467678.pdf
Adelaide: AOA; 2015 (https://www.aoa.org.au/docs/default-source/annualreports/annual-report-2014-2015.pdf?sfvrsn=6) (date last accessed 20 March 2017) 3.,Non-OADS,/arxiv_data1/oa_pdf/cc/50/eor-2-171.PMC5467678.pdf
(Registro Regionale di Implantologia Protesica Ortopedica) Report 2000-2013.  https://ripo.cineca.it/Reports.html (date last accessed 20 March 2017).,Non-OADS,/arxiv_data1/oa_pdf/cc/50/eor-2-171.PMC5467678.pdf
12 Annual Report 2015. http://www.njrcentre.org.uk/njrcentre/Portals/0/ Documents/England/Reports/12th%20annual%20report/NJR%20Online%20Annual%20Report%202015.pdf (date last accessed 16 March 2017).,Non-OADS,/arxiv_data1/oa_pdf/cc/50/eor-2-171.PMC5467678.pdf
Swedish Hip Arthroplasty Register  Annual Report 2013 http://www.shpr.se/Libraries/Documents/%C3%85rsrapport_2013_ eng_webb.sflb.ashx (date last accessed 20 March 2017) 45.,Non-OADS,/arxiv_data1/oa_pdf/cc/50/eor-2-171.PMC5467678.pdf
"lICEnCE © 2017 The author(s)This article is distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International (CC BY-NC 4.0) licence (https://creativecommons.org/ licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribu- tion of the work without further permission provided the original work is attributed.",Non-OADS,/arxiv_data1/oa_pdf/0a/ac/eor-2-135.PMC5467679.pdf
"lICenCe © 2017 The author(s)This article is distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International (CC BY-NC 4.0) licence (https://creativecommons.org/ licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribu- tion of the work without further permission provided the original work is attributed.",Non-OADS,/arxiv_data1/oa_pdf/25/4e/eor-2-117.PMC5467680.pdf
"ConfliCt of interest None funding No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.liCenCe © 2017 The author(s)This article is distributed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International (CC BY-NC 4.0) licence (https://creativecommons.org/ licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribu- tion of the work without further permission provided the original work is attributed.",Non-OADS,/arxiv_data1/oa_pdf/24/61/eor-2-151.PMC5467683.pdf
"lICenCe © 2017 The author(s)This article is distributed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International (CC BY-NC 4.0) licence (https://creativecommons.org/ licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribu- tion of the work without further permission provided the original work is attributed.",Non-OADS,/arxiv_data1/oa_pdf/b0/7c/eor-2-261.PMC5467685.pdf
"https://doi.org/10.1177/1176935117711944 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Cancer Informatics Volume 16: 1–10 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1176935117711944 Introduction Since their discovery as virally transduced oncogenes and trans- forming genes in human tumor DNA, RAS genes have been shown to regulate many cellular processes including cell growth, differentiation, and survival.",Non-OADS,/arxiv_data1/oa_pdf/a1/95/10.1177_1176935117711944.PMC5467702.pdf
"As one of the largest public repositories of cancer genomic  data, The Cancer Genome Atlas (TCGA) project has produced a wealth of new insights into cancer biology and the underlying driver events that give rise to the disease (see http://cancerge-nome.nih.gov/abouttcga/overview).",Non-OADS,/arxiv_data1/oa_pdf/a1/95/10.1177_1176935117711944.PMC5467702.pdf
2 Cancer Informatics   reported (see https://tcga-data.nci.nih.gov/docs/publications/  and http://cancergenome.nih.gov/publications).,OADS,/arxiv_data1/oa_pdf/a1/95/10.1177_1176935117711944.PMC5467702.pdf
"In addition, a series of reports have detailed “pan-cancer” analyses where data aggregated across many tumor types and genomics platforms were used to identify similarities and differences among and between different tumor types (http://www.nature.com/tcga/).",OADS,/arxiv_data1/oa_pdf/a1/95/10.1177_1176935117711944.PMC5467702.pdf
Methods Data preparation The Cancer Genome Atlas data were obtained from the stand- ard release folder from the Broad DCC firehose (http://gdac.broadinstitute.org/runs/stddata__latest/) for each available tumor type.,OADS,/arxiv_data1/oa_pdf/a1/95/10.1177_1176935117711944.PMC5467702.pdf
"In addition, the transcript-level messenger RNA expression data were obtained from the TCGA data portal (https://cancergenome.nih.gov/publications) for each individ-ual sample for each tumor type and merged into a single matrix file per tumor type using R (https://www.r-project.org).",OADS,/arxiv_data1/oa_pdf/a1/95/10.1177_1176935117711944.PMC5467702.pdf
The tumor type codes used throughout this article can be found on the TCGA Web site (https://tcga-data.nci.nih.gov/tcga/).,OADS,/arxiv_data1/oa_pdf/a1/95/10.1177_1176935117711944.PMC5467702.pdf
The copy number variation (CNV) data were obtained from the DCC analysis page (https://confluence.broadinstitute.org/display/GDAC/Dashboard-Analyses) and we loaded the GISTIC (Genomic Identification of Significant Targets in Cancer) 12 data into oracle using   the method outlined above (see https://www.biostars.org/p/   133927/).,OADS,/arxiv_data1/oa_pdf/a1/95/10.1177_1176935117711944.PMC5467702.pdf
"Cancer Cell Line Encyclopedia (CCLE) data were down- loaded from the following Web site: http://www.broadinsti-tute.org/ccle/home, and the mutation and expression files were then analyzed using standard R analysis workflows (see below).",OADS,/arxiv_data1/oa_pdf/a1/95/10.1177_1176935117711944.PMC5467702.pdf
Data analysis We used the ROracle Database interface package (https://cran.r-project.org/web/packages/ROracle/index.html) to con-nect from R to the Oracle TCGA database instance and a series of wrapper functions to facilitate querying.,OADS,/arxiv_data1/oa_pdf/a1/95/10.1177_1176935117711944.PMC5467702.pdf
"https://doi.org/10.1177/1179552217711430Clinical Medicine Insights:  Gastroenterology Volume 10: 1–4 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1179552217711430 Creative Commons CC BY: This article is distributed under the terms of the Creative Commons Attribution 4.0 License   (http://www.creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission  provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Introduction Hepatic artery aneurysms (HAAs) are relatively rare; as stated  above, they only comprise 20% of all visceral artery aneurysms.",Non-OADS,/arxiv_data1/oa_pdf/93/b7/10.1177_1179552217711430.PMC5467703.pdf
"https://doi.org/10.1177/1178222617713018 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Biomedical Informatics Insights Volume 9: 1–14 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1178222617713018 Introduction We focused on the adverse drug reaction (ADR) subset of  adverse drug events (ADEs).",Non-OADS,/arxiv_data1/oa_pdf/85/09/10.1177_1178222617713018.PMC5467704.pdf
"Availability of Data and Materials The FAERS reports analyzed are available at the FDA Adverse Event Reporting System, http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm083765.htm.",OADS,/arxiv_data1/oa_pdf/85/09/10.1177_1178222617713018.PMC5467704.pdf
https://www.va.gov/MS/Professionals/ medications/Adverse_Drug_Reaction_FAQ.pdf.,Non-OADS,/arxiv_data1/oa_pdf/85/09/10.1177_1178222617713018.PMC5467704.pdf
http://archive.ahrq.gov/research/findings/factsheets/errors-safety/aderia/ade.,OADS,/arxiv_data1/oa_pdf/85/09/10.1177_1178222617713018.PMC5467704.pdf
http://www.fda.gov/ Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/ AdverseDrugEffects/.,Non-OADS,/arxiv_data1/oa_pdf/85/09/10.1177_1178222617713018.PMC5467704.pdf
http://online.lexi.com/.,Non-OADS,/arxiv_data1/oa_pdf/85/09/10.1177_1178222617713018.PMC5467704.pdf
http://www.nlm.nih.gov/research/umls/new_ users/online_learning/Meta_005.html.,Non-OADS,/arxiv_data1/oa_pdf/85/09/10.1177_1178222617713018.PMC5467704.pdf
https://uts.nlm.nih.gov/home.html.,Non-OADS,/arxiv_data1/oa_pdf/85/09/10.1177_1178222617713018.PMC5467704.pdf
https://code.google.com/p/negex/downloads/detail?name=GeneralNegEx.Java.v.2.0_10272010.zip.,OADS,/arxiv_data1/oa_pdf/85/09/10.1177_1178222617713018.PMC5467704.pdf
"MeSH Keywords:  Arthroplasty, Replacement, Hip • Blood Loss, Surgical • Blood Transfusion • Drainage, Sanitary  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/904864Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Orthopedic Surgery, The Tenth Peoples’ Hospital, Affiliated to  Tongji University, Shanghai, P.R.",Non-OADS,/arxiv_data1/oa_pdf/93/5b/medscimonit-23-2708.PMC5467705.pdf
"MeSH Keywords:  Amoxicillin • Helicobacter pylori  • Levofloxacin • Proton Pump Inhibitors  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/901514Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection GDepartment of Gastroenterology, Guangzhou First People’s Hospital, Guangzhou,  Guangdong, P.R.",Non-OADS,/arxiv_data1/oa_pdf/14/e2/medscimonit-23-2701.PMC5467706.pdf
"MeSH Keywords:  Alzheimer Disease • Biological Markers • Gene Regulatory Networks  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/905064Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Neurology, The Second People’s Hospital of Liaocheng, Liaocheng  Shandong, P.R.",Non-OADS,/arxiv_data1/oa_pdf/f1/0a/medscimonit-23-2721.PMC5467707.pdf
The microarray datasets of AD were obtained from the GEO  database ( http://www.ncbi.nlm.nih.gov/geo ).,OADS,/arxiv_data1/oa_pdf/f1/0a/medscimonit-23-2721.PMC5467707.pdf
"Functional annotation To analyze the function and the potential pathway of miRNA- target genes, functional annotation including Gene Ontology  (GO) classification (molecular functions, biological processes  and cellular component) and Kyoto Encyclopedia of Genes and  Genomes (KEGG) pathway enrichment was performed by us - ing the online software GeneCodis ( http://genecodis.cnb.csic.",OADS,/arxiv_data1/oa_pdf/f1/0a/medscimonit-23-2721.PMC5467707.pdf
"MeSH Keywords:  Diabetes Mellitus, Type 2 • Diabetic Nephropathies • Diabetic Retinopathy  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/902006Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection GKey Laboratory of Hormones and Development, Ministry of Health, Tianjin Key  Laboratory of Metabolic Diseases, Tianjin Metabolic Diseases Hospital and Tianjin  Institute of Endocrinology, Tianjin Medical University, Tianjin, P.R.",Non-OADS,/arxiv_data1/oa_pdf/09/e7/medscimonit-23-2715.PMC5467710.pdf
"ALZHEIMER ’SSOCIETY , 2015, T ypes of Dementia [Online] (available at: http://www.alzheimers.org.uk/site/Scripts/documents.",Non-OADS,/arxiv_data1/oa_pdf/4d/7c/JLCD-52-392.PMC5467725.pdf
"https://doi.org/10.1177/1178221817704692 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Substance Abuse: Research and Treatment Volume 11: 1–4 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1178221817704692 Perinatal substance use remains a global public health concern.",Non-OADS,/arxiv_data1/oa_pdf/8a/f3/10.1177_1178221817704692.PMC5467766.pdf
http://www.samhsa.gov/data/.,OADS,/arxiv_data1/oa_pdf/8a/f3/10.1177_1178221817704692.PMC5467766.pdf
Learn more about Dr. Dunlop by visiting his institutional webpage here: https://www.newcastle.edu.au/profile/adrian-dunlop.,Non-OADS,/arxiv_data1/oa_pdf/8a/f3/10.1177_1178221817704692.PMC5467766.pdf
"https://doi.org/10.1177/1049732317697079Qualitative Health Research 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/5f/a4/10.1177_1049732317697079.PMC5467781.pdf
Retrieved from  https://goo.gl/qEA9kn Academy of Social Sciences.,Non-OADS,/arxiv_data1/oa_pdf/5f/a4/10.1177_1049732317697079.PMC5467781.pdf
"Retrieved from https://www.alz.co.uk/ research/WorldAlzheimerReport2016.pdf Barca, M. L., Thorsen, K., Engedal, K., Haugen, P. K., &  Johannessen, A.",Non-OADS,/arxiv_data1/oa_pdf/5f/a4/10.1177_1049732317697079.PMC5467781.pdf
Retrieved from https://goo.gl/a59jcE,Non-OADS,/arxiv_data1/oa_pdf/5f/a4/10.1177_1049732317697079.PMC5467781.pdf
"Retrieved  from https://goo.gl/EWtsqq Davies, B.",Non-OADS,/arxiv_data1/oa_pdf/5f/a4/10.1177_1049732317697079.PMC5467781.pdf
Retrieved from https://goo.gl/wmPhWE Department of Health.,Non-OADS,/arxiv_data1/oa_pdf/5f/a4/10.1177_1049732317697079.PMC5467781.pdf
"Retrieved from https://goo.gl/LiXk01 Fontaine, J., & Oyebode, J.",OADS,/arxiv_data1/oa_pdf/5f/a4/10.1177_1049732317697079.PMC5467781.pdf
"Retrieved from https://goo.gl/BDdPx3 Hutchinson, K., Roberts, C., Kurrle, S., & Daly, M. (2016).",OADS,/arxiv_data1/oa_pdf/5f/a4/10.1177_1049732317697079.PMC5467781.pdf
"Retrieved from  https://goo.gl/SqF64T Johannenssen, A., Engedal, K., & Thorsen, K. (2015).",OADS,/arxiv_data1/oa_pdf/5f/a4/10.1177_1049732317697079.PMC5467781.pdf
"Retrieved from https://goo.gl/YtZSKK Little, G. (2016, May 16).",Non-OADS,/arxiv_data1/oa_pdf/5f/a4/10.1177_1049732317697079.PMC5467781.pdf
"Retrieved from https://goo.gl/DMcxSR Luscombe, G., Brodaty, H., & Freeth, S. (1998).",OADS,/arxiv_data1/oa_pdf/5f/a4/10.1177_1049732317697079.PMC5467781.pdf
"Retrieved from http://www.thehealthwell.info/node/99638, http://www.nhs.uk/news/2011/08August/Pages/alzheimers-dementia-press-coverage.aspx.",Non-OADS,/arxiv_data1/oa_pdf/5f/a4/10.1177_1049732317697079.PMC5467781.pdf
"Retrieved from https://goo.gl/7WLNZf Whittle, D. (2016, May 16).",Non-OADS,/arxiv_data1/oa_pdf/5f/a4/10.1177_1049732317697079.PMC5467781.pdf
"Retrieved from https://goo.gl/Kd3ia6 Williams, C. (2016, February 10).",Non-OADS,/arxiv_data1/oa_pdf/5f/a4/10.1177_1049732317697079.PMC5467781.pdf
"In the Human Protein Atlas database, the expression of  hnRNP E1 was positive in pancreatic cancer and the malig - nant cells exhibited moderate to strong cytoplasmic positivity (http://www.proteinatlas.org/ENSG00000169564-PCBP1/cancer/tissue/pancreatic+cancer).",Non-OADS,/arxiv_data1/oa_pdf/d4/f7/ijo-51-01-0169.PMC5467783.pdf
"For functional enrichment analysis of gene ontology terms and molecular signaling pathway the following tools were used: DAVID (https://david.ncifcrf.gov/), WebGestalt (http://bioinfo.vanderbilt.edu/webgestalt/), Enrichr (http://amp.pharm.mssm.edu/Enrichr/) and oPOSSUM 3.0 (http://opossum.cisreg.ca/oPOSSUM3/).",OADS,/arxiv_data1/oa_pdf/7b/f2/ijo-51-01-0128.PMC5467784.pdf
"CAbOMETYX, 2016. https://www.fda.gov/Drugs/Information  OnDrugs/ApprovedDrugs/ucm497483.htm.",Non-OADS,/arxiv_data1/oa_pdf/f9/6b/ijo-51-01-0091.PMC5467791.pdf
"http://doi.org/10.1183/20734735.001317  Breathe | June 2017 | Volume 13 | No 2 117 Cite as: Rai S, Ionescu AA.",Non-OADS,/arxiv_data1/oa_pdf/0e/a8/EDU-0013-2017.PMC5467865.pdf
"http://ow.ly/t4nX30bzJFzCase report Task 1 Based on this information, what is your diagnosis?",Non-OADS,/arxiv_data1/oa_pdf/0e/a8/EDU-0013-2017.PMC5467865.pdf
"http://doi.org/10.1183/20734735.001817  Breathe | June 2017 | Volume 13 | No 2 77 Cite as: Sehlbach C,  Thomson C, Bennett J, et al.",Non-OADS,/arxiv_data1/oa_pdf/ae/47/EDU-0018-2017.PMC5467866.pdf
"To this end, re-certification Re-certification of respiratory professionals: current practice and the future – educational  forum report @ ERSpublications Re-certification of respiratory professionals: a report of an @ERStalk education forum held at #ERSLDN16 http://ow.ly/pUKY30bzcrK",Non-OADS,/arxiv_data1/oa_pdf/ae/47/EDU-0018-2017.PMC5467866.pdf
"http://doi.org/10.1183/20734735.004617  Breathe | June 2017 | Volume 13 | No 2 127Cite as: Bos LD, Bartel S,  Mathioudakis AG, et al.",Non-OADS,/arxiv_data1/oa_pdf/ca/9e/EDU-0046-2017.PMC5467867.pdf
@ ERSpublications Read about upcoming opportunities for @ERStalk Early Career Members http://ow.ly/QFyb30b7iKqEarly Career Forum,Non-OADS,/arxiv_data1/oa_pdf/ca/9e/EDU-0046-2017.PMC5467867.pdf
Please visit http://hermes.ersnet.org/exams/exams.html for more  information.,Non-OADS,/arxiv_data1/oa_pdf/ca/9e/EDU-0046-2017.PMC5467867.pdf
"http://doi.org/10.1183/20734735.007817  Breathe | June 2017 | Volume 13 | No 2 85 raffaele.dellaca@polimi.it Raffaele L. Dellaca’1, Chiara Veneroni1, Ramon Farre’2,3 1Dipartimento di Elettronica, Informazione e Bioingegneria – DEIB, Politecnico di Milano University,  Milan, Italy.",Non-OADS,/arxiv_data1/oa_pdf/01/db/EDU-0078-2017.PMC5467868.pdf
"@ ERSpublications Physiology, medicine and engineering principles have contributed to the advancement of mechanical ventilation http://ow.ly/Fjlb30bFpLlCite as: Dellaca’ RL, Veneroni C, Farre’ R. Trends in mechanical ventilation: are we ventilating our patients in the best possible way?",Non-OADS,/arxiv_data1/oa_pdf/01/db/EDU-0078-2017.PMC5467868.pdf
"http://doi.org/10.1183/20734735.017816  Breathe | June 2017 | Volume 13 | No 2 123 Introduction Catathrenia (from the Greek kata, meaning “below”,  and threnia, meaning “to lament”) is a rare sleep  disorder with very few cases reported in children [1].",Non-OADS,/arxiv_data1/oa_pdf/6b/ec/EDU-0178-2016.PMC5467869.pdf
@ ERSpublicationsThe first report of catathrenia in a child who has been symptomatic from birth   http://ow.ly/XcY830bevOHCase report Task 1 What investigation(s) would you consider?,Non-OADS,/arxiv_data1/oa_pdf/6b/ec/EDU-0178-2016.PMC5467869.pdf
"http://doi.org/10.1183/20734735.018616  Breathe | June 2017 | Volume 13 | No 2 147 Cite as: Scala R, Heunks L,  Gregoretti C, et al.",Non-OADS,/arxiv_data1/oa_pdf/95/4f/EDU-0186-2016.PMC5467870.pdf
Group 02.02: noninvasive  ventilatory support Group 02.01 has a specific interest in both acute  and chronic noninvasive ventilation (NIV) for several  @ ERSpublications Meet @ERStalk Assembly 2: respiratory intensive care http://ow.ly/PnnB30b7nLUMeet the Assemblies,Non-OADS,/arxiv_data1/oa_pdf/95/4f/EDU-0186-2016.PMC5467870.pdf
"https://doi.org/10.1177/1179069517713019 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Journal of Experimental Neuroscience Volume 11: 1–5 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1179069517713019 Introduction As the population of older individuals grows in developed  countries, there is increasing need for surgical treatment of age-related compressive spinal cord lesions and spinal cord injuries.",Non-OADS,/arxiv_data1/oa_pdf/87/41/10.1177_1179069517713019.PMC5467915.pdf
https://www.jstage.jst.go.jp/article/ kitanihon1966/1993/44/1993_44_107/_pdf.,OADS,/arxiv_data1/oa_pdf/73/cd/10.1177_1179543317709275.PMC5467916.pdf
http://hdl.handle.net/1957/20798.,Non-OADS,/arxiv_data1/oa_pdf/73/cd/10.1177_1179543317709275.PMC5467916.pdf
"https://doi.org/10.1177/1177625017713996 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Gene Regulation and Systems Biology Volume 11: 1–13 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1177625017713996 Introduction Membrane type 1-matrix metalloproteinase (MT1-MMP) is a  transmembrane matrix metalloprotease which degrades inter-stitial collagens and extracellular matrix (ECM) components under both normal and pathophysiological processes including atherosclerosis, muscular diseases, and cancer.",Non-OADS,/arxiv_data1/oa_pdf/a7/95/10.1177_1177625017713996.PMC5467917.pdf
The detailed list of these key transcription factor genes can be found on the manufacturer’s Web site (http://www.sabiosciences.com/ArrayList.php).,Non-OADS,/arxiv_data1/oa_pdf/a7/95/10.1177_1177625017713996.PMC5467917.pdf
The resulting raw data were then analyzed using the PCR Array Data Analysis Template (http://www.sabiosciences.com/pcrarraydataanalysis.php).,OADS,/arxiv_data1/oa_pdf/a7/95/10.1177_1177625017713996.PMC5467917.pdf
"https://doi.org/10.1177/1178632917710533 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Health Services Insights Volume 10: 1–23 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1178632917710533 Marketization of health and social service organizations  includes the ideas of privatizing funding streams and com-mercializing services.",Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
"http://www.ssb.no/en/helse/statistikker/pleie/aar-forelopige/2014-07-08#content; http://ssb.no/helse/statistikker/pleie/aar/2016-06-29?fane=tabell&sort=nummer&tabell=271503; https://www.ssb.no/statistikkbanken/SelectVarVal/Define.asp?MainTable=KostHelseTjen&;Kortnavnw eb=helsesat&PLanguage=0&checked=true; https://www.fhi.no/en/hn/elderly-health/elderly-over-65-years-in-norway—f/; http://ec.europa.eu/eurostat/statistics-explained/index.php/File:Population_age_structure_by_major_age_groups,_2005_ and_2015_(%25_of_the_total_population)_yB16.png; http://www.ssb.no/a/histstat/tabeller/4-19.html; https://www.ssb.no/statistikkbanken/selectvarval/Define.asp?subjectcode=&;ProductId=&MainTable=KostHelTjenny&nvl=&PLanguage=0&nyTmpVar=true&CMSSubjectArea=nasjonalregnskap-og-konjunkturer&Kortnavnw eb=helsesat&StatVariant=&checked=true; http://www.ssb.no/offentlig-sektor/kommune-stat-rapportering/kostra-databasen.",Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
; http://ssb.no/helse/statistikker/pleie/aar/2016-06-29?fane=tabell&sort=nummer&tabell=71503.,OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
https://www.diva-portal.org/smash/get/diva2:196545/FULLTEXT01 .pdf.1 .,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
https://www.eqt.se/Portfolio-Companies/Divestments/Aleris/; https://www.eqt.se/news/Press-Releases/2010/EQT -III-sells-Aleris/; https://www.brreg.no/home/.2.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
http://www.largestcompanies.com/company/Unicare-Bab-AS-281824/closing-figures-and-key-ratios?currency=nOK; https://www.brreg.no/home/.3.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
http://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=23378451; http://www.norlandia.se/sv/resources/nCg_AR2015.pdf; http://norlandiacare.com/en/eldreomsorg#!&country=norge&;area=; http://norlandiacare.com/en/om-oss; http://www.newsweb.no/newsweb/search.do?messageId=397325; https://www.healthcarebusinessinternational.com/ceo-to-leave-low-margin-norlandia/; http://www.unquote.com/nordics/official-record/63626/fsn-capital-exits-norlandia-care-to-founders; http://realdeals.eu.com/article/22641; http://www.largestcompanies.com/company/norlandia-Care-AB-263181/closing-figures-and-key-ratios?currency=SEK; http://www.norlandiacare.com/en/om-oss.4.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
http://investors.attendo.com/afw/files/press/attendo/201604146586-1 .pdf.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
Historical data from Stolt and Jansson: https://www.diva-portal.org/smash/get/diva2:196545/FULLTEXT01 .pdf.,OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
http://investors.attendo.com/afw/files/press/attendo/201604146586-1 .pdf.2.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
http://www.ambea.com/ http://www.triton-partners.com/investments/private-equity/ambea/; http://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=41570535; https://www.ambea.com/ambea-intends-to-list-its-shares-on-nasdaq-stockholm/.3.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
http://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=23378451 .4. http://www.norlandia.se/sv/resources/nCg_AR2015.pdf; http://norlandiacare.com/en/eldreomsorg#!&country=norge&;area=; http://norlandiacare.com/en/om-oss; https://www.healthcarebusinessinternational.com/ceo-to-leave-low-margin-norlandia/; http://www.unquote.com/nordics/official-record/63626/fsn-capital-exits-norlandia-care-to-founders; http://realdeals.eu.com/article/22641; http://www.largestcompanies.com/company/norlandia-Care-AB-263181/closing-figures-and-key-ratios?currency=SEK; http://www.norlandiacare.com/en/om-oss.5.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
https://www.eqt.se/Portfolio-Companies/Divestments/Aleris/; https://www.eqt.se/news/Press-Releases/2010/EQT -III-sells-Aleris/; http://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=20373998; http://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=20373998.Table 4.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
"cData obtained from latest published financial accounts available (via http://beta.companieshouse.gov.uk) and other published sources (Financial Times, Laing and Buisson).",OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
"Four Seasons: http://www.fshc.co.uk/; https://www.theguardian.com/business/2016/apr/27/four-seasons-health-care-reports-264m-annual-loss, Burns et al.30 2. https://www.bupa.co.uk/care-services/care-homes; https://www.bupa.com/corporate/about-us/our-history; https://www.ft.com/content/9eca70fa-6cdc-11e5-aca9-d87542bf8673; https://www.bupa.com/sharedcontent/articles/bupa-agrees-sale-of-bupa-home- healthcare-to-celesio; http://www.carehomeprofessional.com/bupa-writes-down-value-of-uk-elderly-care-business-by-almost-300-million/; https://www.bupa.com/~/media/files/site-specific-files/our%20performance/pdfs/financial%20results%20-%20historical%20financial%20info/archive%20group%20annual%20reports%20and%20accounts/annual-report-and-accounts-2005.pdf.3.",Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
http://www.hc-one.co.uk/; http://www.hc-one.co.uk/about/company-information/; http://www.carehome.co.uk/news/article.cfm/id/1565811/hc-one-care-homes-477m.4.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
"https://www.barchester.com/; https://www.barchester.com/company-profile; https://www.duedil.com/company/02792285/barchester-healthcare-limited, Burns et al.",Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
30 5. http://www.careuk.com/; http://www.bridgepoint.eu/en/investors/investor-profile/; http://www.careukgroup.com/sites/group/files/Care_UK_Health_%26_Social_Care_Investments_Limited_Risk_Factors_Fy2015.pdf; http://www.careukgroup.com/sites/group/files/Care_UK_Health_%26_Social_Care_Investments_Limited_Business_Fy2015.pdf; http://www.bridgepoint.eu/.Table 5.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
"genesis HealthCare Reports: http://www.genesishcc.com/; http://www.genesishcc.com/business-partners/business-services, SEC Annual Report 10-K (December 31, 2015); https://www.sec.gov/Archives/edgar/data/1351051/000155837016004101/gen-20151231x10k.htm; https://www.sec.gov/Archives/edgar/data/1351051/000155837016004101/0001558370-16-004101-index.htm; http://www.welltower.com/wp-content/uploads/2016/02/10-K_2015.pdf.2.",Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
June 2006:41-45. http://www.hcr-manorcare.com/about-hcr-manorcare/our-history/; http://media.corporate-ir.net/media_files/IROL/67/67541/(ii)%202014%20Annual%20Report.pdf; http://www.bloomberg.com/news/articles/2016-05-09/hcp-to-spin-off-hcr-manorcare-portfolio-into-independent-reit-inzuko9m; http://www.advfn.com/stock-market/ny SE/ HCR/financials.3.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
http://www.fillmorecap.com/index.php/about_us; http://listings.findthecompany.com/l/19083540/golden-gate-national-Senior-Care-Llc-in-Fort-Smith-AR; http://www.goldenliving.com/home.aspx?showpage=true; https://www.sec.gov/Archives/edgar/data/1236736/000089882207000667/exhibit993.htm; http://www.forbes.com/companies/golden-living/.4.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
http://listings.findthecompany.com/l/5115590/Life-Care-Centers-Of-America-Inc-in-Cleveland-Tn; http://www.hoovers.com/company-information/cs/company-profile.Life_Care_Centers_of_America_Inc.6146f2099cb2811e.html; http://www.forbes.com/companies/life-care-centers-of-america/.5.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
http://www.hoovers.com/company-information/company-search.html?term=savaseniorcare; http://www.hoovers.com/company-information/cs/company-profile.savaseniorcare_llc.0d3cc73de160d155.html.Table 6.,OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
"November 1, 2011. https://briarpatchmagazine.com/arti - cles/view/crisis-in-care.",Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
"Annual 10-K report, 2015; New York,  NY, 2016. http://www.welltower.com/wp-content/uploads/2016/02/10-K_2015.pdf.",Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
https://www.justice.gov/opa/pr/extendicare-health-services-inc-agrees-pay-38-million-settle-false-claims-act-allegations.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
http://www.triton-partners.com/investments/private-equity/ambea/.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
"Stockholm, Sweden: University of Stockholm; https://www.diva- portal.org/smash/get/diva2:196545/FULLTEXT01.pdf.",Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
"August 9, 2015. https://www.politicshome.com/news/uk/health-and- care/news/68099/social-care-system-failing-workers-cqc-chief-inspector.",Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
"June  30, 2012. http://www.nytimes.com/2012/07/01/business/how-delaware- thrives-as-a-corporate-tax-haven.html.",Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
https://www.justice.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
https://www.justice.gov/usao-edva/pr/government-sues-skilled-nursing-chain-hcr-manorcare-allegedly-providing-medically.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
2013. https:// www.fbi.gov/atlanta/press-releases/2013/golden-living-nursing-homes-set - tle-allegations-of-substandard-wound-care; http://www.justice.gov/opa/pr/us-files-complaint-against-national-chain-hospice-providers-alleging-false-claims-medicare.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
https://www.justice.gov/opa/pr/life-care-centers-america- inc-agrees-pay-145-million-resolve-false-claims-act-allegations.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
https://www.justice.gov/opa/pr/government- intervenes-lawsuits-alleging-skilled-nursing-chain-savaseniorcare-provided.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
"London, England; 2015; http://www.laingbuisson.com/.",Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
"Washington, DC: GAO; August 2009;  http://www.gao.gov/new.items/d09689.pdf.",Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
2016. http://www5.statcan.gc.ca/subject-sujet/theme-theme.action?pid=40000&la ng=eng&more=0&MM.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
"Ottawa,  ON: CIHI (in Canadian dollars) https://secure.cihi.ca/estore/productFamily.htm?locale=en&pf=PFC2740 and Chartwell Senior Housing REIT Annual  Information Form, 2006.",Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
2016. http://www.statistikdatabasen.scb.se/pxweb/en/ssd/?rxid=5ac9ea98-5967-477e-9db3-a8de0f7c4f88.,OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
http://www.cqc.org.uk/ content/care-homes.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
"Baltimore, MD: CMS; 2015. https://www.cms.",Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
Baltimore: MD; 2015. https://www.cms.gov/Research- Statistics-Data-and-Systems/Statistics-Trends-and-Reports/National   HealthExpendData/NationalHealthAccountsHistorical.html.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
Annual Report ; 2005-2016. https://www.extendicare.com/   investors/about-extendicare/.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
reveraliving.com/; http://www.investpsp.com/pdf/info-source-revera-en.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
pdf; http://www.investpsp.com/pdf/PSP-AR-2016-complete.pdf; http://www.welltower.com/about-us/welltowers-history/; http://www.welltower.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
"siennaliving.ca/; http://www.sedar.com/CheckCode.do; Leisureworld from  Macquarie Power & Infrastructure Income Fund, Annual Information Form ;  2005:3.",OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
"Management’s Discussion & Analysis , http://chartwell.com/index;  June 30, 2016. http://investors.chartwell.com/Cache/1001207528.PDF?Y=& O=PDF&D=&fid=1001207528&T=&iid=4100072.",Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
http://schlegelvillages.com/about-us; http://www.,Non-OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
Data for 2005 from 2011 Web site: https://web.archive.org/ web/20110315072657/; http://www.schlegelvillages.com/about-us.,OADS,/arxiv_data1/oa_pdf/fe/fc/10.1177_1178632917710533.PMC5467918.pdf
"https://doi.org/10.1177/1177625017713193 Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial   4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without  further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).Gene Regulation and Systems Biology Volume 11: 1–11 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1177625017713193 Introduction Hypoxia caused by aquatic ecosystem enrichment with nutri- ents and organic matter is a major global threat that is pre-dicted to worsen as climate change progresses.",Non-OADS,/arxiv_data1/oa_pdf/67/a3/10.1177_1177625017713193.PMC5467919.pdf
"Available at: http://www.accessdata.fda.gov/scripts/sda/sdNavigation.cfm?sd ¼labeling database (accessed November 29, 2016).",OADS,/arxiv_data1/oa_pdf/a2/9f/10.1177_2045893217695567.PMC5467922.pdf
"Available at: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/ UCM342195.pdf (accessed March 31, 2016).",Non-OADS,/arxiv_data1/oa_pdf/a2/9f/10.1177_2045893217695567.PMC5467922.pdf
Available at: https://bpca.nichd.,Non-OADS,/arxiv_data1/oa_pdf/a2/9f/10.1177_2045893217695567.PMC5467922.pdf
"Available at: http://www.fda.govdown-loads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/UCM320472.pdf (accessed November 29, 2016).",Non-OADS,/arxiv_data1/oa_pdf/a2/9f/10.1177_2045893217695567.PMC5467922.pdf
"Available at: http://www.fda.gov/Drugs/ DrugSafety/ucm390876.htm (accessed June 1, 2016).",Non-OADS,/arxiv_data1/oa_pdf/a2/9f/10.1177_2045893217695567.PMC5467922.pdf
Available at: https://clinicaltrials.gov/ct2/ results?term ¼pulmonary þhypertension þtransition&Search ¼ Search.,OADS,/arxiv_data1/oa_pdf/47/cf/10.1177_2045893217706357.PMC5467943.pdf
"Available at: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2008/021779s008lbl.pdf (2015, accessed on 13 July 2015).",Non-OADS,/arxiv_data1/oa_pdf/a0/5a/10.1177_2045893217706691.PMC5467944.pdf
"Available at: http://www.ema.europa.eu/ema/index.jsp?curl ¼pages/includes/document/document_ detail.jsp?webContentId ¼WC500109686%26mid ¼WC0b01ac 058009a3dc (2011, accessed on 1 August 2016).21.",Non-OADS,/arxiv_data1/oa_pdf/a0/5a/10.1177_2045893217706691.PMC5467944.pdf
"Available at: https://www.pmda.go.jp/files/000206209.pdf (2013, accessedon 1 August 2016).",Non-OADS,/arxiv_data1/oa_pdf/a0/5a/10.1177_2045893217706691.PMC5467944.pdf
"Our Submissions Guidelines page outlines the requirements for each article type: https://us.sagepub.com/ Creative Commons Non Commercial CC-BY -NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided theoriginal work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at- sage).",Non-OADS,/arxiv_data1/oa_pdf/b7/9f/10.1177_2045893217713107.PMC5467951.pdf
"In contrast to HLA-B *15:02, which is specifically prevalent in some populations in south- east Asia, HLA-A *24:02 is prevalent in most of the populations (http://www.allelefrequencies.net).",Non-OADS,/arxiv_data1/oa_pdf/67/55/NEUROLOGY2016780551.PMC5467955.pdf
"https://doi.org/10.1177/2050313X17713912 SAGE Open Medical Case Reports Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction  and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages  (https://us.sagepub.com/en-us/nam/open-access-at-sage).SAGE Open Medical Case Reports Volume 5: 1 –4 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2050313X17713912 journals.sagepub.com/home/sco Introduction Angioedema is a life-threatening condition due to the risk  of airway compromise throughout the perioperative period.",Non-OADS,/arxiv_data1/oa_pdf/51/70/10.1177_2050313X17713912.PMC5467965.pdf
"2003, http://www.ahrq.gov/clinic/uspstf/uspshivi.htm (accessed 12 October 2009).",OADS,/arxiv_data1/oa_pdf/cc/68/10.1177_2050312117712656.PMC5467966.pdf
"(SMA) 14-4863, 2014, https://www.samhsa.",Non-OADS,/arxiv_data1/oa_pdf/cc/68/10.1177_2050312117712656.PMC5467966.pdf
"2016, https://www.uspreven-tiveservicestaskforce.org/Page/Name/recommendations  22.",Non-OADS,/arxiv_data1/oa_pdf/cc/68/10.1177_2050312117712656.PMC5467966.pdf
"2011, https://dhosth.files.wordpress.com/2011/12/cochrane-handbook-for-systematic-reviews-of-interventions.pdf  28.",Non-OADS,/arxiv_data1/oa_pdf/cc/68/10.1177_2050312117712656.PMC5467966.pdf
"Published with license by Taylor & Francis Group, LLC © Keisuke Fujii, Yoshihiro Miyahara, Naozumi Harada, Daisuke Muraoka, Mitsuhiro Komura, Rui Ya maguchi, Hideo Yagita, Junko Nakamura, Sahoko Sugino, Satoshi Okumura, Seiya Imoto, Satoru Miyano, and Hiroshi Shiku.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered , transformed, or built upon in any way.ONCOIMMUNOLOGY 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
"5, e1306617 (14 pages)https://doi.org/10.1080/2162402X.2017.1306617",Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
"Complete lists of mutation-containing peptides, each ranging from 8 to 10 amino acids, were prepared and ﬁl- tered based on their predicted binding af ﬁnities to each of the murine H-2Kd,Dd,o rLdalleles using the IEDB analysis resource ( http://tools.immuneepitope.org/analyze/html/ mhc_binding.html ).",OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
Nature 2014; 515:577-81; PMID:25428507; https://doi.org/10.1038/nature13988 2.,Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
Cancer Res 2012; 72:1081-91;PMID:22237626; https://doi.org/10.1158/0008-5472.CAN-11-3722 3.,Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
Genome Res 2014; 24:743-50;PMID:24782321; https://doi.org/10.1101/gr.165985.113 4.,OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
"N Engl J Med 2014;371:2189-99; PMID:25409260; https://doi.org/10.1056/NEJMoa1406498 5. van Rooij N, van Buuren MM, Philips D, Velds A, Toebes M, Heem- skerk B, van Dijk LJ, Behjati S, Hilkmann H, El Atmioui D et al.Tumor exome analysis reveals neoantigen-speci ﬁc T-cell reactivity in an ipilimumab-responsive melanoma.",OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
J Clin Oncol 2013; 31:e439-42; PMID:24043743; https://doi.org/10.1200/JCO.2012.47.7521 6.,Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992; https://doi.org/10.1056/NEJMoa1003466 7.,Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
N Engl J Med 2015; 372:2509-20; PMID:26028255; https://doi.org/10.1056/NEJMoa1500596 9.,Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
Nat Med 2013; 19:747-52; PMID:23644516; https://doi.org/DOI:10.1038/nm.3161 10.,OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
Science 2014; 344:641-5; PMID:24812403; https://doi.org/10.1126/science 11.,OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
Nat Med 2016; 22:433-8; PMID:26901407; https://doi.org/10.1038/nm.4051 12.,Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
J Transl Med 2011; 9:143; PMID:21871084; https://doi.org/10.1186/1479-5876-9-143 15.,Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
J Immunol 2000; 165:948-55; PMID:10878370; https://doi.org/ 10.4049/jimmunol.165.2.948 17.,Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
J Gen Virol 1994; 75:2489-93; PMID:7521394; https://doi.org/10.1099/0022-1317-75-9-2489 18.,Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
Immunity 2000; 13:265-76; PMID:10981969; https://doi.org/10.1016/S1074-7613(00)00026-1 20.,OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
J Transl Med 2013; 11:246; PMID:24093426; https://doi.org/10.1186/1479-5876-11-246 21.,Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
Vaccine 2013; 31:2110-8; PMID:23499606; https://doi.org/10.1016/j.vaccine.2013.02.056 22.,Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
J Immun-other 2010; 33:965-74; PMID:20948440; https://doi.org/10.1097/ CJI.0b013e3181fb045d 23.,Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
Ann NY Acad Sci 2009; 1173:310-7; PMID:19758167; https://doi.org/10.1111/j.1749-6632.2009.04813.x 25.,OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
Cancer Res 2008; 68:8437-45; PMID:18922917; https://doi.org/ 10.1158/0008-5472.CAN-08-1440 26.,Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
J Pathol 2009; 217:21-31; PMID:18980207; https://doi.org/10.1002/path.2448 27.,Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
Cancer Res 2009; 69:3077-85; PMID:19293190; https://doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
Cancer Sci 2006; 97:780-6; PMID:16863511; https://doi.org/10.1111/j.1349-7006.2006.00231.x 29.,Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
J Pathol 1999; 189:552-8; PMID:10629557; https://doi.org/10.1002/(SICI)1096-9896(199912)189:4%3c552::AID-PATH469%3e3.0.CO;2-I 30.,Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
Cancer Immunol Immunother2012; 61:1019-31; PMID:22146893; https://doi.org/10.1007/s00262-011-1172-6 32.,Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
Cancer 1975; 36:2441-4; PMID:1212662; https://doi.org/ 10.1002/1097-0142(197512)36:6%3c2441::AID- CNCR2820360627%3e3.0.CO;2-P 34.,Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
J Immunol Methods 1999; 227:99-107; PMID:10485258; https://doi.org/10.1016/S0022-1759(99) 00074-5 36.,Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
Bioinformatics 2009; 25:1754-60; PMID:19451168;https://doi.org/10.1093/bioinformatics/btp324 37.,Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
Bioinforma tics 2009; 25:1105-11; PMID:19289445; https://doi.org/10.1093/bioinformatics/btp120 38.,Non-OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
Nat Biotechnol 2006; 24:817-9; PMID:16767078; https://doi.org/10.1038/ nbt1215e1306617-14 K. FUJII ET AL.,OADS,/arxiv_data1/oa_pdf/05/b4/koni-06-05-1306617.PMC5467990.pdf
"However, topical hemostatic agents have limited  efficacy in multiple clinical scenarios, such as when bleeding originates deep within a  wound, when damaged vessels cannot be located, or when wounds cannot be compressed,  This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ Conflicts of interest J.R.B.",Non-OADS,/arxiv_data1/oa_pdf/bc/e4/nihms6717.PMC5468094.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/6c/8d/41669_2017_Article_20.PMC5468101.pdf
http://www.cms.gov/Medicare/Medicare-Fee- for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.html .,Non-OADS,/arxiv_data1/oa_pdf/6c/8d/41669_2017_Article_20.PMC5468101.pdf
http://www.aamc.org/ advocacy/medicare/154226/quality_regulations.html .,Non-OADS,/arxiv_data1/oa_pdf/6c/8d/41669_2017_Article_20.PMC5468101.pdf
https://innovation.cms.gov/initiatives/bundled-payments .,Non-OADS,/arxiv_data1/oa_pdf/6c/8d/41669_2017_Article_20.PMC5468101.pdf
https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/Downloads/How-To-Use-NCCI-Tools.pdf .,Non-OADS,/arxiv_data1/oa_pdf/6c/8d/41669_2017_Article_20.PMC5468101.pdf
http://my.americanheart.org/professional/ StatementsGuidelines/ByPublicationDate/PreviousYears/Classiﬁca- tion-of-Functional-Capacity-and-Objective-Assessment_UCM_423 811_Article.jsp#.VjzWp_Mo6JA .,Non-OADS,/arxiv_data1/oa_pdf/6c/8d/41669_2017_Article_20.PMC5468101.pdf
http://www.aha.org/content/13/hospbill-explain.pdf .,Non-OADS,/arxiv_data1/oa_pdf/6c/8d/41669_2017_Article_20.PMC5468101.pdf
http://www.resdac.org/calculating-cost-cost-to- charge-ratios.html .,Non-OADS,/arxiv_data1/oa_pdf/6c/8d/41669_2017_Article_20.PMC5468101.pdf
http://www.bls.gov/data/inﬂation_calculator.htm .,Non-OADS,/arxiv_data1/oa_pdf/6c/8d/41669_2017_Article_20.PMC5468101.pdf
23 September 2015. http://healthaffairs.org/blog/2015/09/ 23/physician-level-practice-variation-who-you-see-is-what-you-get/ .,Non-OADS,/arxiv_data1/oa_pdf/6c/8d/41669_2017_Article_20.PMC5468101.pdf
http://www.biostat.jhsph.edu/project/seermed/ paper/pap033104.pdf .,Non-OADS,/arxiv_data1/oa_pdf/6c/8d/41669_2017_Article_20.PMC5468101.pdf
http://support.sas.com/documentation/cdl/en/ statug/66103/HTML/default/view er.htm#statug_genmod_overview.,OADS,/arxiv_data1/oa_pdf/6c/8d/41669_2017_Article_20.PMC5468101.pdf
34.http://kff.org/other/state-indicator/expenses-per-inpatient-day/?,Non-OADS,/arxiv_data1/oa_pdf/6c/8d/41669_2017_Article_20.PMC5468101.pdf
be Supportin ginformat ionforthisarticle canbefound under : http://dx.doi.or g/10.10 02/cnma.2017 00006.,OADS,/arxiv_data1/oa_pdf/a2/84/CNMA-3-223.PMC5468115.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/1d/41/jpts-29-1001.PMC5468184.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/d4/94/jpts-29-1006.PMC5468185.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/60/1e/jpts-29-1010.PMC5468186.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/c9/f2/jpts-29-1014.PMC5468187.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/25/fa/jpts-29-1019.PMC5468188.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/5c/62/jpts-29-1021.PMC5468189.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/53/96/jpts-29-1025.PMC5468190.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/45/74/jpts-29-1029.PMC5468191.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/85/5a/jpts-29-1032.PMC5468192.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/7b/8c/jpts-29-1036.PMC5468193.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/fa/bf/jpts-29-1040.PMC5468194.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/74/b8/jpts-29-1043.PMC5468195.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/f9/ad/jpts-29-1045.PMC5468196.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/92/10/jpts-29-1048.PMC5468197.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/3d/f2/jpts-29-1054.PMC5468198.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/d7/57/jpts-29-1057.PMC5468199.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/b7/af/jpts-29-1062.PMC5468200.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/e8/75/jpts-29-1066.PMC5468201.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/48/2a/jpts-29-1070.PMC5468202.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/f7/6b/jpts-29-1074.PMC5468203.pdf
http://www.sports.re.kr.,Non-OADS,/arxiv_data1/oa_pdf/f7/6b/jpts-29-1074.PMC5468203.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/4e/70/jpts-29-1079.PMC5468204.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/b9/4a/jpts-29-1082.PMC5468205.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/18/c9/jpts-29-1085.PMC5468206.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/3a/4b/jpts-29-1089.PMC5468207.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/cb/c0/jpts-29-1092.PMC5468208.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/71/c6/jpts-29-1095.PMC5468209.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/7e/05/jpts-29-1098.PMC5468210.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/jpts-29-1102.PMC5468211.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/71/52/jpts-29-1108.PMC5468212.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/52/c2/jpts-29-1113.PMC5468213.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/91/d2/jpts-29-1116.PMC5468214.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/9c/01/jpts-29-964.PMC5468215.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ae/41/jpts-29-966.PMC5468216.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/33/d7/jpts-29-970.PMC5468217.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/0e/e1/jpts-29-974.PMC5468218.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/a4/41/jpts-29-978.PMC5468219.pdf
2013. http://www.mhlw.go.jp/english/database/db-hh/2–2.html.,Non-OADS,/arxiv_data1/oa_pdf/a4/41/jpts-29-978.PMC5468219.pdf
http://www.who.int/gho/ncd/risk_factors/overweight_text/en/.,Non-OADS,/arxiv_data1/oa_pdf/a4/41/jpts-29-978.PMC5468219.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/f3/7c/jpts-29-984.PMC5468220.pdf
"http://www.mie-uk.com/Gonio/Index.htm	(Accessed	Feb.	21,	2017)13)	 MedCalc	Manual	Version	7.4.3.0	Ostend,	Belgium,	1993	revised,	2017.14)	 SPSS	11.0	Brief	Guide,	Upper	Saddle	River.",Non-OADS,/arxiv_data1/oa_pdf/f3/7c/jpts-29-984.PMC5468220.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/3b/2c/jpts-29-989.PMC5468221.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/df/32/jpts-29-993.PMC5468222.pdf
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <https://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/46/a6/jpts-29-996.PMC5468223.pdf
https://doi.org/10.4111/icu.2017.58.S1.S1pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/92/bf/icu-58-S1.PMC5468259.pdf
S2 www.icurology.orgLee and Han https://doi.org/10.4111/icu.2017.58.S1.S1 magnetic resonance voiding cystography has also been  attempted.,Non-OADS,/arxiv_data1/oa_pdf/92/bf/icu-58-S1.PMC5468259.pdf
"Keywords: Cost-benefit analysis; Ionizing radiation; Technetium Tc 99m dimercaptosuccinic acid; Urinary tract infections; Vesicoureteral reflux This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 9 January, 2017  •  Accepted: 14 March, 2017 Corresponding Author: Antoine E. Khoury Department of Urology, University of California, Irvine, Children’s Hospital of Orange County, 505 S. Main Street, Suite 100, Orange, CA 92868, USATEL: +1-714-509-3914, FAX: +1-714-509-3915, E-mail: aekhoury@uci.edu ⓒ The Korean Urological Association, 2017bladder dysfunction, perineal hygiene, clinical presentation  (antenatally diagnosed vs. symptomatic UTI) and circum­ cision status are some of the factors that significantly alter  the natural history of the disease and the individual risk  for UTI, parenchymal scarring and renal insufficiency [1 ­5].",Non-OADS,/arxiv_data1/oa_pdf/48/5d/icu-58-S14.PMC5468260.pdf
Treatment plan should be guided by the risk of future UTIs  or renal scarring rather than merely the presence or absence  www.icurology.orgInvestig Clin Urol 2017;58 Suppl 1:S14-22.https://doi.org/10.4111/icu.2017.58.S1.S14pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/48/5d/icu-58-S14.PMC5468260.pdf
S16 www.icurology.orgAbdelhalim and Khoury https://doi.org/10.4111/icu.2017.58.S1.S14 an abnormal initial scan.,Non-OADS,/arxiv_data1/oa_pdf/48/5d/icu-58-S14.PMC5468260.pdf
"S18 www.icurology.orgAbdelhalim and Khoury https://doi.org/10.4111/icu.2017.58.S1.S14 hydronephrosis, pyonephrosis, hydroureter, duplication  anomalies, renal scars, asymmetric renal size, bladder wall  thickening, … etc.)",Non-OADS,/arxiv_data1/oa_pdf/48/5d/icu-58-S14.PMC5468260.pdf
S20 www.icurology.orgAbdelhalim and Khoury https://doi.org/10.4111/icu.2017.58.S1.S14 be made between the diffuse radiation exposure in DMSA  scans and the localized exposure in VCUG.,Non-OADS,/arxiv_data1/oa_pdf/48/5d/icu-58-S14.PMC5468260.pdf
S22 www.icurology.orgAbdelhalim and Khoury https://doi.org/10.4111/icu.2017.58.S1.S14 infection.,Non-OADS,/arxiv_data1/oa_pdf/48/5d/icu-58-S14.PMC5468260.pdf
"Keywords: Biomarkers; Technetium Tc 99m dimercaptosuccinic acid; Urinary tract infections; Urography; Vesicoureteral reflux This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 12 December, 2016  •  Accepted: 19 January, 2017 Corresponding Author: Michaella Maloney Prasad Medical University of South Carolina, 96 Jonathan Lucas St, CSB 644, MSC 620, Charleston, SC 29464, USATEL: +1-843-792-7687, FAX: +1-843-792-8523, E-mail: prasadm@musc.edu ⓒ The Korean Urological Association, 2017relationship is now being challenged.",Non-OADS,/arxiv_data1/oa_pdf/cf/86/icu-58-S23.PMC5468261.pdf
BACKGROUND UTIs in young children are common with an overall  prevalence of 7.0% among infants presenting with fever and  a pooled prevalence of 7.8% among children with urinary  www.icurology.orgInvestig Clin Urol 2017;58 Suppl 1:S23-31.https://doi.org/10.4111/icu.2017.58.S1.S23pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/cf/86/icu-58-S23.PMC5468261.pdf
S24 www.icurology.orgPrasad and Cheng https://doi.org/10.4111/icu.2017.58.S1.S23 symptoms [1] .,Non-OADS,/arxiv_data1/oa_pdf/cf/86/icu-58-S23.PMC5468261.pdf
S26 www.icurology.orgPrasad and Cheng https://doi.org/10.4111/icu.2017.58.S1.S23 screen for abnormalities detected by VCUG.,Non-OADS,/arxiv_data1/oa_pdf/cf/86/icu-58-S23.PMC5468261.pdf
S28 www.icurology.orgPrasad and Cheng https://doi.org/10.4111/icu.2017.58.S1.S23 of these were detected by VCUG; most were identified with  CEVUS.,OADS,/arxiv_data1/oa_pdf/cf/86/icu-58-S23.PMC5468261.pdf
Available from: https://www.nice.org.uk/ guidance/cg54.,Non-OADS,/arxiv_data1/oa_pdf/cf/86/icu-58-S23.PMC5468261.pdf
S30 www.icurology.orgPrasad and Cheng https://doi.org/10.4111/icu.2017.58.S1.S23 24.,Non-OADS,/arxiv_data1/oa_pdf/cf/86/icu-58-S23.PMC5468261.pdf
"Keywords: Antibiotic prophylaxis; Pyelonephritis; Urinary tract infection; Vesicoureteral reflux This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 28 December, 2016  •  Accepted: 16 January, 2017 Corresponding Author: Ted Lee Department of Urology, University of Michigan Health Systems, 1500 E Medical Center Dr, Ann Arbor, MI 48109, USATEL: +1-201-543-7520, FAX: +1-734-615-0886, E-mail: lted@med.umich.edu ⓒ The Korean Urological Association, 2017submucosal tunnel mechanism [3].",Non-OADS,/arxiv_data1/oa_pdf/72/19/icu-58-S32.PMC5468262.pdf
https://doi.org/10.4111/icu.2017.58.S1.S32pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/72/19/icu-58-S32.PMC5468262.pdf
"S34 www.icurology.orgLee and Park https://doi.org/10.4111/icu.2017.58.S1.S32 reflux management is now individualized based on the risk  for further infections and renal scarring, gender, likelihood  of spontaneous resolution, and parental preferences.",Non-OADS,/arxiv_data1/oa_pdf/72/19/icu-58-S32.PMC5468262.pdf
"S36 www.icurology.orgLee and Park https://doi.org/10.4111/icu.2017.58.S1.S32 revealed benefit only to children with high ­grade reflux, but  addition of data from RIVUR study revealed pooled data  that supports CAP in all children with reflux.",Non-OADS,/arxiv_data1/oa_pdf/72/19/icu-58-S32.PMC5468262.pdf
http://doi.org/10.1016/j.jpurol.2016.06.020.,OADS,/arxiv_data1/oa_pdf/72/19/icu-58-S32.PMC5468262.pdf
"Keywords: Endoscopy; Injections; Vesicoureteral reflux This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 13 March, 2017  •  Accepted: 18 May, 2017 Corresponding Author: Sang Won Han Department of Urology, Urological Science Institute, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, KoreaTEL: +82-2-2228-2310, FAX: +82-2-312-2538, E-mail: swhan@yuhs.ac ⓒ The Korean Urological Association, 2017(PFTE, Teflon) injection at the ureteral orifice to treat VUR  [2], endoscopic injection treatment has been widely used  by urologists.",Non-OADS,/arxiv_data1/oa_pdf/2e/ed/icu-58-S38.PMC5468263.pdf
https://doi.org/10.4111/icu.2017.58.S1.S38pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/icu-58-S38.PMC5468263.pdf
S40 www.icurology.orgKim et al https://doi.org/10.4111/icu.2017.58.S1.S38 by O'Donnell and Puri [3] in 1984 and has been used as  a representative technique for endoscopic injection.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/icu-58-S38.PMC5468263.pdf
S42 www.icurology.orgKim et al https://doi.org/10.4111/icu.2017.58.S1.S38 1).,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/icu-58-S38.PMC5468263.pdf
S44 www.icurology.orgKim et al https://doi.org/10.4111/icu.2017.58.S1.S38 23.,Non-OADS,/arxiv_data1/oa_pdf/2e/ed/icu-58-S38.PMC5468263.pdf
"Keywords: Congenital anomalies of the kidney and urinary tract; Genetic association studies; Organogenesis; Vesicoureteral reflux This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 2 January, 2017  •  Accepted: 20 March, 2017 Corresponding Author: Jae Il Shin Department of Pediatrics, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, KoreaTEL: +82-2-2228-2050, FAX: +82-2-393-9118, E-mail: shinji@yuhs.ac ⓒ The Korean Urological Association, 2017and decreased renal function causing reflux nephropathy [4] .",Non-OADS,/arxiv_data1/oa_pdf/e5/68/icu-58-S4.PMC5468264.pdf
"In this article, we will  www.icurology.orgInvestig Clin Urol 2017;58 Suppl 1:S4-13.https://doi.org/10.4111/icu.2017.58.S1.S4pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/e5/68/icu-58-S4.PMC5468264.pdf
S6 www.icurology.orgLee et al https://doi.org/10.4111/icu.2017.58.S1.S4 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/e5/68/icu-58-S4.PMC5468264.pdf
S8 www.icurology.orgLee et al https://doi.org/10.4111/icu.2017.58.S1.S4 Gata protein family that is expressed in the ureteric buds.,Non-OADS,/arxiv_data1/oa_pdf/e5/68/icu-58-S4.PMC5468264.pdf
S10 www.icurology.orgLee et al https://doi.org/10.4111/icu.2017.58.S1.S4 with intact kidney function to severe hypodysplasia and end  stage renal failure.,Non-OADS,/arxiv_data1/oa_pdf/e5/68/icu-58-S4.PMC5468264.pdf
"S12 www.icurology.orgLee et al https://doi.org/10.4111/icu.2017.58.S1.S4 agaki T, et al.",OADS,/arxiv_data1/oa_pdf/e5/68/icu-58-S4.PMC5468264.pdf
"Keywords: Urinary incontinence; Urethral obstruction; Vesicoureteral reflux This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 7 April, 2017  •  Accepted: 30 May, 2017 Corresponding Author: Hideo Nakai Department of Pediatric Urology, Jichi Medical University, Children's Medical Center Tochigi, 3311-1, Yakushiji Shimotsuke-shi, Tochigi, 329-0498, JapanTEL: +81-285-58-7716, FAX: +81-285-44-8329, E-mail: hnakai@jichi.ac.jp ⓒ The Korean Urological Association, 2017which is elusive and overlooked easily in VCUG even if it  contributes to VUR or detrusor overactivity.",Non-OADS,/arxiv_data1/oa_pdf/ed/9c/icu-58-S46.PMC5468265.pdf
www.icurology.orgInvestig Clin Urol 2017;58 Suppl 1:S46-53.https://doi.org/10.4111/icu.2017.58.S1.S46pISSN 2466-0493  •  eISSN 2466-054X,Non-OADS,/arxiv_data1/oa_pdf/ed/9c/icu-58-S46.PMC5468265.pdf
"S48 www.icurology.orgNakai et al https://doi.org/10.4111/icu.2017.58.S1.S46 attention further in diagnosing infants is not to misdiagnose  physiologic discoordination of the external urethral sphincter  as PUV, in which the site of mechanical obstruction is  located more distally than physiologic discoordination ( Fig.",Non-OADS,/arxiv_data1/oa_pdf/ed/9c/icu-58-S46.PMC5468265.pdf
S50 www.icurology.orgNakai et al https://doi.org/10.4111/icu.2017.58.S1.S46 formation of posterolateral folds ( Fig.,Non-OADS,/arxiv_data1/oa_pdf/ed/9c/icu-58-S46.PMC5468265.pdf
"Scan this QR  code to see the accompanying video, or visit www.icurology.org or https://youtu.be/xtDrhVnQhQA.",Non-OADS,/arxiv_data1/oa_pdf/ed/9c/icu-58-S46.PMC5468265.pdf
S52 www.icurology.orgNakai et al https://doi.org/10.4111/icu.2017.58.S1.S46 transurethral incision for PUV in boys with intractable  daytime urinary incontinence and nocturnal enuresis.,Non-OADS,/arxiv_data1/oa_pdf/ed/9c/icu-58-S46.PMC5468265.pdf
"The supplementary video clip can also be accessed by  scanning a QR code located on the figure of this article, or  be available on YouTube: https://youtu.be/xtDrhVnQhQA.",Non-OADS,/arxiv_data1/oa_pdf/ed/9c/icu-58-S46.PMC5468265.pdf
https://doi.org/10.1007/s00345-017-2018- 4.,Non-OADS,/arxiv_data1/oa_pdf/ed/9c/icu-58-S46.PMC5468265.pdf
"Keywords: Cohen cross trigonal reimplant; Neurogenic urinary bladder; Type A botulinum toxins; Vesicoureteral reflux This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article Received: 15 December, 2016  •  Accepted: 6 March, 2017 Corresponding Author: Israel Franco Department of Urology, Section of Pediatric Urology, Yale University, 789 Howard Ave, New Haven, CT 06520, USATEL: +1-203-785-5339, FAX: +1-203-785-4043, E-mail: Israel.Franco@yale.edu ⓒ The Korean Urological Association, 2017as such, the classifications are not considered mutually  exclusive.",Non-OADS,/arxiv_data1/oa_pdf/90/9d/icu-58-S54.PMC5468266.pdf
"Those affected may have detrusor external sphincter  dyssynergia and/or poor bladder compliance, leading to  www.icurology.orgInvestig Clin Urol 2017;58 Suppl 1:S54-58.https://doi.org/10.4111/icu.2017.58.S1.S54pISSN 2466-0493  •  eISSN 2466-054X",Non-OADS,/arxiv_data1/oa_pdf/90/9d/icu-58-S54.PMC5468266.pdf
S56 www.icurology.orgWu and Franco https://doi.org/10.4111/icu.2017.58.S1.S54 aggressive measures later on [1] .,Non-OADS,/arxiv_data1/oa_pdf/90/9d/icu-58-S54.PMC5468266.pdf
S58 www.icurology.orgWu and Franco https://doi.org/10.4111/icu.2017.58.S1.S54 tion in patients with myelodysplasia.,Non-OADS,/arxiv_data1/oa_pdf/90/9d/icu-58-S54.PMC5468266.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Xuchen Zhang , MD, PhD, Department of  Pathology,  Yale University School of Medicine, 310 Cedar Street,  LH 108, PO Box 208023, New Haven, CT 06520,  United States.",Non-OADS,/arxiv_data1/oa_pdf/36/ed/WJH-9-715.PMC5468341.pdf
"However, the exact pathogenic  mechanism of NAFLD still remains unclear, and there Submit a Manuscript: http://www.f6publishing.com DOI: 10.4254/wjh.v9.i16.715World J Hepatol   2017  June 8; 9(16): 715-732 ISSN 1948-5182 (online)",Non-OADS,/arxiv_data1/oa_pdf/36/ed/WJH-9-715.PMC5468341.pdf
World J Hepatol  2017; 9(16): 715-732  Available  from: URL:  http://www.wjgnet.co m/1948-5182 /full/v9/i16/715.,Non-OADS,/arxiv_data1/oa_pdf/36/ed/WJH-9-715.PMC5468341.pdf
htm  DOI: http://dx.doi.org/10.4254/wjh.v9.i16.,OADS,/arxiv_data1/oa_pdf/36/ed/WJH-9-715.PMC5468341.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USATele - phone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/36/ed/WJH-9-715.PMC5468341.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Rossano Girometti, MD,  Institute of  Diagnostic Radiology, Department of Medicine, University of  Udine, University Hospital “S.",Non-OADS,/arxiv_data1/oa_pdf/5d/3c/WJH-9-733.PMC5468342.pdf
Core tip:  Associating liver partition and portal vein  ligation for staged hepatectomy (ALPPS) is a variant Submit a Manuscript: http://www.f6publishing.com DOI: 10.4254/wjh.v9.i16.733World J Hepatol   2017  June 8; 9(16): 733-745 ISSN 1948-5182 (online),Non-OADS,/arxiv_data1/oa_pdf/5d/3c/WJH-9-733.PMC5468342.pdf
htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5d/3c/WJH-9-733.PMC5468342.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USATele - phone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/5d/3c/WJH-9-733.PMC5468342.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Sittisak Honsawek, MD, PhD, Depart - ment of Biochemistry, Faculty of Medicine, Chulalongkorn  University, King Chulalongkorn Memorial Hospital, Thai Red  Cross Society, 1873 Rama IV Road, Patumwan, Bangkok 10330,  Thailand.",Non-OADS,/arxiv_data1/oa_pdf/88/84/WJH-9-746.PMC5468343.pdf
BMD  of the lumbar spine was analyzed using dual energy Submit a Manuscript: http://www.f6publishing.com DOI: 10.4254/wjh.v9.i16.746World J Hepatol   2017  June 8; 9(16): 746-751 © 2017 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/88/84/WJH-9-746.PMC5468343.pdf
World J Hepatol   2017; 9(16): 746-751  Available from: URL:  http://www.wjgnet.,OADS,/arxiv_data1/oa_pdf/88/84/WJH-9-746.PMC5468343.pdf
"htm  DOI: http://dx.doi.org/10.4254/ wjh.v9.i16.746 INTRODUCTION Biliary atresia (BA) is a progressive, idiopathic, necro­ inflammatory process resulting in obliteration of the  extrahepatic biliary tree resulting in intrahepatic cholestasis,  hepatic fibrosis, biliary cirrhosis, and advanced chronic liver  failure[1].",Non-OADS,/arxiv_data1/oa_pdf/88/84/WJH-9-746.PMC5468343.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USATele - phone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/88/84/WJH-9-746.PMC5468343.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to:  Shota Akabane, MD,  Department of  Surgery, Shonan Fujisawa Tokushukai Hospital, 1-5-1 Kandai  Tsujido, Fujisawa City, Kanagawa 251-0041,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/9b/cd/WJH-9-752.PMC5468344.pdf
"Although  CoCC is a rare primary hepatic tumor, it demonstrates  certain specific clinical features, including a better prognosis Submit a Manuscript: http://www.f6publishing.com DOI: 10.4254/wjh.v9.i16.752World J Hepatol   2017  June 8; 9(16): 752-756 ISSN 1948-5182 (online)",Non-OADS,/arxiv_data1/oa_pdf/9b/cd/WJH-9-752.PMC5468344.pdf
World J Hepatol  2017; 9(16): 752-756  Available from: URL:   http://www.wjgnet.co m/1948-5182 /full/v9/i16/752.,Non-OADS,/arxiv_data1/oa_pdf/9b/cd/WJH-9-752.PMC5468344.pdf
htm  DOI:  http://dx.doi.org/10.4254/wjh.v9.i16.,OADS,/arxiv_data1/oa_pdf/9b/cd/WJH-9-752.PMC5468344.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USATele - phone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/9b/cd/WJH-9-752.PMC5468344.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2017 Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp).Adipose PPAR γ, depression and anxiety M Guo et al 1068 Molecular Psychiatry (2017), 1056 –1068",Non-OADS,/arxiv_data1/oa_pdf/5b/27/mp2016225a.PMC5468488.pdf
"Deep brain stimulation (DBS) hasFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services1May 19, 2017",Non-OADS,/arxiv_data1/oa_pdf/d8/f0/tre-07-461-7522-1.PMC5468509.pdf
"Cortical and subcortical myoclonus affecting the patient’s speech and limb movements.Ramdhani RA, Frucht SJ, Kopell BH DBS for Post-hypoxic Myoclonus Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/d8/f0/tre-07-461-7522-1.PMC5468509.pdf
"The patient is able to drink from a water bottle, push himself up to stand, and takes a few steps withassistance.DBS for Post-hypoxic Myoclonus Ramdhani RA, Frucht SJ, Kopell BH Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/d8/f0/tre-07-461-7522-1.PMC5468509.pdf
"1Assessed during an episode of a myoclonic volley.Ramdhani RA, Frucht SJ, Kopell BH DBS for Post-hypoxic Myoclonus Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/d8/f0/tre-07-461-7522-1.PMC5468509.pdf
"aOne post-hypoxic myoclonus patient compared with four age matched controls b12 of 14 PHM patients had brain MRI.DBS for Post-hypoxic Myoclonus Ramdhani RA, Frucht SJ, Kopell BH Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/d8/f0/tre-07-461-7522-1.PMC5468509.pdf
"doi: 10.1016/S0013-4694(98)00058-3Ramdhani RA, Frucht SJ, Kopell BH DBS for Post-hypoxic Myoclonus Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/d8/f0/tre-07-461-7522-1.PMC5468509.pdf
"doi: 10.1227/01.NEU.0000064805.91249.F5DBS for Post-hypoxic Myoclonus Ramdhani RA, Frucht SJ, Kopell BH Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/d8/f0/tre-07-461-7522-1.PMC5468509.pdf
"Primers for PCR ampli ﬁcation and sequencing were designed using Primer3 (v 4.0.0) (http://bioinfo.ut.ee/primer3-0.4.0/primer3/) and bidirectional sequencing on an ABI 3730 DNA analyzer (Applied Biosystems) was done as previouslydescribed.13 Bioinformatics analysis of gene expression, co-expression and biological function enrichment Expression data based on RNA sequencing of 53 different tissues, including 13 brain regions, were downloaded from the GTEx portal.38To identify genes with a brain expression pattern that correlates with that of SCN9A , we calculated the Pearson ’s correlation coef ﬁcient for each gene and SCN9A .",OADS,/arxiv_data1/oa_pdf/54/71/mp2016222a.PMC5468514.pdf
"RESULTS Family exome analysis We sequenced 10 exomes from ﬁve families with cousins affected with autism, which are deposited in NDAR (https://ndar.nih.gov/edit_collection.html?id = 1919).",OADS,/arxiv_data1/oa_pdf/54/71/mp2016222a.PMC5468514.pdf
"single-cell RNA sequencing studies,44as well as with previous results from monkeys.45In addition evidence for SCN9A brain expression in mice has been documented, although not published(Mouse Genome Database (MGD), MGI: 3631994, (URL: http://www.informatics.jax.org/) (April 2016)).",OADS,/arxiv_data1/oa_pdf/54/71/mp2016222a.PMC5468514.pdf
"ACKNOWLEDGMENTS We acknowledge the clinicians, organizations and families that contributed to data and samples used in this study (https://www.nimhgenetics.org/acknowledgements.",Non-OADS,/arxiv_data1/oa_pdf/54/71/mp2016222a.PMC5468514.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2018 Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Rare missense Na V1.7 variants in familial autism M Rubinstein et al 239 Molecular Psychiatry (2018), 231 –239",Non-OADS,/arxiv_data1/oa_pdf/54/71/mp2016222a.PMC5468514.pdf
"See: http://creativecommons.org/licenses/by- nc/4.0/ REFERENCES 1 Rago L, Santoso B.",Non-OADS,/arxiv_data1/oa_pdf/6a/6d/bmjinnov-2016-000157.PMC5468520.pdf
2 International Conference on Harmonization of T echnical Requirements for Registration of Pharmaceuticals forHuman Use 2015. http://www.ich.org/home (accessed Sep2016).,Non-OADS,/arxiv_data1/oa_pdf/6a/6d/bmjinnov-2016-000157.PMC5468520.pdf
2016http://www.hhs.gov/hipaa/for-professionals/privacy/(accessed Sep 2016).,OADS,/arxiv_data1/oa_pdf/6a/6d/bmjinnov-2016-000157.PMC5468520.pdf
HealthT alk.Org 2016. http://www.healthtalk.org/peoples-experiences/improving-health-care/patient-and-public-involvement-research/what-patient-and-public-involvement-and-why-it-important(accessed Sep 2016).,Non-OADS,/arxiv_data1/oa_pdf/6a/6d/bmjinnov-2016-000157.PMC5468520.pdf
March 2015. https://globalgenes.org/wp-content/uploads/2015/03/Drug-Development-White-Paper-2015-FINAL.pdf (accessedSep 2016).,Non-OADS,/arxiv_data1/oa_pdf/6a/6d/bmjinnov-2016-000157.PMC5468520.pdf
"Orbis Biosciences March 13 th, 2015. http://www.orbisbio.com/blog/listen-to-reason-patient-reasons-for-medication-noncompliance (accessed Jan 2017).",Non-OADS,/arxiv_data1/oa_pdf/6a/6d/bmjinnov-2016-000157.PMC5468520.pdf
Global Life Sciences Report 2012 http://www.ey.com/GL/en/Industries/Life-Sciences/Progressions-2012 —Health-care-everywhere — Overview (accessed Sep 2016).,Non-OADS,/arxiv_data1/oa_pdf/6a/6d/bmjinnov-2016-000157.PMC5468520.pdf
2015. http://www.fda.gov/ForIndustry/ UserFees/PrescriptionDrugUserFee/ucm347317.htm (accessed Sep 2016).,Non-OADS,/arxiv_data1/oa_pdf/6a/6d/bmjinnov-2016-000157.PMC5468520.pdf
2015. http://blogs.fda.gov/fdavoice/index.php/2015/09/fda-announces-first-ever-patient-engagement-advisory-committee/ (accessed 5 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/6a/6d/bmjinnov-2016-000157.PMC5468520.pdf
https://www.federalregister.gov/articles/2015/12/28/2015-32476/externally-led-patient-focused-drug-development-meetings(accessed Sep 2016).,Non-OADS,/arxiv_data1/oa_pdf/6a/6d/bmjinnov-2016-000157.PMC5468520.pdf
"News Release, 21 September 2015. http://www.ema.europa.eu/ema/index.jsp?curl=pages/ news_and_events/news/2015/09/news_detail_002394.jsp&mid=WC0b01ac058004d5c1 (accessed Sep 2016).",Non-OADS,/arxiv_data1/oa_pdf/6a/6d/bmjinnov-2016-000157.PMC5468520.pdf
http://www.imshealth .com:90/files/web/Global/ Services/Strategy%20&%20M anagement%20Consulting/ Consulting%20Group%20TL/IMS_Patient_Centricity .pdf (accessed Jan 2017).,Non-OADS,/arxiv_data1/oa_pdf/6a/6d/bmjinnov-2016-000157.PMC5468520.pdf
The patient voice in value: The National Health Council Patient-centered value model rubric.March 2016. http://www.nationalhealthcouncil.org/sites/default/files/Value-Rubric.pdf (accessed Jan 2017).,Non-OADS,/arxiv_data1/oa_pdf/6a/6d/bmjinnov-2016-000157.PMC5468520.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Bachynski KE.,Non-OADS,/arxiv_data1/oa_pdf/f4/f2/bmjinnov-2016-000151.PMC5468521.pdf
"US Department of Health and Human Services Centers for Disease Control and Prevention, 2010.http://www.cdc.gov/traumaticbraininjury/pdf/blue_book.pdf 14 Bramley H, Mcfarland C, Lewis MM, et al.",Non-OADS,/arxiv_data1/oa_pdf/f4/f2/bmjinnov-2016-000151.PMC5468521.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/31/5e/10.1177_2325967117711121.PMC5468764.pdf
"Reprints and permissions: http://www.sagepub.co.uk/ journalsPermissions.nav Correspondence to: Anthony Feinstein Sunnybrook Health Sciences Center, 2075 BayviewAvenue, Toronto, Ontario, M4N 3M5, Canada.",Non-OADS,/arxiv_data1/oa_pdf/ad/86/10.1177_2055217317713027.PMC5468765.pdf
"creativecommons.org/ licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the origin al work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/ad/86/10.1177_2055217317713027.PMC5468765.pdf
"https://doi.org/10.1177/2050313X17713148 SAGE Open Medical Case Reports Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction  and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages  (https://us.sagepub.com/en-us/nam/open-access-at-sage).SAGE Open Medical Case Reports Volume 5: 1 –3 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2050313X17713148 journals.sagepub.com/home/sco Introduction Myocarditis is defined as the inflammation of the heart mus- cle.1 It has a broad range of causes including infectious  organisms and also non-infective insults to the myocardium involving chemicals, toxins, and drugs and a diverse group of collagen vascular disorders such as lupus, scleroderma and dermatomyositis.",Non-OADS,/arxiv_data1/oa_pdf/cd/bf/10.1177_2050313X17713148.PMC5468772.pdf
Available from: http://www.google.com/.,Non-OADS,/arxiv_data1/oa_pdf/80/08/ABR-6-70.PMC5468784.pdf
Available  from: http://www.Scholar.google.com/.,Non-OADS,/arxiv_data1/oa_pdf/80/08/ABR-6-70.PMC5468784.pdf
Available from:  http://www.cancer.gov/cancertopics/what‑is‑cancer.,Non-OADS,/arxiv_data1/oa_pdf/63/91/ABR-6-68.PMC5468802.pdf
"For molecular dynamics simulations, LEWIS has been implemented in GRO-MACS as an add-on (see http://people.brandeis.edu/ /C24herzfeld/ LEWIS/) and eFF has been implemented in LAMMPS.",OADS,/arxiv_data1/oa_pdf/64/a4/SC-008-C7SC01181D.PMC5468998.pdf
There were some important but negative trials results in the  ACC 2017 as well and DECISION-CTO (Optimal Medical Therapy With or Without Stenting For Coronary Chronic Total Occlu- sion) was one of them (http://www.acc.org/latest-in-cardiology/clinical-trials/2017/03/17/08/40/decision-cto?w_nav = LC).,Non-OADS,/arxiv_data1/oa_pdf/3f/1e/AJC-17-351.PMC5469080.pdf
Bioinformatics analysis (http://david.abcc.ncifcrf.gov/) of this data demonstrated that several  genes that are involved in the apoptotic pathway were likely  RORα target genes (Fig.,OADS,/arxiv_data1/oa_pdf/fb/8a/AJC-17-362.PMC5469082.pdf
The GRS  for in-hospital death was calculated using the specific software  available on-line at http://www.outcomes-umassmed.org/grace/ acs_risk/acs_risk_content.html.,OADS,/arxiv_data1/oa_pdf/58/70/AJC-17-276.PMC5469107.pdf
The 2.11 version of the online SXS score calculator (http://www.syntaxscore.com/calc/syntaxscore/frameset.htm)  was used.,OADS,/arxiv_data1/oa_pdf/58/70/AJC-17-276.PMC5469107.pdf
"The statistical analyzes were performed using the  MedCalc Statistical Software version 15.4 (MedCalc Software  bvba, Ostend, Belgium; https://www.medcalc.org; 2015).",OADS,/arxiv_data1/oa_pdf/58/70/AJC-17-276.PMC5469107.pdf
http://www.accriva.com/products/verifynow-sys-tem-platelet-reactivity-test.,Non-OADS,/arxiv_data1/oa_pdf/05/bc/AJC-17-303.PMC5469111.pdf
http://www.pharmgkb.org.,Non-OADS,/arxiv_data1/oa_pdf/05/bc/AJC-17-303.PMC5469111.pdf
Definition of prospective cohort study - NCI Dictionary of Cancer  Terms 3. https://onlinecourses.science.psu.edu/stat507/node/54 4.,Non-OADS,/arxiv_data1/oa_pdf/5b/e4/AJC-17-341.PMC5469118.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).http://dx.doi.org/10.1016/j.hrcr.2017.02.007,Non-OADS,/arxiv_data1/oa_pdf/6f/91/main.PMC5469275.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).http://dx.doi.org/10.1016/j.hrcr.2017.03.002,Non-OADS,/arxiv_data1/oa_pdf/bc/9e/main.PMC5469276.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).http://dx.doi.org/10.1016/j.hrcr.2017.03.001,Non-OADS,/arxiv_data1/oa_pdf/be/a7/main.PMC5469278.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).http://dx.doi.org/10.1016/j.hrcr.2017.02.006,Non-OADS,/arxiv_data1/oa_pdf/ce/cb/main.PMC5469279.pdf
Appendix Supplementary data Supplementary data associated with this article can be foundin the online version at http://dx.doi.org/10.1016/j.hrcr.2017.,OADS,/arxiv_data1/oa_pdf/ce/cb/main.PMC5469279.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).http://dx.doi.org/10.1016/j.hrcr.2017.03.005,Non-OADS,/arxiv_data1/oa_pdf/f4/4a/main.PMC5469282.pdf
Appendix Supplementary data Supplementary data associated with this article can be foundin the online version at http://dx.doi.org/10.1016/j.hrcr.2017.,OADS,/arxiv_data1/oa_pdf/f4/4a/main.PMC5469282.pdf
PR9 2 (2017) e584http://dx.doi.org/10.1097/PR9.0000000000000584 2 (2017) e584 www.painreportsonline.com 1,Non-OADS,/arxiv_data1/oa_pdf/6f/51/painreports-2-e584.PMC5469295.pdf
Raw data on development of DAMGO-induced postoperative antihypersensi- tivity is shown in Supplementary Figure 1 (http://links.lww.com/ PR9/A3).,Non-OADS,/arxiv_data1/oa_pdf/6f/51/painreports-2-e584.PMC5469295.pdf
"2B, http://links.lww.com/PR9/A3).Therefore, these data are not taken into account in Figure 4A, B .",Non-OADS,/arxiv_data1/oa_pdf/6f/51/painreports-2-e584.PMC5469295.pdf
"2, http://links.lww.com/PR9/ A3).",Non-OADS,/arxiv_data1/oa_pdf/6f/51/painreports-2-e584.PMC5469295.pdf
"2, http://links.lww.com/ PR9/A3).",Non-OADS,/arxiv_data1/oa_pdf/6f/51/painreports-2-e584.PMC5469295.pdf
Raw data on development of buprenorphine- induced postoperative antihypersensitivity are shown in Supple-mentary Figure 4 (http://links.lww.com/PR9/A3).,Non-OADS,/arxiv_data1/oa_pdf/6f/51/painreports-2-e584.PMC5469295.pdf
"5A, B, http://links.lww.com/PR9/A3).",Non-OADS,/arxiv_data1/oa_pdf/6f/51/painreports-2-e584.PMC5469295.pdf
"5A, B, http://links.lww.com/PR9/A3; for 1 mg buprenorphine adult vs aged, 2-way ANOVA; **** P,0.0001 first 30 minutes; ** P,0.01 second 30 minutes; * P,0.05 third and fourth 30 minutes).",Non-OADS,/arxiv_data1/oa_pdf/6f/51/painreports-2-e584.PMC5469295.pdf
Supplemental Digital Content Supplemental Digital Content associated with this article can befound online at http://links.lww.com/PR9/A3.,Non-OADS,/arxiv_data1/oa_pdf/6f/51/painreports-2-e584.PMC5469295.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).http://dx.doi.org/10.1016/j.hrcr.2017.04.005,Non-OADS,/arxiv_data1/oa_pdf/ca/b6/main.PMC5469314.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).http://dx.doi.org/10.1016/j.hrcr.2017.03.007,Non-OADS,/arxiv_data1/oa_pdf/8b/42/main.PMC5469315.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).http://dx.doi.org/10.1016/j.hrcr.2017.04.009,Non-OADS,/arxiv_data1/oa_pdf/69/78/main.PMC5469316.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).http://dx.doi.org/10.1016/j.hrcr.2017.03.009,Non-OADS,/arxiv_data1/oa_pdf/89/18/main.PMC5469317.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).http://dx.doi.org/10.1016/j.hrcr.2017.03.008,Non-OADS,/arxiv_data1/oa_pdf/4c/d8/main.PMC5469318.pdf
"MeSH Keywords:  Heat-Shock Proteins • Mesenchymal Stromal Cells • Transfection  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/905216Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Plastic Surgery, Affiliated Hospital of Qingdao University, Qingdao,  Shandong, P.R.",Non-OADS,/arxiv_data1/oa_pdf/8c/39/medscimonit-23-2751.PMC5469319.pdf
"MeSH Keywords:  Angiogenesis Inducing Agents • Carcinoma, Hepatocellular • Prognosis •   Retinoblastoma-Binding Protein 2  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/905262Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of General Surgery, Renmin Hospital of Wuhan University, Wuhan,  Hubei, P.R.",Non-OADS,/arxiv_data1/oa_pdf/56/fe/medscimonit-23-2736.PMC5469320.pdf
"MeSH Keywords:  Gastric Dilatation • Gastroparesis • Intra-Abdominal Hypertension • Prader-Willi Syndrome  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/903608Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Paediatric Endocrinology, Parc Tauli Sabadell, Hospital Universitari,  Universitat Autònoma de Barcelona, Sabadell, Spain 2 Department of Paediatric Gastroenterology, Parc Tauli Sabadell, Hospital  Universitari.",Non-OADS,/arxiv_data1/oa_pdf/c7/83/amjcaserep-18-637.PMC5469321.pdf
"Published by Oxford University Press on behalf of the Entomological Society of America.This is an Open Access article distributed un der the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-us e, distribution, and reproduc- tion in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/ef/iex013.PMC5469378.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/e3/iex019.PMC5469379.pdf
(http://www.epa.gov/fedrgstr/EPA-PEST/2006/February/Day-15/p2160.htm).,OADS,/arxiv_data1/oa_pdf/63/e3/iex019.PMC5469379.pdf
(http://dx.doi.org/10.1093/jis/5.1.50).,OADS,/arxiv_data1/oa_pdf/63/e3/iex019.PMC5469379.pdf
(http://www.bls.gov/data/inﬂation_calculator.htm) (accessed 27 October 2016).,OADS,/arxiv_data1/oa_pdf/63/e3/iex019.PMC5469379.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/87/iex018.PMC5469380.pdf
"The precise clock times of sunrise and sunset foreach day were obtained from http://www.timeanddate.com.2 Journal of Insect Science , 2017, Vol.",OADS,/arxiv_data1/oa_pdf/22/87/iex018.PMC5469380.pdf
"R Foundation for Statistical Computing, Vienna, http://www.R-project.org.",Non-OADS,/arxiv_data1/oa_pdf/22/87/iex018.PMC5469380.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/0a/iex041.PMC5469381.pdf
"Mitogenome Assembly, Annotation, and Analysis The mitogenomes were assembled using SOAP denovo (BGI com-pany, Shenzhen, China) and preliminary annotations made with theMITOS WebServer (http://mitos.bioinf.uni-leipzig.de/index.py).tRNA genes and their secondary structures were inferred usingtRNAscan-SE 1.21 (http://lowelab.ucsc.edu/tRNAscan-SE/).",OADS,/arxiv_data1/oa_pdf/00/0a/iex041.PMC5469381.pdf
protein-coding genes (PCGs) were determined by ORF Finder (http://www.ncbi.nlm.nih.gov/gorf/gorf.html) under the invertebratemitochondrial genetic code.,OADS,/arxiv_data1/oa_pdf/00/0a/iex041.PMC5469381.pdf
"Institute of Evolutionary Biology, University of Edinburgh, http://tree.bio.",Non-OADS,/arxiv_data1/oa_pdf/00/0a/iex041.PMC5469381.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/a1/iex015.PMC5469382.pdf
Sequence Analysis The amino acid sequences of NLGP andNLGS were translated from cDNA sequences using the tool available at the ExPASyProteomics website (http://expasy.org/tools/dna.html).,OADS,/arxiv_data1/oa_pdf/2c/a1/iex015.PMC5469382.pdf
"The NLGPand NLGS putative sequences obtained were compared to proteinsequences deposited in GenBank, using the BLAST-N or BLAST-Xtools available at the National Center for BiotechnologyInformation (NCBI) website (http://www.ncbi.nlm.nih.gov/).",OADS,/arxiv_data1/oa_pdf/2c/a1/iex015.PMC5469382.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/8c/iex002.PMC5469383.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/af/2d/iex023.PMC5469384.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/5e/iex043.PMC5469385.pdf
"Slides were examined with alight microscope Leitz DMBRE (Leica), fitted with a Leica DFC 450C,and processed with ImageJ software (version 2.0.0, Wayne Rasband,http://imagej.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/86/5e/iex043.PMC5469385.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/d3/iex044.PMC5469386.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/09/iex031.PMC5469387.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/1c/iex014.PMC5469388.pdf
"Unigene sequences were searched by BLASTX to NCBI nucleotide databases, and aligned with Swiss-Prot knowledgebase (UniProtKB)/Swiss-Prot, KEGG (http://www.genome.ad.jp/kegg/) and COG data-bases (http://www.ncbi.nlm.nih.gov/COG/) (with a cutoff e-value- 1e /C010).",OADS,/arxiv_data1/oa_pdf/15/1c/iex014.PMC5469388.pdf
Sequences with BLASTX hits were annotated according toGO terms using Blast2GO (http://www.blast2GO.com) and dis-played by WEGO (http://wego.genomics.org.cn/cgi-bin/wego/index.pl).,OADS,/arxiv_data1/oa_pdf/15/1c/iex014.PMC5469388.pdf
Potential simple sequence repeat (SSR) markers were identified with the software MicroSAtellite (http://pgrc.ipk-gatersleben.de/misa/) ( Sharma et al.,OADS,/arxiv_data1/oa_pdf/15/1c/iex014.PMC5469388.pdf
The prediction of the ORFs) and amino acid sequence translationwere carried out using ExPaSy (http://www.expasy.org/tools/dna.html).,OADS,/arxiv_data1/oa_pdf/15/1c/iex014.PMC5469388.pdf
"Insecticide Resistance Action Committee, IRAC, http://www.irac-online.org (accessed 14 July 2014).",Non-OADS,/arxiv_data1/oa_pdf/15/1c/iex014.PMC5469388.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1d/18/iex030.PMC5469389.pdf
"Sunrise, sunset, moonrise and moonsettimes, and moon phase data were downloaded from the US Navalobservatory (http://aa.usno.navy.mil/data/docs/RS_OneDay.php).For analysis of moon visibility, days in which the moon had not yetrisen before foraging were counted as “no moon”.",OADS,/arxiv_data1/oa_pdf/1d/18/iex030.PMC5469389.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/dc/iew122.PMC5469391.pdf
"1521-009X/45/7/855 –866$25.00 https://doi.org/10.1124/dmd.116.074005 DRUGMETABOLISM AND DISPOSITION Drug Metab Dispos 45:855 –866, July 2017 Copyright ª2017 by The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license.",Non-OADS,/arxiv_data1/oa_pdf/58/c7/dmd.116.074005.PMC5469400.pdf
https://doi.org/10.1124/dmd.116.074005.,Non-OADS,/arxiv_data1/oa_pdf/58/c7/dmd.116.074005.PMC5469400.pdf
"The predicted CL hwas 0.55 ml/min per kilogram,which is ,7-fold underpredicted than in vivo plasma clearance (3.8 ml/min per kilogram) (data also available at http://www.capkr.man.ac.uk).",OADS,/arxiv_data1/oa_pdf/58/c7/dmd.116.074005.PMC5469400.pdf
Available at: https://insight.shrp2nds.us/home.,Non-OADS,/arxiv_data1/oa_pdf/73/7e/i1552-5783-58-7-2959.PMC5469423.pdf
Available at: http://www.canada-nds.net/in dex.html.,Non-OADS,/arxiv_data1/oa_pdf/73/7e/i1552-5783-58-7-2959.PMC5469423.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/91/nihms867055.PMC5469507.pdf
https://www.assessmentcenter.net/documents/PROMIS %20Physical%20Function%20Scoring%20Manual.pdf 20.,Non-OADS,/arxiv_data1/oa_pdf/73/91/nihms867055.PMC5469507.pdf
2005. http://www.ispor.org/workpaper/emea-hrql-guidance.pdfGelhorn et al.,OADS,/arxiv_data1/oa_pdf/73/91/nihms867055.PMC5469507.pdf
"Dr Lowe receives research support from GE Healthcare, Siemens Mole- cular Imaging, AVID Radiopharmaceuticals Supplemental Material The online supplemental data are available at http://journals.sagepub .com/doi/suppl/10.1177/1536012116673793.",OADS,/arxiv_data1/oa_pdf/8d/e5/10.1177_1536012116673793.PMC5469518.pdf
Supplemental Material The online supplemental figures are available at http://journals.sage pub.com/doi/suppl/10.1177/1536012117704768.References 1.,Non-OADS,/arxiv_data1/oa_pdf/e2/ea/10.1177_1536012117704768.PMC5469519.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/14/af/sfw075.PMC5469550.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/58/a7/sfw100.PMC5469552.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/01/sfw099.PMC5469553.pdf
Supplementary data Supplementary data are available online at http://ckj.oxford journals.org.,Non-OADS,/arxiv_data1/oa_pdf/19/01/sfw099.PMC5469553.pdf
"https://www.gov.uk/government/ publications/the-nhs-constitution-for-england (19 May 2016, date last accessed) 16.",Non-OADS,/arxiv_data1/oa_pdf/19/01/sfw099.PMC5469553.pdf
"Fluck R. National Kidney Care Audit: Vascular Access 2011: Health and Social Care Information Centre (HSCIC), 2011. http://www.ic.nhs.uk/catalo gue/PUB02688/nati-kidn-care- 2011-vasc-acce-rep.pdf (6 March 2016, date last accessed) 25.",Non-OADS,/arxiv_data1/oa_pdf/19/01/sfw099.PMC5469553.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/89/0b/sfw102.PMC5469555.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/a9/sfw127.PMC5469556.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/8c/sfw074.PMC5469557.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/b6/sfw113.PMC5469558.pdf
Supplementary data Supplementary data are available online at http://ckj.oxford journals.org .,Non-OADS,/arxiv_data1/oa_pdf/03/b6/sfw113.PMC5469558.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0f/13/sfw141.PMC5469559.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/41/sfw122.PMC5469560.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/f4/54/sfw062.PMC5469561.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/ae/sfw089.PMC5469562.pdf
"Schmidt RJ, Holley JL, Schwab SJ et al.Noninfectious complications of peritoneal dialysis catheters 2016. http://www.uptodate.com/ contents/noninfectious-complications-of-peritoneal-dialysis- catheters?source=search_result&search=noninfectious+CLINICAL KIDNEY JOURNAL133 Cuff-shaving procedure |",Non-OADS,/arxiv_data1/oa_pdf/ab/ae/sfw089.PMC5469562.pdf
http://www.cancerresearchuk.org/health-professional/cancer- statistics/statistics-by-cancer-type/prostate-cancer/incidence.,Non-OADS,/arxiv_data1/oa_pdf/d0/0b/nur-31-210.PMC5469566.pdf
https://www.gov.uk/government/publications/ national-cancer-patient-experi ence-survey-programme-2010- national-survey-report.,Non-OADS,/arxiv_data1/oa_pdf/d0/0b/nur-31-210.PMC5469566.pdf
http://tinyurl.com/crpdaxx.,Non-OADS,/arxiv_data1/oa_pdf/d0/0b/nur-31-210.PMC5469566.pdf
http://tinyurl.com/ntxeh52.,Non-OADS,/arxiv_data1/oa_pdf/d0/0b/nur-31-210.PMC5469566.pdf
http://tinyurl.com/oz96j68.,Non-OADS,/arxiv_data1/oa_pdf/d0/0b/nur-31-210.PMC5469566.pdf
nationalarchives.gov.uk/20130513211237/http://www.ncat.,Non-OADS,/arxiv_data1/oa_pdf/d0/0b/nur-31-210.PMC5469566.pdf
A census of the cancer specialist nurse workforce in England 2010. http://alisonleary.co.uk/docs/Clinical%20Nurse% 20Specialistsin%20Cancer%20Care_%20Provision.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d0/0b/nur-31-210.PMC5469566.pdf
http://journals.rcni.com/doi/a bs/10.7748/cnp2013.02.12.1.5.,Non-OADS,/arxiv_data1/oa_pdf/d0/0b/nur-31-210.PMC5469566.pdf
https://www.gov.uk/government/uploads/system/uploads/ attachment_data/file/213785/dh_123394.pdf.,OADS,/arxiv_data1/oa_pdf/d0/0b/nur-31-210.PMC5469566.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/be/sfw149.PMC5469568.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/60/fa/sfw106.PMC5469569.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/ea/sfw097.PMC5469570.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/fd/sfw131.PMC5469571.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/b4/7c/sfw095.PMC5469572.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/7e/sfw139.PMC5469573.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/46/sfw105.PMC5469574.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/79/44/sfw128.PMC5469575.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/00/sfw060.PMC5469576.pdf
Supplementary data Supplementary data are available online at http://ckj.oxfordjour- nals.org.,OADS,/arxiv_data1/oa_pdf/c9/00/sfw060.PMC5469576.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/aa/37/sfw077.PMC5469577.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/86/60/sfw092.PMC5469578.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cb/f0/iex004.PMC5469579.pdf
"Food and Agricultural Organization of the United Nations, Rome (http://www.fao.org/docrep/x2230e/x2230e00.htm#con).",Non-OADS,/arxiv_data1/oa_pdf/cb/f0/iex004.PMC5469579.pdf
"Afatinib (Gilotrif, Boehringer Ingelheim; Ingelheim, Germany, https://www.boehringer-ingelheim.com/) is an irreversible ErbB family blocker of EGFR, erb-b2 receptor tyrosine kinase 2 (ErbB2), and ErbB4 [16, 17], with in vitro activity against ErbB3 phosphorylation [18].",Non-OADS,/arxiv_data1/oa_pdf/a8/25/onco12104.PMC5469580.pdf
"More recently, high response rates were noted in a completed phase I study for ceritinib (Zykadia, Novartis Pharmaceuticals; Ea st Hanover, NJ, https://www.pharma.us.",Non-OADS,/arxiv_data1/oa_pdf/a8/25/onco12104.PMC5469580.pdf
"Nivolumab (Opdivo, Bristol-MyersSquibb; Princeton, NJ, http://www.bms.com), a human anti-programmed death-1 antibody, gained approval in March 2015 for patients with advanced or metastatic squamous NSCLC fol- lowing platinum-based chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/a8/25/onco12104.PMC5469580.pdf
"Although nivolumab treatment did not improve PFS compared with doce-taxel, the rate of PFS at 1 year was higher with nivolumab [49].Pembrolizumab (Keytruda, Merck & Company; Whitehouse Station, NJ, http://www.merck.com) was approved in October 2015 for the treatment of advanced or metastatic NSCLC with expression of the immune checkpoint protein PD-L1 as deter- mined by an FDA-approved test.",Non-OADS,/arxiv_data1/oa_pdf/a8/25/onco12104.PMC5469580.pdf
Available at https://www.cancer.org/research/ cancer-facts-statistics/all-cancer-facts-ﬁgures/cancer- facts-ﬁgures-2016.html.,Non-OADS,/arxiv_data1/oa_pdf/a8/25/onco12104.PMC5469580.pdf
Available at https://www.fda.gov/ downloads/Drugs/DevelopmentApprovalProcess/ DevelopmentResources/CancerDrugs/ucm094744.,Non-OADS,/arxiv_data1/oa_pdf/a8/25/onco12104.PMC5469580.pdf
Available athttps://www.fda.gov/downl oads/drugs/guidances/ ucm259421.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a8/25/onco12104.PMC5469580.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0 Un - ported Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e6/8b/1591.PMC5469603.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/05/5d/1601.PMC5469604.pdf
"Molecular Biology of the Cell(https://github.com/bnoi/MAARS/tree/   master/doc/demos), our software is able to  record cell division, specifically find mitotic  cells, and extract on-the-fly multiple mitotic  parameters.",OADS,/arxiv_data1/oa_pdf/05/5d/1601.PMC5469604.pdf
Documentation and source code are available in a public repository  (https://github.com/bnoi/MAARS/releases/tag/v1.0.0 ).,OADS,/arxiv_data1/oa_pdf/05/5d/1601.PMC5469604.pdf
Metrics related to the  distance between the two SPBs or their position within the cell can precisely the installation instructions ( https://github.com/bnoi/ MAARS/blob/master/doc/install_MAARS.md ).,OADS,/arxiv_data1/oa_pdf/05/5d/1601.PMC5469604.pdf
Several tutorials are  also provided (https://github.com/bnoi/MAARS/tree/master/doc/ demos) to illustrate the simplicity and efficiency of MAARS software.,Non-OADS,/arxiv_data1/oa_pdf/05/5d/1601.PMC5469604.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/eb/92/1612.PMC5469605.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/eb/ab/1622.PMC5469606.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f3/66/1636.PMC5469607.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b7/dc/1652.PMC5469608.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/25/4d/1667.PMC5469609.pdf
"Briefly, four single guide RNAs (sgRNAs) targeting ex - ons 2–5 of the Vps35 gene (5 ′-ATGACTGAACCTTCACAGCC -3 ′,  5′-GAGCTCTCCAAGCATATTGG-3 ′, 5 ′-TGATGAACTGCACTAC- TTGG-3 ′, and 5 ′-GATTTGGTAGAAATGTGCCG-3 ′, respectively)  were designed using online software ( http://crispr.mit.edu ; http:// chopchop.cbu.uib.no) .",OADS,/arxiv_data1/oa_pdf/25/4d/1667.PMC5469609.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/1f/ca/1676.PMC5469610.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/97/07/1688.PMC5469611.pdf
MorphoQuant is freely  available (https://github.com/tischi/MorphoQuant).,Non-OADS,/arxiv_data1/oa_pdf/97/07/1688.PMC5469611.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/99/d8/1701.PMC5469612.pdf
"https://doi.org/10.1177/2150131916687919Journal of Primary Care & Community Health 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/b6/85/10.1177_2150131916687919.PMC5469696.pdf
https://www.ssa.gov/OP_Home/ssact/title18/1886.htm.,Non-OADS,/arxiv_data1/oa_pdf/b6/85/10.1177_2150131916687919.PMC5469696.pdf
1995. http://www.hrsa.gov/shortage/mua/.,Non-OADS,/arxiv_data1/oa_pdf/b6/85/10.1177_2150131916687919.PMC5469696.pdf
"Stem Cell Reports Report Intestinal Stem Cell Pool Regulation in Drosophila Yinhua Jin,1,2,4Parthive H. Patel,1,2,4Alexander Kohlmaier,1,2Bojana Pavlovic,1,2Chenge Zhang,1,2 and Bruce A. Edgar1,2,3,* 1Center for Molecular Biology, University of Heidelberg (ZMBH) 2German Cancer Research Center (DKFZ) 69120 Heidelberg, Germany 3Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA 4Co-ﬁrst author *Correspondence: bruce.edgar@hci.utah.edu http://dx.doi.org/10.1016/j.stemcr.2017.04.002 SUMMARY Intestinal epithelial renewal is mediated by intestinal stem cells (ISCs) that exist in a state of neutral drift, wherein individual ISC lineages are regularly lost and born but ISC numbers remain constant.",Non-OADS,/arxiv_data1/oa_pdf/2a/92/main.PMC5469868.pdf
1479 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/92/main.PMC5469868.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2017.04.002 .",Non-OADS,/arxiv_data1/oa_pdf/2a/92/main.PMC5469868.pdf
"Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202, USA 8Present address: Center for Stem Cell and Regenerative Medicine, Brown Foundation Institute of Molecular Medicine, University of Texas Health Scie nce Center at Houston, Houston, TX 77030, USA*Correspondence: bhadland@fredhutch.org http://dx.doi.org/10.1016/j.stemcr.2017.04.007 SUMMARY Recent evidence points to the embryonic emergence of some tissue-resident innate immune cells, such as B-1a lymphocytes, prior to and independently of hematopoietic stem cells (HSCs).",Non-OADS,/arxiv_data1/oa_pdf/9b/8a/main.PMC5469918.pdf
1563 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9b/8a/main.PMC5469918.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes two ﬁgures and two tables andcan be found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2017.04.007 .,Non-OADS,/arxiv_data1/oa_pdf/9b/8a/main.PMC5469918.pdf
"Stem Cell Reports Report Comprehensive Monosynaptic Rabies Virus Mapping of Host Connectivity with Neural Progenitor Grafts after Spinal Cord Injury Andrew F. Adler,1Corinne Lee-Kubli,1Hiromi Kumamaru,1Ken Kadoya,1,3and Mark H. Tuszynski1,2,* 1Department of Neurosciences, University of California – San Diego, La Jolla, CA 92093, USA 2Veterans Administration San Diego Healthcare System, San Diego, CA 92161, USA 3Present address: Department of Orthopaedic Surgery, Hokkaido University, Sapporo 060-8638, Japan *Correspondence: mtuszynski@ucsd.edu http://dx.doi.org/10.1016/j.stemcr.2017.04.004 SUMMARY Neural progenitor cells grafted to sites of spinal cord injury have supported electrophysiological and functional recovery in several studies.",OADS,/arxiv_data1/oa_pdf/1b/c4/main.PMC5469919.pdf
1525 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1b/c4/main.PMC5469919.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2017.04.004 .",Non-OADS,/arxiv_data1/oa_pdf/1b/c4/main.PMC5469919.pdf
"http://dx.doi.org/10.1016/j.stemcr.2017.04.005 SUMMARY The bone size and quality, acquired during adolescent growth under the inﬂuence of anabolic hormones, growth factors, and nutrients, determine the height and bone stability and forecast osteoporosis risks in late life.",Non-OADS,/arxiv_data1/oa_pdf/38/72/main.PMC5469920.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/38/72/main.PMC5469920.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and seven ﬁgures and can be found with this article on-line at http://dx.doi.org/10.1016/j.stemcr.2017.04.005 .AUTHOR CONTRIBUTIONS B.L., H.Z., Z.Z., and W.Z.",OADS,/arxiv_data1/oa_pdf/38/72/main.PMC5469920.pdf
"pISSN: 1011-8942  eISSN: 2092-9382 © 2017 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.183 Review ArticleKorean J Ophthalmol 2017;31(3):183-193 https://doi.org/10.3341/kjo.2017.0024 Imaging of Cranial Nerves III, IV, VI in Congenital Cranial  Dysinnervation Disorders Jae Hyoung Kim1, Jeong-Min Hwang2 1Department of Radiology, Seoul National University Bundang Hospital, Seoul National University College of Medicine,  Seongnam, Korea 2Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine,  Seongnam, Korea Congenital cranial dysinnervation disorders are a group of diseases caused by abnormal development of cranial  nerve nuclei or their axonal connections, resulting in aberrant innervation of the ocular and facial musculature.",Non-OADS,/arxiv_data1/oa_pdf/5b/7c/kjo-31-183.PMC5469921.pdf
"pISSN: 1011-8942  eISSN: 2092-9382 © 2017 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.194 Original ArticleKorean J Ophthalmol 2017;31(3):194-201 https://doi.org/10.3341/kjo.2016.0034 Orbital Lymphangioma: Characteristics and Treatment Outcomes  of 12 Cases Young Jun Woo1, Chang Yeom Kim1, Bradford Sgrignoli2, Jin Sook Yoon1 1Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea 2Department of Ophthalmology, Saint John’s Episcopal Hospital, Far Rockaway, NY, USA Purpose:  To report the patient characteristics and treatment outcomes in 12 cases of orbital lymphangioma.",Non-OADS,/arxiv_data1/oa_pdf/25/60/kjo-31-194.PMC5469922.pdf
"pISSN: 1011-8942  eISSN: 2092-9382 © 2017 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.202 Original ArticleKorean J Ophthalmol 2017;31(3):202-208 https://doi.org/10.3341/kjo.2016.0042 Korean Version Self-testing Application for Reading Speed Soolienah Rhiu1, Moses Kim2, Jae-hyung Kim3*, Hye Jin Lee4, Tae-Hyung Lim5* 1Department of Ophthalmology, Hallym University Dongtan Sacred Heart Hospital, Hallym University  College of Medicine, Hwaseong, Korea 2Republic of Korea Air Force 17th Fighter Wing, Cheongju, Korea 3Department of Ophthalmology, Chungbuk National University College of Medicine, Cheongju, Korea 4Department of Ophthalmology, Jeju National University School of Medicine, Jeju, Korea 5HanGil Eye Hospital, Incheon, Korea Purpose:  This study introduces a reading chart application for the iPad tablet in the Korean language and inves - tigates the reading speed in a normal-sighted population according to age group.",Non-OADS,/arxiv_data1/oa_pdf/d7/92/kjo-31-202.PMC5469923.pdf
"pISSN: 1011-8942  eISSN: 2092-9382 © 2017 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.209 Original ArticleKorean J Ophthalmol 2017;31(3):209-216 https://doi.org/10.3341/kjo.2015.0158 Comparison of Ranibizumab and Bevacizumab for Macular Edema Associated with Branch Retinal Vein Occlusion Bo Kwon Son, Hyung Woo Kwak, Eung Suk Kim, Seung-Young Yu Department of Ophthalmology, Kyung Hee University Medical Center, Kyung Hee University School of Medicine, Seoul, Korea Purpose:  To assess the effectiveness and safety of intravitreal ranibizumab compared with bevacizumab for  the treatment of macular edema associated with branch retinal vein occlusion (BRVO).",Non-OADS,/arxiv_data1/oa_pdf/16/4c/kjo-31-209.PMC5469924.pdf
"pISSN: 1011-8942  eISSN: 2092-9382 © 2017 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.217 Original ArticleKorean J Ophthalmol 2017;31(3):217-229 https://doi.org/10.3341/kjo.2016.0018 Predictors and Outcomes of Vitrectomy and Silicone Oil Injection   in Advanced Diabetic Retinopathy Alireza Ramezani1,2,3, Hamid Ahmadieh2,3, Amin Rozegar2, Masoud Soheilian2,3, Morteza Entezari2,3,   Siamak Moradian1,3, Mohammad H Dehghan2,3, Homayoun Nikkhah2, Mehdi Yaseri2,4 1Ophthalmic Epidemiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran 2Ophthalmic Research Center, Labbafinejad and Imam Hossein Medical Centers,  Shahid Beheshti University of Medical Sciences, Tehran, Iran 3Department of Ophthalmology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran 4Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences, Tehran, Iran Purpose:  To evaluate visual and anatomical results and identify factors that influence vitrectomy and silicone oil  (SO) injection outcomes in proliferative diabetic retinopathy (PDR).",Non-OADS,/arxiv_data1/oa_pdf/12/31/kjo-31-217.PMC5469925.pdf
"pISSN: 1011-8942  eISSN: 2092-9382 © 2017 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.230 Original ArticleKorean J Ophthalmol 2017;31(3):230-239 https://doi.org/10.3341/kjo.2016.0035 Polypoidal Choroidal Vasculopathy with Feeder Vessels:  Characteristics, Fellow Eye Findings, and Long-term Treatment  Outcomes Hyun Ji Hwang1, Jae Hui Kim1, Young Suk Chang2, Jong Woo Kim1, Chul Gu Kim1 1Department of Ophthalmology, Kim ’s Eye Hospital, Konyang University College of Medicine, Seoul, Korea 2Department of Ophthalmology, Konyang University College of Medicine, Daejeon, Korea Purpose:  To evaluate the long-term outcomes of anti-vascular endothelial growth factor (VEGF) therapy for pol - ypoidal choroidal vasculopathy (PCV) with feeder vessels and to investigate fellow-eye findings.",Non-OADS,/arxiv_data1/oa_pdf/39/c7/kjo-31-230.PMC5469926.pdf
"pISSN: 1011-8942  eISSN: 2092-9382 © 2017 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.240 Original ArticleKorean J Ophthalmol 2017;31(3):240-248 https://doi.org/10.3341/kjo.2016.0026 Treatment of Bilateral Retinal Angiomatous Proliferation   with Anti-vascular Endothelial Growth Factor: 12-Month Outcome Jae Min Kim1, Jae Hui Kim1, Young Suk Chang2, Jong Woo Kim1, Chul Gu Kim1, Dong Won Lee1 1Department of Ophthalmology, Kim ’s Eye Hospital, Konyang University College of Medicine, Seoul, Korea 2Department of Ophthalmology, Konyang University College of Medicine, Daejeon, Korea Purpose:  To evaluate the 12-month outcome of intravitreal anti-vascular endothelial growth factor therapy in  eyes with bilateral retinal angiomatous proliferation (RAP).",Non-OADS,/arxiv_data1/oa_pdf/5d/6f/kjo-31-240.PMC5469927.pdf
"pISSN: 1011-8942  eISSN: 2092-9382 © 2017 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.249 Original ArticleKorean J Ophthalmol 2017;31(3):249-256 https://doi.org/10.3341/kjo.2016.0007 Cycloplegic Refraction in Hyperopic Children: Effectiveness of a 0.5%  Tropicamide and 0.5% Phenylephrine Addition to 1% Cyclopentolate  Regimen Seul Gi Yoo1, Myung Jin Cho1, Ungsoo Samuel Kim1,2, Seung-Hee Baek1  1Department of Ophthalmology, Kim ’s Eye Hospital, Seoul, Korea 2Department of Ophthalmology, Konyang University College of Medicine, Daejeon, Korea Cycloplegic refraction is a procedure that allows estima - tion of a true refractive error by inhibiting accommoda - tion.",Non-OADS,/arxiv_data1/oa_pdf/4f/9d/kjo-31-249.PMC5469928.pdf
"pISSN: 1011-8942  eISSN: 2092-9382 © 2017 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.257 Original ArticleKorean J Ophthalmol 2017;31(3):257-262 https://doi.org/10.3341/kjo.2016.0021 Measurement of Angle Kappa Using Ultrasound Biomicroscopy and  Corneal Topography Joon Hyung Yeo, Nam Ju Moon, Jeong Kyu Lee Department of Ophthalmology, Chung-Ang University College of Medicine, Seoul, Korea Angle kappa is the angle between the visual axis and the  pupillary axis.",Non-OADS,/arxiv_data1/oa_pdf/ae/cd/kjo-31-257.PMC5469929.pdf
"However, it can be simply calculated by Microsoft Excel or  other free calculation software (http://www.rapidtables.",Non-OADS,/arxiv_data1/oa_pdf/ae/cd/kjo-31-257.PMC5469929.pdf
"pISSN: 1011-8942  eISSN: 2092-9382 © 2017 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.263 Original ArticleKorean J Ophthalmol 2017;31(3):263-267 https://doi.org/10.3341/kjo.2015.0161 Ophthalmologic Features of Lennox-Gastaut Syndrome Bo Hee Kim1, Young Suk Yu1,2, Seong-Joon Kim1,2 1Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea 2Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Korea Lennox-Gastaut syndrome (LGS) is a childhood epilep - tic encephalopathy characterized by an electroclinical triad  of generalized slow spike and wave complex of 1.5 to 2.5  Hz on electroencephalogram, multiple types of seizures  such as atypical absence and tonic seizures, and behavioral  disorders including cognitive development disorder [1].",Non-OADS,/arxiv_data1/oa_pdf/24/c5/kjo-31-263.PMC5469930.pdf
"pISSN: 1011-8942  eISSN: 2092-9382 © 2017 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.268 Original ArticleKorean J Ophthalmol 2017;31(3):268-274 https://doi.org/10.3341/kjo.2015.0168 The Effect of Preoperative Occlusion Therapy on Long-term Outcome  after Surgery for Early-onset Exotropia Kwang Hoon Shin, Iris Naheah Kim, Hae Jung Paik Department of Ophthalmology, Gachon University Gil Hospital, Incheon, Korea Exotropia in healthy children younger than 1 year of age is rare, and several studies have been conducted on this  disease entity [1-7].",Non-OADS,/arxiv_data1/oa_pdf/0e/74/kjo-31-268.PMC5469931.pdf
"pISSN: 1011-8942  eISSN: 2092-9382 © 2017 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.275A Case of Retinal Cavernous Hemangioma   Diagnosed with Spectral Domain Optical  Coherence Tomography Dear Editor, Retinal cavernous hemangioma (RCH) is a rare, benign,  congenital vascular anomaly, incidentally diagnosed in as - ymptomatic patients.",Non-OADS,/arxiv_data1/oa_pdf/3d/74/kjo-31-275.PMC5469932.pdf
"In conclusion, SD-OCT can be a useful tool for diagnosis  and monitoring of RCH patients.Korean J Ophthalmol 2017;31(3):275-276 https://doi.org/10.3341/kjo.2017.0013Correspondence",Non-OADS,/arxiv_data1/oa_pdf/3d/74/kjo-31-275.PMC5469932.pdf
"Through vasodi - lation over time, subsequent anterior movement of epinephKorean J Ophthalmol 2017;31(3):277-279 https://doi.org/10.3341/kjo.2017.0004",Non-OADS,/arxiv_data1/oa_pdf/1f/d8/kjo-31-277.PMC5469933.pdf
"Furthermore, his visual outcome was predict -Korean J Ophthalmol 2017;31(3):279-281 https://doi.org/10.3341/kjo.2017.0002",Non-OADS,/arxiv_data1/oa_pdf/1f/d8/kjo-31-277.PMC5469933.pdf
"Furthermore, his visual outcome was predict -Korean J Ophthalmol 2017;31(3):279-281 https://doi.org/10.3341/kjo.2017.0002",Non-OADS,/arxiv_data1/oa_pdf/ba/96/kjo-31-279.PMC5469934.pdf
A VA of Korean J Ophthalmol 2017;31(3):281-282 https://doi.org/10.3341/kjo.2016.0111,Non-OADS,/arxiv_data1/oa_pdf/ba/96/kjo-31-279.PMC5469934.pdf
A VA of Korean J Ophthalmol 2017;31(3):281-282 https://doi.org/10.3341/kjo.2016.0111,Non-OADS,/arxiv_data1/oa_pdf/4c/16/kjo-31-281.PMC5469935.pdf
"Stem Cell Reports Article Increasing Human Neural Stem Cell T ransplantation Dose Alters Oligodendroglial and Neuronal Differentiation after Spinal Cord Injury Katja M. Piltti,1,2,3,*Gabriella M. Funes,1,4Sabrina N. Avakian,1,4Ara A. Salibian,1Kevin I. Huang,1,4 Krystal Carta,1Noriko Kamei,1,2Lisa A. Flanagan,1,3,4,5,6Edwin S. Monuki,1,3,7Nobuko Uchida,8 Brian J. Cummings,1,2,3,4and Aileen J. Anderson1,2,3,4 1Sue & Bill Gross Stem Cell Center, University of California Irvine, Irvine, CA 92697, USA 2Physical & Medical Rehabilitation 3Institute for Memory Impairments & Neurological Disorders 4Anatomy & Neurobiology 5Department of Biomedical Engineering 6Department of Neurology 7Department of Pathology and Laboratory Medicine University of California Irvine, Irvine, CA 92697, USA 8BOCO Silicon Valley, ReGen Med Division, Palo Alto, CA 94303, USA *Correspondence: kpiltti@uci.edu http://dx.doi.org/10.1016/j.stemcr.2017.04.009 SUMMARY Multipotent human central nervous system-derived neural stem cells transplanted at doses ranging from 10,000 (low) to 500,000 (very high) cells differentiated predominantly into the oligodendroglial lineage.",Non-OADS,/arxiv_data1/oa_pdf/89/ea/main.PMC5469937.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/ea/main.PMC5469937.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, ﬁve ﬁgures, and two tables and can be found withthis article online at http://dx.doi.org/10.1016/j.stemcr.2017.",OADS,/arxiv_data1/oa_pdf/89/ea/main.PMC5469937.pdf
(Oxford University Press) http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/ea/main.PMC5469937.pdf
"Cerebral malaria has been reported to result in diffuse edema and less commonly, bithalamic and cerebellar lesions inFreely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/07/4a/tre-07-471-7522-1.PMC5469941.pdf
Postural instabilityis noted on the pull test.Park JE Parkinsonism and Tremor in Malaria Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/07/4a/tre-07-471-7522-1.PMC5469941.pdf
"Stem Cell Reports Article Schwann Cell Precursors from Human Pluripotent Stem Cells as a Potential Therapeutic T arget for Myelin Repair Han-Seop Kim,1Jungwoon Lee,1Da Yong Lee,2Young-Dae Kim,1Jae Yun Kim,1,3Hyung Jin Lim,1,3 Sungmin Lim,1,3and Yee Sook Cho1,3,* 1Stem Cell Research Laboratory, Immunotherapy Convergence Research Center 2Rare Disease Research Center Korea Research Institute of Bioscience and Biotechnology, 125 Gwahak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea 3Department of Bioscience, KRIBB School, University of Science & Technology, 113 Gwahak-ro, Yuseong-gu, Daejeon 34113, Republic of Korea *Correspondence: june@kribb.re.kr http://dx.doi.org/10.1016/j.stemcr.2017.04.011 SUMMARY Schwann cells play a crucial role in successful nerve repair and regeneration by supporting both axonal growth and myelination.",OADS,/arxiv_data1/oa_pdf/83/14/main.PMC5469943.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/14/main.PMC5469943.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, six ﬁgures, and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2017.04.",OADS,/arxiv_data1/oa_pdf/83/14/main.PMC5469943.pdf
"Morcos,1Kristina B. Schoedel,1Anja Hoppe,1Rayk Behrendt,1Onur Basak,2Hans C. Clevers,2,3 Axel Roers,1and Alexander Gerbaulet1,* 1Institute for Immunology, Faculty of Medicine, TU Dresden, Fetscherstrasse 74, 01307 Dresden, Germany 2Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht 3Princess Ma ´xima Centre 3584 CT Utrecht, the Netherlands *Correspondence: alexander.gerbaulet@tu-dresden.de http://dx.doi.org/10.1016/j.stemcr.2017.04.012 SUMMARY Blood cell generation depends on continuous cellular output by the sequential hierarchy of hematopoietic stem cell (HSC) and progenitor populations that all contain quiescent and actively cycling cells.",Non-OADS,/arxiv_data1/oa_pdf/81/13/main.PMC5469944.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/13/main.PMC5469944.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes two ﬁgures and one table and can be found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2017.04.012 .,Non-OADS,/arxiv_data1/oa_pdf/81/13/main.PMC5469944.pdf
"Stem Cell Reports Report NEUROD1 Instructs Neuronal Conversion in Non-Reactive Astrocytes Rebecca Brulet,1Taito Matsuda,2Ling Zhang,1Carlos Miranda,3Mauro Giacca,5Brian K. Kaspar,3,4 Kinichi Nakashima,2and Jenny Hsieh1,* 1Departments of Molecular Biology, Neurology and Neurotherapeutics, and Hamon Center for Regenerative Science and Medicine, UT Southwestern Medical Center, Dallas, TX 75390, USA 2Stem Cell Biology and Medicine, Department of Stem Cell Biology and Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan 3Center for Gene Therapy, The Research Institute at Nationwide Children’s Hospital, Columbus, OH 43205, USA 4Departments of Neuroscience and Pediatrics, The Ohio State University, Columbus, OH 43210, USA 5International Centre for Genetic Engineering and Biotechnology, Padriciano 99, 34149 Trieste, Italy *Correspondence: jenny.hsieh@utsouthwestern.edu http://dx.doi.org/10.1016/j.stemcr.2017.04.013 SUMMARY Currently, all methods for converting non-neuronal cells into neurons involve injury to the brain; however, whether neuronal trans- differentiation can occur long after the period of insult remains largely unknown.",Non-OADS,/arxiv_data1/oa_pdf/3e/14/main.PMC5470076.pdf
"8 j1506–1515 jJune 6, 2017 j This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/3e/14/main.PMC5470076.pdf
"Rod Hardy,1Michael R. Green,1,3 Feixia Chu,2and Thomas G. Fazzio1,* 1Department of Molecular, Cell, and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA 2Department of Molecular, Cellular, and Biomedical Sciences, University of New Hampshire, Durham, NH 03824, USA 3Howard Hughes Medical Institute, University of Massachusetts Medical School, Worcester, MA 01605, USA *Correspondence: thomas.fazzio@umassmed.edu http://dx.doi.org/10.1016/j.stemcr.2017.04.020 SUMMARY The Nucleosome Remodeling and Deacetylase (NuRD) complex is a chromatin regulatory complex that functions as a transcriptional co- repressor in metazoans.",OADS,/arxiv_data1/oa_pdf/98/a9/main.PMC5470077.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/98/a9/main.PMC5470077.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, and three tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/98/a9/main.PMC5470077.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/98/a9/main.PMC5470077.pdf
"), michael.rosu-myles@hc-sc.gc.ca (M.R.-M.), pmenendez@carrerasresearch.org (P.M.) http://dx.doi.org/10.1016/j.stemcr.2017.04.019 SUMMARY Bone marrow mesenchymal stem/stromal cells (BM-MSCs) are key components of the hematopoietic niche thought to have a direct role in leukemia pathogenesis.",Non-OADS,/arxiv_data1/oa_pdf/70/89/main.PMC5470078.pdf
1573 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/89/main.PMC5470078.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and one ﬁgure and can be found with this article online athttp://dx.doi.org/10.1016/j.stemcr.2017.04.019 .,Non-OADS,/arxiv_data1/oa_pdf/70/89/main.PMC5470078.pdf
Leukemia http://dx.doi.org/10.1038/leu.2016.324 .,Non-OADS,/arxiv_data1/oa_pdf/70/89/main.PMC5470078.pdf
"Cheah,1,4and Martin Cheung1,2,4,* 1Department of Biochemistry 2Department of Anatomy Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong, China 3Department of Orthopedic Surgery, Gifu University, Gifu 501-1194, Japan 4Present address: School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, School of Biomedical Sciences, The University of Hong Kong, Pokfula m, Hong Kong, China*Correspondence: mcheung9@hku.hk http://dx.doi.org/10.1016/j.stemcr.2017.04.018 SUMMARY Recent studies using deﬁned transcription factors to convert skin ﬁbroblasts into chondrocytes have raised the question of whether osteo- chondroprogenitors expressing SOX9 and RUNX2 could also be generated during the course of the reprogramming process.",Non-OADS,/arxiv_data1/oa_pdf/76/81/main.PMC5470079.pdf
1587 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/81/main.PMC5470079.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, three ﬁgures, and one table and can be found withthis article online at http://dx.doi.org/10.1016/j.stemcr.2017.",OADS,/arxiv_data1/oa_pdf/76/81/main.PMC5470079.pdf
mass values were obtained using MarvinSketch (version 6.1.0; ChemAxon http://www.chemaxon.com).,OADS,/arxiv_data1/oa_pdf/23/91/10.1177_1536012115624920.PMC5470083.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/7e/rjx103.PMC5470090.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/8c/rjx107.PMC5470091.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/8c/rjx105.PMC5470092.pdf
"http://dx.doi.org/10.1016/j.stemcr.2017.04.024 SUMMARY Despite the importance of molecular subtype classiﬁcation of glioblastoma (GBM), the extent of extracellular vesicle (EV)-driven molec- ular and phenotypic reprogramming remains poorly understood.",OADS,/arxiv_data1/oa_pdf/b0/43/main.PMC5470095.pdf
"8 j1497–1505 jJune 6, 2017 j1497 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/b0/43/main.PMC5470095.pdf
Clinical data were downloaded from the TCGA data portal ( https://tcga-data.nci.nih.gov/ ).,OADS,/arxiv_data1/oa_pdf/b0/43/main.PMC5470095.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, two tables, and two movies and can be found with this article online at http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/b0/43/main.PMC5470095.pdf
"http://dx.doi.org/10.1016/j.stemcr.2017.04.025 SUMMARY Adriamycin-based combination chemotherapy is the standard ﬁrst-line treatment for osteosarcoma, but tumor recurrence and metastasis occurs in most cases.",Non-OADS,/arxiv_data1/oa_pdf/6a/b8/main.PMC5470096.pdf
1617 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/b8/main.PMC5470096.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes four ﬁgures and two tables and can be found with this article online at http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/6a/b8/main.PMC5470096.pdf
"Stem Cell Reports Report Directed Differentiation of Human Pluripotent Stem Cells to Microglia Panagiotis Douvaras,1,*Bruce Sun,1Minghui Wang,2Ilya Kruglikov,1Gregory Lallos,1Matthew Zimmer,1 Cecile Terrenoire,1Bin Zhang,2Sam Gandy,3Eric Schadt,2Donald O. Freytes,4Scott Noggle,1,5 and Valentina Fossati1,5 1The New York Stem Cell Foundation Research Institute, New York, NY 10019, USA 2Department of Genetics and Genomic Sciences, Icahn Institute for Genomics and Multiscale Biology 3Department of Neurology, Department of Psychiatry, Alzheimer’s Disease Research Center Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA 4The Joint Department of Biomedical Engineering, North Carolina State University and University of North Carolina-Chapel Hill, Raleigh, NC 27695, USA 5Senior author *Correspondence: pdouvaras@nyscf.org http://dx.doi.org/10.1016/j.stemcr.2017.04.023 SUMMARY Microglia, the immune cells of the brain, are crucial to proper development and maintenance of the CNS, and their involvement in numerous neurological disorders is increasingly being recognized.",Non-OADS,/arxiv_data1/oa_pdf/e7/2c/main.PMC5470097.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e7/2c/main.PMC5470097.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, four ﬁgures, three tables, and one movie and can be found with this article online at http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/e7/2c/main.PMC5470097.pdf
"Cabral,2Evan W. Miller,3,4,5 Dirk Hockemeyer,4and David V. Schaffer1,3,4,5,* 1Department of Bioengineering, University of California, Berkeley, Berkeley, CA 94720-1762, USA 2Department of Bioengineering and Institute for Bioengineering and Biosciences, Instituto Superior Te ´cnico, Universidade de Lisboa, 1049-001 Lisbon, Portugal 3Department of Chemical and Biomolecular Engineering, University of California, Berkeley, Berkeley, CA 94720-1462, USA 4Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720-3370, USA 5The Helen Wills Neuroscience Institute, University of California, Berkeley, CA 94720-3370, USA *Correspondence: schaffer@berkeley.edu http://dx.doi.org/10.1016/j.stemcr.2017.04.027 SUMMARY Oligodendrocyte precursor cells (OPCs) offer considerable potential for the treatment of demyelinating diseases and injuries of the CNS.",Non-OADS,/arxiv_data1/oa_pdf/ab/14/main.PMC5470111.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/14/main.PMC5470111.pdf
"Statistical signiﬁcance was calculated using the Mann-Whitney test or an (unpaired) one-tailed Student’s t test us- ing GraphPad Prism, as indicated in the ﬁgure legends.SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, six ﬁgures, and four tables and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/ab/14/main.PMC5470111.pdf
"Mark Simpson,6and Jing Huang1,* 1Cancer and Stem Cell Epigenetics Section, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Buildi ng 37, Room 3140A, Bethesda, MD 20892, USA 2Department of Orthopaedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430070, China 3Cancer Genetics Section, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute 4Transgenic Core, National Heart, Lung, and Blood Institute, National Institutes of Health 5Animal Models Core Facility, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute 6Molecular Pathology Unit, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute Bethesda, MD 20892, USA 7Co-ﬁrst author 8Present address: Institute for Cell Engineering and Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA *Correspondence: huangj3@mail.nih.gov http://dx.doi.org/10.1016/j.stemcr.2017.04.029 SUMMARY Bone marrow-derived mesenchymal stem cells (BMSCs) are proposed as the cells of origin of several subtypes of osteosarcoma (OS).",Non-OADS,/arxiv_data1/oa_pdf/63/53/main.PMC5470112.pdf
"8 j1630–1644 jJune 6, 2017 j This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/63/53/main.PMC5470112.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁve ﬁgures and four tables and can be found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2017.04.029 .,OADS,/arxiv_data1/oa_pdf/63/53/main.PMC5470112.pdf
"Statistical Analysis Data are presented as mean +standard deviatio n. Statistical analysis was performed using a paired ttest (GraphPad Prism, version 6.03, GraphPad Software, La Jolla California USA, http://www.graphpad.com) to compare differences between radioconjugates injected in the same mice and an unpaired t test (GraphPad Prism, version 6.03) to compare differences between radioconjugates inje cted in separate mice.",OADS,/arxiv_data1/oa_pdf/df/53/10.1177_1536012116647535.PMC5470130.pdf
Supplemental Material The online supplemental figures are available at http://journals.sage pub.com/doi/suppl/10.1177/1536012117704767.,Non-OADS,/arxiv_data1/oa_pdf/b6/99/10.1177_1536012117704767.PMC5470131.pdf
2016;6(6):20160061. doi:http://dx.doi .org/10.1098/rsfs.2016.0061.,Non-OADS,/arxiv_data1/oa_pdf/24/1d/10.1177_1536012117706237.PMC5470134.pdf
"All atlases were con- structed by manually outlining the heart region slice by slice under the supervision of experts in 3 orthogonal views (axial, coronal, and sagittal) using the Medical Imaging Interaction Toolkit (http://www.mitk.org).",OADS,/arxiv_data1/oa_pdf/fa/7f/10.1177_1536012117708735.PMC5470135.pdf
"Elastix, an open-source software commonly used to solve medical image registration problems, is publicly available on http://elastix.isi .uu.nl/.",OADS,/arxiv_data1/oa_pdf/fa/7f/10.1177_1536012117708735.PMC5470135.pdf
http://www.who.int/ mediacentre/factsheets/fs310/en/.,Non-OADS,/arxiv_data1/oa_pdf/fa/7f/10.1177_1536012117708735.PMC5470135.pdf
2003. http://www.who.int/ bulletin/volumes/81/9/Woolf.pdf.,Non-OADS,/arxiv_data1/oa_pdf/93/34/10.1177_1536012116683597.PMC5470142.pdf
http://dx.do i.org/10.2312/PE.VMV.,Non-OADS,/arxiv_data1/oa_pdf/2b/9d/10.1177_1536012116687651.PMC5470145.pdf
Available from : http://journals.lww.com/ neurotodayonline/Citation/2016/07070/Most_Strokes_Worldwide_ Caused_by_Modifiable.1.aspx.,Non-OADS,/arxiv_data1/oa_pdf/8d/65/AIAN-20-158.PMC5470146.pdf
Available from: http://www.cdc.gov/vaccines/pubs/pinkbook/varicella.,Non-OADS,/arxiv_data1/oa_pdf/41/72/AIAN-20-149.PMC5470156.pdf
Source: http://www.mmcneuro.word,Non-OADS,/arxiv_data1/oa_pdf/c8/be/AIAN-20-103.PMC5470157.pdf
Available from: http://www.sancd.org/Updated%20 Stroke%20Fact%20sheet%202012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/db/3e/AIAN-20-153.PMC5470159.pdf
Available from: http://www.goodsamaritanlaw.in/.,Non-OADS,/arxiv_data1/oa_pdf/27/31/AIAN-20-109.PMC5470161.pdf
Available from: http://www.huffingtonpost.in/2016/11/09/karnataka-  drafts-bill-to-protect-good-samaritans-helping-acciden/.,Non-OADS,/arxiv_data1/oa_pdf/27/31/AIAN-20-109.PMC5470161.pdf
"No.19 Beykoz, 34810 Istanbul, Turkey *Correspondence: gage@salk.edu http://dx.doi.org/10.1016/j.stemcr.2017.05.011 SUMMARY Astrocyte dysfunction and neuroinﬂammation are detrimental features in multiple pathologies of the CNS.",Non-OADS,/arxiv_data1/oa_pdf/a3/d1/main.PMC5470172.pdf
1757 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a3/d1/main.PMC5470172.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, three ﬁgures, one table, and four movies and can befound with this article online at http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/a3/d1/main.PMC5470172.pdf
"Stem Cell Reports Article T ransplantation of Human Pancreatic Endoderm Cells Reverses Diabetes Post T ransplantation in a Prevascularized Subcutaneous Site Andrew R. Pepper,1,3Rena Pawlick,1Antonio Bruni,1,3John Wink,1Yasmin Raﬁei,1Doug O’Gorman,1 Richard Yan-Do,2Boris Gala-Lopez,1,3Tatsuya Kin,1Patrick E. MacDonald,2and A.M. James Shapiro1,3,* 1Clinical Islet Transplant Program, University of Alberta, 112 Street & 87 Avenue, Edmonton, AB T6G 2E1, Canada 2Department of Pharmacology, University of Alberta, 9-70 Medical Science Building, Edmonton, AB T6G 2H7, Canada 3Department of Surgery, University of Alberta, 8440 Walter C Mackenzie Health Centre 112 Street, Edmonton, AB T5G 2B7, Canada *Correspondence: amjs@islet.ca http://dx.doi.org/10.1016/j.stemcr.2017.05.004 SUMMARY Beta-cell replacement therapy is an effective means to restore glucose homeostasis in select humans with autoimmune diabetes.",Non-OADS,/arxiv_data1/oa_pdf/08/4b/main.PMC5470173.pdf
1689 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/08/4b/main.PMC5470173.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures and three ﬁgures and can be found with this article on- line at http://dx.doi.org/10.1016/j.stemcr.2017.05.004 .,Non-OADS,/arxiv_data1/oa_pdf/08/4b/main.PMC5470173.pdf
"Stem Cell Reports Article Hypoxia Epigenetically Confers Astrocytic Differentiation Potential on Human Pluripotent Cell-Derived Neural Precursor Cells Tetsuro Yasui,1,2Naohiro Uezono,1Hideyuki Nakashima,1Hirofumi Noguchi,1Taito Matsuda,1 Tomoko Noda-Andoh,3Hideyuki Okano,3and Kinichi Nakashima1,4,* 1Department of Stem Cell Biology and Medicine 2Department of Otorhinolaryngology Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka 812-8582, Japan 3Department of Physiology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan 4Laboratory of Molecular Neuroscience, Graduate School of Biological Sciences, Nara Institute of Science and Technology, Ikoma, Nara 630-0192, Jap an *Correspondence: kin1@scb.med.kyushu-u.ac.jp http://dx.doi.org/10.1016/j.stemcr.2017.05.001 SUMMARY Human neural precursor cells (hNPCs) derived from pluripotent stem cells display a high propensity for neuronal differentiation, but they require long-term culturing to differentiate efﬁciently into astrocytes.",OADS,/arxiv_data1/oa_pdf/0d/5f/main.PMC5470174.pdf
1743 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/5f/main.PMC5470174.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, four ﬁgures, and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2017.05.001 .",OADS,/arxiv_data1/oa_pdf/0d/5f/main.PMC5470174.pdf
"http://dx.doi.org/10.1016/j.stemcr.2017.05.012 SUMMARY Both the promises and pitfalls of the cell reprogramming research platform rest on human genetic variation, making the measurement of its impact one of the most urgent issues in the ﬁeld.",Non-OADS,/arxiv_data1/oa_pdf/02/37/main.PMC5470233.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/37/main.PMC5470233.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes six ﬁgures and two tables and can be found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2017.05.012 .,OADS,/arxiv_data1/oa_pdf/02/37/main.PMC5470233.pdf
http://dx.doi.org/10.1101/ 091660 .,Non-OADS,/arxiv_data1/oa_pdf/02/37/main.PMC5470233.pdf
bioRxiv http://dx.doi.org/10.1101/055160 .,Non-OADS,/arxiv_data1/oa_pdf/02/37/main.PMC5470233.pdf
Available from: http://www.ssmvm030.,Non-OADS,/arxiv_data1/oa_pdf/d2/24/JEHP-6-48.PMC5470293.pdf
Available from: https://www.dora.dmu.ac.uk/bitstream/ handle/2086/3422/ZihouZhou_Thesis‑Final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d2/24/JEHP-6-48.PMC5470293.pdf
Available from: http://infed.org/mobi/elliot‑w‑eisner‑ connoisseurship‑criticism ‑and‑the‑art‑of‑education/.,Non-OADS,/arxiv_data1/oa_pdf/3e/90/JEHP-6-55.PMC5470294.pdf
Available  from: http://www.jha.iums.ac.ir/files/site1/user_files_2e7092/ kiani‑A‑10‑1044‑3‑ec37f48.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8a/2c/JEHP-6-46.PMC5470298.pdf
Available from: https://www.arxiv.org/ftp/arxiv/ papers/1203/1203.1647.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8a/2c/JEHP-6-46.PMC5470298.pdf
Available from:  http://tsd.cbi.ir/Display/Content.aspx.,Non-OADS,/arxiv_data1/oa_pdf/de/47/JEHP-6-52.PMC5470303.pdf
Available from: http://www.wes.,Non-OADS,/arxiv_data1/oa_pdf/3b/d6/JEHP-6-58.PMC5470307.pdf
Available from: http://www.pnra.org/ medical%20therapy.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3b/d6/JEHP-6-58.PMC5470307.pdf
Available from: http://www.goums.ac.ir/journal/ browse.php?.,Non-OADS,/arxiv_data1/oa_pdf/9d/1d/JEHP-6-53.PMC5470311.pdf
"Stem Cell Reports Perspective Using Zebraﬁsh to Study Pathways that Regulate Hematopoietic Stem Cell Self-Renewal and Migration Avik Choudhuri,1,2,6Eva M. Fast,1,2,6and Leonard I. Zon1,2,3,4,5,* 1Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA 2Stem Cell Program and Division of Hematology/Oncology, Children’s Hospital Boston, Howard Hughes Medical Institute, Boston, MA 02115, USA 3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA 4Harvard Stem Cell Institute, Boston, MA 02115, USA 5Harvard Medical School, Boston, MA 02115, USA 6Co-ﬁrst author *Correspondence: zon@enders.tch.harvard.edu http://dx.doi.org/10.1016/j.stemcr.2017.05.018 The HSC Niche The specialized microenvironment that surrounds he-matopoietic stem cells (HSCs) is termed as the niche,which is a critical regulator of self-renewal and differenti-ation of HSCs into blood and immune cell lineages (Orkin and Zon, 2008; Morrison and Scadden, 2014; Bou- lais and Frenette, 2015 ).",Non-OADS,/arxiv_data1/oa_pdf/4b/06/main.PMC5470329.pdf
1465 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/06/main.PMC5470329.pdf
This  is an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/76/main.PMC5470337.pdf
"E-mail: onur.guneser@usak.edu.tr  (O.  Guneser).consequently,  considerable  costs  to  various  industries.1 Therefore, using  agro-wastes  is  the  most  popular  aspect  in biotechnological processes  for  production  of  high  value-added products in  terms  of  the  reducing  production  cost.2,3Recently, agro-wastes  have  been  focused  in  biotechnological  ﬂavor production by  using  microbial  fermentation  or  biotransfor- mation  owing  to  their  high  amount  of  reusable  components http://dx.doi.org/10.1016/j.bjm.2016.08.003 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/81/76/main.PMC5470337.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/76/main.PMC5470337.pdf
This  is an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/03/main.PMC5470338.pdf
"E-mail: m  bekcibasi@hotmail.com  (M.  Bekc¸ibas¸ı).diminished due to the  development  of  polysaccharide  and conjugate vaccines  in  recent  years,  1.2  million  cases  of  bac- terial  meningitis  is  estimated  to  occur  annually  worldwide.1 The  incidence  and  mortality  rates  of  bacterial  meningitis  vary http://dx.doi.org/10.1016/j.bjm.2016.06.014 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/fa/03/main.PMC5470338.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/03/main.PMC5470338.pdf
"10.  http://www.vircell.com/ﬁleadmin/Material  Tecnico/Dossier Speed-oligo  Ingles  v3.2.pdf  Granada,  Spain.",Non-OADS,/arxiv_data1/oa_pdf/fa/03/main.PMC5470338.pdf
1455 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cc/d7/main.PMC5470339.pdf
The society’s informational website ‘‘A Closer Look atStem Cells’’ ( http://www.closerlookatstemcells.org/ ) con- tinues to provide a valuable resource for those interestedin knowing more about the science and for would-beconsumers to learn more about what is known—and un- known—about stem cell therapies.,Non-OADS,/arxiv_data1/oa_pdf/cc/d7/main.PMC5470339.pdf
"Sally Temple ISSCR President, 2016–2017 http://dx.doi.org/10.1016/j.stemcr.2017.05.032 1456 Stem Cell Reports jVol.",OADS,/arxiv_data1/oa_pdf/cc/d7/main.PMC5470339.pdf
This  is an open access article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/1f/main.PMC5470340.pdf
http://dx.doi.org/10.1016/j.bjm.2016.08.002 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/c7/1f/main.PMC5470340.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/1f/main.PMC5470340.pdf
This  is an open access article under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/ab/main.PMC5470341.pdf
"The  draft  genome  consists  of  6,253,055  bp  covering  almost http://dx.doi.org/10.1016/j.bjm.2015.09.002 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",OADS,/arxiv_data1/oa_pdf/84/ab/main.PMC5470341.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/ab/main.PMC5470341.pdf
"The  assembled  contigs  were  submitted to  the  RAST  annotation  server  (http://rast.nmpdr.org/ )  for subsystem  classiﬁcation  and  functional  annotation.9This analysis predicted 6,010  protein-coding sequences  (CDS), of  which  46%  were  assigned  to  recognized  functional genes.",OADS,/arxiv_data1/oa_pdf/84/ab/main.PMC5470341.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/08/main.PMC5470342.pdf
http://dx.doi.org/10.1016/j.bjm.2016.07.027 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/c4/08/main.PMC5470342.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/08/main.PMC5470342.pdf
"2010,  http://dx.doi.org/10.1101/ cshperspectives.org .",Non-OADS,/arxiv_data1/oa_pdf/c4/08/main.PMC5470342.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/c1/main.PMC5470343.pdf
"The  reads  were  then  aligned with  the  reference  sequence  using  SOAPaligner  (version 2.21) software  to  calculate  average  depth  and  coverage ratio  (http://soap.genomics.org.cn/soapaligner.html ,  version 2.21).10The  ﬁltered  short  reads  were  ﬁrst  de  novo  assembled using  SOAPdenovo  v  2.04  according  to  the  method  described previously  (http://soap.genomics.org.cn/soapdenovo.html ),11 and  then  contigs  were  manually  connected  according  to  their 500  bp  paired-end  relationships.",OADS,/arxiv_data1/oa_pdf/44/c1/main.PMC5470343.pdf
V2  strain  comprised  of  643  contigs  and http://dx.doi.org/10.1016/j.bjm.2016.06.015 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,OADS,/arxiv_data1/oa_pdf/44/c1/main.PMC5470343.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/c1/main.PMC5470343.pdf
"The  genome  annotation  was  per- formed using  the  (BASys)  server  (https://www.basys.ca/ )  and the  output  was  downloaded  in  GenBank  format  resulting in  3742  (CDSs).13The  genome  was  further  annotated  with Rapid Annotation using  Subsystems  Technology  (RAST)  server (http://rast.nmpdr.org/ ).14Among  the  predicted  3742  protein- coding  genes  by  BASys,  79.4%  (2971genes)  have  been  assigned putative functions  according  to  the  subsystem  categorization.",OADS,/arxiv_data1/oa_pdf/44/c1/main.PMC5470343.pdf
"2015, http://dx.doi.org/10.1002/jobm.201500263 .",Non-OADS,/arxiv_data1/oa_pdf/44/c1/main.PMC5470343.pdf
This  is an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/bf/main.PMC5470344.pdf
The  formation  of  metabolite  and  its  role  in  the  body before excretion  is  important  to  understand  drug’s  safety  and http://dx.doi.org/10.1016/j.bjm.2016.11.003 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/b3/bf/main.PMC5470344.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/bf/main.PMC5470344.pdf
Get  to  know  an  enzyme:  CYP3A4 ;  2008 http://www.pharmacytimes.com/publications/issue/2008/ 2008-09/2008-09 .,Non-OADS,/arxiv_data1/oa_pdf/b3/bf/main.PMC5470344.pdf
Available  at  http://www.chem.agilent.com/Library/ applications/5989-6068EN.pdf [accessed  15.08.14].,OADS,/arxiv_data1/oa_pdf/b3/bf/main.PMC5470344.pdf
http://dx.doi.org/10.1016/j.stemcr.2017.05.019 SUMMARY Pluripotent stem cells have been proposed as an unlimited source of pancreatic bcells for studying and treating diabetes.,Non-OADS,/arxiv_data1/oa_pdf/93/4b/main.PMC5470345.pdf
1675 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/4b/main.PMC5470345.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, ﬁve ﬁgures, and three tables and can be found withthis article online at http://dx.doi.org/10.1016/j.stemcr.2017.05.",OADS,/arxiv_data1/oa_pdf/93/4b/main.PMC5470345.pdf
Available from: http://www.cms.gov/Research‑ Statistics‑ Data‑and‑ Systems/Statistics‑Trends‑and‑Reports/NationalHealthExpendData/ NationalHealthAccountsHistorical.html 44.,OADS,/arxiv_data1/oa_pdf/1f/c1/SJG-23-133.PMC5470372.pdf
Available from: http://www.cancer.,Non-OADS,/arxiv_data1/oa_pdf/06/3a/SJG-23-161.PMC5470375.pdf
Available from: https://www.cancer.ca/~/media/ cancer.ca/CW/cancer%20information/cancer%20101/Canadian%20 cancer%20statistics/Canadian‑Cancer‑Statistics‑2015‑EN.pdf.,Non-OADS,/arxiv_data1/oa_pdf/06/3a/SJG-23-161.PMC5470375.pdf
Available from:  http://www.chs.gov.sa/Ar/HealthRecords/CancerRegistry/ CancerRegistryReports/Incidence%20Report%202004.pdf.,Non-OADS,/arxiv_data1/oa_pdf/06/3a/SJG-23-161.PMC5470375.pdf
Available from: http://applications.emro.who.,OADS,/arxiv_data1/oa_pdf/06/3a/SJG-23-161.PMC5470375.pdf
Available from: http://apps.who.int/gb/ebwha/pdf_files/ WHA58‑REC1/english/A58_2005_REC1‑en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/06/3a/SJG-23-161.PMC5470375.pdf
Available from:  http://www.who.int/cancer/FINAL‑Advocacy‑Module%206.pdf.,Non-OADS,/arxiv_data1/oa_pdf/06/3a/SJG-23-161.PMC5470375.pdf
Available from: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/06/3a/SJG-23-161.PMC5470375.pdf
Available from: http://www.icpolicyadvocacy.org/sites/icpa/files/ downloads/writing_effective_public_policy_papers_young_quinn.,Non-OADS,/arxiv_data1/oa_pdf/06/3a/SJG-23-161.PMC5470375.pdf
Available  from: https://www.cancercare.on.ca/common/pages/UserFile.,Non-OADS,/arxiv_data1/oa_pdf/06/3a/SJG-23-161.PMC5470375.pdf
Available at: http://apps.who.int/gb/ ebwha/pdf_files/WHA61‑REC1/A61_REC1‑en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/06/3a/SJG-23-161.PMC5470375.pdf
Available at: http://www.uicc.org/ sites/main/files/private/Annual%20report%202006%20.pdf.,Non-OADS,/arxiv_data1/oa_pdf/06/3a/SJG-23-161.PMC5470375.pdf
[31] The assembled sequenced  were initially searched for similarity using BLAST  software (http://www.ncbi.nlm.nih.gov/BLAST/).,OADS,/arxiv_data1/oa_pdf/92/c9/SJG-23-176.PMC5470377.pdf
Mini Nutritional Assessment MNA® 2009 [Available  from: http://www.mna‑elderly.org/forms/MNA_english.pdf].,Non-OADS,/arxiv_data1/oa_pdf/f0/31/SJG-23-199.PMC5470380.pdf
"It  is  worth noting  that  the  fungus  Aspergillus  ﬂavus  produces  aﬂatoxin, http://dx.doi.org/10.1016/j.bjm.2017.01.002 1517-8382/©  2017  Published  by  Elsevier  Editora  Ltda.",Non-OADS,/arxiv_data1/oa_pdf/f2/dd/main.PMC5470430.pdf
This  is  an  open  access  article under the  CC  BY -NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/dd/main.PMC5470430.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e7/a4/main.PMC5470431.pdf
"E-mail: iara  rossi@hotmail.com  (I.  Rossi  Gonc ¸ alves).hospitalization,  and  higher  costs  compared  to  those  infec- tions caused by  susceptible  strains.1–3Infections  caused  by these resistant microorganisms  are  often  associated  with  age, cancer,  heart  disease,  diabetes,  intensive  use  of  antibiotics, and  invasive  procedures  such  as  hemodialysis,  mechanical ventilation  catheter,  tracheostomy,  and  others.4 http://dx.doi.org/10.1016/j.bjm.2016.11.004 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/e7/a4/main.PMC5470431.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e7/a4/main.PMC5470431.pdf
Department of Bacteriology;  2004 http://textbookofbacteriology.net/pseudomonas.html .,Non-OADS,/arxiv_data1/oa_pdf/e7/a4/main.PMC5470431.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/3d/main.PMC5470432.pdf
"Furlan).Among  these  products,  types  /H92753  and  /H92756  polyunsaturated fatty acids  (PUFAs)  have  received  a  great  deal  of  attention due to their  health  beneﬁts  and  their  extensive  applications in  the  food  and  pharmaceutical  industries.1Docosahe- xaenoic acid  (DHA,  C22:6  /H92753),  for  example,  is  necessary for  the  brain  development  of  newborn  children  and  con- tributes to  increasing  their  intelligence  and  verbal  and reasoning skills.2Furthermore,  DHA  is  helpful  in  treating http://dx.doi.org/10.1016/j.bjm.2017.01.001 1517-8382/©  2017  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/d4/3d/main.PMC5470432.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/3d/main.PMC5470432.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/95/main.PMC5470434.pdf
http://dx.doi.org/10.1016/j.bjm.2016.09.017 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/94/95/main.PMC5470434.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/94/95/main.PMC5470434.pdf
"2015;6,  http://dx.doi.org/10.1038/ncommms7102 .",Non-OADS,/arxiv_data1/oa_pdf/94/95/main.PMC5470434.pdf
Available  at: http://www.R-project.org .,Non-OADS,/arxiv_data1/oa_pdf/94/95/main.PMC5470434.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/fc/main.PMC5470435.pdf
Resistance-related  genes  were  analyzed  using  ResFinder  2.1.4 The multilocus  sequence  typing  (MLST)  analysis  from  the http://dx.doi.org/10.1016/j.bjm.2016.10.020 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,OADS,/arxiv_data1/oa_pdf/b7/fc/main.PMC5470435.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b7/fc/main.PMC5470435.pdf
This  is an open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/41/main.PMC5470436.pdf
"Thus,  some  HA-MRSA  isolates are  susceptible  to  many  non-/H9252-lactam  antibiotics,  includ- ing the isolates  related  USA800  clone,  for  example.1,3The in  vitro  antimicrobial  susceptibility  to  clindamycin  and/or sulfamethoxazole/trimethoprim is  a  relevant  characteristic described  in  strains  with  SCC mec  IV.2The  genotyping  of  Brazil- ian MRSA  isolates  allowed  a  better  understanding  of  the dissemination  patterns  of  the  epidemic  clones,  such  as,  typ- ically HA-MRSA  and  CA-MRSA.4The  known  virulence  factor http://dx.doi.org/10.1016/j.bjm.2016.09.016 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/51/41/main.PMC5470436.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/41/main.PMC5470436.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5d/ba/main.PMC5470439.pdf
She  had  signiﬁcant  smoking http://dx.doi.org/10.1016/j.ijscr.2017.05.032 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/5d/ba/main.PMC5470439.pdf
"65  (1)  (2015) 5–29,  http://dx.doi.org/10.3322/caac.21254 .",Non-OADS,/arxiv_data1/oa_pdf/5d/ba/main.PMC5470439.pdf
"[3]  G.  Porter,  N.  Baxter,  P.  Pisters,  Retroperitoneal  sarcoma,  Cancer  106  (7)  (2006) 1610–1616, http://dx.doi.org/10.1002/cncr.21761 .",Non-OADS,/arxiv_data1/oa_pdf/5d/ba/main.PMC5470439.pdf
"13  (1)  (2015), http://dx.doi.org/10.1186/s12957-015-0548-z .",Non-OADS,/arxiv_data1/oa_pdf/5d/ba/main.PMC5470439.pdf
"63 (2)  (2011) 119–124, http://dx.doi.org/10.1007/s13304-011-0061-z .",Non-OADS,/arxiv_data1/oa_pdf/5d/ba/main.PMC5470439.pdf
"128  (1)  (2015)  85,  http://dx.doi.org/10.4103/ 0366-6999.147822 .",Non-OADS,/arxiv_data1/oa_pdf/5d/ba/main.PMC5470439.pdf
"[8]  N.  Valsangkar,  A.  Sehdev,  S.  Misra,  T.  Zimmers,  B.  O’Neil,  L.  Koniaris,  Current management  of  gastrointestinal  stromal  tumors:  surgery,  current  biomarkers, mutations, and  therapy,  Surgery  158  (5)  (2015)  1149–1164,  http://dx.doi.org/ 10.1016/j.surg.2015.06.027 .",OADS,/arxiv_data1/oa_pdf/5d/ba/main.PMC5470439.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/e1/main.PMC5470440.pdf
http://dx.doi.org/10.1016/j.bjm.2016.12.003 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/f7/e1/main.PMC5470440.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/e1/main.PMC5470440.pdf
"Search strategy  and  selection  criteria Articles  were  searched  in  the  following  databases:  Cumula- tive Index  to  Nursing  and  Allied  Health  Literature  (CINAHL –  http://www.cinahl.com ),  Cochrane  Library  (http://www.",OADS,/arxiv_data1/oa_pdf/f7/e1/main.PMC5470440.pdf
"update-software.com/cochrane ),  Latin  American  and Caribbean Literature  in  Health  Sciences  (LILACS;  http:// lilacs.bvsalud.org/ ),  MEDLINE  (http://www.nlm.nih.gov ),  Sci- entiﬁc Electronic  Library  Online  (SciELO;  http://www.scielo.br ), Scopus  (http://www.scopus.com ),  Web  of  Science  (http://www.",Non-OADS,/arxiv_data1/oa_pdf/f7/e1/main.PMC5470440.pdf
"sciencedirect.com ),  ExcerptaMedica  Database  (EMBASE; http://www.embase.com ), CAPES Theses  Database,  and public  domain  internet  databases  (http://www.periodicos.",OADS,/arxiv_data1/oa_pdf/f7/e1/main.PMC5470440.pdf
Available  from:  http://portal.saude.gov.br/ portal/arquivos/pdf/nota tecnica  versao  28  de  agosto  v  5. pdf [cited  10.11.14].,Non-OADS,/arxiv_data1/oa_pdf/f7/e1/main.PMC5470440.pdf
Available  from:  http://www.fundacaoataul phodepaiva.com.br/wp-content/uploads/2013/03/Relatorio-XpertMTBRIF-CP5.pdf [acessed  22.10.15].,Non-OADS,/arxiv_data1/oa_pdf/f7/e1/main.PMC5470440.pdf
Available  from:  http://www.r-project.org/ .,Non-OADS,/arxiv_data1/oa_pdf/f7/e1/main.PMC5470440.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/3c/main.PMC5470441.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.05.033 2049-0801/Crown Copyright ©2017 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.,Non-OADS,/arxiv_data1/oa_pdf/ce/3c/main.PMC5470441.pdf
"17 (9) (2015) O180 eO183, http://dx.doi.org/10.1111/codi.13057 .",Non-OADS,/arxiv_data1/oa_pdf/ce/3c/main.PMC5470441.pdf
"27 (9) (2013Sep) 3500, http://dx.doi.org/10.1007/s00464-013-2925-4 .",Non-OADS,/arxiv_data1/oa_pdf/ce/3c/main.PMC5470441.pdf
This  is an open access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/48/main.PMC5470442.pdf
"It  is  caused  by  Herpesvirus  of  the  fam- ily  Gammaherpesvirinae  and  Macavirus ,  a  group  of  antigenic and genetically  related  viruses,  known  as  MCF  viruses,2 which  cause  clinical  or  subclinical  infection  in  susceptible animals.3–5To  date,  ten  MCF  viruses  have  been  identiﬁed,  with the most  frequent  being  ovine  herpesvirus  type  2  (OvHV-2), which  causes  MCF  in  sheep  (SA-MCF).6 Diagnosis of  SA-MCF  is  generally  made  from  clinical  his- tory and  signs,  non-speciﬁc  lesions  observed  during  necropsy, http://dx.doi.org/10.1016/j.bjm.2016.10.021 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/b9/48/main.PMC5470442.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/48/main.PMC5470442.pdf
Available  from: http://www.ictvonline.org/virustaxonomy.asp?,Non-OADS,/arxiv_data1/oa_pdf/b9/48/main.PMC5470442.pdf
Available  from: http://www.oie.int/ﬁleadmin/Home/eng/Health  standards/ tahm/2.04.15 MCF .pdf  Version=2013.,Non-OADS,/arxiv_data1/oa_pdf/b9/48/main.PMC5470442.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/64/51/main.PMC5470443.pdf
"However,  the  limited  stress  resistance  of S.  cerevisiae  has  led  to  an  increased  focus  on  the  potential  of  the http://dx.doi.org/10.1016/j.bjm.2016.11.005 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/64/51/main.PMC5470443.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/64/51/main.PMC5470443.pdf
"2015, http://dx.doi.org/10.1016/j.bbamem.2015.04.005 .",OADS,/arxiv_data1/oa_pdf/64/51/main.PMC5470443.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/9a/main.PMC5470444.pdf
"We studied  48  isolates,  including  negative  controls and  Enterobacteriaceae ,  Pseudomonas  aeruginosa ,  Acinetobacter http://dx.doi.org/10.1016/j.bjm.2016.09.015 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/e5/9a/main.PMC5470444.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/9a/main.PMC5470444.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/04/main.PMC5470445.pdf
"Gonc ¸ alves).meat  is  a  complex  niche  with  particular  physicochemical  char- acteristics  that  allow  colonization  and  development  of  a  wide variety of  organisms,2making  it  highly  susceptible  to  be  con- taminated  by  spoilage  bacteria.3Microbial  spoilage  can  lead  to food  disposal  and  consequent  economic  losses  to  the  industry and a  decrease  in  consumer  trust.4 Various conservation  methods  are  available  to  increase  the shelf  life  of  fresh  meat  including  refrigeration.5The  use  of  cold http://dx.doi.org/10.1016/j.bjm.2016.12.006 1517-8382/©  2017  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/a2/04/main.PMC5470445.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/04/main.PMC5470445.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3d/a6/main.PMC5470446.pdf
Most  of  cag PAI  genes  belong to the  East  Asian-type  and  is  found  associated  with  high  risk http://dx.doi.org/10.1016/j.bjm.2016.12.004 1517-8382/©  2017  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/3d/a6/main.PMC5470446.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3d/a6/main.PMC5470446.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/ce/main.PMC5470447.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.05.034 2049-0801/ ©2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/45/ce/main.PMC5470447.pdf
http://dx.doi.org/10.1016/j.bjm.2016.12.001 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/96/85/main.PMC5470448.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/85/main.PMC5470448.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/85/main.PMC5470448.pdf
"2016, http://dx.doi.org/10.1007/s40011-016-0722-2 .",Non-OADS,/arxiv_data1/oa_pdf/96/85/main.PMC5470448.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1d/5c/main.PMC5470450.pdf
"When  new  hyphae  grow,  the  two  nuclei  syn- chronously divide,  and  each  new  compartment  keeps  two nuclei1;  karyogamy  only  occurs  before  the  initiation  of  sexual http://dx.doi.org/10.1016/j.bjm.2016.12.005 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/1d/5c/main.PMC5470450.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1d/5c/main.PMC5470450.pdf
"Genome  mapping  and  gene  expression  analysis Clean  reads  were  mapped  to  the  reference  genome  sequence of Pleurotus  ostreatus  PC15  (http://genome.jgi-psf.org/ PleosPC15 2/PleosPC15  2.home.html )  using  Bowtie231;  then, the gene  expression  level  was  calculated  using  RSEM.32 Differential  unigene  expression  analysis The  unigene  expression  levels  were  calculated  using  the  Reads per  kb  per  Million  reads  (RPKM)  method.33Under  the  null hypothesis of  equal  expression  between  two  samples,  the  fol- lowing  test  gives  the  p-values  for  identifying  differentially expressed genes (DEGs)  between  two  samples.34 P(y|x)  =/parenleftBigN2 N1/parenrightBigy(x  +  y)!",OADS,/arxiv_data1/oa_pdf/1d/5c/main.PMC5470450.pdf
"We  mapped  clean  reads  to  the  reference  genome  sequence of Pleurotus ostreatus PC15 (http://genome.jgi-psf.org/ PleosPC15  2/PleosPC15  2.home.html )  using  HISAT .37On average, 60.44%  of  reads  are  mapped,  and  the  uniformity  of the mapping result  for  each  sample  suggests  that  the  samples are  comparable.",OADS,/arxiv_data1/oa_pdf/1d/5c/main.PMC5470450.pdf
"The  poure  gene  sequences  of  MK13 (GenBank access  number:  KF312589.1)  were  97%  and 97%  identical  to  those  of  P.  ostreatus  PC15  v2.0,  PC9  v1.0, (http://genome.jgi-psf.org/PleosPC15 2/PleosPC15  2.home.html; http://genome.jgi-psf.org/PleosPC9  1/PleosPC9  1.home.html ); those for  MK3  (GenBank  access  number:  KF312590.1)  were 96% and  95%  identical.",OADS,/arxiv_data1/oa_pdf/1d/5c/main.PMC5470450.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/58/main.PMC5470451.pdf
This  stress  causes  irreversible oxidative damage  because  the  activity  of  the  plant’s http://dx.doi.org/10.1016/j.bjm.2016.09.018 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/6d/58/main.PMC5470451.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/58/main.PMC5470451.pdf
Avaliable  at:  http://www.fao.org  20.11.2013 .,Non-OADS,/arxiv_data1/oa_pdf/6d/58/main.PMC5470451.pdf
This  is an open access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/c2/main.PMC5470452.pdf
They  can http://dx.doi.org/10.1016/j.bjm.2016.02.001 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,OADS,/arxiv_data1/oa_pdf/02/c2/main.PMC5470452.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/c2/main.PMC5470452.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/22/main.PMC5470453.pdf
Nonlinear mathematical  models  used  to  identify  growth parameters.1 http://dx.doi.org/10.1016/j.bjm.2016.12.007 1517-8382/©  2017  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/54/22/main.PMC5470453.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/22/main.PMC5470453.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/e8/main.PMC5470454.pdf
"These  include  two  geno- types  isolated  from  humans  alone  (HEV-1  and  HEV-2),  two genotypes  reported  in  both  humans  and  different  animal species and  associated  with  the  zoonotic  cases  (HEV-3  and HEV-4),  two  isolates  from  wild  boar  in  Japan  (genotype  HEV-5 and  HEV-6)  and  a  single  isolate  from  dromedary  camel  in  Dubai http://dx.doi.org/10.1016/j.bjm.2016.10.022 1517-8382/©  2017  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/22/e8/main.PMC5470454.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/22/e8/main.PMC5470454.pdf
Available  at: http://www.ibge.gov.br/home/estatistica/indicadores/ agropecuaria/producaoagropecuaria/default.shtm Accessed 14.05.15.,Non-OADS,/arxiv_data1/oa_pdf/22/e8/main.PMC5470454.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/5a/main.PMC5470456.pdf
http://dx.doi.org/10.1016/j.bjm.2016.10.019 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/e1/5a/main.PMC5470456.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e1/5a/main.PMC5470456.pdf
This  is an open access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/3e/main.PMC5470457.pdf
http://dx.doi.org/10.1016/j.bjm.2016.10.018 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.,Non-OADS,/arxiv_data1/oa_pdf/6d/3e/main.PMC5470457.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6d/3e/main.PMC5470457.pdf
Available  at:  http://www.cprm.gov.br/publique/ media/avali contami.pdf  [accessed  September  2009].,Non-OADS,/arxiv_data1/oa_pdf/6d/3e/main.PMC5470457.pdf
"2015, http://dx.doi.org/10.1371/ journal.pone.0128272 .",Non-OADS,/arxiv_data1/oa_pdf/6d/3e/main.PMC5470457.pdf
This  is an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/df/45/main.PMC5470458.pdf
"E-mail: chengguojun@mail.scuec.edu.cn  (G.  Cheng).processes,  such  as  oil  reﬁneries,  cooking  plants,  indus- trial  resin  manufacturing,  petroleum-based  processing  plants, pharmaceuticals, plastic  manufacturing,  and  varnish  man- ufacturing industries.1Their  extensive  use  has  led  to  the widespread  contamination  of  soils,  rivers,  industrial  efﬂuents, http://dx.doi.org/10.1016/j.bjm.2016.12.002 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/df/45/main.PMC5470458.pdf
This  is  an  open  access  article  under  the  CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/df/45/main.PMC5470458.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/56/main.PMC5470459.pdf
"As  a  result,  the overall production  cost  is  increased  due  to  the  extra  down- stream  processing  steps  required  to  release  the  hEGF  from  the http://dx.doi.org/10.1016/j.bjm.2016.10.017 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/d9/56/main.PMC5470459.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d9/56/main.PMC5470459.pdf
This  is an open  access  article  under  the  CC  BY -NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/7d/main.PMC5470508.pdf
"Patil).the concept  of  an  R.  solanacearum  “species  complex”  (RsSC).4 As  R.  solanacearum  strains  have  been  isolated  from  virgin forest-soils of  all  ﬁve  continents,  the  origin  of  the  species complex is  believed  to  predate  the  geographical  separation of  continents.5The  pathogen  is  hierarchically  classiﬁed  into four phylotypes  according  to  newly  proposed  phylotype sub-classiﬁcation  system  based  on  16S-23S  ITS  region,  egl and  hrpB  genes  and  on  comparative  genomic  hybridization (CGH) which reﬂect  their  origin  as  Asia  (Phylotype  I),  Amer- ica (II), Africa (III)  or  Indonesia  (IV).6These  phylotypes  are http://dx.doi.org/10.1016/j.bjm.2016.10.016 1517-8382/©  2016  Sociedade  Brasileira  de  Microbiologia.",Non-OADS,/arxiv_data1/oa_pdf/8f/7d/main.PMC5470508.pdf
This  is  an  open  access  article  under  the  CC BY -NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/7d/main.PMC5470508.pdf
"The  high  quality  reads were aligned using GS  De  Novo  Assembler  (version  2.5.3) and  gene  prediction  using  the  prokaryotic  GeneMark.hmm (Version 2.2a)  and  AUGUSTUS  (http://bioinf.uni-greifswald.de/ augustus/submission/ )  revealed  a  total  of  4590,  4732,  4817  and 4867  protein  coding  regions  (CDSs)  respectively  for  RS2,  RS25, RS48 and RS75 spread over  megaplasmid  as  well  as  chromo- somal genomes.",OADS,/arxiv_data1/oa_pdf/8f/7d/main.PMC5470508.pdf
The  presence  of  repetitive  elements  was  ana- lyzed using  MISA  (http://pgrc.ipk-gatersleben.de/misa/ )  and was observed that  nearly  90%  of  the  elements  were  of  di  or tri  and  7.3%  hexa  mer  repeats.,OADS,/arxiv_data1/oa_pdf/8f/7d/main.PMC5470508.pdf
"2013, http://dx.doi.org/10.1007/s10658-013-0299-z .",Non-OADS,/arxiv_data1/oa_pdf/8f/7d/main.PMC5470508.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not alter ed, transformed, or built upon in any way.BIOENGINEERED 2017, VOL.",Non-OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"3, 265 –273 https://doi.org/10.1080/21655979.2017.1282018",Non-OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"ORCID Shota Nakade http://orcid.org/0000-0003-4721-9408 References [1] Mohanraju P, Makarova KS, Zetsche B, Zhang F, Koonin EV, van der Oost J.",Non-OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Science 2016; 353(6299):aad5147; PMID:27493190; https://doi.org/10.1126/science.aad5147 [2] Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, Pirzada ZA, Eckert MR, Vogel J, Charpentier E.CRISPR RNA maturation by trans-encoded small RNAand host factor RNase III.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nature 2011; 471(7340):602-7;PMID:21455174; https://doi.org/10.1038/nature09886 [3] Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraf ﬁni LA, et al.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Science2013; 339(6121):819-23; PMID:23287718; https://doi.org/0.1126/science.1231143 [4] Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Science 2013; 339(6121):823-6; PMID:23287722; https://doi.org/10.1126/science.1232033 [5] Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNAendonuclease in adaptive bacterial immunity.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Science2012; 337(6096):816-21; PMID:22745249; https://doi.org/10.1126/science.1225829 [6] Doudna JA, Charpentier E. Genome editing.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Genome Biol 2015; 16:87;PMID:25924609; https://doi.org/10.1186/s13059-015-0653-x [8] Sakuma T, Nishikawa A, Kume S, Chayama K, Yama- moto T. Multiplex genome engineering in human cellsusing all-in-one CRISPR/Cas9 vector system.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Sci Rep2014; 4:5400; PMID:24954249; https://doi.org/10.1038/srep05400 [9] Ota S, Hisano Y, Ikawa Y, Kawahara A.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"J Mol Cell Biol 2015; 7(4):284-98;PMID:25757625; https://doi.org/10.1093/jmcb/mjv016 [11] Choi PS, Meyerson M. Targeted genomic rearrangements using CRISPR/Cas technology.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nat Commun 2014; 5:3728; PMID:24759083; https://doi.org/10.1038/ ncomms4728 [12] Maddalo D, Manchado E, Concepcion CP, Bonetti C, Vidigal JA, Han YC, Ogrodowski P, Crippa A,Rekhtman N, de Stanchina E, et al.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nature 2014; 516(7531):423-7; PMID:25337876; https://doi.org/10.1038/ nature13902 [13] Doench JG, Hartenian E, Graham DB, Tothova Z, Hegde M, Smith I, Sullender M, Ebert BL, Xavier RJ, Root DE.Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nat Biotechnol 2014;32(12):1262-7; PMID:25184501; https://doi.org/10.1038/nbt.3026 [14] Gasiunas G, Barrangou R, Horvath P, Siksnys V. Cas9- crRNA ribonucleoprotein complex mediates speci ﬁcD N A cleavage for adaptive immunity in bacteria.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"NatBiotechnol 2013; 31(9):822-6; PMID:23792628; https://doi.org/10.1038/nbt.2623 [17] Wang X, Wang Y, Wu X, Wang J, Wang Y, Qiu Z, Chang T, Huang H, Lin RJ, Yee JK.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nat Biotechnol 2015; 33(2):175-8; PMID:25599175; https://doi.org/10.1038/nbt.3127 [18] Tsai SQ, Zheng Z, Nguyen NT, Liebers M, Topkar VV, Thapar V, Wyvekens N, Khayter C, Iafrate AJ, Le LP,et al.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nat Biotechnol 2015; 33(2):187-97; PMID:25513782; https://doi.org/ 10.1038/nbt.3117 [19] Frock RL, Hu J, Meyers RM, Ho YJ, Kii E, Alt FW.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nat Biotechnol 2015;33(2):179-86; PMID:25503383; https://doi.org/10.1038/nbt.3101 [20] Crosetto N, Mitra A, Silva MJ, Bienko M, Dojer N, Wang Q, Karaca E, Chiarle R, Skrzypczak M, Ginalski K, et al.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nat Methods 2013; 10(4):361-5; PMID:23503052; https://doi.org/10.1038/nmeth.2408 [21] Kim D, Bae S, Park J, Kim E, Kim S, Yu HR, Hwang J, Kim JI, Kim JS.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Science 2016; 351(6268):84-8; PMID:26628643; https://doi.org/10.1126/science.aad5227 [23] Kleinstiver BP, Pattanayak V, Prew MS, Tsai SQ, Nguyen NT, Zheng Z, Joung JK.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nature 2016; 529(7587):490-5; PMID:26735016;https://doi.org/10.1038/nature16526 [24] Guilinger JP, Pattanayak V, Reyon D, Tsai SQ, Sander JD, Joung JK, Liu DR. Broad speci ﬁcity pro ﬁling of TALENs results in engineered nucleases with improved DNA-cleavage speci ﬁcity.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nat Methods 2014; 11(4):429-35; PMID:24531420; https://doi.org/10.1038/nmeth.2845 [25] Kleinstiver BP, Prew MS, Tsai SQ, Topkar VV, N g u y e nN T ,Z h e n gZ ,G o n z a l e sA P ,L iZ ,P e t e r s o nRT, Yeh JR, et al.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nature 2015; 523 (7561):481-5; PMID:26098369; https://doi.org/10.1038/nature14592 [26] Feng Y, Chen C, Han Y, Chen Z, Lu X, Liang F, Li S, Qin W, Lin S. Expanding CRISPR/Cas9 Genome Editing Capacity in Zebra ﬁsh Using SaCas9.",Non-OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"G3 (Bethesda) 2016; 6(8):2517-21; PMID:27317783; https://doi.org/10.1534/g3.116.031914 [27] Paquet D, Kwart D, Chen A, Sproul A, Jacob S, Teo S, Olsen KM, Gregg A, Noggle S, Tessier-Lavigne M. Ef ﬁ- cient introduction of speci ﬁc homozygous and heterozy- gous mutations using CRISPR/Cas9.",Non-OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nature 2016; 533(7601):125-9; PMID:27120160; https://doi.org/10.1038/ nature17664 [28] Gilbert LA, Larson MH, Morsut L, Liu Z, Brar GA, Torres SE, Stern-Ginossar N, Brandman O, WhiteheadEH, Doudna JA, et al.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Cell2013; 154(2):442-51; PMID:23849981; https://doi.org/10.1016/j.cell.2013.06.044 [29] Mali P, Aach J, Stranges PB, Esvelt KM, Moosburner M, Kosuri S, Yang L, Church GM.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nat Biotechnol2013; 31(9):833-8; PMID:23907171; https://doi.org/10.1038/nbt.2675 [30] Ran FA, Hsu PD, Lin CY, Gootenberg JS, Konermann S, Trevino AE, Scott DA, Inoue A, Matoba S, Zhang Y,et al.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
Cell 2013; 154(6):1380-9; PMID:23992846; https://doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nat Biotechnol 2014; 32(6):569-76;PMID:24770325; https://doi.org/10.1038/nbt.2908 [32] Guilinger JP, Thompson DB, Liu DR. Fusion of catalyti- cally inactive Cas9 to FokI nuclease improves the speci-ﬁcity of genome modi ﬁcation.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nat Biotechnol 2014; 32 (6):577-82; PMID:24770324; https://doi.org/10.1038/nbt.2909 [33] Barrangou R, Doudna JA.",Non-OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nat Biotechnol 2016;34(9):933-941; PMID:27606440; https://doi.org/10.1038/ nbt.3659 [34] Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR. Pro- grammable editing of a target base in genomic DNAwithout double-stranded DNA cleavage.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nature 2016;533(7603):420-4; PMID:27096365; https://doi.org/10.1038/nature17946 [35] Nishida K, Arazoe T, Yachie N, Banno S, Kakimoto M, Tabata M, Mochizuki M, Miyabe A, Araki M, Hara KY, et al.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Science2016; 353(6305); PMID:27492474; https://doi.org/10.1126/science.aaf8729 [36] Ma Y, Zhang J, Yin W, Zhang Z, Song Y, Chang X. Tar- geted AID-mediated mutagenesis (TAM) enables ef ﬁ- cient genomic diversi ﬁcation in mammalian cells.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nat Methods 2016; 13(12):1029-1035; PMID:27723754; https://doi.org/10.1038/nmeth.4027 [37] Hess GT, Fr /C19esard L, Han K, Lee CH, Li A, Cimprich KA, Montgomery SB, Bassik MC.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nat Methods 2016; 13(12):1036-1042;PMID:27798611; https://doi.org/10.1038/nmeth.4038 [38] O ’Connell MR, Oakes BL, Sternberg SH, East-Seletsky A, Kaplan M, Doudna JA.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nature 2014; 516(7530):263-6; PMID:25274302; https://doi.org/10.1038/nature13769 [39] Nelles DA, Fang MY, O ’Connell MR, Xu JL, Markmiller SJ, Doudna JA, Yeo GW.",Non-OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Cell 2016; 165(2):488-96; PMID:26997482; https://doi.org/10.1016/j.cell.2016.02.054 [40] Nishimasu H, Cong L, Yan WX, Ran FA, Zetsche B, Li Y, Kurabayashi A, Ishitani R, Zhang F, Nureki O.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Cell 2015; 162(5):1113-26; PMID:26317473; https://doi.org/10.1016/j.cell.2015.08.007 [41] Kleinstiver BP, Prew MS, Tsai SQ, Topkar VV, Nguyen NT, Zheng Z, Gonzales AP, Li Z, Peterson RT, Yeh JR,et al.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
Nature 2015; 523(7561):481-5; PMID:26098369; https://doi.org/10.1038/nature14592BIOENGINEERED 271,Non-OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"[42] Karvelis T, Gasiunas G, Young J, Bigelyte G, Silanskas A, Cigan M, Siksnys V. Rapid characterization of CRISPR-Cas9 protospacer adjacent motif sequence elements.Genome Biol 2015; 16:253; PMID:26585795; https://doi.org/10.1186/s13059-015-0818-7 [43] Hirano H, Gootenberg JS, Horii T, Abudayyeh OO, Kimura M, Hsu PD, Nakane T, Ishitani R, Hatada I, Zhang F, et al.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Cell 2016; 164(5):950-61; PMID:26875867;https://doi.org/10.1016/j.cell.2016.01.039 [44] Zetsche B, Gootenberg JS, Abudayyeh OO, Slaymaker IM, Makarova KS, Essletzbichler P, Volz SE, Joung J, vander Oost J, Regev A, et al.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Cell 2015;163(3):759-71; PMID:26422227; https://doi.org/10.1016/ j.cell.2015.09.038 [45] Kim HK, Song M, Lee J, Menon AV, Jung S, Kang YM, Choi JW, Woo E, Koh HC, Nam JW, Kim H. In vivohigh-throughput pro ﬁling of CRISPR-Cpf1 activity.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nature 2016; 532(7600):517-21; PMID:27096362; https://doi.org/10.1038/nature17945 [47] Kim D, Kim J, Hur JK, Been KW, Yoon SH, Kim JS.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nat Biotechnol 2016; 34(8):863-8; PMID:27272384; https://doi.org/10.1038/nbt.3609 [48] Kleinstiver BP, Tsai SQ, Prew MS, Nguyen NT, Welch MM, Lopez JM, McCaw ZR, Aryee MJ, JoungJK.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nat Biotechnol 2016; 34(8):869-74; PMID:27347757; https://doi.org/10.1038/nbt.3620 [49] Kim Y, Cheong SA, Lee JG, Lee SW, Lee MS, Baek IJ, Sung YH.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nat Biotechnol 2016; 34(8):808-10; PMID:27272387; https://doi.org/10.1038/nbt.3614 [50] Hur JK, Kim K, Been KW, Baek G, Ye S, Hur JW, Ryu SM, Lee YS, Kim JS.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nat Biotech-nol 2016; 34(8):807-8; PMID:27272385; https://doi.org/10.1038/nbt.3596 [51] T /C19oth E, Weinhardt N, Bencsura P, Husz /C19ar K, Kulcs /C19ar PI, T/C19alas A, Fodor E, Welker E. Cpf1 nucleases demonstrate robust activity to induce DNA modi ﬁcation by exploiting homology directed repair pathways in mammalian cells.Biol Direct 2016; 11:46; PMID:27630115; https://doi.org/10.1186/s13062-016-0147-0 [52] Shmakov S, Abudayyeh OO, Makarova KS, Wolf YI, Gootenberg JS, Semenova E, Minakhin L, Joung J, Koner-mann S, Severinov K, et al.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Science2016; 353(6299):aaf5573; PMID:27256883; https://doi.org/ 10.1126/science.aaf5573 [54] East-Seletsky A, O ’Connell MR, Knight SC, Burstein D, Cate JH, Tjian R, Doudna JA.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nature 2016; 538(7624):270-273;PMID:27669025; https://doi.org/10.1038/nature19802 [55] Gao F, Shen XZ, Jiang F, Wu Y, Han C. DNA-guided genome editing using the Natronobacterium gregoryi Argonaute.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nat Biotechnol 2016; 34(7):768-73; PMID:27136078; https://doi.org/10.1038/nbt.3547 [56] Cyranoski D. Replications, ridicule and a recluse: the controversy over NgAgo gene-editing intensi ﬁes.",Non-OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nature 2016; 536(7615):136-7; PMID:27510204; https://doi.org/10.1038/536136a [57] Lee SH, Turchiano G, Ata H, Nowsheen S, Romito M, Lou Z, Ryu SM, Ekker SC, Cathomen T, Kim JS.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nat Biotechnol 2016; 35:17-18;PMID:27893702; https://doi.org/10.1038/nbt.3753 [58] Varshney GK, Burgess SM.",Non-OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
Genome Biol2016; 17(1):187; PMID:27640875; https://doi.org/10.1186/s13059-016-1055-4 [59] Komiyama M. Cut-and-Paste of DNA Using an Arti ﬁcial Restriction DNA Cutter.,OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Int J Mol Sci 2013; 14(2):3343-57; PMID:23385238; https://doi.org/10.3390/ijms14023343 [60] Bahal R, Ali McNeer N, Quijano E, Liu Y, Sulkowski P, Turchick A, Lu YC, Bhunia DC, Manna A, Greiner DL,et al.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nat Commun 2016; 7:13304; PMID:27782131;https://doi.org/10.1038/ncomms13304 [61] Suzuki T, Imada T, Nishigaki N, Kobayashi M, Matsuoka I, Kamiya H. Cleavage of Target DNA PromotesSequence Conversion with a Tailed Duplex.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Biol PharmBull 2016; 39(8):1392-5; PMID:27476948; https://doi.org/10.1248/bpb.b16-00325 [62] Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mik- kelsen TS, Heckl D, Ebert BL, Root DE, Doench JG, et al.Genome-scale CRISPR-Cas9 knockout screening in human cells.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Science 2014; 343(6166):84-7; PMID:24336571; https://doi.org/10.1126/science.1247005 [63] Wang T, Wei JJ, Sabatini DM, Lander ES.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Science 2014; 343(6166):80-4; PMID:24336569; https://doi.org/10.1126/science.1246981 [64] Gilbert LA, Horlbeck MA, Adamson B, Villalta JE, Chen Y, Whitehead EH, Guimaraes C, Panning B, Ploegh HL, Bassik MC, et al.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Cell 2014; 159(3):647-61; PMID:25307932; https://doi.org/10.1016/j.cell.2014.09.029 [65] Chen B, Gilbert LA, Cimini BA, Schnitzbauer J, Zhang W, Li GW, Park J, Blackburn EH, Weissman JS, Qi LS,Huang B.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Cell2013; 155(7):1479-91; PMID:24360272; https://doi.org/ 10.1016/j.cell.2013.12.001 [66] Hilton IB, D ’Ippolito AM, Vockley CM, Thakore PI, Crawford GE, Reddy TE, Gersbach CA.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Nat Biotechnol2015; 33(5):510-7; PMID:25849900; https://doi.org/10.1038/nbt.3199 [67] McKenna A, Findlay GM, Gagnon JA, Horwitz MS, Schier AF, Shendure J. Whole-organism lineage tracing by combinatorial and cumulative genome editing.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"Science2016; 353(6304):aag0511; PMID:27540006; https://doi.org/10.1126/science.aag0511 [69] Hou Z, Zhang Y, Propson NE, Howden SE, Chu LF, Sontheimer EJ, Thomson JA.",OADS,/arxiv_data1/oa_pdf/ff/33/kbie-08-03-1282018.PMC5470521.pdf
"3, 248 –255 https://doi.org/10.1080/21655979.2016.1226714",Non-OADS,/arxiv_data1/oa_pdf/17/70/kbie-08-03-1226714.PMC5470523.pdf
"Nat Meth 2007; 4:613-4; https://doi.org/10.1038/nmeth0807-613 [2] Martinez GJ, Rao A.",OADS,/arxiv_data1/oa_pdf/17/70/kbie-08-03-1226714.PMC5470523.pdf
"Science 2012; 338:891-2; PMID:23161983; https://doi.org/10.1126/science.1231310 [3] Kilpinen H, Barrett JC.",OADS,/arxiv_data1/oa_pdf/17/70/kbie-08-03-1226714.PMC5470523.pdf
"Trends Genet-ics 2013; 29:23-30; PMID:23103023; https://doi.org/ 10.1016/j.tig.2012.10.001 [4] Chikina MD, Troyanskaya OG.",OADS,/arxiv_data1/oa_pdf/17/70/kbie-08-03-1226714.PMC5470523.pdf
Bioinformatics2012; 28:607-13; PMID:22262674; https://doi.org/10.1093/bioinformatics/bts009 [5] Furey TS.,OADS,/arxiv_data1/oa_pdf/17/70/kbie-08-03-1226714.PMC5470523.pdf
"IEEE/ ACM Transactions Computational Biol Bioinformatics 2012; 9:580-91; https://doi.org/10.1109/TCBB.2011.135 [9] Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W,et al.",OADS,/arxiv_data1/oa_pdf/17/70/kbie-08-03-1226714.PMC5470523.pdf
"Genome Biol 2008; 9:R137; PMID:18798982; https://doi.org/10.1186/gb-2008-9-9-r137 [10] Lan X, Bonneville R, Apostolos J, Wu W, Jin VX.",OADS,/arxiv_data1/oa_pdf/17/70/kbie-08-03-1226714.PMC5470523.pdf
Bioinformatics2011; 27:428-30; PMID:21138948; https://doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/17/70/kbie-08-03-1226714.PMC5470523.pdf
"BMC Bioinformatics 2009;10:299; PMID:19772557; https://doi.org/10.1186/1471-2105-10-299 [12] Fejes AP, Robertson G, Bilenky M, Varhol R, Bainbridge M, Jones SJ.",OADS,/arxiv_data1/oa_pdf/17/70/kbie-08-03-1226714.PMC5470523.pdf
"Bioinformatics 2008; 24:1729-30; PMID:18599518; https://doi.org/10.1093/bioinformatics/btn305 [13] Zhu L, Guo WL, Deng SP, Huang DS.",OADS,/arxiv_data1/oa_pdf/17/70/kbie-08-03-1226714.PMC5470523.pdf
"IEEE/ACMTransactions Computational Biol Bioinformatics 2016;13:55-63; https://doi.org/10.1109/TCBB.2015.2465893 [14] Cheng AS, Jin VX, Fan M, Smith LT, Liyanarachchi S, Yan P S ,L e uY W ,C h a nM W ,P l a s sC ,N e p h e wK P ,e ta l .C o m b i - natorial analysis of transcription factor partners revealsrecruitment of c-MYC to estrogen receptor- aresponsive promoters.",OADS,/arxiv_data1/oa_pdf/17/70/kbie-08-03-1226714.PMC5470523.pdf
"Mol Cell 2006; 21:393-404; PMID:16455494;https://doi.org/10.1016/j.molcel.2005.12.016 [15] Ou YY, Chen SA, Gromiha MM.",OADS,/arxiv_data1/oa_pdf/17/70/kbie-08-03-1226714.PMC5470523.pdf
"EMBO J 2009;28:1418-28; PMID:19339991; https://doi.org/10.1038/emboj.2009.88 [17] Hurtado A, Holmes KA, Ross-Innes CS, Schmidt D, Car- roll JS.",OADS,/arxiv_data1/oa_pdf/17/70/kbie-08-03-1226714.PMC5470523.pdf
"Nat Genet 2011; 43:27-33; PMID:21151129; https://doi.org/10.1038/ng.730 [18] Cheung E, Ruan Y.",Non-OADS,/arxiv_data1/oa_pdf/17/70/kbie-08-03-1226714.PMC5470523.pdf
Nat Genet 2011; 43:11-12; PMID:21217639;https://doi.org/10.1038/ng0111-11BIOENGINEERED 255,Non-OADS,/arxiv_data1/oa_pdf/17/70/kbie-08-03-1226714.PMC5470523.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/6b/main.PMC5470525.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2017.06.014 2049-0801/ ©2017 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/5f/6b/main.PMC5470525.pdf
"Currently more than hundred mutations in the IDUA gene have been reported (Human Gene Mutation Database, http://www.hgmd.org /)[14,15] .",Non-OADS,/arxiv_data1/oa_pdf/66/f6/main.PMC5470527.pdf
http://dx.doi.org/10.1016/j.ymgmr.2017.06.001 Received 2 June 2017; Accepted 2 June 2017⁎Corresponding author.,OADS,/arxiv_data1/oa_pdf/66/f6/main.PMC5470527.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/66/f6/main.PMC5470527.pdf
"We performed in-silico analysis for the pathogenic variant, it is identi ﬁed by SIFT as deleterious ( http://sift.jcvi.org /) and probably damaging by Polyphen ( http://genetics.bwh.harvard.edu/pph2/ ).",Non-OADS,/arxiv_data1/oa_pdf/66/f6/main.PMC5470527.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/a8/main.PMC5470528.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.05.008 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/a8/main.PMC5470528.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 22 (2017) 28 e30,Non-OADS,/arxiv_data1/oa_pdf/ac/a8/main.PMC5470528.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/15/main.PMC5470530.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2017.05.015 2213-0071/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/86/15/main.PMC5470530.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 22 (2017) 31 e33,Non-OADS,/arxiv_data1/oa_pdf/86/15/main.PMC5470530.pdf
"33 (2016) 29, http://dx.doi.org/10.1007/s12032-016-0744-x .",Non-OADS,/arxiv_data1/oa_pdf/86/15/main.PMC5470530.pdf
The drug showed to improve http://dx.doi.org/10.1016/j.ymgmr.2017.05.010 Received 22 March 2017; Received in revised form 30 May 2017; Accepted 30 May 2017⁎Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/ac/e4/main.PMC5470531.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ac/e4/main.PMC5470531.pdf
"This article describes how United States Forest Service (USFS) Forest Inventory and Analysis (FIA) data from multiple state inventories were aggregated and used to extract ten annual timberland vari-ables for trend analysis in two case study bioenergy fuelshed areas.This dataset is made publically available to enable critical or extended analyses of changes in forest conditions, either for the fuelshed areas supplying the ports of Savannah, Georgia and Che-sapeake, Virginia, or for other southeastern US forested areas con-Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/dibData in Brief http://dx.doi.org/10.1016/j.dib.2017.05.048 2352-3409/ &2017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/8f/df/main.PMC5470533.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).DOI of original article: http://dx.doi.org/10.1016/j.foreco.2017.03.022 ☆This manuscript has been authored by UT-Battelle, LLC under Contract No.",Non-OADS,/arxiv_data1/oa_pdf/8f/df/main.PMC5470533.pdf
The Department of Energywill provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan (http://energy.gov/downloads/doe-public-access-plan ).,OADS,/arxiv_data1/oa_pdf/8f/df/main.PMC5470533.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/df/main.PMC5470533.pdf
Supplementary material Transparency data associated with this article can be found in the online version at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/df/main.PMC5470533.pdf
"Miles, Forest Inventory EVALIDator Web-application Version 1.6.0.03, U.S. Department of Agriculture, Forest Service, Northern Research Station, St. Paul, MN, 2016 (Available online at 〈http://apps.fs.fed.us/Evalidator/evalidator.jsp 〉), (Acces- sed 31 December 2016).E.S.",OADS,/arxiv_data1/oa_pdf/8f/df/main.PMC5470533.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals .elsevier.com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2017.05.003 2352-2895/ ©2017 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/7a/9d/main.PMC5470534.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 7 (2017) 80 e88,Non-OADS,/arxiv_data1/oa_pdf/7a/9d/main.PMC5470534.pdf
